{"7": {}, "6": {"heart failure with preserved ejection fraction": 44, "recommendations on the treatment of anemia": 1, "heart failure or coronary heart disease": 4, "emergency department in acute heart failure": 2, "dose nesiritide in acute heart failure": 2, "nucleolin as a regulator of growth": 1, "plasticity in the setting of disease": 1, "canine model of chronic heart failure": 2, "apoptosis during the development of pacing": 1, "dogs during the development of heart": 1, "apoptosis in the pathogenesis of heart": 1, "physician at the time of discharge": 1, "survival from the time of inclusion": 1, "survival at the time of admission": 1, "levels at the time of admission": 1, "mice model of hypertensive heart disease": 2, "biventricular pacing on left heart twist": 2, "porcine model of right heart failure": 2, "ring annuloplasty for ischemic mitral regurgitation": 4, "valve plasty for degenerative mitral regurgitation": 2, "valve plasty and annular size reduction": 2, "observation at the time of surgery": 1, "blocker therapy in chronic heart failure": 2, "kinase a nor soluble guanylate cyclase": 2, "diastolic pressure and myocardial oxygen consumption": 2, "association of the score with death": 1, "\u03b2 - adrenergic receptor blocker therapy": 6, "ejection time in acute heart failure": 2, "time from the treatment of heart": 1, "heart failure and reduced ejection fraction": 10, "variation in the use of guideline": 1, "hospitalization through the date of death": 1, "resynchronization therapy in mild heart failure": 2, "global left ventricular longitudinal systolic strain": 12, "% with the majority of patients": 1, "arterial coupling in hypertensive heart failure": 2, "resistin as a link between inflammation": 1, "heart rate and aortic blood flow": 4, "adaptation of the myocardium in response": 1, "case of a patient with diagnosis": 1, "peptides at the point of care": 1, "control via the targeting of chromatin": 2, "values before the administration of contrast": 1, "stress echocardiography and cardiopulmonary exercise testing": 2, "crossover study with masked outcome assessments": 2, "dysfunction during the onset of heart": 1, "time interval between local myocyte depolarization": 2, "filling time by controlling heart rate": 2, "increase in the ratio of peak": 2, "peak early diastolic mitral flow velocity": 18, "peak early diastolic mitral annular velocity": 18, "data on the potential of diuretics": 1, "heart failure with reduced ejection fraction": 16, "hrqol in a cohort of patients": 1, "supplementation during a program of exercise": 1, "endothelial function in chronic heart failure": 2, "left anterior descending coronary artery occlusion": 6, "rat model of postischemic heart failure": 2, "insight into the potential of mirnas": 1, "trends in the risk of heart": 1, "reduction program for congestive heart failure": 2, "hospital stay for congestive heart failure": 2, "improvements in the treatment of heart": 1, "causes for a worsening of heart": 1, "strategies for the treatment of end": 1, "plateau phase of ventricular action potentials": 2, "kidney infection or urinary tract infection": 2, "role in the progression of heart": 1, "periods on the basis of heart": 1, "oxygen uptake and higher metabolic exercise": 2, "reduction in the ratio of phosphocreatine": 1, "review of the effects of air": 1, "heart failure and mechanical support devices": 2, "implementation strategies in improving physician adherence": 2, "impact of the intervention on adherence": 1, "women with a history of hypertension": 1, "exercise protocol with respiratory gas analysis": 2, "scale prospective randomized multicenter trial paradigm": 6, "heart failure with systolic dysfunction treatment": 2}, "5": {"patients with respect to alterations": 1, "respect to alterations in body": 1, "dual energy x - ray": 5, "changes in nps or adiponectin": 1, "% of patients with heart": 2, "requires a presence of signs": 1, "presence of signs and symptoms": 1, "treatment of anemia in patients": 2, "anemia in patients with heart": 2, "treatment of anemia and iron": 1, "literature in the english language": 1, "language on anemia and iron": 1, "deficient adult patients with heart": 3, "clinical practice guidelines grading system": 5, "restrictive red blood cell transfusion": 5, "red blood cell transfusion strategy": 5, "treatment in patients with heart": 1, "harms of treatments for anemia": 1, "treatments for anemia in adults": 1, "anemia in adults with heart": 1, "agents in adults with anemia": 1, "quality of life in patients": 2, "life in patients with heart": 1, "transfusions in patients with heart": 1, "symptoms in patients with heart": 2, "conditioning for patients with heart": 1, "management of patients with heart": 2, "low left ventricular ejection fraction": 5, "preserved left ventricular ejection fraction": 35, "predictors of mortality in patients": 1, "predictors of mortality in heart": 1, "identified strong reliable mortality predictors": 5, "many multisite studies in practice": 3, "global changes in chromatin subproteomes": 2, "recapitulates conserved developmental chromatin remodeling": 5, "conserved developmental chromatin remodeling events": 5, "analysis of a new chromatin": 1, "studies in the complementary model": 1, "complementary model system of zebrafish": 3, "left bundle branch block pattern": 5, "mortality in patients with heart": 2, "common applications of readmission metrics": 2, "differential impact on hospital performance": 2, "hospitals in an extreme decile": 1, "different approaches to computing readmissions": 2, "recent hospital discharge in patients": 3, "discharge in patients with heart": 1, "readmission to hospital for heart": 1, "studies with a contemporaneous control": 1, "mortality for recently discharged patients": 1, "preserved left ventricular ejection fractions": 5, "ambulatory patients with heart failure": 4, "reductions in the composite end": 1, "low co - morbidity burden": 5, "natriuretic peptide levels in patients": 3, "evaluate the relationship between sex": 1, "levels with the greatest difference": 1, "medical management of heart failure": 2, "cause of morbidity and mortality": 1, "application in the clinical setting": 1, "catheterization during the same period": 1, "comparison of predictors of heart": 1, "death in patients with versus": 1, "study the impact of self": 1, "counseling on the primary outcome": 1, "effects via stimulation of endothelial": 3, "protective effects of exercise training": 2, "correlation between changes in hdl": 1, "determination of a predictive cutoff": 1, "predictive cutoff value for plasma": 3, "predictive cutoff value for admission": 3, "novel heart failure mice model": 5, "hypertensive heart disease by angiotensin": 3, "weight with a high incidence": 1, "deaths in the experimental procedures": 1, "% in women and men": 1, "limited mortality at hospital discharge": 2, "left ventricular assist device use": 5, "practice for a limited number": 1, "acute right ventricular pressure overload": 5, "medical treatment for heart failure": 4, "annular size reduction by surgery": 6, "prolapse of a degenerative mitral": 1, "lesions in the major branches": 1, "hypertension with vasodilators and diuretics": 1, "reasons for the modest reduction": 1, "reduction by the surgical ring": 1, "mild restriction of leaflet motion": 2, "evaluation of the surgical indications": 1, "prognostic factor in heart failure": 2, "reliable measure of health status": 2, "equivalent dose of metoprolol succinate": 2, "approach for the acute treatment": 1, "acute treatment of heart failure": 2, "safety of spironolactone in adults": 1, "adults with newly diagnosed heart": 1, "independent association between spironolactone use": 2, "patients with a median follow": 1, "acute kidney injury during spironolactone": 3, "risks of hospitalization or death": 1, "vascular endothelial growth factor blockade": 5, "post - myocardial infarction heart": 10, "- adrenergic receptor blocker therapy": 5, "proangiogenic effects of b act": 2, "cardiac angiogenesis in heart failure": 2, "outcomes for patients with heart": 1, "responsible diagnosis of heart failure": 2, "twofold increase in lung weight": 2, "groups versus the sham group": 2, "assessing left ventricular filling pressure": 5, "ventricular filling pressure in patients": 3, "stable severe systolic heart failure": 5, "early transmitral blood flow velocity": 5, "early diastolic mitral annulus velocity": 5, "estimating pulmonary capillary wedge pressure": 5, "systolic pressure relationship in heart": 3, "tricuspid annular plane systolic excursion": 5, "relevance in the clinical follow": 1, "nonsurvivors with a similar distribution": 1, "relationship as a possible index": 1, "% of the left ventricle": 1, "implantation of a novel bottleneck": 1, "left ventricle in heart failure": 2, "isolated hr reduction by ivabradine": 3, "isolated hr reduction in patients": 3, "levels to survival in patients": 1, "left ventricular assist device implantation": 10, "indicator in patients with heart": 1, "investigate the association of hypoalbuminemia": 1, "undergoing left ventricular assist device": 5, "approaches to these difficult problems": 1, "young adults with heart failure": 4, "rates across the respective age": 2, "differences in presentation and outcomes": 1, "minutes of exercise per week": 1, "outcomes in patients with heart": 2, "improve the management of patients": 1, "shortens left ventricular ejection time": 5, "precapillary ph with heart failure": 4, "higher serum levels of brain": 3, "higher serum levels of creatinine": 3, "embolism to the pulmonary arteries": 1, "standard error of measurement value": 2, "quality of life for people": 1, "life for people with heart": 1, "assess the benefits of participation": 1, "participation in a structured exercise": 1, "structured exercise programme for patients": 3, "programme for patients with heart": 1, "relation to sustainability with commissioning": 1, "assess the association between frailty": 1, "association between frailty and risk": 1, "assessed the association between frailty": 1, "improving the prognosis of patients": 1, "use of antagonists and inhibitors": 1, "excessive secretion of arginine vasopressin": 2, "induction of a fetal gene": 1, "mir-25 by a specific antagomir": 1, "expression of the bhlh transcription": 1, "embryonic gene programs in heart": 3, "base of treatment of heart": 1, "includes the use of angiotensin": 1, "blockers in case of angiotensin": 1, "cause of death in patients": 1, "death in patients with type": 1, "impaired cardiac metabolic gene expression": 5, "impaired cardiac energy metabolism gene": 5, "cardiac energy metabolism gene expression": 5, "action through activation of p38": 1, "cardiac dysfunction during insulin resistance": 2, "medications among outpatients with heart": 3, "variation in rates of guideline": 1, "treatment for outpatients with heart": 1, "examine the association between treatment": 1, "rates of treatment with angiotensin": 1, "medications for patients with heart": 1, "quality of care for patients": 1, "care for patients with heart": 2, "older patients with breast cancer": 2, "trastuzumab in the adjuvant setting": 1, "age of the entire cohort": 1, "mortality in women with heart": 1, "recommendations for patients with heart": 1, "scores with mortality among postmenopausal": 1, "trend toward an inverse association": 2, "promising biomarker in heart failure": 2, "higher frequency of diabetes mellitus": 2, "assessments of patients with heart": 1, "age of patients with heart": 1, "rate for patients with heart": 1, "outcome in patients with heart": 1, "using cardiac magnetic resonance t1": 5, "cardiac magnetic resonance t1 mapping": 5, "assess the relationship between pathobiology": 1, "cardiac magnetic resonance t1 time": 5, "disease in patients with thalassaemia": 1, "verify the impact of heart": 1, "predictive value for heart failure": 2, "fraction on the clinical response": 1, "results of patients with baseline": 1, "frequent comorbidities in heart failure": 2, "myocardial dd of collagen deposition": 2, "site of the elastic n2bus": 1, "strain as a major predictor": 1, "failure during an average follow": 1, "outperformed left ventricular ejection fraction": 5, "reduction in the primary end": 1, "reduction in the primary outcome": 1, "component of the primary outcome": 1, "ratio for the primary outcome": 1, "resistant volume overload in heart": 3, "significant decrease in re -": 2, "cardiac resynchronization therapy in dialysis": 3, "dependent patients with heart failure": 4, "heterogenous improvement in ejection fraction": 2, "+9.2 \u00b1 9.5 % increase": 5, "compelling improvement after device implantation": 2, "human resistin in heart failure": 2, "fold induction of serum resistin": 2, "fibrillation in patients with heart": 1, "free probability after catheter ablation": 2, "administration of doxorubicin in rats": 1, "contents in addition to cytochrome": 1, "alleviating the decrement of heart": 1, "restoring mitochondrial oxidative phosphorylation capacity": 5, "isolated coronary artery bypass grafting": 5, "risk for the primary outcome": 1, "events after adjustment for age": 1, "clinical burden in adult medicine": 2, "cellular responses to heart failure": 2, "molecular scaffolds in heart pathology": 2, "beneficial adaptation to stress conditions": 2, "kinases into a linear pathway": 1, "prognostic indicator in heart failure": 2, "improve the potential for success": 1, "acute heart failure in patients": 3, "frame of a patient consultation": 1, "advantage of the faster turnaround": 1, "rethinking the quality of outcome": 1, "improve the quality of care": 1, "epigenetic changes in chromatin structure": 2, "investigating the role of bets": 1, "model of neurohormonally induced heart": 1, "induction of a substantial subset": 1, "pathological cardiac gene expression programme": 5, "t1 in swine with heart": 1, "percentage of fibrosis of heart": 1, "ventricular tissue from control animals": 2, "using trichrome blue histologic analysis": 5, "induced pulmonary artery systolic pressure": 5, "increase by means of stress": 1, "echocardiography as a possible measure": 1, "impaired right ventricular pump function": 5, "targeted pulmonary arterial hypertension medication": 5, "use of devices in heart": 1, "become a cornerstone of heart": 1, "attention in the medical literature": 1, "contemporary trends in heart failure": 2, "hemostasis in patients with heart": 1, "selective \u03b2 - blocker metoprolol": 5, "thromboembolic events in heart failure": 2, "dosages of carvedilol or metoprolol": 1, "events in patients with heart": 1, "medications to adults with heart": 1, "thirds of patients with heart": 1, "sympathetic control of heart rate": 2, "increased vascular endothelial growth factor": 5, "vascular endothelial growth factor protein": 5, "protein in the left ventricle": 1, "contractility of the left ventricle": 1, "addition to the left bundle": 1, "left bundle branch block type": 5, "delay the onset of myofiber": 1, "prospective assessment of body composition": 2, "test the effects of treatment": 1, "effects of treatment with ivabradine": 1, "treatment with ivabradine on exercise": 1, "filling in patients with heart": 1, "delay the onset of symptoms": 1, "early diastolic mitral flow velocity": 15, "rate at the same exercise": 1, "slower increase in heart rate": 2, "correlates of increase in exercise": 1, "improved left ventricular filling pressure": 5, "left ventricular filling pressure response": 5, "coronary artery disease in patients": 3, "angiography with a primary diagnosis": 1, "proximal left anterior descending artery": 5, "eliminate the need for angiography": 1, "angiography in a substantial proportion": 1, "vasopressin type 2 receptor antagonist": 5, "diuretic use in heart failure": 2, "accurate risk stratification of patient": 3, "stratification of patient with heart": 1, "subject of this brief review": 1, "remarkable increase in camp hydrolysis": 2, "reduced the rise in camp": 1, "efficacy of eplerenone in patients": 2, "underuse of eplerenone in patients": 1, "analysis of subgroups of patients": 1, "hospitalization for hyperkalemia or discontinuation": 1, "explore the relation of hemoglobin": 1, "beneficial effect of exercise training": 4, "effects of hrqol from exercise": 1, "structure in patients with heart": 1, "alterations in markers of skm": 1, "medicine as an adjunctive treatment": 1, "cardiomyopathy in patients with heart": 1, "left ventricular diastolic end diameter": 10, "enzymes in patients with heart": 1, "patients with newly diagnosed heart": 1, "variables with an important contribution": 1, "evaluating the effect of interventions": 1, "acute care surgery in heart": 3, "year of oht in recipients": 1, "interval from transplantation to consultation": 1, "interval from consultation to operation": 1, "extracorporeal membrane oxygenation as bridge": 3, "oxygenation as bridge to recovery": 1, "bridge to recovery in infarction": 1, "diagnosis of a posterior wall": 1, "right heart failure with therapy": 3, "acute ischemic right heart failure": 5, "half of patients with heart": 1, "given the lack of improvement": 1, "mean \u00b1 sd testosterone levels": 5, "similar improvements in shuttle walk": 2, "improvements from baseline in peak": 1, "emotional status in heart failure": 2, "ejection fraction 63 % \u00b1": 5, "reduced left ventricular ejection fraction": 5, "potential candidates for cell therapy": 2, "better tools for risk stratification": 2, "agents in combination with anticoagulants": 1, "dietary interventions in heart failure": 2, "biomarkers in patients with heart": 1, "bolus of metoprolol or atropine": 1, "reduce the rate of death": 1, "rate of death or hospitalization": 1, "single center retrospective observational study": 5, "receiving ventricular assist device support": 5, "significant difference in outcome ratings": 2, "older adults with heart failure": 2, "significant improvement in outcome ratings": 2, "ratings from admission to discharge": 1, "insight on the possible contribution": 1, "contribution of nursing to outcomes": 1, "highlighting the contribution of nursing": 1, "reciprocal regulation in mouse hearts": 2, "chronic \u03b2 - adrenergic receptor": 5, "deleterious \u03b21ar overstimulation in heart": 3, "readmission after discharge among patients": 1, "discharge among patients with heart": 3, "rates of death and readmission": 1, "readmission among patients with heart": 3, "proportional hazard models with time": 3, "analyze the effect of follow": 1, "physician within the first month": 2, "discharge on the primary outcome": 1, "visits with a familiar physician": 1, "outcomes among patients with heart": 3, "hospitalizations in patients with heart": 1, "demonstrated no change in type": 1, "instability in patients with heart": 1, "aim of the present study": 1, "trend toward a higher baseline": 2, "- adrenoceptor blockade with esmolol": 3, "acute autonomic nervous system modulation": 5, "congestive heart failure in survivors": 3, "- hct exposure to anthracyclines": 3, "right ventricle in heart failure": 2, "definitions of the distinctive components": 1, "components of the right heart": 1, "consensus on a universal definition": 1, "insight into mechanisms of disease": 1, "large outcomes trial of heart": 3, "result of shortcomings in research": 1, "statistical standards in biomarker studies": 2, "provide an overview of biomarker": 1, "new targets in disease management": 2, "therapeutic targets for heart failure": 2, "dual x - ray absorptiometry": 5, "relative appendicular lean mass index": 5, "plasma by use of immunoprecipitation": 1, "fragments of the full length": 1, "development of a next generation": 1, "ventricular hypertrophy in heart failure": 2, "impact of carvedilol and metoprolol": 2, "evaluate the effects of carvedilol": 1, "effects of carvedilol and metoprolol": 1, "inappropriate therapy in heart failure": 2, "blockers on the primary endpoint": 1, "investigate the occurrence of heart": 1, "users of bisphosphonates and raloxifene": 1, "absolute risk of heart failure": 2, "% in the exposed group": 1, "reduce the risk of heart": 1, "alterations by metoprolol in heart": 1, "examine the reversibility of heart": 1, "rates of changes in pressure": 1, "elevated levels of plasma norepinephrine": 2, "advanced stages of heart failure": 2, "reduction in the elevated levels": 1, "elevated levels of plasma catecholamines": 2, "assess the association between psoriasis": 1, "disease from the general population": 1, "events as subjects without psoriasis": 1, "levels in patients with pad": 1, "intensive transitions of care program": 4, "mortality within a few years": 2, "various measures of hr dynamics": 2, "linear measures of hr variability": 2, "non - linear hr variability": 5, "- linear hr variability measures": 5, "remodeling of the arrhythmia substrate": 1, "early measurement of hr variability": 2, "routine measurement of hr variability": 2, "clinical tool for risk stratification": 2, "activation of the renin- angiotensin": 1, "form the foundation of management": 1, "foundation of management of patients": 1, "revascularization with angioplasty and stenting": 1, "guidelines on evaluation and management": 1, "bioinformatic analysis of microarray data": 2, "non - ischemic heart failure": 5, "- ischemic heart failure samples": 5, "controls during this same time": 1, "race as an independent predictor": 1, "investigate the association between race": 1, "association between race and outcomes": 1, "explored an interaction with exercise": 1, "recent onset af at risk": 3, "af at risk for stroke": 1, "control as an initial approach": 1, "increase in incidence and prevalence": 1, "causes of death and hospitalisation": 1, "consequence of the worldwide increase": 1, "worldwide increase in life expectancy": 2, "congestive heart failure in humans": 3, "preclude the provision of life": 1, "public reporting on quality aims": 2, "composite quality measure for heart": 3, "estimated the odds of future": 1, "point of death or hospitalization": 1, "modest effects on heart failure": 2, "analyze the relationship between length": 1, "relationship between length of stay": 1, "length of stay and rehospitalization": 1, "post - acute care transfer": 10, "- acute care transfer policy": 10, "declines in length of stay": 1, "decrease in length of stay": 1, "outcomes of care for patients": 1, "costs for patients with heart": 1, "outcomes for medically managed diseases": 1, "volume within strata of hospital": 3, "symptomatic chronic advanced heart failure": 5, "chronic advanced heart failure patients": 10, "standard therapy with beta blockade": 2, "post - myocardial infarction patients": 5, "myocardial infarction patients with heart": 3, "reduction in mortality and hospitalizations": 1, "provide the background for aldosterone": 1, "- myocardial infarction heart failure": 5, "myocardial infarction heart failure patients": 5, "improvement in survival of patients": 1, "survival of patients with heart": 1, "large idiopathic dilated cardiomyopathy cohort": 5, "marked decreases in heart failure": 2, "indeterminable anaerobic threshold in heart": 3, "obese body mass index categories": 5, "overweight body mass index strata": 5, "decreased mitochondrial energy production precede": 5, "systolic heart failure after pressure": 3, "significant alterations in energy metabolism": 2, "failure in the hypertrophied heart": 1, "rates of glycolysis and glucose": 1, "reduced mitochondrial complex v activity": 5, "progression from hypertrophy to heart": 1, "search of the electronic databases": 1, "expenditure on health per capita": 2, "greater risk of heart failure": 2, "assessing the link between air": 1, "cardiac dysfunction with conduction abnormalities": 2, "patients in the terminal phase": 1, "requires the collaboration of professionals": 1, "aims of the present consensus": 1, "safety of these antihyperglycemic agents": 1, "users of saxagliptin or sitagliptin": 1, "provided left ventricular function assessment": 5, "assess the impact of implementation": 1, "contextual factors on physician adherence": 2, "patients with an implantable cardioverter": 2, "reduce the number of patients": 1, "shocks at end of life": 1, "objective of this clinical trial": 1, "using cardiopulmonary exercise testing guide": 5, "cardiopulmonary exercise testing guide exercise": 5, "patients as control without exercise": 1, "nosignificant changes in control group": 2, "systolic function in hfpef patients": 2, "training of the lower limbs": 1, "evaluation of the muscular strength": 1, "association in the usual care": 1, "impact the effect of exercise": 1, "assessed the impact of hr": 1, "respiratory gas analysis at baseline": 3, "little hr reduction with beta": 3, "treatment of patients with heart": 1, "reduce the risk of hospital": 1, "evaluations at baseline and months": 1, "prospective randomized multicenter trial paradigm": 5, "common form of heart failure": 2, "effect on quality of life": 1, "improvements in functioning and use": 1, "advancement of the pathophysiologic state": 1}, "4": {"trends in patient safety": 1, "decade of national efforts": 1, "database to assess national": 1, "trends in adverse event": 1, "decline in adverse event": 1, "hospital adverse events averted": 4, "overall improvements for patients": 2, "ulcers in surgical patients": 1, "attention to these problems": 1, "national patient safety initiatives": 4, "progress in some areas": 1, "talk between the heart": 1, "tissue in cachectic heart": 1, "cachectic heart failure patients": 4, "failure patients with respect": 2, "alterations in body composition": 1, "changes in body composition": 1, "body composition with regard": 2, "dual energy x -": 4, "energy x - ray": 8, "x - ray absorptiometry": 12, "non - diabetic patients": 4, "patients with chronic heart": 9, "non - cachectic chf": 4, "biomarkers of neurohormonal stimulation": 1, "unaltered in all groups": 1, "total adiponectin at baseline": 2, "diagnosis of heart failure": 3, "patients with heart failure": 60, "heart failure show preserved": 4, "prevalence of heart failure": 1, "combination with other factors": 1, "in the general population": 1, "mild clinical diastolic dysfunction": 4, "symptoms of heart failure": 2, "fraction of a non": 1, "- dilated left ventricle": 4, "evidence of diastolic dysfunction": 1, "patients with heart disease": 6, "recommendations on the treatment": 1, "iron deficiency in adult": 2, "deficiency in adult patients": 1, "adult patients with heart": 4, "literature in the english": 1, "english language on anemia": 2, "evaluated for this guideline": 1, "congestive heart failure exacerbation": 4, "audience for this guideline": 1, "target patient population is": 3, "clinical practice guidelines grading": 4, "practice guidelines grading system": 4, "restrictive red blood cell": 4, "red blood cell transfusion": 4, "blood cell transfusion strategy": 4, "patients with coronary heart": 1, "recommends against the use": 1, "benefits of anemia treatment": 1, "anemia treatment in patients": 2, "adults with heart disease": 1, "language trials of blood": 2, "trials of blood transfusions": 1, "observational studies of transfusion": 2, "data on study design": 1, "term mortality rates compared": 4, "relative risk among trials": 4, "occurred in a small": 1, "small trial of patients": 2, "patients with the acute": 1, "trials of intravenous iron": 1, "data supporting iron use": 4, "ischemic conditioning for patients": 2, "made in the pharmacological": 1, "resort to cardiac transplantation": 1, "right ventricular assist devices": 4, "low left ventricular ejection": 8, "left ventricular ejection fraction": 120, "preserved left ventricular ejection": 16, "admitted to the hospital": 1, "better ways to deal": 2, "deal with this worldwide": 1, "impact on medical resources": 1, "role of the emergency": 1, "department in acute heart": 1, "categorization in the emergency": 1, "modern acute heart failure": 4, "appropriate risk stratification is": 3, "studies in this area": 1, "patients with an implantable": 3, "current predictors of mortality": 2, "mortality in heart failure": 1, "evaluated before the use": 1, "use of implantable cardioverter": 2, "association between any predictor": 1, "high confidence in estimates": 2, "95 % confidence interval": 152, "baseline glomerular filtration rate": 4, "chronic obstructive pulmonary disease": 20, "independent predictors of mortality": 2, "identified strong reliable mortality": 4, "strong reliable mortality predictors": 4, "strong predictors of mortality": 2, "study other potential predictors": 1, "nesiritide in acute heart": 1, "failure with renal dysfunction": 1, "acute heart failure randomized": 4, "heart failure randomized trial": 4, "renal function in patients": 4, "patients with acute heart": 5, "estimated glomerular filtration rate": 44, "randomized in an open": 1, "ratio to the dopamine": 1, "randomized in a double": 1, "ratio to active treatment": 1, "compared with the pooled": 1, "hour cumulative urine volume": 12, "change in serum cystatin": 1, "cystatin c from enrollment": 2, "renal function end point": 4, "change in cystatin c": 2, "nesiritide on secondary end": 1, "participants with acute heart": 1, "participating in a multihospital": 1, "multihospital study to promote": 2, "adoption of heart failure": 1, "lessons for nurse leaders": 1, "multisite studies in practice": 2, "studies in practice settings": 1, "involvement in a multisite": 1, "proteomics of cardiac chromatin": 1, "cardiac chromatin identifies nucleolin": 4, "nucleolin as a regulator": 1, "cellular plasticity in cardiomyocytes": 2, "heart failure involves changes": 4, "changes in global gene": 1, "accessibility on a genomic": 1, "proteins alter chromatin structure": 8, "known about the global": 1, "global changes in chromatin": 2, "changes in chromatin subproteomes": 1, "plasticity in the setting": 1, "conserved developmental chromatin remodeling": 4, "developmental chromatin remodeling events": 4, "quantitative proteomics to identify": 2, "proteins in this subproteome": 1, "expression during cardiac hypertrophy": 1, "conducted extensive functional characterization": 4, "displayed severe developmental impairment": 4, "defects in cardiac looping": 1, "bone morphogenetic protein 4": 4, "analysis of a new": 1, "subproteome in the normal": 1, "studies in the complementary": 1, "model system of zebrafish": 2, "associated with the development": 1, "ischemic events in patients": 2, "receive cardiac resynchronization therapy": 8, "limited data regarding risk": 4, "data regarding risk factors": 4, "factors for the development": 2, "development of ischemic events": 1, "patients with ischemic cardiomyopathy": 1, "therapy with a defibrillator": 2, "effect on the efficacy": 1, "efficacy of the device": 1, "present study population comprised": 4, "proportional hazards regression modeling": 4, "interventions during the trial": 1, "risk for subsequent heart": 2, "predictors for the development": 1, "coronary artery bypass surgery": 4, "increased systolic blood pressure": 4, "left bundle branch block": 16, "bundle branch block pattern": 4, "pattern on the baseline": 1, "attenuated after the development": 1, "ies in this population": 1, "term mortality in patients": 2, "improved outcomes among patients": 4, "term mortality after hospitalization": 2, "term mortality as patients": 4, "interaction term analysis showed": 4, "difference in the risk": 1, "p value for age": 2, "mortality in this population": 1, "attenuated in the older": 1, "outcome in heart failure": 1, "involved in the process": 1, "process of endothelial repair": 1, "factor in cardiovascular diseases": 1, "association between serial measurements": 1, "outcomes in heart failure": 2, "decrease in cd34+vegfr2 +": 2, "cell decrease in cd34+vegfr2": 2, "associated with an increase": 1, "mortality in nondiabetic patients": 1, "basis for these differences": 1, "implications of metric choice": 1, "choice for common applications": 1, "common applications of readmission": 2, "applications of readmission metrics": 1, "differential impact on hospital": 2, "impact on hospital performance": 1, "day readmission rates using": 4, "differences in longitudinal performance": 1, "hospitals in an extreme": 1, "different approaches to computing": 2, "approaches to computing readmissions": 1, "produce different hospital rankings": 4, "choice for these applications": 1, "monitoring after recent hospital": 1, "hospital discharge in patients": 2, "hospital for heart failure": 1, "potential to deliver specialised": 1, "needs of the heart": 1, "studies with a contemporaneous": 1, "rm interventions included home": 4, "interventions included home telemonitoring": 4, "support to the control": 1, "beneficial effect on mortality": 2, "apoptosis in a canine": 1, "model of chronic heart": 1, "chronic heart failure induced": 4, "apoptosis during the development": 1, "rapid right ventricular pacing": 4, "dogs during the development": 1, "development of heart failure": 3, "levels of these genes": 1, "genes by western blot": 1, "method from autopsy samples": 1, "unchanged during the pacing": 1, "compared to the control": 1, "found in the normal": 1, "significant difference between numbers": 2, "numbers of apoptotic cells": 1, "apoptosis in the pathogenesis": 1, "pathogenesis of heart failure": 1, "failure in this model": 1, "activation of other systems": 1, "pump sternal sparing approach": 4, "left ventricular assist devices": 12, "patients with advanced heart": 5, "incidence of pump dysfunction": 1, "pump dysfunction requiring pump": 4, "dysfunction requiring pump replacement": 4, "blocker therapy in patients": 2, "left ventricular ejection fractions": 8, "ambulatory patients with heart": 4, "uptitration after a hospitalization": 1, "blocker uptitrations in patients": 2, "- blocker dose changes": 4, "months after an index": 1, "\u03b2 - blocker dose": 4, "- blocker dose increase": 4, "increase of \u226510 %": 1, "reductions in the composite": 1, "\u03b2 - blocker uptitration": 4, "uptitration of neurohumoral blockers": 1, "patients with low co": 1, "clinical outcome in patients": 2, "type natriuretic peptide levels": 4, "peptide levels in patients": 2, "associations with inhospital outcomes": 1, "findings from the get": 1, "differences in plasma b": 1, "levels with the greatest": 1, "patients above the median": 1, "similar among all subgroups": 2, "p for heterogeneity =": 1, "in a large registry": 1, "difference in the ability": 1, "mortality among these subgroups": 2, "medical management of heart": 2, "management of heart failure": 2, "heart failure in children": 2, "important cause of morbidity": 2, "guidelines for the recognition": 1, "children with undiagnosed heart": 1, "application in the clinical": 1, "recommendations for advanced management": 1, "involving ventricular assist devices": 4, "assessment of cognitive impairment": 1, "cognitive impairment at hospitalization": 2, "documented by the physician": 1, "physician at the time": 1, "discharge in a cohort": 1, "cohort of elderly patients": 1, "association of cognitive impairment": 1, "intubations for congestive heart": 1, "congestive heart failure declined": 4, "treatment of congestive heart": 1, "presenting to the emergency": 1, "year of the study": 1, "determined chf visit rates": 4, "95 % confidence intervals": 12, "congestive heart failure visits": 4, "heart failure visits declined": 4, "% of all ed": 1, "rates of annual ed": 1, "normal systolic ventricular function": 4, "context of significant liver": 1, "low systemic vascular resistance": 4, "catheterization during the same": 1, "incidence of abnormal liver": 1, "abnormal liver texture changes": 4, "compared with the pediatric": 1, "disease in the adults": 1, "derangement with hemodynamic features": 1, "limited ability to augment": 2, "ability to augment cardiac": 1, "predictors of heart failure": 1, "recognized as a major": 1, "cause of cardiovascular morbidity": 1, "risk for adverse outcomes": 1, "patients having heart failure": 1, "counseling on the primary": 1, "primary outcome of death": 4, "followed for a median": 1, "predictors of primary outcome": 1, "adherence to prescribed medications": 1, "indicators of functional status": 1, "common to both patients": 1, "adherence to prescribed therapy": 1, "chronic heart failure promotes": 4, "heart failure promotes restoration": 4, "protective effects via stimulation": 4, "stimulation of endothelial cell": 1, "patients with cardiovascular disease": 1, "protective effects of exercise": 2, "effects of exercise training": 1, "molecular pathways in patients": 2, "proteome of hdl particles": 1, "lower stimulation of phosphorylation": 2, "higher amount of malondialdehyde": 2, "effect on hdl function": 1, "determination of a predictive": 1, "objective of this study": 6, "cutoff value for plasma": 2, "value for plasma n": 1, "admission to the emergency": 1, "cutoff value for admission": 2, "year survival of patients": 2, "survival from the time": 1, "age of the patients": 1, "patients in this study": 1, "survival at the time": 1, "area under the curve": 2, "levels at the time": 1, "cause mortality in patients": 2, "novel heart failure mice": 4, "heart failure mice model": 4, "model of hypertensive heart": 2, "heart disease by angiotensin": 2, "therapeutic targets for hhd": 2, "using simple experimental procedures": 4, "differences in those parameters": 1, "wk after the procedures": 1, "increases in lung weight": 1, "weight with a high": 1, "deaths in the experimental": 1, "upregulated in the hearts": 1, "addition of salt loading": 1, "predict heart failure risk": 4, "atherosclerosis risk in communities": 2, "largest increases in incidence": 2, "measured with a high": 1, "prevalent coronary heart disease": 4, "area under the receiver": 2, "over a mean follow": 2, "simpler laboratory report model": 4, "incorporated in a laboratory": 1, "results in an excellent": 1, "left ventricular assist device": 24, "temporary right ventricular support": 4, "failure after the insertion": 1, "insertion of a left": 1, "heterogeneous group of patients": 2, "shock after myocardial infarction": 1, "chronic decompensated heart failure": 4, "right ventricular assist device": 4, "purpose of this study": 4, "year survival in patients": 2, "conjunction with a temporary": 1, "support at the time": 1, "duration of biventricular support": 1, "survival to hospital discharge": 1, "limited mortality at hospital": 2, "mortality at hospital discharge": 1, "ventricular assist device use": 4, "based on a systematic": 1, "evidence on clinical effects": 1, "recommendations on the basis": 1, "% for medical therapy": 1, "effectiveness limits in models": 2, "practice for a limited": 1, "limited number of patients": 2, "patients in many regions": 1, "limitations in economic models": 1, "lack of canadian data": 1, "point to the importance": 1, "effects of biventricular pacing": 1, "pacing on left heart": 1, "strain in a porcine": 1, "model of right heart": 1, "selected cardiac surgery patients": 4, "understanding of the mechanism": 1, "used speckle tracking echocardiography": 4, "acute right ventricular pressure": 4, "right ventricular pressure overload": 4, "left ventricular midpapillary level": 4, "taken of the left": 1, "in an open chest": 1, "noninvasive surrogates for changes": 2, "changes in rs synchrony": 1, "varying regional strain contributions": 4, "medical treatment for heart": 4, "treatment for heart failure": 3, "annuloplasty for ischemic mitral": 2, "combination of annular size": 2, "size reduction by surgery": 4, "diastolic mitral valve tethering": 8, "posteriorly displaced papillary muscles": 8, "history of successful mitral": 1, "successful mitral valve plasty": 4, "plasty for degenerative mitral": 1, "patients with a history": 1, "history of successful valve": 2, "dilated by another disease": 3, "improve such functional ms": 1, "prolapse of a degenerative": 1, "grade 4/6 holosystolic murmur": 4, "sound in the apex": 1, "underwent mitral valve plasty": 4, "disappeared and postoperative echocardiography": 1, "preserved mitral valve opening": 4, "opening with a mitral": 1, "obtained by a continuity": 1, "mitral filling flow volume": 4, "flow by continuous wave": 1, "limited mitral valve opening": 4, "resulting in a significant": 1, "lesions in the major": 1, "diastolic mitral leaflet motions": 4, "restricted without any clear": 2, "disappeared with a reduction": 1, "reduction in blood pressure": 1, "improvement of the mitral": 1, "observation at the time": 1, "reasons for the modest": 1, "reduction by the surgical": 1, "mild restriction of leaflet": 2, "restriction of leaflet motion": 1, "motion by the leaflet": 1, "disappeared after the surgery": 1, "opening without any clear": 2, "patient with successful valve": 1, "years after valve plasty": 1, "according to the guideline": 1, "after aggressive medical treatment": 4, "patients with functional ms": 1, "addition to the leaflet": 1, "patient with a history": 1, "evaluation of the surgical": 1, "risk stratification for death": 2, "hospitalization in heart failure": 1, "heart failure clinic outpatients": 4, "available outpatient models use": 4, "complex set of variables": 2, "month risk of death": 4, "date for the cohort": 1, "model included blood urea": 4, "included blood urea nitrogen": 4, "history of atrial fibrillation": 1, "hospitalization within the prior": 2, "demonstrated excellent risk stratification": 4, "available data to predict": 2, "resources within health systems": 4, "renal disease in outpatients": 2, "prognostic factor in heart": 2, "factor in heart failure": 1, "hazard models for time": 2, "included in the analyses": 1, "median left ventricular ejection": 4, "ventricular ejection fraction was": 3, "patients with an egfr": 1, "uncontrolled hypertension identify patients": 4, "preserved and reduced ejection": 2, "epidemic of heart failure": 1, "valid measure of patients": 2, "class in both patients": 1, "demonstrated high internal consistency": 4, "internal consistency among patients": 4, "reliable measure of health": 2, "measure of health status": 1, "offers excellent prognostic ability": 4, "responsiveness to clinical change": 1, "concentrations of the interleukin": 1, "interleukin receptor family member": 4, "therapy in chronic heart": 1, "prognosis in heart failure": 1, "doses of \u03b2 -": 1, "subjects with heart failure": 1, "left ventricular systolic dysfunction": 4, "examined as a function": 1, "function of baseline sst2": 1, "equivalent dose of metoprolol": 2, "dose of metoprolol succinate": 1, "patients with low sst2": 1, "lowest cardiovascular event rate": 4, "patients with high sst2": 1, "highest cardiovascular event rate": 4, "ratios for cardiovascular events": 1, "benefits across all study": 2, "sst2 measurement identifies patients": 4, "approach for the acute": 1, "acute treatment of heart": 2, "treatment of heart failure": 5, "vasodilator effects in vivo": 2, "effects of a novel": 1, "hearts in experimental models": 1, "rise in the peak": 1, "inhibition of protein kinase": 1, "soluble guanylate cyclase altered": 4, "dogs with coronary microembolization": 1, "maximal ventricular power index": 4, "conscious dogs with tachypacing": 2, "left and right heart": 1, "right heart filling pressures": 4, "efficacy of a novel": 1, "donor to enhance myocardial": 1, "predictors of reverse remodeling": 1, "remodeling after cardiac resynchronization": 1, "studies of echocardiographic predictors": 1, "echocardiographic predictors of response": 2, "response after cardiac resynchronization": 1, "strain of left ventricle": 2, "echocardiographic score for prediction": 2, "association of the score": 1, "hospitalization during 57\u00b122 months": 1, "57\u00b122 months of follow": 2, "right ventricular fractional area": 4, "echocardiographic score allowed prediction": 4, "remodeling with a sensitivity": 1, "lv assist device implantations": 4, "93 heart failure admissions": 4, "spironolactone for systolic heart": 1, "randomized trials to reduce": 2, "symptomatic systolic heart failure": 4, "diagnosed systolic heart failure": 4, "failure in clinical practice": 1, "patients with baseline serum": 1, "baseline serum creatinine level": 4, "independent association between spironolactone": 2, "association between spironolactone use": 1, "patients with a median": 1, "% confidence interval 0.77": 4, "rates of severe hyperkalemia": 1, "kidney injury during spironolactone": 2, "injury during spironolactone use": 1, "within a diverse community": 1, "incident systolic heart failure": 4, "spironolactone in clinical practice": 1, "vascular endothelial growth factor": 12, "endothelial growth factor blockade": 4, "growth factor blockade prevents": 4, "beneficial effects of beta": 2, "therapy on cardiac function": 2, "remodeling in heart failure": 2, "angiogenesis in the post": 1, "post - myocardial infarction": 12, "- myocardial infarction heart": 8, "myocardial infarction heart contributes": 4, "contributes to the progression": 1, "progression to heart failure": 2, "crucial for the transition": 1, "transition from compensatory hypertrophy": 1, "hypertrophy to cardiac failure": 1, "- adrenergic receptor blocker": 4, "adrenergic receptor blocker therapy": 4, "revealed reduced cardiac diameters": 4, "cardiac function in b": 2, "weeks after b treatment": 1, "proangiogenic effects of b": 2, "effects of b act": 1, "b act via activation": 4, "start of the treatment": 1, "coronary perfusion in b": 2, "positive effects of b": 2, "b on cardiac function": 1, "cardiac angiogenesis in heart": 2, "angiogenesis in heart failure": 1, "heart failure via activation": 4, "enhancement of cardiac angiogenesis": 1, "effects of this therapy": 1, "cohort of all adults": 1, "responsible diagnosis of heart": 2, "higher risk of death": 2, "visit in the subsequent": 1, "hospitalized at the time": 1, "management of acute heart": 1, "oxidase inhibition preserves left": 4, "function in cardiac volume": 1, "myocytes with volume overload": 1, "inhibition improves cardiomyocyte bioenergetics": 4, "twofold increase in lung": 2, "increase in lung weight": 1, "groups versus the sham": 2, "versus the sham group": 1, "velocity of circumferential shortening": 1, "occurred in the absence": 1, "changes in the maximum": 1, "improvement in contractile function": 1, "paralleled by any attenuation": 1, "patients with severe heart": 2, "left ventricular filling pressure": 8, "filling pressure in patients": 2, "stable severe systolic heart": 4, "severe systolic heart failure": 4, "early transmitral blood flow": 4, "transmitral blood flow velocity": 4, "flow velocity over tissue": 2, "early diastolic mitral annulus": 4, "diastolic mitral annulus velocity": 4, "estimating pulmonary capillary wedge": 4, "pulmonary capillary wedge pressure": 8, "decompensated systolic heart failure": 4, "patients with a left": 1, "transthoracic echocardiography with measurement": 2, "measurement of transmitral flow": 1, "predictive value of e": 2, "showed good diagnostic performance": 8, "detecting normal filling pressures": 4, "annular plane systolic excursion": 8, "pulmonary arterial systolic pressure": 8, "arterial systolic pressure relationship": 4, "pressure relationship in heart": 2, "relationship in heart failure": 1, "right ventricular contractile function": 4, "tricuspid annular plane systolic": 4, "relevance in the clinical": 1, "two- to threefold increase": 1, "increase in cardiac risk": 1, "type natriuretic peptide assessment": 4, "downward regression line shift": 4, "line shift in nonsurvivors": 2, "distribution along the regression": 2, "hazard ratios for variables": 2, "retained in the multivariate": 1, "nonsurvivors with a similar": 1, "relationship as a possible": 1, "index of the length": 1, "affected by the quality": 1, "heart failure in pigs": 2, "crucial for the development": 1, "coated with a polytetrafluoroethylene": 1, "formed in a bottleneck": 1, "implanted in the proximal": 1, "proximal left anterior descending": 8, "antiarrhythmic medication to prevent": 2, "medication to prevent sudden": 1, "time of the bottleneck": 1, "timing of myocardial infarction": 1, "modulated by the duration": 1, "duration of antiplatelet medication": 1, "fractional flow reserve measurements": 4, "positron emission tomography imaging": 4, "emission tomography imaging showed": 4, "severe ischemia after bottleneck": 2, "% of the left": 1, "ventricle in the proximal": 1, "wk after the stent": 1, "competitive collateral growth patterns": 4, "implantation of a novel": 1, "stent in the proximal": 1, "feasible for the development": 1, "selective heart rate reduction": 4, "rate reduction with ivabradine": 2, "left ventricle in heart": 2, "ventricle in heart failure": 2, "patients with systolic heart": 5, "afterload of the heart": 1, "derived from the pressure": 1, "ejection fraction \u226435 %": 8, "ivabradine in the shift": 1, "included in the echocardiographic": 1, "reduced in the ivabradine": 1, "resulting in a higher": 1, "hr reduction by ivabradine": 2, "unloading of the heart": 1, "contribute to the beneficial": 1, "effect of isolated hr": 1, "hr reduction in patients": 2, "relation of preoperative serum": 1, "preoperative serum albumin levels": 4, "albumin levels to survival": 2, "ventricular assist device implantation": 8, "recognized as a prognostic": 1, "prognostic indicator in patients": 2, "hypoalbuminemia with postoperative mortality": 1, "postoperative mortality in patients": 2, "postoperative survival of patients": 2, "patients with preoperative hypoalbuminemia": 2, "% confidence interval 0.290": 4, "normalization of albumin levels": 2, "support on postoperative survival": 1, "analyzed in both groups": 1, "subgroup analysis of patients": 2, "normalization of albumin level": 1, "attention to albumin levels": 1, "effective way to improve": 2, "correction of aortic valve": 1, "instituting mechanical circulatory support": 4, "in the present report": 1, "underwent aortic valve surgery": 4, "patients underwent lvad implantation": 4, "sternotomy for aortic valve": 1, "1 dacron patch closure": 4, "transcatheter aortic valve procedure": 4, "revision by open surgery": 1, "surgery for aortic valve": 1, "improvement in functional capacity": 1, "bioprosthetic aortic valve replacement": 4, "aortic valve replacement is": 3, "approaches to these difficult": 1, "alternatives to conventional surgery": 1, "young adults with heart": 4, "adults with heart failure": 4, "outcomes of young adults": 1, "rates across the respective": 2, "across the respective age": 1, "compared with the referent": 1, "population within cardiac rehabilitation": 4, "effects of nordic walking": 1, "standard cardiac rehabilitation care": 12, "care on functional capacity": 1, "increased right grip strength": 4, "important outcomes in patients": 2, "alternative for this population": 1, "left ventricular ejection time": 8, "time in acute heart": 1, "acute heart failure complicating": 4, "complicating precapillary pulmonary hypertension": 4, "patients with pulmonary hypertension": 1, "major right ventricle overload": 4, "right ventricle overload leads": 4, "arterial tonometry study tested": 4, "prognostic value in patients": 2, "patients with precapillary ph": 2, "precapillary ph with heart": 4, "ph with heart failure": 2, "radial artery tonometry variables": 4, "measured from the reconstructed": 1, "reconstructed aortic pressure curve": 4, "patients with unfavorable outcome": 1, "prognostic factors at admission": 2, "serum levels of brain": 2, "at the second evaluation": 1, "serum levels of creatinine": 2, "prognostic factor in patients": 2, "confirmed in this cohort": 1, "located in the left": 1, "followed by the right": 1, "embolize to the pulmonary": 1, "report of a patient": 1, "embolism to the pulmonary": 1, "right atrial mass removal": 4, "right atrium mass presented": 4, "prolapse through the tricuspid": 1, "brief hypothermic circulatory arrest": 4, "advanced chronic organ failure": 4, "median body mass index": 4, "performed on the same": 1, "standard error of measurement": 6, "relative minimal detectable change": 4, "occurred in the total": 1, "sample from the first": 1, "trial with large limits": 1, "large limits of agreement": 2, "information to the first": 1, "for the total sample": 1, "error of measurement value": 1, "95 % confidence level": 8, "found between the first": 1, "found for the subgroups": 1, "patients with advanced copd": 1, "values of standard error": 1, "practice with these populations": 1, "failure risk among patients": 4, "patients with rheumatoid arthritis": 1, "elevations in tumor necrosis": 1, "agents to treat rheumatoid": 1, "non - biological disease": 4, "use of loop diuretics": 1, "antagonist with similar baseline": 1, "subjects with a history": 1, "associated with a dose": 1, "compared with no use": 1, "associated with a risk": 1, "people with heart failure": 1, "interventions in chronic disease": 1, "participation in a structured": 1, "exercise programme for patients": 2, "improvements in functional capacity": 1, "secondary outcome measures related": 4, "sustainability of the intervention": 1, "significant improvements with others": 2, "completion of the study": 1, "risk for heart failure": 2, "failure in older adults": 1, "aim of this study": 4, "mean age of participants": 2, "during a median follow": 1, "non - frail participants": 4, "associated with a higher": 2, "sd decrease in score": 2, "sub - groups based": 4, "cardiovascular disease at baseline": 2, "vasopressin in congestive heart": 1, "contribute to the pathophysiology": 1, "pathophysiology of congestive heart": 1, "inhibitors of the renin": 1, "excessive secretion of arginine": 2, "secretion of arginine vasopressin": 1, "potential for deleterious effects": 1, "vasopressin receptor antagonist therapy": 4, "receptor antagonist therapy is": 3, "beneficial new therapeutic approach": 4, "reactivation of embryonic gene": 1, "healthy heart muscle cells": 4, "heart muscle cells developed": 4, "phenotype of pathological hypertrophy": 1, "marked resistance to pressure": 2, "induction of a fetal": 1, "vivo inhibition of mir-25": 2, "mir-25 by a specific": 1, "evoked spontaneous cardiac dysfunction": 4, "murine myocardium to heart": 2, "myocardium to heart failure": 1, "expression of the bhlh": 1, "mammalian myocardium with impact": 2, "impact on embryonic gene": 1, "gene programs in heart": 2, "programs in heart failure": 3, "treatment of chronic heart": 2, "prevalence of chronic heart": 1, "% in the adult": 1, "blockade of the neuro": 1, "angiotensin converting enzyme inhibitors": 8, "receptor blockers in case": 2, "converting enzyme inhibitors intolerance": 4, "neglected for a long": 1, "time from the treatment": 1, "past decades several studies": 4, "beta blockers decrease mortality": 4, "documented in a number": 1, "major cause of death": 2, "diabetes to heart failure": 1, "insulin receptor substrates 1": 4, "causes myocardial insulin resistance": 4, "box class o-1 signaling": 4, "impaired cardiac metabolic gene": 4, "cardiac metabolic gene expression": 4, "features of heart failure": 1, "impaired cardiac energy metabolism": 4, "cardiac energy metabolism gene": 4, "energy metabolism gene expression": 4, "neonatal rat ventricular cardiomyocytes": 4, "chronic insulin exposure reduced": 4, "insulin action through activation": 2, "mechanism of cardiac dysfunction": 1, "cardiac dysfunction during insulin": 2, "dysfunction during insulin resistance": 1, "level variation in use": 2, "outpatients with heart failure": 2, "level variation in rates": 2, "association between treatment variation": 1, "practice rates of treatment": 2, "optimal combined treatment measure": 4, "multivariable hierarchical regression models": 4, "calculated for each therapy": 1, "treatment of a patient": 1, "level prescription rates ranged": 4, "% for \u03b2 -": 1, "adjusted median rate ratio": 4, "angiotensin receptor blockers therapy": 4, "variation in the use": 1, "reduced ejection fraction exists": 4, "exists in the outpatient": 1, "cardiotoxicity among older patients": 4, "older patients with breast": 2, "patients with breast cancer": 1, "trastuzumab in the adjuvant": 1, "adjuvant setting improves outcomes": 4, "chf among older patients": 4, "age of the entire": 1, "% in nontrastuzumab users": 1, "in this large cohort": 2, "cohort of older breast": 1, "older breast cancer patients": 4, "plays in the development": 1, "women with heart failure": 1, "dietary recommendations for patients": 2, "non - hf populations": 4, "associations of dietary patterns": 1, "dietary patterns with outcomes": 2, "diet scores with mortality": 2, "mortality among postmenopausal women": 4, "hospitalization through the date": 1, "proportional hazards models adjusted": 4, "quartiles of the dash": 1, "higher dash diet scores": 4, "lower mortality in women": 2, "trend toward an inverse": 2, "toward an inverse association": 1, "support for the concept": 1, "association with functional capacity": 2, "signaling in the myocardium": 1, "promising biomarker in heart": 2, "biomarker in heart failure": 1, "outcomes in a cohort": 1, "cohort of ambulatory patients": 2, "study of exercise training": 1, "analyzed in a subset": 1, "patients with evaluable plasma": 1, "measures of functional capacity": 1, "hazard ratios for log2": 2, "ratios for log2 ng": 1, "adjustment for clinical variables": 1, "changes in the c": 1, "experience with extended criteria": 1, "extended criteria cardiac transplantation": 4, "extended criteria cardiac transplant": 4, "excluded from the transplant": 1, "outcomes with this strategy": 1, "undergoing isolated heart transplant": 4, "standard criteria cardiac transplant": 12, "criteria cardiac transplant recipients": 4, "compared with the patients": 1, "higher frequency of diabetes": 2, "frequency of diabetes mellitus": 1, "adjustment for baseline characteristics": 1, "criteria cardiac transplant survival": 4, "post - transplant mortality": 4, "alternative for advanced heart": 1, "advanced heart failure therapy": 4, "therapy in select patients": 1, "post - transplant morbidity": 4, "part of a heart": 1, "heart failure readmission quality": 4, "failure readmission quality improvement": 4, "readmission quality improvement initiative": 4, "day readmissions as part": 2, "part of a hospital": 1, "hospital quality improvement initiative": 4, "outpatient assessments of patients": 2, "days of hospital discharge": 1, "review of all heart": 1, "rate after the initiative": 1, "average age of patients": 2, "heart failure nurse practitioner": 4, "patients had blood work": 1, "discrepancy between the discharge": 1, "readmission rate for patients": 4, "parallel with an increase": 1, "medication changes at follow": 2, "cardiac magnetic resonance postcontrast": 8, "pathophysiology of heart failure": 1, "myocardial extracellular matrix accumulation": 4, "estimate myocardial extracellular matrix": 4, "using cardiac magnetic resonance": 4, "cardiac magnetic resonance t1": 8, "magnetic resonance t1 mapping": 4, "enrolled in this prospective": 1, "cardiac magnetic resonance imaging": 4, "magnetic resonance imaging including": 4, "resonance imaging including t1": 4, "imaging including t1 mapping": 4, "magnetic resonance t1 time": 4, "times below the median": 1, "risk of cardiac events": 1, "rest of the group": 1, "right ventricular ejection fraction": 4, "heart magnetic resonance imaging": 8, "risk of heart disease": 1, "heart disease in patients": 2, "compliance in a single": 1, "predictive value for heart": 2, "value for heart failure": 1, "treatment in most subjects": 1, "year for heart failure": 1, "choice of chelation regimens": 1, "impact of ejection fraction": 1, "fraction on the clinical": 1, "response to cardiac resynchronization": 1, "therapy in mild heart": 1, "recommend cardiac resynchronization therapy": 4, "evaluated in which patients": 1, "determined by a blinded": 1, "improvement in the clinical": 1, "end systolic volume index": 4, "improved time to death": 2, "fraction in a rat": 1, "rat metabolic risk model": 4, "important metabolic risk factors": 4, "frequent comorbidities in heart": 2, "comorbidities in heart failure": 1, "importance for myocardial dd": 1, "myocardial dd of collagen": 2, "dd of collagen deposition": 1, "rats after heart failure": 1, "preserved ejection fraction development": 4, "weeks with repeat metabolic": 1, "high muscle strip stiffness": 4, "site of the elastic": 1, "rats developed heart failure": 4, "ventricular longitudinal systolic strain": 8, "strain as a major": 1, "predictor of cardiovascular events": 1, "cardiovascular events in patients": 2, "patients with atrial fibrillation": 4, "relationship with adverse cardiovascular": 1, "events in atrial fibrillation": 1, "cardiology in a university": 1, "method for cv events": 1, "non - fatal stroke": 8, "hospitalisation for heart failure": 1, "hospitalisations for heart failure": 1, "failure during an average": 1, "systolic mitral annulus velocity": 4, "predicting adverse cv events": 8, "containing chronic heart failure": 4, "benefit in the prediction": 1, "outcomes after cardiac resynchronization": 1, "duration on the effectiveness": 1, "effectiveness of cardiac resynchronization": 1, "assessed in a large": 1, "associated with a significant": 1, "reduction in the primary": 2, "patients in atrial fibrillation": 1, "reviewed by a panel": 1, "included in this study": 1, "receiving implantable cardioverter defibrillator": 4, "component of the primary": 1, "ratio for the primary": 1, "benefit from implantable cardioverter": 1, "refractory congestive heart failure": 4, "failure with peritoneal dialysis": 1, "diuretic resistant volume overload": 4, "volume overload in heart": 2, "overload in heart failure": 1, "therapy in severe end": 1, "transplant ineligible patients receiving": 4, "post - pd initiation": 4, "% with the majority": 1, "severe right ventricular dysfunction": 4, "improvement in diuretic response": 1, "significant decrease in re": 2, "decrease in re -": 1, "hospitalization from an average": 1, "average length of stay": 2, "treatment of diuretic refractory": 1, "viable option in refractory": 2, "stage congestive heart failure": 4, "consequences of cardiac resynchronization": 1, "resynchronization therapy in dialysis": 2, "dependent patients with heart": 4, "assessment of these patients": 1, "ii receptor blocker use": 4, "evidence of reverse remodeling": 1, "heterogenous improvement in ejection": 2, "improvement in ejection fraction": 1, "demonstrated superior reverse remodeling": 4, "% increase in ejection": 2, "increase in ejection fraction": 1, "certain dialysis patients demonstrated": 4, "compelling improvement after device": 2, "improvement after device implantation": 1, "risk for adverse events": 1, "sodium dash diet improves": 4, "coupling in hypertensive heart": 1, "failure of cardiovascular reserve": 1, "reserve in multiple domains": 1, "dietary sodium restriction improves": 4, "dietary approaches to stop": 2, "left ventricular diastolic function": 8, "function with echocardiographic measures": 1, "quantified via the parametrized": 2, "parametrized diastolic filling formalism": 4, "constants through the analysis": 1, "defined as the ratio": 1, "pre - post comparisons": 4, "human resistin in chemotherapy": 2, "mediator of insulin resistance": 1, "connected elevated resistin levels": 4, "levels with the development": 1, "severity of heart failure": 1, "understanding of the role": 1, "role of human resistin": 1, "human resistin in heart": 2, "resistin in heart failure": 1, "mouse model lacking murine": 4, "model lacking murine resistin": 4, "transgenic for the human": 1, "fold induction of serum": 2, "induction of serum resistin": 1, "controls not expressing human": 1, "increased cardiac mrna levels": 4, "cell adhesion genes compared": 4, "treated breast cancer patients": 4, "resistin levels in women": 2, "decline in ejection fraction": 1, "fraction in these women": 1, "contribute in the development": 1, "direct effects on macrophages": 2, "resistin as a link": 1, "outcomes of catheter ablation": 1, "ablation of atrial fibrillation": 1, "atrial fibrillation in patients": 2, "safety of catheter ablation": 1, "ablation for atrial fibrillation": 1, "factor for clinical deterioration": 1, "performed in a consecutive": 1, "free probability after catheter": 2, "probability after catheter ablation": 1, "maintenance of sinus rhythm": 3, "strain rate at systole": 2, "strain rate at diastole": 2, "patients maintaining sinus rhythm": 4, "sinus rhythm at follow": 2, "treated with a composite": 1, "composite of repeat procedures": 1, "larger randomized control studies": 4, "ablation in this cohort": 1, "mitochondrial dysfunction in doxorubicin": 2, "heart failure in rats": 4, "possible mechanism of cardioprotection": 2, "anti - neoplastic agent": 4, "agent in the treatment": 1, "treatment of several cancers": 1, "in the present study": 1, "cardioprotective effect of nicorandil": 2, "cumulative administration of doxorubicin": 2, "last dose of doxorubicin": 2, "nucleotides contents in addition": 2, "addition to cytochrome c": 1, "mitochondrial oxidative phosphorylation capacity": 8, "decrement of heart rate": 1, "state of mitochondrial oxidative": 1, "mitochondrial oxidative stress induced": 4, "restoring mitochondrial oxidative phosphorylation": 4, "significant cardioprotection via inhibition": 4, "cytotoxic effect of doxorubicin": 2, "doxorubicin against the growth": 1, "effective against the development": 1, "improvement of hemodynamic perturbations": 1, "isolated coronary artery bypass": 4, "coronary artery bypass grafting": 8, "infarction after coronary artery": 1, "early risk of stroke": 2, "from the swedish web": 1, "heart failure \u226490 days": 4, "risk for the primary": 1, "secondary outcome of death": 2, "death from any cause": 2, "developed acute kidney injury": 4, "intervals for cardiovascular events": 1, "cardiovascular events after adjustment": 2, "history of myocardial infarction": 2, "introduced into the statistical": 1, "% confidence interval 1.38": 4, "adjustment for all confounders": 1, "events during the first": 1, "failure in the young": 1, "clinical burden in adult": 2, "burden in adult medicine": 1, "cause of heart failure": 1, "cardiac transplants in children": 2, "cardiac symptoms in children": 2, "result of congenital lesions": 1, "most of these lesions": 1, "expand on the management": 1, "management of congenital heart": 1, "lesions in this review": 1, "small subgroup of children": 2, "failure from cardiomyopathic restriction": 1, "cardiomyopathic restriction to flow": 2, "aetiologies in some cases": 1, "particular topics of debate": 2, "debate in paediatric heart": 1, "paediatric heart failure concern": 4, "new onset heart failure": 4, "cellular responses to heart": 2, "responses to heart failure": 1, "molecular scaffolds in heart": 2, "scaffolds in heart pathology": 1, "cardiomyocytes to detect mechanical": 1, "adaptation of the myocardium": 1, "response to new conditions": 1, "beneficial adaptation to stress": 2, "adaptation to stress conditions": 1, "kinases into a linear": 1, "linear pathway to facilitate": 2, "targeting specific effector molecules": 4, "promising field of investigation": 2, "investigation for the development": 1, "development of therapeutic strategies": 1, "deals with the case": 1, "case of a patient": 1, "based on the history": 1, "diagnosis of multiple myeloma": 1, "frailty in heart failure": 1, "prognostic indicator in heart": 2, "indicator in heart failure": 1, "defined as a biological": 1, "evaluated in the same": 1, "according to the biological": 2, "defined as the proportion": 1, "% intermediate frail according": 4, "increase in the deficit": 1, "as the biological phenotype": 1, "feasible alternative to ascertain": 2, "future of acute heart": 1, "acute heart failure trials": 4, "decade of acute heart": 1, "disappointments in large phase": 1, "pharmacologic studies of therapeutics": 2, "adverse event rates remain": 4, "role of appropriate timing": 1, "timing of patient enrollment": 1, "selecting appropriate end points": 4, "success in future trials": 1, "measurement of natriuretic peptides": 2, "peptides at the point": 1, "care in the emergency": 1, "tool in the diagnosis": 1, "diagnosis of acute heart": 1, "heart failure in patients": 6, "mixed on the absolute": 1, "risk of adverse outcomes": 1, "outcomes in other patients": 1, "measured at the point": 1, "nps to clinical care": 1, "delivery in the emergency": 1, "risk of acute heart": 1, "frame of a patient": 1, "processes of care delivery": 1, "advantage of the faster": 1, "faster turnaround times provided": 4, "measuring heart failure care": 4, "quality of outcome measures": 1, "hospital quality of care": 2, "quality of care outcomes": 1, "objective of the measure": 1, "expansion to other conditions": 1, "inhibition halts heart failure": 4, "mortality in modern society": 1, "consequence of pathological remodelling": 1, "remodelling of the heart": 1, "at the molecular level": 1, "targets for the prevention": 1, "set of transcription factors": 1, "pathological changes in cardiomyocytes": 2, "occur through an interplay": 1, "interplay between these transcription": 1, "epigenetic changes in chromatin": 2, "changes in chromatin structure": 1, "resulting in the suppression": 1, "profiling of cultured cardiomyocytes": 1, "cardiomyocytes in the presence": 1, "induction of a substantial": 1, "effects on systemic blood": 1, "analysis of cardiac tissue": 1, "cardiac tissue from mice": 2, "pathological cardiac gene expression": 4, "cardiac gene expression programme": 4, "bets in the mouse": 1, "crucial role in chromatin": 2, "activating transcription factor networks": 4, "promoting transcriptional pause release": 4, "readers in cardiac biology": 1, "manipulation of cardiac gene": 1, "control via the targeting": 2, "abrogate pathological gene expression": 4, "mri during tidal respiration": 1, "tidal respiration for quantification": 2, "quantification of myocardial t1": 1, "myocardial t1 in swine": 2, "swine with heart failure": 1, "purpose of this article": 1, "sequence to quantify myocardial": 1, "quantify myocardial t1 changes": 4, "changes in a swine": 1, "swine model of tachycardia": 2, "minutes after the administration": 1, "administration of a gadolinium": 1, "compared between the baseline": 1, "fibrosis of heart failure": 1, "similar left ventricular tissue": 4, "ventricular tissue from control": 2, "tissue from control animals": 1, "using trichrome blue histologic": 4, "trichrome blue histologic analysis": 4, "found between the baseline": 1, "values before the administration": 1, "administration of contrast agent": 1, "animals with heart failure": 1, "percentage of myocardial collagen": 2, "tissue from healthy control": 1, "quantify diffuse myocardial changes": 4, "failure without the use": 2, "use of a contrast": 1, "increases in the percentage": 1, "myocardial delayed enhancement imaging": 4, "right ventricular contractile reserve": 16, "contractile reserve in patients": 4, "new approach to assess": 2, "induced pulmonary artery systolic": 4, "pulmonary artery systolic pressure": 4, "echocardiography as a possible": 1, "in this prospective study": 1, "diagnosed pulmonary arterial hypertension": 4, "chronic thromboembolic pulmonary hypertension": 4, "impaired right ventricular pump": 4, "right ventricular pump function": 4, "stable targeted pulmonary arterial": 4, "targeted pulmonary arterial hypertension": 4, "pulmonary arterial hypertension medication": 4, "arterial hypertension medication underwent": 4, "panel of noninvasive assessments": 1, "basis of the assumption": 1, "according to an exercise": 1, "remained independent prognostic markers": 4, "relevance in pulmonary hypertension": 1, "tool for prognostic assessment": 1, "assessment in pulmonary hypertension": 1, "contemporary use of devices": 2, "devices in heart failure": 1, "cornerstone of heart failure": 1, "patients with systolic dysfunction": 2, "detection of fluid overload": 1, "cause of cardiovascular hospitalization": 2, "portion of the health": 1, "achieved in the development": 1, "regulates cardiac sodium current": 4, "systolic human heart failure": 4, "increases alternative mrna splicing": 4, "splicing of the type": 1, "trapped in the endoplasmic": 1, "human induced pluripotent stem": 4, "induced pluripotent stem cell": 4, "expression of exogenous variants": 1, "receptor potential cation channel": 4, "potential cation channel m7": 4, "channel mrna splice variants": 8, "involved in the reduction": 1, "important role in downregulation": 2, "acute right heart failure": 8, "failure in pulmonary hypertension": 1, "attention in the medical": 1, "used in the management": 1, "intrinsic left ventricular dysfunction": 4, "concentrating on the pathophysiologic": 1, "mechanisms behind the development": 2, "distinct populations of patients": 2, "chronic pulmonary arterial hypertension": 4, "failure in the setting": 1, "setting of pulmonary embolism": 1, "contemporary trends in heart": 2, "trends in heart failure": 1, "fraction after myocardial infarction": 1, "occurred in the epidemiology": 1, "epidemiology of myocardial infarction": 1, "changes in patient presentation": 1, "further adjustment for patient": 2, "characteristics yielded hazard ratios": 4, "change in the case": 1, "requires new prevention strategies": 4, "nonselective \u03b2 - blocker": 4, "selective \u03b2 - blocker": 4, "\u03b2 - blocker metoprolol": 4, "risk of thromboembolic events": 2, "thromboembolic events in heart": 2, "events in heart failure": 1, "levels of various serum": 1, "stable heart failure patients": 4, "equipotent dosages of carvedilol": 2, "secondary outcomes included markers": 4, "resulted in a lower": 1, "reduction of sympathetic activity": 1, "thromboembolic events in patients": 2, "competing priorities impact prescribing": 4, "impact prescribing of guideline": 2, "angiotensin converting enzyme inhibitor": 8, "primary care clinicians caring": 4, "caring for these patients": 1, "drugs for heart failure": 1, "indicated in the patient": 1, "structure of medical records": 1, "documentation of contextual reasons": 1, "parasympathetic tone by pyridostigmine": 2, "dysfunction during the onset": 1, "onset of heart failure": 1, "control of the heart": 1, "increase in parasympathetic function": 1, "therapeutic alternative to slow": 2, "effects of the acetylcholinesterase": 1, "pyridostigmine on sympathovagal balance": 1, "function in the onset": 1, "wk of pyridostigmine administration": 1, "sympathetic control of heart": 2, "control of heart rate": 1, "increased vascular endothelial growth": 4, "endothelial growth factor protein": 4, "protein in the left": 1, "means of the pressure": 1, "volume conductance catheter system": 4, "contractility of the left": 1, "term administration of pyridostigmine": 2, "coronary artery ligation augmented": 4, "dysfunction during the progression": 1, "delay in dyssynchronous heart": 1, "addition to the left": 1, "bundle branch block type": 4, "type of electrical activation": 1, "behavior of the heart": 1, "interval between local myocyte": 1, "goal of this study": 2, "models of dyssynchronous nonfailing": 1, "block electrical activation sequence": 4, "simulated in all models": 1, "slows myofiber shortening velocity": 4, "changes in myofiber dynamics": 1, "onset of myofiber shortening": 1, "prognosis in advanced heart": 1, "function on body composition": 1, "prospective assessment of body": 2, "assessment of body composition": 1, "lower body mass index": 4, "lower fat mass index": 4, "greater antecedent weight loss": 4, "lean body mass ratio": 4, "over a median follow": 2, "increased body mass index": 4, "associated with a lower": 1, "mediated by a higher": 1, "surrogate of enhanced catabolism": 1, "cardioprotective in the context": 1, "inhibition on hemodynamic status": 1, "tolerance in heart failure": 1, "ivabradine on exercise capacity": 1, "ventricular filling in patients": 2, "optimization of diastolic filling": 1, "days in this double": 1, "assessment of myocardial function": 1, "significant improvement between baseline": 2, "simultaneous reduction in exercise": 2, "increase in the ratio": 2, "early diastolic mitral flow": 12, "diastolic mitral flow velocity": 12, "velocity to peak early": 3, "peak early diastolic mitral": 12, "diastolic mitral annular velocity": 16, "difference in heart rate": 1, "rate at the same": 1, "time at the baseline": 1, "slower increase in heart": 2, "increase in heart rate": 1, "heart rate during exercise": 2, "treatment in exertional increase": 1, "independent correlates of increase": 2, "increase in exercise capacity": 1, "increase in peak oxygen": 1, "term treatment with ivabradine": 2, "ivabradine increased exercise capacity": 4, "improved left ventricular filling": 4, "ventricular filling pressure response": 4, "reflected by the ratio": 1, "abnormal exercise hemodynamic status": 4, "simple validated clinical tool": 4, "clinical tool to predict": 2, "absence of coronary artery": 1, "artery disease in patients": 2, "failure of unclear etiology": 1, "cause of systolic heart": 1, "angiography with a primary": 1, "multivariate logistic regression analysis": 8, "stenosis in the left": 1, "left anterior descending artery": 4, "validated in a separate": 1, "patients in the derivation": 1, "% of the patients": 2, "in the prospective validation": 1, "simple clinical prediction rule": 4, "angiography in a substantial": 1, "substantial proportion of patients": 2, "experience of a vasopressin": 1, "indication in japanese heart": 1, "japanese heart failure patients": 4, "indicated for the treatment": 1, "treatment of severe hyponatremia": 1, "hyponatremia in most countries": 1, "congestive heart failure patients": 4, "failure patients in addition": 2, "diuretic use in heart": 2, "use in heart failure": 1, "congestive symptoms in patients": 2, "data on the potential": 1, "occur in the absence": 1, "absence of fluid overload": 1, "knowledge on diuretic use": 1, "risk patient with heart": 2, "patient with heart failure": 2, "failure with reduced ejection": 3, "therapy to implantable defibrillators": 1, "risk stratification of patient": 2, "appropriate to the level": 1, "subject of this brief": 1, "adrenergic responses in cardiomyocytes": 2, "diminished cyclic adenosine monophosphate": 4, "augmented cyclic guanosine monophosphate": 4, "leading to a remarkable": 1, "remarkable increase in camp": 2, "increase in camp hydrolysis": 1, "fluorescence resonance energy transfer": 4, "stimulation via catecholamine infusions": 4, "catecholamine infusions in rats": 2, "stimulation of cgmp synthesis": 1, "synthesis via nitric oxide": 4, "overexpression in healthy cardiomyocytes": 1, "rise in camp levels": 1, "mechanism during cardiac stress": 1, "intracellular antiadrenergic therapeutic strategy": 4, "patients at high risk": 3, "high risk for hyperkalemia": 4, "hospitalized for a cardiovascular": 1, "pre - specified analysis": 4, "specified analysis of subgroups": 2, "high risk of hyperkalemia": 2, "discontinuation of study medication": 1, "endpoint in all subgroups": 1, "subgroups at high risk": 1, "health status in patients": 2, "factor for poor outcomes": 1, "hrqol in a cohort": 1, "trial of exercise training": 1, "exercise training in patients": 4, "group effects on hrqol": 2, "using linear mixed models": 4, "according to the intention": 1, "beneficial effect of exercise": 4, "effect of exercise training": 3, "beneficial effects of hrqol": 2, "hrqol from exercise training": 1, "cost analysis of rhythm": 2, "treatment strategies in patients": 2, "failure from the province": 1, "care expenditures of patients": 2, "compared from a single": 1, "% of total expenditures": 1, "hospitalizations for noncardiovascular diagnoses": 1, "implantable cardiac arrhythmia devices": 4, "drugs in the rate": 1, "total cost per patient": 4, "severe heart failure appears": 4, "influence on the overall": 1, "perturbations in skeletal muscle": 1, "skeletal muscle sarcomere structure": 4, "sarcomere structure in patients": 2, "detrimental alterations in skm": 2, "reversal of detrimental alterations": 1, "alterations in sarcomeric microstructure": 1, "severe perturbations in components": 2, "sarcomeric microstructure at baseline": 2, "co - ordinated fashion": 4, "markers of skm growth": 1, "medicine as an adjunctive": 1, "treatment for dilated cardiomyopathy": 1, "dilated cardiomyopathy in patients": 2, "adjunctive treatment for patients": 2, "patients with dilated cardiomyopathy": 1, "studies on biomedical treatment": 1, "performed on the overall": 1, "effects on effective rate": 1, "left ventricular diastolic end": 8, "ventricular diastolic end diameter": 8, "improvement in effective rate": 1, "observed in the studies": 1, "systemic adverse events evaluation": 4, "treatment in all patients": 1, "metabolic enzymes in patients": 2, "compared with the controls": 1, "intolerance in heart failure": 1, "exercise parameters for diagnosis": 2, "feature of chronic heart": 1, "update on cardiopulmonary exercise": 1, "accepted peak oxygen consumption": 4, "partial pressure of end": 2, "attention in the interpretation": 1, "interpretation of cardiopulmonary exercise": 1, "variables with an important": 1, "assessment with the inclusion": 1, "care surgery in heart": 2, "surgery in heart transplant": 1, "optimal treatment for end": 2, "transplantation with medical therapy": 1, "consultation for abdominal problems": 1, "membrane oxygenation as bridge": 2, "refractory right heart failure": 4, "man with cardiac arrest": 1, "cardiac arrest in need": 2, "need of cardiopulmonary resuscitation": 1, "diagnosis of a posterior": 1, "obstruction of the right": 1, "after percutaneous coronary revascularization": 4, "admitted to the intensive": 1, "based on the acute": 1, "heart failure with therapy": 2, "failure with therapy refractory": 1, "team for an extra": 1, "extra corporeal membrane oxygenation": 4, "days after the emergency": 1, "extracorporeal life support is": 3, "acute ischemic right heart": 4, "ischemic right heart failure": 4, "focused on the importance": 1, "importance of diastolic dysfunction": 1, "dysfunction in the pathophysiology": 1, "non - diastolic abnormalities": 4, "abnormalities in cardiovascular function": 1, "discussion of novel treatment": 1, "promise for the future": 1, "mortality outcomes of heart": 2, "outcomes of heart failure": 1, "first acute myocardial infarction": 4, "impact on the incidence": 1, "linked administrative health data": 4, "hospitalized with an index": 1, "hazard ratio for death": 2, "fatality rate for patients": 2, "associated with a multivariate": 1, "days of the index": 1, "declines in the incidence": 1, "problem with high mortality": 1, "attention to these high": 1, "therapy during exercise rehabilitation": 1, "rehabilitation in male patients": 1, "week program of exercise": 2, "data for key health": 1, "mean \u00b1 sd testosterone": 4, "\u00b1 sd testosterone levels": 4, "incremental shuttle walk test": 4, "- brain natriuretic peptide": 16, "similar improvements in shuttle": 2, "improvements in shuttle walk": 1, "observed in both groups": 1, "exercise with testosterone group": 1, "testosterone group showed improvements": 4, "baseline in peak oxygen": 1, "form quality of life": 2, "quality of life domains": 1, "apparent in the exercise": 1, "exercise with placebo group": 1, "shows for the first": 1, "supplementation during a program": 1, "program of exercise rehabilitation": 1, "impact on a range": 1, "range of key health": 1, "stimulation of peripheral muscles": 1, "emotional status in heart": 2, "status in heart failure": 1, "function in chronic heart": 1, "completion of training protocol": 1, "tendency toward lower mitral": 4, "lack of effective evidence": 1, "therapies in these patients": 1, "transforming growth factor beta": 4, "decline in atrial explant": 1, "functions after myocardial infarction": 1, "majority of potential candidates": 1, "potential candidates for cell": 2, "candidates for cell therapy": 1, "phenotype of cardiac explant": 1, "anterior descending coronary artery": 4, "descending coronary artery occlusion": 4, "used as a control": 1, "selected on the basis": 1, "basis of left ventricle": 1, "expression of pluripotency markers": 1, "cell differentiation toward cardiomyocyte": 4, "optimizing cardiac progenitor function": 4, "protocols for clinical application": 1, "breathing with no heart": 1, "cardiac arrest in humans": 2, "advantage of the period": 1, "part of this study": 1, "displayed permanent periodic breathing": 4, "excluded from the final": 1, "presented in this report": 1, "phase of a pb": 1, "effect on pb characteristics": 1, "perfusion of the carotid": 1, "originating from the central": 1, "absence of atrial fibrillation": 1, "options for these patients": 1, "patients in sinus rhythm": 1, "better tools for risk": 2, "tools for risk stratification": 1, "need for antiplatelet agents": 1, "antiplatelet agents in combination": 2, "nutrition in heart failure": 1, "recognized as a multisystem": 1, "disease with important comorbidities": 1, "evidence points to alterations": 2, "alterations in intestinal morphology": 1, "absorption function in patients": 2, "overview of the sonographic": 1, "knowledge of nutritional abnormalities": 1, "anti - inflammatory effects": 4, "effects in the treatment": 1, "dietary interventions in heart": 2, "interventions in heart failure": 1, "target of further heart": 1, "stable coronary artery disease": 4, "ventricular cardiomyocytes in response": 2, "response to an increase": 1, "increase in ventricular wall": 1, "prognostic biomarkers in patients": 2, "patients with coronary artery": 1, "derived from a great": 1, "great number of studies": 2, "amount of recent data": 1, "associated with the extent": 1, "information for an unfavourable": 1, "balance in conscious rabbits": 1, "rabbits with chronic heart": 1, "hallmark of chronic heart": 1, "improve cardiac autonomic balance": 4, "time domain heart rate": 4, "domain heart rate variability": 4, "levels by renal dnx": 1, "power spectral analysis indicated": 4, "compared with the sham": 1, "sham levels by dnx": 2, "due to a withdrawal": 1, "withdrawal of sympathetic tone": 1, "increase in parasympathetic tone": 1, "measured after an intravenous": 1, "intravenous bolus of metoprolol": 2, "response to intravenous atropine": 1, "improves cardiac autonomic balance": 4, "reduction of sympathetic tone": 1, "resynchronization therapy in heart": 2, "therapy in heart failure": 2, "failure with a narrow": 1, "chronic systolic heart failure": 4, "failure with a wide": 1, "patients with a narrow": 1, "patients underwent device implantation": 4, "futility on the recommendation": 1, "recommendation of the data": 1, "followed for a mean": 1, "hospitalization for heart failure": 3, "effects of ventricular assist": 1, "oxygenation on renal function": 1, "function in pediatric heart": 1, "support on renal function": 1, "renal function in children": 4, "impact of ventricular assist": 1, "observational study in children": 2, "stage heart failure supported": 4, "pediatric mechanical cardiac support": 4, "receiving ventricular assist device": 4, "ventricular assist device support": 4, "patients receiving extracorporeal membrane": 4, "receiving extracorporeal membrane oxygenation": 4, "extracorporeal membrane oxygenation membrane": 4, "membrane oxygenation membrane support": 4, "ecmo+vad group included patients": 4, "comparison of baseline characteristics": 1, "patients in the ecmo+vad": 1, "steady improvement in egfr": 2, "ecmo+vad group until day": 2, "decline in renal function": 1, "steady decline in egfr": 2, "group in the first": 1, "basis of these data": 1, "sensitive outcome change scores": 4, "older adults with heart": 4, "social mandate to ensure": 2, "mandate to ensure effective": 1, "accountable for the outcomes": 1, "outcomes of nursing care": 1, "using standardized nursing terminologies": 4, "standardized nursing terminologies makes": 4, "aspects of nursing care": 1, "significant difference in outcome": 2, "difference in outcome ratings": 1, "retrospective descriptive research design": 4, "inpatient records of patients": 2, "significant improvement in outcome": 2, "improvement in outcome ratings": 1, "outcome ratings from admission": 2, "findings from this study": 1, "insight on the possible": 1, "possible contribution of nursing": 2, "future prospective experimental research": 4, "contribute to the advancement": 1, "treatment of older adults": 1, "contribution of nursing care": 1, "nursing care to outcomes": 2, "influences cardiac hypertrophic response": 4, "expressed in the heart": 2, "actions on adenylyl cyclase": 1, "regulated by the actions": 1, "simultaneous activation of \u03b21ars": 2, "action on camp production": 1, "- adrenergic receptor agonist": 4, "reciprocal regulation in mouse": 2, "regulation in mouse hearts": 1, "- adrenergic receptor stimulation": 4, "model of postischemic heart": 1, "restoration of cardiac plasma": 1, "cardiac plasma membrane levels": 4, "\u03b21ar overstimulation in heart": 2, "overstimulation in heart failure": 1, "impact of physician continuity": 1, "physician continuity on death": 2, "urgent readmission after discharge": 2, "lower rates of death": 2, "continuity further influences outcomes": 1, "influences outcomes after discharge": 2, "databases for all adults": 1, "time diagnosis of heart": 2, "hazard models with time": 2, "dependent covariates to analyze": 2, "physician within the first": 2, "within the first month": 1, "first month after discharge": 4, "discharge on the primary": 1, "year before the index": 1, "in the first month": 1, "visits with a familiar": 1, "better outcomes among patients": 4, "post - translational state": 4, "- adrenergic receptor blockade": 4, "adrenergic receptor blockade reduces": 4, "- adrenergic receptor activation": 4, "post - translational states": 4, "total myosin binding protein": 4, "western blots with site": 2, "mutant ri\u03b1 proteins demonstrated": 4, "myocardium displays altered expression": 4, "post - translational modification": 4, "modulation of repolarization instability": 1, "repolarization instability in patients": 2, "aim of the present": 1, "autonomic nervous system activity": 4, "min records of surface": 2, "records of surface ecgs": 1, "surface ecgs at baseline": 2, "expressed as the sd": 1, "calculated as an index": 1, "trend toward a higher": 2, "toward a higher baseline": 1, "compared with the hfvt(-": 1, "acute \u03b2 - adrenoceptor": 4, "\u03b2 - adrenoceptor blockade": 8, "adrenoceptor blockade with esmolol": 2, "larger fluctuations in beat": 2, "consequence of heart rate": 1, "acute autonomic nervous system": 4, "autonomic nervous system modulation": 4, "related congestive heart failure": 4, "heart failure in survivors": 2, "survivors of haematopoietic cell": 1, "developing congestive heart failure": 4, "pre - hct exposure": 4, "hct exposure to anthracyclines": 2, "association between the development": 1, "anti - oxidant defence": 4, "chf predictive model performed": 4, "right ventricle in heart": 2, "common language to describe": 2, "syndrome of right heart": 1, "definitions of the distinctive": 1, "components of the right": 1, "consensus on a universal": 1, "definition of right heart": 1, "nomenclature for right heart": 1, "right heart circulatory failure": 4, "failure with a view": 1, "foster collaborative research initiatives": 4, "education in an effort": 1, "class angiotensin receptor neprilysin": 4, "angiotensin receptor neprilysin inhibitor": 8, "neprilysin inhibitor in heart": 2, "inhibitor in heart failure": 1, "receptor neprilysin inhibitor composed": 4, "composed of a neprilysin": 1, "angiotensin receptor antagonist valsartan": 4, "promise in a pilot": 1, "pilot trial of heart": 2, "trial of heart failure": 2, "tested in a large": 1, "outcomes trial of heart": 2, "preserved ejection fraction outcomes": 4, "ejection fraction outcomes trial": 4, "treatment of acute heart": 1, "defined as the rapid": 1, "signs of heart failure": 1, "situation in which diagnosis": 1, "principles of pharmacologic treatment": 1, "therapeutic implications of biomarkers": 2, "biomarkers in chronic heart": 1, "understanding of chronic heart": 1, "progressed from the concept": 1, "focus of research investigations": 1, "window into the pathophysiology": 1, "biomarkers in the treatment": 1, "shortcomings in research studies": 1, "statistical standards in biomarker": 2, "standards in biomarker studies": 1, "guided clinical trial design": 4, "potential of a multimarker": 1, "micrornas in heart failure": 1, "new targets in disease": 2, "targets in disease management": 1, "mortality in western society": 1, "subclass of cardiovascular diseases": 1, "progression of heart failure": 2, "expression of target genes": 1, "target genes by sequence": 2, "untranslated region of messenger": 2, "role in diverse aspects": 1, "aspects of cardiac remodeling": 1, "overview of these mirnas": 1, "role in cardiac pathogenesis": 1, "insight into the potential": 1, "therapeutic targets for heart": 2, "targets for heart failure": 1, "system inhibitors in heart": 2, "inhibitors in heart failure": 1, "evidence for the treatment": 1, "target in the treatment": 1, "evidence for these drugs": 1, "exercise capacity in adults": 2, "cardiac filling during exercise": 2, "reduced skeletal muscle mass": 4, "underwent cardiopulmonary exercise testing": 4, "quantification with dual x": 1, "dual x - ray": 4, "single tertiary referral centre": 4, "skeletal muscle mass assessed": 4, "relative appendicular lean mass": 4, "appendicular lean mass index": 4, "low skeletal muscle mass": 4, "skeletal muscle mass correlated": 4, "skeletal muscle mass t": 4, "sarcopenic range muscle wasting": 4, "measured by the rate": 1, "659 heart failure patients": 4, "performed confirmatory factor analysis": 4, "used exploratory factor analysis": 4, "presence of separate scale": 1, "separate sub - sample": 4, "validity of individual scales": 1, "showed excellent fit indices": 4, "understanding of the structure": 1, "use in clinical practice": 1, "natriuretic peptides in plasma": 2, "contribute to the misdiagnosis": 1, "misdiagnosis of heart failure": 1, "patient plasma by use": 2, "consistent with this result": 1, "fragments of the full": 1, "improved with the use": 1, "development of a next": 1, "region of this molecule": 1, "concentric left ventricular hypertrophy": 4, "ventricular hypertrophy in heart": 2, "hypertrophy in heart failure": 1, "occur in these patients": 1, "outcome data among groups": 4, "lower systolic blood pressure": 4, "similar rates of hypertension": 2, "ratio of systolic blood": 1, "elevated cardiac filling pressures": 4, "metoprolol on the endpoint": 1, "metoprolol on inappropriate therapy": 1, "inappropriate therapy in heart": 2, "failure patients with devices": 2, "different types of beta": 2, "blockers on the primary": 1, "endpoint of inappropriate therapy": 1, "patients during a follow": 1, "risk of inappropriate therapy": 2, "general use of beta": 2, "adherence in this study": 1, "heart failure patients undergoing": 4, "undergoing either cardiac resynchronization": 4, "lower rate in patients": 2, "occurrence of heart failure": 1, "nationwide retrospective cohort study": 4, "risk of heart failure": 8, "absolute risk of heart": 2, "% in the exposed": 1, "% in the control": 1, "used for the same": 1, "different mechanism of action": 2, "trends in the risk": 1, "refill compliance for etidronate": 2, "reduction in this risk": 1, "reversal of cardiac dysfunction": 1, "subcellular alterations by metoprolol": 2, "metoprolol in heart failure": 1, "reversibility of heart failure": 1, "negative rates of changes": 2, "changes in pressure development": 1, "20 weeks mi animals": 4, "elevated levels of plasma": 4, "levels of plasma norepinephrine": 1, "elevated levels of epinephrine": 2, "reduced in the infarcted": 1, "mrna level for \u03b2": 2, "- myosin heavy chain": 4, "improvement of cardiac performance": 1, "cardiac performance by \u03b2": 2, "blockade at advanced stages": 1, "advanced stages of heart": 2, "stages of heart failure": 1, "partial reversal of changes": 2, "complete reverse cardiac remodeling": 4, "reduction in the elevated": 1, "levels of plasma catecholamines": 1, "factor for cardiovascular disease": 1, "embedded within the population": 2, "using general linear models": 4, "hazards of cardiovascular events": 1, "cardiovascular events for psoriasis": 2, "higher diastolic blood pressure": 4, "body mass index levels": 4, "coronary artery calcium scores": 4, "% confidence interval 0.50": 4, "disease from the general": 1, "cardiovascular events as subjects": 2, "presence of diastolic dysfunction": 1, "diastolic dysfunction in patients": 2, "patients with peripheral artery": 1, "share many risk factors": 4, "consecutive patients with pad": 2, "defined by an ankle": 1, "logistic regression analysis established": 4, "associated with the highest": 1, "highest quartile of e": 2, "hospital readmission reduction program": 4, "program for congestive heart": 1, "day readmission rate following": 4, "readmission rate following hospital": 4, "rate following hospital stay": 4, "stay for congestive heart": 1, "indicating possible suboptimal care": 4, "suboptimal care of patients": 2, "patients with this condition": 1, "located in a community": 1, "diagnosis of congestive heart": 1, "intensive transitions of care": 4, "transitions of care program": 2, "management training of patients": 2, "monitoring of the patient": 1, "patient by the health": 1, "documented for those patients": 1, "participating in the pilot": 1, "cost of the intervention": 1, "patients with congestive heart": 2, "failure in a non": 1, "- urbanized midwestern state": 4, "rate variability in risk": 2, "variability in risk stratification": 1, "stratification of cardiac patients": 2, "abnormal hr variability have": 3, "mortality within a few": 2, "within a few years": 1, "years after an ami": 1, "various measures of hr": 2, "measures of hr dynamics": 1, "non - linear measures": 4, "linear measures of hr": 2, "measures of hr variability": 1, "power of various measures": 1, "non - linear hr": 4, "- linear hr variability": 4, "linear hr variability measures": 4, "term fractal scaling exponent": 4, "- sudden cardiac death": 4, "remodeling of the arrhythmia": 1, "early measurement of hr": 2, "measurement of hr variability": 2, "trials using hr variability": 4, "- defined inclusion criteria": 4, "routine measurement of hr": 2, "clinical tool for risk": 2, "tool for risk stratification": 1, "form of peripheral arterial": 1, "resulting in the activation": 1, "activation of the renin-": 1, "end stage kidney failure": 4, "magnetic resonance angiography is": 3, "adequate blood pressure control": 4, "percutaneous revascularization with angioplasty": 2, "showed modest clinical benefit": 4, "clinical benefit for patients": 2, "provide more concrete data": 1, "treatment plans for patients": 2, "bioinformatic analysis of microarray": 2, "analysis of microarray data": 1, "reveals several key genes": 4, "major public health problem": 8, "ischemic heart failure samples": 8, "non - ischemic heart": 4, "- ischemic heart failure": 4, "interactors of the degs": 1, "part of the network": 1, "functional enrichment analysis revealed": 4, "types of heart failure": 1, "effects of care management": 1, "longitudinal analysis using medicare": 4, "analysis using medicare data": 4, "effects of an intervention": 1, "individuals with congestive heart": 1, "retrospective matched cohort study": 4, "score matched control group": 4, "telehealth system with care": 2, "system with care management": 1, "negative binomial regression models": 4, "relationship between the intervention": 1, "reductions in the number": 1, "inpatient admissions from baseline": 2, "baseline to the study": 1, "controls during this same": 1, "number of hospital days": 1, "hospital days for participants": 2, "fewer admissions for individuals": 2, "telehealth technology has potential": 2, "outcomes in chronic heart": 1, "race as an independent": 1, "outcomes in a contemporary": 1, "contemporary chronic heart failure": 4, "association with exercise training": 1, "interactions with exercise training": 1, "% to usual care": 1, "interaction with exercise training": 1, "socioeconomic status versus whites": 4, "risk for all outcomes": 1, "given similar cardiovascular mortality": 4, "black race in patients": 2, "prevalence of modifiable risk": 1, "differential response to exercise": 2, "treatment of atrial fibrillation": 2, "optimal therapy including anticoagulation": 4, "safety of rhythm control": 1, "modern rhythm control therapy": 4, "patients with recent onset": 2, "onset af at risk": 2, "early rhythm control therapy": 8, "therapy in a prospective": 1, "blinded outcome assessment trial": 4, "end of the trial": 1, "trial for the composite": 1, "outcome of cardiovascular death": 1, "counted as a coprimary": 1, "control as an initial": 1, "therapy by antiarrhythmic drugs": 1, "electrocardiographic device to monitor": 2, "patients with ventricular assist": 2, "implantation of a long": 1, "term ventricular assist device": 4, "use of these devices": 1, "bleeding in this population": 1, "asked about the management": 1, "management of gastrointestinal bleeding": 1, "array of diagnostic procedures": 1, "treatments for this complication": 1, "understanding of this topic": 1, "management of end stage": 1, "end stage heart failure": 12, "dependent increase in incidence": 2, "hospitalisation among the elderly": 2, "consequence of the worldwide": 1, "worldwide increase in life": 2, "increase in life expectancy": 1, "improvements in the treatment": 1, "failure in recent years": 1, "phase of the disease": 1, "patients with end stage": 1, "stage heart failure fall": 4, "advanced structural heart disease": 4, "heart failure at rest": 2, "requires special therapeutic interventions": 4, "causes for a worsening": 1, "worsening of heart failure": 1, "strategies for the treatment": 1, "treatment of end stage": 1, "potent inhibition of l": 2, "phase of ventricular action": 1, "coupling in the myocardium": 1, "family of monomeric g": 1, "ventricular action potential duration": 4, "ability to inhibit cardiac": 1, "heart failure in humans": 2, "type channel isoforms known": 4, "inhibition of both channels": 1, "movement of both channels": 1, "rule out the possibility": 1, "mistargeting or altered regulation": 1, "complex situations in pediatrics": 2, "age of legal majority": 1, "sickle cell disease has": 3, "cell disease has life": 2, "common inpatient medical conditions": 4, "public reporting on quality": 2, "reporting on quality aims": 1, "derived composite quality measure": 4, "quality measure for heart": 2, "measure for heart failure": 1, "variance in future hospital": 1, "cohort of older patients": 1, "treated at an acute": 1, "hospitals on the basis": 1, "performance on the composite": 1, "mortality at the worst": 1, "best quintile of hospitals": 2, "hospital in the worst": 1, "best quintile of performance": 2, "composite measures of quality": 2, "variation in future mortality": 1, "spironolactone in severe heart": 1, "efficacy of mineralocorticoid receptor": 2, "receptor antagonists in heart": 2, "antagonists in heart failure": 1, "higher estimated glomerular filtration": 4, "non - aa participants": 4, "race by treatment interaction": 1, "higher throughout the trial": 2, "attain maximal spironolactone dose": 4, "higher rates of hyperkalemia": 2, "lower rates of hypokalemia": 2, "differences in baseline characteristics": 1, "achieved study drug dose": 4, "end point of death": 2, "derive less clinical benefit": 4, "pathway analysis of pressure": 2, "free shotgun proteomics approach": 4, "associated signaling pathway changes": 4, "pathway changes using ingenuity": 4, "changes using ingenuity pathway": 4, "using ingenuity pathway analysis": 4, "categories of actin cytoskeleton": 1, "congestive heart failure phenotypes": 4, "parallel with global attenuation": 1, "attenuation of mitochondrial proteome": 1, "% of nonmitochondrial protein": 1, "ingenuity pathway analysis noted": 4, "modest effects on heart": 2, "effects on heart failure": 1, "attenuation of global proteomics": 1, "alterations by the mitochondrial": 1, "many of the pathway": 1, "pathway alterations in tac": 2, "drugs for the treatment": 1, "length of stay increase": 1, "increase rehospitalization of medicare": 2, "rehospitalization of medicare fee": 1, "post - acute care": 8, "- acute care transfer": 8, "acute care transfer policy": 8, "policy as a quasi": 1, "care transfer policy led": 4, "immediate declines in length": 2, "day decrease in length": 2, "associated with an absolute": 1, "ami without major complications": 4, "day reduction in hospital": 2, "reduction in hospital length": 1, "hospital length of stay": 2, "higher rate of rehospitalization": 2, "urgent need to improve": 2, "better outcomes for patients": 2, "admissions to acute care": 1, "costs across volume groups": 4, "physician volume within strata": 4, "strata of hospital volume": 1, "relationship between physician volume": 1, "antagonism in heart failure": 1, "role in the progression": 1, "groups with heart failure": 1, "symptomatic chronic advanced heart": 4, "chronic advanced heart failure": 8, "advanced heart failure patients": 8, "standard therapy with beta": 2, "therapy with beta blockade": 1, "myocardial infarction heart failure": 8, "- myocardial infarction patients": 4, "infarction patients with heart": 2, "significant reduction in mortality": 2, "randomized to the aldosterone": 1, "background for aldosterone antagonist": 1, "infarction heart failure patients": 4, "patients with reduced ejection": 1, "survival rates of patients": 2, "substantial improvement in survival": 2, "prognosis of a large": 1, "large idiopathic dilated cardiomyopathy": 4, "idiopathic dilated cardiomyopathy cohort": 4, "followed during the past": 1, "including negative coronary angiography": 4, "periods on the basis": 1, "basis of heart failure": 1, "heart failure treatment eras": 4, "devices at final evaluation": 1, "enrollment of older patients": 1, "severe left ventricular dilatation": 4, "dysfunction during the years": 1, "end point including death": 4, "recent enrollment period represented": 4, "predictor of favorable outcome": 1, "42 % risk reduction": 4, "reduction versus the previous": 2, "marked decreases in heart": 2, "decreases in heart failure": 1, "improvement in the prognosis": 1, "cardiomyopathy during the past": 1, "replicated in the real": 1, "term continuity of care": 2, "value of indeterminable anaerobic": 1, "anaerobic threshold in heart": 2, "threshold in heart failure": 1, "maximal cardiopulmonary exercise test": 4, "cardiopulmonary exercise test investigations": 4, "test investigations at study": 2, "investigations at study enrollment": 1, "achievement of anaerobic metabolism": 1, "peak respiratory quotient \u22641.05": 4, "primary study end point": 8, "composite of cardiovascular death": 1, "secondary end point was": 3, "at multivariable logistic analysis": 4, "reduced peak oxygen uptake": 4, "kidney index score value": 4, "diet in renal disease": 1, "obtained for the secondary": 1, "secondary study end point": 4, "failure mortality in men": 2, "associations among cardiorespiratory fitness": 4, "number of cardiovascular risk": 1, "men without a history": 2, "history of cardiovascular disease": 1, "measures included body mass": 4, "included body mass index": 4, "duration of maximal treadmill": 1, "maximal treadmill exercise testing": 4, "during a mean follow": 1, "obese body mass index": 4, "body mass index categories": 4, "mass index categories were": 3, "overweight body mass index": 4, "body mass index strata": 4, "matched for the same": 1, "mortality risk in men": 2, "activity with the goal": 1, "decreased mitochondrial energy production": 4, "mitochondrial energy production precede": 4, "development of systolic heart": 1, "heart failure after pressure": 2, "significant alterations in energy": 2, "alterations in energy metabolism": 1, "changes in energy metabolism": 1, "contribute to the development": 1, "failure in the hypertrophied": 1, "overload as a result": 1, "result of an abdominal": 1, "rates of energy substrate": 1, "development of cardiac hypertrophy": 2, "assessment of cardiac function": 1, "% increase in e": 2, "% decrease in %": 2, "decrease in % ejection": 1, "evidenced by a significant": 1, "significant decrease in insulin": 2, "membrane translocation of glucose": 2, "translocation of glucose transporter": 1, "reduction in mitochondrial oxidation": 1, "mitochondrial oxidation of glucose": 2, "accompanied by an increase": 1, "increase in myocardial glycolysis": 1, "reduced mitochondrial complex v": 4, "mitochondrial complex v activity": 4, "concomitant with a reduction": 1, "reduction in the ratio": 1, "development of cardiac insulin": 1, "decreased mitochondrial oxidative metabolism": 4, "changes in the development": 1, "contribute to the progression": 1, "hypertrophy to heart failure": 1, "reality of heart failure": 1, "guide health service planning": 4, "planning in the prevention": 1, "adequacy of relevant health": 1, "relevant health service provision": 4, "health service provision related": 4, "search of the electronic": 1, "total expenditure on health": 4, "developed and nondeveloped countries": 1, "raised blood glucose levels": 4, "lower gross national income": 4, "national income per capita": 4, "renal chloride channel gene": 4, "greater risk of heart": 2, "confirmation on other populations": 1, "link between air pollution": 1, "factor for cardiovascular health": 1, "review of the effects": 1, "effects of air pollution": 1, "air pollution on heart": 2, "pollution on heart failure": 1, "professionals in public health": 1, "heart failure in mice": 2, "regulator of cytoskeletal actin": 1, "cardiac dysfunction with conduction": 2, "dysfunction with conduction abnormalities": 1, "mass in the transgenic": 1, "decreases in ejection fraction": 1, "tac cardiac functional deterioration": 4, "future of advanced heart": 1, "considerable number of patients": 2, "developments in diagnostic procedure": 1, "addition to palliative care": 1, "palliative care of patients": 2, "patients in the terminal": 1, "recognition of advanced disease": 1, "vital in the determination": 1, "determination of therapeutic options": 1, "overall management of patients": 2, "professionals from multiple disciplines": 1, "experienced in the management": 1, "access to therapeutic options": 1, "aims of the present": 1, "results about the risk": 1, "uncertainty about the safety": 1, "safety of these antihyperglycemic": 1, "health system data partners": 4, "recorded as the principal": 1, "ratios from the disease": 1, "without prior cardiovascular disease": 4, "effectiveness of implementation strategies": 1, "recommendations in heart failure": 1, "systematic review to identify": 2, "physician adherence to class": 2, "search in the databases": 1, "prospective studies evaluating implementation": 4, "studies evaluating implementation interventions": 4, "impact of the intervention": 1, "adherence to the cpgs": 1, "proportion of eligible patients": 1, "care education at discharge": 2, "left ventricular function assessment": 4, "impact of implementation strategies": 1, "contextual factors on physician": 2, "factors on physician adherence": 1, "findings through briefing reports": 1, "perceptions of implantable cardioverter": 1, "recommendation for implantable cardioverter": 1, "perspective on the timing": 1, "timing of implantable cardioverter": 2, "25 heart failure patients": 4, "sound mind to engage": 2, "decisions about implantable cardioverter": 1, "identified in this study": 1, "information on implantable cardioverter": 1, "defibrillator deactivation at implant": 2, "change in clinical status": 1, "broader discussions about end": 2, "experiencing distressing implantable cardioverter": 4, "defibrillator shocks at end": 2, "objective of this clinical": 1, "efficacy of carotid baroreflex": 1, "carotid baroreflex activation therapy": 4, "reduction of sympathetic outflow": 1, "primary safety end point": 4, "primary efficacy end points": 4, "minute hall walk distance": 4, "improvements in the distance": 1, "associated with a trend": 1, "trend toward fewer days": 4, "burden of heart failure": 1, "failure hospitalizations in patients": 2, "using cardiopulmonary exercise testing": 4, "cardiopulmonary exercise testing guide": 4, "exercise testing guide exercise": 4, "testing guide exercise rehabilitation": 4, "exercise rehabilitation in patients": 2, "exercise rehabilitation in patient": 2, "patient with chronic heart": 1, "exercise patients used \u03b450%w": 4, "patients used \u03b450%w intensity": 4, "nosignificant changes in control": 2, "changes in control group": 1, "half of these patients": 1, "systolic function in hfpef": 2, "function in hfpef patients": 1, "reduced long axis function": 4, "subtle changes on exercise": 2, "women with a history": 1, "other cardiovascular risk factors": 4, "cornerstone in the assessment": 1, "extent of the symptoms": 1, "presence of peripheral oedema": 1, "peripheral oedema allows assessment": 4, "assessment of the patient": 1, "regular physical activity controls": 4, "physical activity controls acquired": 4, "acquired cardiovascular risk factors": 4, "reduction in adverse events": 1, "events from coronary artery": 1, "beyond the cardiovascular system": 1, "exercise prevents cell senescence": 4, "certain malignancies including cancer": 4, "cancer of the prostate": 1, "aerobic exercise per week": 4, "lower volumes of exercise": 2, "exercise below these recommendations": 1, "recommendations confer health benefits": 4, "cardiac disease including heart": 4, "disease including heart failure": 4, "cardiac death in athletes": 2, "abnormalities of the heart": 1, "cause of nontraumatic death": 1, "nontraumatic death during sport": 2, "sport in young athletes": 1, "pre - participation screening": 4, "screening of young athletes": 1, "ability to detect congenital": 1, "detect congenital accessory pathways": 4, "training for heart failure": 2, "\u00ae system in heart": 2, "system in heart failure": 1, "week aerobic training period": 4, "integrated dynamic resistance training": 4, "training of the lower": 1, "quality of life score": 1, "evaluation of the muscular": 1, "resulted in an improvement": 1, "improvement in peak work": 1, "quality of life assessment": 1, "safe in this trial": 1, "intervention with augmented feedback": 1, "benefits in exercise capacity": 1, "validation in larger studies": 1, "adherence with exercise training": 1, "exercise training for heart": 2, "association between social support": 1, "surveys to assess social": 1, "perceived social support score": 4, "levels of social support": 1, "higher exercise time associated": 4, "interaction between the randomization": 1, "corresponded to a borderline": 1, "hospitalization in the exercise": 1, "% confidence interval 0.99": 4, "association in the usual": 1, "% confidence interval 0.66": 4, "high barriers to exercise": 2, "exercise training on outcomes": 2, "greater impact on patients": 2, "patients with lower btes": 1, "exercise training improves outcomes": 4, "individualized approaches to implement": 2, "implement exercise training therapy": 4, "therapy in clinical practice": 1, "recent onset heart failure": 4, "blocker hypo - response": 4, "readmissions in heart failure": 1, "effect on heart rate": 1, "impact of hr reduction": 1, "hr reduction with beta": 4, "reduction with beta blockers": 1, "beta blockers on exercise": 2, "blockers on exercise capacity": 1, "capacity in recent onset": 1, "protocol with respiratory gas": 1, "gas analysis at baseline": 2, "participated in a quality": 1, "quality of care programme": 1, "target doses for beta": 2, "hr<70 versus \u226570 bpm": 4, "former versus the latter": 2, "kg increase in patients": 2, "interventions to reduce elevated": 1, "elevated left atrial pressure": 4, "atrial pressure improve symptoms": 4, "risk of hospital admission": 1, "efficacy of therapeutic left": 1, "enrolled under the canadian": 1, "canadian special access programme": 4, "transseptal catheterisation with transoesophageal": 2, "guidance under general anaesthesia": 1, "echocardiography evaluations at baseline": 2, "implanted in all patients": 1, "6 min walk test": 4, "min walk test distance": 4, "reduced from a mean": 1, "hospital with gastrointestinal bleeding": 1, "gastrointestinal bleeding at month": 2, "incessant ventricular tachycardia storm": 4, "haemodynamic outcomes in patients": 2, "shift in the treatment": 1, "problem of current cardiology": 1, "occurred in the therapy": 1, "therapy in recent years": 1, "first results of studies": 2, "effect of natriuretic peptides": 1, "prospective randomized multicenter trial": 4, "randomized multicenter trial paradigm": 4, "stabilized chronic heart failure": 4, "failure with systolic dysfunction": 2, "decrease in primary endpoint": 1, "- specified subgroup analyses": 4, "stable chronic heart failure": 4, "contributed to this study": 1, "common form of heart": 2, "form of heart failure": 1, "failure among older persons": 4, "determinant of reduced quality": 1, "reduced quality of life": 2, "urban academic medical center": 4, "indicate worse heart failure": 4, "total score with exercise": 2, "correlated with the change": 1, "percent lean body mass": 4, "change in thigh muscle": 1, "related serious adverse events": 4, "among obese older patients": 4, "aerobic exercise training increased": 4, "exercise training increased peak": 4, "significant effect on quality": 2, "left ventricular assist system": 4, "term support to patients": 2, "rotor with wide blood": 1, "aim of this single": 1, "adults with ejection fraction": 1, "88 % performance goal": 4, "adverse events included reoperation": 4, "favorable adverse event profile": 4, "effectiveness of disease management": 1, "management programs in heart": 4, "heart failure disease management": 8, "failure disease management programs": 8, "influence medical resource use": 4, "based on a modified": 1, "projections of resource use": 1, "pairs of virtual cohorts": 1, "estimates of resource use": 1, "effectiveness ratios from user": 2, "ratios from user inputs": 1, "effectiveness of heart failure": 1, "program in which short": 1, "term improvements in functioning": 2, "value to the health": 1, "providers with a tool": 1, "effectiveness analyses of disease": 2, "analyses of disease management": 1, "nurses in all settings": 1, "medical management to alleviate": 2, "advancement of the pathophysiologic": 1}, "3": {"national efforts dedicated": 3, "improve patient safety": 3, "patient safety remain": 3, "database to assess": 1, "assess national trends": 3, "adverse event rates": 9, "acute myocardial infarction": 33, "congestive heart failure": 84, "conditions requiring surgery": 3, "large study sample": 3, "hospital adverse events": 3, "adverse events averted": 3, "measurable overall improvements": 3, "improvements for patients": 1, "admitted with pneumonia": 1, "considerable national attention": 3, "national patient safety": 3, "patient safety initiatives": 3, "cross - talk": 3, "cachectic heart failure": 3, "heart failure patients": 60, "patients with respect": 1, "respect to alterations": 1, "alterations in body": 1, "associated with changes": 1, "changes in body": 1, "increased energy expenditure": 3, "b natriuretic peptides": 3, "play a role": 2, "tested the hypothesis": 3, "neurohormones and adipokines": 1, "associated with body": 1, "fat free mass": 3, "composition with regard": 1, "body fat distribution": 3, "dual energy x": 3, "energy x -": 6, "x - ray": 9, "- ray absorptiometry": 9, "- diabetic patients": 3, "chronic heart failure": 96, "- cachectic chf": 3, "chf and individuals": 1, "prior myocardial infarction": 3, "follow up body": 1, "correlation to changes": 1, "associated with plasma": 1, "adiponectin at baseline": 1, "correlate to changes": 1, "changes in nps": 1, "nps or adiponectin": 1, "adiponectin during follow": 1, "stable body weight": 3, "diagnosis of heart": 3, "failure with preserved": 24, "preserved ejection fraction": 90, "% of patients": 12, "patients with heart": 66, "heart failure show": 3, "prevalence of heart": 1, "lv diastolic dysfunction": 6, "major underlying mechanism": 3, "clinical diastolic dysfunction": 3, "diastolic dysfunction leading": 3, "guidelines based definition": 3, "requires a presence": 1, "presence of signs": 1, "signs and symptoms": 1, "symptoms of heart": 2, "dilated left ventricle": 3, "treatment of anemia": 3, "anemia in patients": 2, "clinical practice guideline": 3, "developed this guideline": 1, "guideline to present": 1, "present the evidence": 1, "provide clinical recommendations": 3, "anemia and iron": 2, "deficiency in adult": 1, "language on anemia": 1, "guideline included mortality": 3, "quality of life": 27, "heart failure exacerbation": 3, "venous thromboembolic events": 3, "ischemic cerebrovascular events": 3, "includes all clinicians": 1, "target patient population": 3, "patient population is": 4, "deficient adult patients": 3, "grades the evidence": 1, "evidence and recommendations": 1, "clinical practice guidelines": 3, "practice guidelines grading": 3, "guidelines grading system": 3, "restrictive red blood": 3, "red blood cell": 3, "blood cell transfusion": 3, "cell transfusion strategy": 3, "trigger hemoglobin threshold": 3, "higher hemoglobin levels": 3, "coronary heart disease": 15, "use of erythropoiesis": 1, "agents in patients": 1, "benefits of anemia": 1, "treatment in patients": 1, "evaluate the benefits": 1, "benefits and harms": 1, "harms of treatments": 1, "treatments for anemia": 1, "anemia in adults": 1, "adults with heart": 6, "clinical trial registries": 3, "trials of blood": 1, "agents in adults": 1, "adults with anemia": 1, "studies of transfusion": 1, "data on study": 1, "assessed for quality": 1, "observational studies suggests": 3, "liberal transfusion protocols": 3, "term mortality rates": 3, "less aggressive protocols": 3, "combined relative risk": 3, "risk among trials": 3, "decreased mortality rates": 3, "trial of patients": 1, "acute coronary syndrome": 3, "intravenous iron found": 3, "term exercise tolerance": 3, "tolerance and quality": 1, "life in patients": 2, "trials of erythropoiesis": 1, "stimulating agent therapy": 3, "associated with harms": 1, "transfusions in patients": 1, "confounded by indication": 1, "data supporting iron": 3, "supporting iron use": 3, "higher transfusion thresholds": 3, "consistently improve mortality": 3, "improve mortality rates": 3, "symptoms in patients": 2, "failure and iron": 1, "warrants further study": 1, "anemia and heart": 1, "remote ischemic conditioning": 3, "conditioning for patients": 1, "management of patients": 6, "implantable cardioverter defibrillators": 6, "cardiac resynchronization therapy": 39, "right ventricular assist": 6, "ventricular assist devices": 27, "left ventricular ejection": 102, "ventricular ejection fraction": 93, "fraction and patients": 1, "ways to deal": 1, "acute heart failure": 57, "heart failure clinical": 3, "failure clinical trials": 3, "enriching patient identification": 3, "identification and enrollment": 1, "as the authors": 1, "modern acute heart": 3, "appropriate risk stratification": 3, "predictors of mortality": 4, "mortality in patients": 5, "implantable cardiac defibrillator": 3, "review and meta": 1, "many current predictors": 3, "mortality in heart": 1, "conducted a meta": 1, "analysis to identify": 1, "associated with mortality": 5, "reviewers selected citations": 3, "addressed the association": 1, "predictor and mortality": 1, "using multivariable regression": 3, "confidence in estimates": 2, "found for age": 1, "95 % confidence": 132, "% confidence interval": 114, "baseline glomerular filtration": 3, "glomerular filtration rate": 36, "obstructive pulmonary disease": 15, "peripheral vascular disease": 9, "10 % increase": 3, "strong reliable mortality": 3, "reliable mortality predictors": 3, "shocks during follow": 1, "male sex were": 2, "failure randomized trial": 3, "small studies suggest": 3, "preserve renal function": 6, "function in patients": 3, "compared with placebo": 6, "min without bolus": 3, "controlled clinical trial": 3, "estimated glomerular filtration": 33, "hours of admission": 1, "1:1 allocation ratio": 3, "within each strategy": 1, "treatment or placebo": 1, "pooled placebo group": 3, "hour cumulative urine": 9, "cumulative urine volume": 9, "decongestion end point": 3, "change in serum": 1, "serum cystatin c": 3, "c from enrollment": 1, "renal function end": 3, "function end point": 3, "change in cystatin": 2, "cystatin c level": 6, "dopamine or nesiritide": 1, "secondary end points": 3, "end points reflective": 3, "conclusion and relevance": 3, "nesiritide enhanced decongestion": 3, "improved renal function": 3, "study to promote": 1, "adoption of heart": 1, "heart failure guidelines": 3, "lessons for nurse": 1, "many multisite studies": 3, "studies in practice": 1, "processes of care": 2, "improving patient outcomes": 3, "specific research questions": 3, "issues and strategies": 1, "individuals and organizations": 1, "utilizing voluntary testimonies": 3, "testimonies and conversations": 1, "conversations with participating": 1, "benefits of involvement": 1, "extend beyond meeting": 3, "beyond meeting magnet": 3, "cardiac chromatin identifies": 3, "chromatin identifies nucleolin": 3, "regulator of growth": 1, "plasticity in cardiomyocytes": 1, "failure involves changes": 3, "global gene expression": 3, "mechanisms to coordinate": 1, "coordinate dna accessibility": 3, "proteins alter chromatin": 6, "alter chromatin structure": 6, "structure by changing": 1, "altering the gene": 1, "gene expression profile": 6, "changes in chromatin": 2, "accompany heart failure": 3, "present study tests": 3, "growth and plasticity": 1, "setting of disease": 1, "conserved developmental chromatin": 3, "developmental chromatin remodeling": 3, "chromatin remodeling events": 3, "used quantitative proteomics": 3, "proteomics to identify": 1, "extracted via detergent": 3, "abundance during disease": 1, "using strong acid": 3, "of these proteins": 1, "exhibited altered expression": 3, "hypertrophy and failure": 1, "extensive functional characterization": 3, "knockdown of nucleolin": 1, "nearly abolished protein": 3, "abolished protein expression": 3, "gross morphological development": 3, "hearts of fish": 1, "severe developmental impairment": 3, "abnormal chamber patterning": 3, "looping and myocyte": 1, "underlying these defects": 1, "bone morphogenetic protein": 3, "protein 4 expression": 3, "decreased rrna transcription": 3, "new chromatin subproteome": 3, "diseased mouse heart": 3, "complementary model system": 3, "system of zebrafish": 1, "examine the role": 1, "genomic reprogramming events": 3, "shared between development": 1, "development and disease": 2, "factors and outcomes": 1, "myocardial ischemic events": 3, "events in patients": 3, "receive cardiac resynchronization": 6, "limited data regarding": 3, "data regarding risk": 3, "regarding risk factors": 3, "present study population": 3, "proportional hazards regression": 3, "identify risk factors": 3, "acute coronary syndromes": 6, "among study patients": 6, "identify the effect": 1, "subsequent heart failure": 6, "included previous revascularization": 3, "coronary artery bypass": 9, "artery bypass surgery": 3, "percutaneous coronary intervention": 3, "increased systolic blood": 3, "systolic blood pressure": 18, "left bundle branch": 12, "bundle branch block": 12, "branch block pattern": 3, "compared with defibrillator": 1, "dependent analysis showed": 3, "development of ies": 2, "failure or death": 2, "reduce the risk": 4, "contemporary heart failure": 3, "outcomes among patients": 6, "mortality after hospitalization": 1, "years after hospitalization": 1, "among the study": 1, "patients with preserved": 4, "mortality as patients": 2, "increased increase rate": 3, "interaction term analysis": 3, "patients \u226475 years": 3, "among older patients": 9, "value for age": 1, "older age group": 3, "changes in circulating": 1, "circulating progenitor cells": 6, "associated with outcome": 3, "outcome in heart": 1, "evaluated the association": 1, "capacity and outcomes": 1, "outcomes in heart": 2, "cd133 + cells": 3, "ventricular assist device": 36, "decrease in cd34+vegfr2": 2, "cd34+vegfr2 + cells": 9, "increased functional capacity": 3, "min in peak": 1, "found an interaction": 1, "cfus and diabetes": 1, "patients without diabetes": 3, "patients with diabetes": 2, "noted differential relations": 3, "outcomes in patients": 5, "improved functional capacity": 6, "requires further examination": 1, "applications of readmission": 1, "impact on hospital": 1, "three readmission metrics": 3, "day readmission rates": 3, "three disease groups": 3, "change and correlation": 1, "correlation between performance": 1, "percent of hospitals": 2, "deciles and level": 1, "level of agreement": 1, "average hospital rates": 3, "conditions and metrics": 1, "using the ppr": 1, "extreme decile according": 3, "correlations among metrics": 3, "hospital longitudinal change": 3, "approaches to computing": 1, "produce different hospital": 3, "different hospital rankings": 3, "rankings and impact": 1, "placed on readmission": 1, "readmission metric choice": 3, "recent hospital discharge": 6, "discharge in patients": 1, "review and network": 2, "readmission to hospital": 1, "hospital for heart": 1, "potential to deliver": 1, "deliver specialised care": 3, "care and management": 1, "way to meet": 1, "heart failure population": 3, "strategies improve outcomes": 3, "outcomes for adults": 1, "supplemented by hand": 1, "searching relevant articles": 3, "observational cohort studies": 3, "contemporaneous control group": 3, "interventions included home": 3, "included home telemonitoring": 3, "implanted monitoring devices": 6, "medical support provided": 6, "provided during office": 2, "structured telephone support": 3, "delivered via human": 3, "extracted and validity": 1, "trial of implanted": 1, "met the inclusion": 1, "reaching statitistical significance": 3, "% credible interval": 3, "95 % cri": 6, "effect on mortality": 1, "generally improved health": 3, "showed beneficial trends": 3, "recently discharged patients": 3, "investigation of apoptosis": 1, "participation of apoptosis": 1, "development of pacing": 1, "induced dilated cardiomyopathy": 3, "right ventricular pacing": 3, "interventricular septum biopsies": 3, "21 beagle dogs": 3, "development of heart": 3, "evaluated protein levels": 3, "blot and dna": 1, "moderate heart failure": 3, "increased in heart": 1, "increased in dogs": 1, "weeks of pacing": 1, "band of activated": 1, "difference between numbers": 1, "favour of apoptosis": 1, "pathogenesis of heart": 1, "attributed to activation": 1, "pump sternal sparing": 3, "sternal sparing approach": 3, "left ventricular assist": 30, "advanced heart failure": 33, "incidence of pump": 1, "dysfunction requiring pump": 3, "requiring pump replacement": 3, "failure or driveline": 1, "isolated pump replacement": 3, "avoids a redo": 1, "used this technique": 1, "technique to exchange": 1, "loss and transfusion": 1, "deaths or strokes": 1, "angiotensin system blocker": 3, "blocker and beta": 1, "therapy in patients": 2, "hospitalized for heart": 3, "failure with reduced": 7, "ventricular ejection fractions": 6, "in ambulatory patients": 3, "reduced ejection fraction": 57, "blockers at guideline": 1, "recommended target dose": 6, "mortality and readmissions": 2, "assesses the impact": 1, "- blocker uptitrations": 6, "uptitrations in patients": 1, "in consecutive patients": 3, "- blocker dose": 6, "blocker dose changes": 3, "\u03b2 - blocker": 24, "blocker dose increase": 3, "compared with patients": 3, "patients without uptitration": 3, "higher heart rate": 3, "better renal function": 3, "correction for age": 1, "\u03b2 - blockers": 12, "95 % ci": 66, "- blocker uptitration": 3, "low co -": 3, "- morbidity burden": 3, "predicts clinical outcome": 3, "outcome in patients": 2, "relationship between sex": 2, "type natriuretic peptide": 45, "natriuretic peptide levels": 6, "levels in patients": 2, "hospitalized with heart": 1, "failure and associations": 1, "in heart failure": 6, "differences in plasma": 1, "levels between reduced": 1, "explored sex differences": 3, "evaluate the relationship": 1, "determine prognostic significance": 3, "relates to sex": 1, "patients with reduced": 3, "primary end point": 9, "compute odds ratios": 3, "accounting for hospital": 1, "37 % female": 3, "48 % female": 3, "65 % female": 3, "compared with men": 1, "higher admission median": 3, "difference among reduced": 3, "difference among preserved": 3, "women vs men": 3, "fraction and sex": 1, "predict inhospital mortality": 6, "among all subgroups": 1, "p for heterogeneity": 1, "among these subgroups": 1, "management of heart": 2, "failure in children": 1, "pediatric heart failure": 6, "cause of morbidity": 1, "morbidity and mortality": 9, "mortality in childhood": 1, "article presents guidelines": 3, "early medical management": 3, "practitioners in office": 1, "based or emergency": 1, "emergency room practice": 3, "undiagnosed heart disease": 3, "disease and symptoms": 1, "received surgical palliation": 3, "advanced management involving": 3, "involving ventricular assist": 3, "relationships with mortality": 1, "read the article": 1, "impairment at hospitalization": 1, "time of discharge": 1, "elderly patients hospitalized": 3, "analyzed the association": 1, "mortality or readmission": 1, "consecutive patients seen": 3, "patients as having": 1, "for each year": 1, "determined chf visit": 3, "chf visit rates": 3, "calculated the percentage": 1, "% confidence intervals": 9, "performed regression analyses": 3, "\u00b1 14 years": 3, "heart failure visits": 3, "% relative decrease": 3, "annual ed visits": 3, "better chf treatments": 3, "systolic ventricular function": 3, "significant liver disease": 3, "traditional heart failure": 3, "low systemic vascular": 3, "systemic vascular resistance": 6, "preserved cardiac index": 3, "perform a control": 1, "case cohort analysis": 3, "mean catheterization findings": 3, "central venous pressure": 3, "pressure 18 \u00b1": 3, "\u00b1 3 mm": 3, "550 dyn s": 2, "index 2.7 \u00b1": 3, "\u00b1 0.7 l": 3, "abnormal liver texture": 3, "liver texture changes": 3, "patients with failing": 1, "similar cardiac index": 3, "cardiac index compared": 3, "distinct circulatory derangement": 3, "hemodynamic features similar": 3, "ability to augment": 1, "augment cardiac output": 3, "comparison of predictors": 1, "predictors of heart": 1, "hospitalization or death": 3, "death in patients": 2, "patients with versus": 1, "versus without preserved": 3, "ability to identify": 1, "studied the patients": 1, "patients having heart": 1, "study the impact": 1, "impact of self": 1, "outcome of death": 3, "final multivariate models": 3, "minute walk test": 6, "80 % adherence": 3, "co - morbidities": 3, "gender and adherence": 1, "prescribed therapy were": 2, "training in patients": 3, "failure promotes restoration": 3, "density lipoprotein functional": 3, "lipoprotein functional properties": 3, "effects via stimulation": 3, "stimulation of endothelial": 1, "impaired in patients": 1, "effects of exercise": 1, "evaluate the impact": 1, "mediated protective effects": 3, "respective molecular pathways": 3, "pathways in patients": 1, "methods and results": 93, "incubated with hdl": 1, "malondialdehyde and hdl": 1, "induced no production": 6, "assessed by flow": 1, "proteome of hdl": 1, "profiled by shotgun": 1, "stimulation of phosphorylation": 1, "amount of malondialdehyde": 1, "bound to hdl(nyha": 1, "in healthy individuals": 3, "effect on hdl": 1, "significantly improved hdl": 3, "improved hdl function": 3, "correlation between changes": 1, "changes in hdl": 1, "production and flow": 1, "mediated dilatation improvement": 3, "improved the hdl": 1, "mediated vascular effects": 3, "exerts beneficial effects": 3, "predictive cutoff value": 9, "value for plasma": 1, "survival of patients": 4, "time of admission": 3, "first research done": 3, "value for admission": 1, "measured in plasma": 1, "patients with dyspnea": 1, "left ventricular dysfunction": 15, "time of inclusion": 1, "\u00b1 10.3 years": 3, "non - survivors": 3, "\u00b1 11.07 years": 3, "point for predicting": 1, "85.9 % sensitivity": 3, "39.1 % specificity": 3, "years after admission": 1, "optimal cutoff level": 3, "novel heart failure": 3, "heart failure mice": 3, "failure mice model": 3, "hypertensive heart disease": 6, "disease by angiotensin": 1, "mouse heart failure": 3, "investigate the pathophysiology": 1, "new therapeutic targets": 3, "targets for hhd": 1, "simple experimental procedures": 3, "develop a novel": 1, "combining salt loading": 3, "loading and uninephrectomy": 2, "infusion and uninephrectomy": 1, "infusion and salt": 1, "showed significant decreases": 3, "shortening and increases": 1, "increases in lung": 1, "after the addition": 1, "addition of salt": 1, "infusion mouse model": 3, "model to study": 1, "study the transition": 1, "transition from compensated": 1, "approach to predict": 1, "predict heart failure": 3, "heart failure risk": 6, "risk in communities": 1, "various cardiovascular diseases": 3, "increases in incidence": 1, "cardiac troponin t": 3, "associated with incident": 1, "age and race": 1, "antihypertensive medication use": 3, "body mass index": 36, "prevalent coronary heart": 3, "operating characteristic curve": 6, "integrated discrimination improvement": 6, "net reclassification improvement": 6, "participants developed incident": 3, "% in women": 1, "women and men": 1, "simpler laboratory report": 3, "laboratory report model": 3, "clinical characteristics results": 3, "survival after left": 1, "right ventricular support": 3, "group of patients": 2, "chronic decompensated heart": 3, "decompensated heart failure": 3, "requiring biventricular support": 6, "hybrid system consisting": 3, "survival in patients": 2, "requiring isolated lvad": 3, "lvad and patients": 1, "required biventricular support": 3, "\u00b1 11.9 days": 3, "survival to hospital": 1, "mortality at hospital": 1, "however biventricular dysfunction": 3, "eligibility for heart": 1, "assist device use": 3, "stage heart failure": 24, "bridge to transplantation": 2, "reviewed the evidence": 1, "effects and cost": 1, "using simulation models": 3, "studies per outcome": 3, "made policy recommendations": 3, "complications after implantation": 1, "transplantation eligibility status": 6, "status and device": 1, "meet traditional cost": 3, "limits in models": 1, "using historical data": 3, "number of patients": 3, "conclude that evidence": 1, "selected and program": 1, "infrastructure and budget": 1, "canadian data point": 3, "use and outcomes": 2, "effects of biventricular": 1, "left heart twist": 3, "right heart failure": 27, "improves cardiac output": 3, "selected cardiac surgery": 3, "cardiac surgery patients": 3, "used speckle tracking": 3, "speckle tracking echocardiography": 3, "right ventricular pressure": 3, "ventricular pressure overload": 3, "materials and methods": 9, "inferior vena cava": 3, "establish a control": 1, "pulmonary artery snared": 3, "ventricular midpapillary level": 3, "varying atrioventricular delay": 3, "regional circumferential strain": 3, "left ventricular base": 3, "analysis of twist": 1, "mixed linear models": 3, "correlated with twist": 1, "correlated with rs": 1, "free wall rs": 3, "open chest model": 3, "surrogates for changes": 1, "changes in rs": 1, "varying regional strain": 3, "regional strain contributions": 3, "lack of correlation": 1, "correlation of remaining": 1, "reflect postsystolic function": 3, "treatment for heart": 3, "functional mitral stenosis": 6, "develops after ring": 2, "ischemic mitral regurgitation": 6, "annular size reduction": 12, "reduction by surgery": 2, "diastolic mitral valve": 6, "mitral valve tethering": 6, "anterior leaflet opening": 6, "posteriorly displaced papillary": 6, "displaced papillary muscles": 6, "muscles with left": 1, "left ventricular dilatation": 6, "report the case": 1, "successful mitral valve": 3, "mitral valve plasty": 9, "degenerative mitral regurgitation": 3, "developed heart failure": 9, "mild mitral regurgitation": 3, "significant mitral stenosis": 3, "aggressive medical treatment": 9, "reported in patients": 1, "successful valve plasty": 9, "old man had": 2, "degenerative mitral valve": 3, "third heart sound": 3, "underwent mitral valve": 3, "2 chordal ruptures": 3, "underwent triangular resection": 3, "after the surgery": 2, "postoperative echocardiography confirmed": 3, "diastolic volume index": 6, "preserved mitral valve": 3, "mitral valve opening": 9, "mitral valve area": 3, "mean pressure gradient": 9, "mitral filling flow": 6, "filling flow volume": 3, "\u00d7 velocity time": 3, "velocity time integral": 3, "without major concerns": 3, "limited mitral valve": 3, "coronary angiography revealed": 3, "diastolic mitral leaflet": 3, "mitral leaflet motions": 3, "clear organic lesion": 6, "hypertension with vasodilators": 1, "vasodilators and diuretics": 1, "cardiac murmurs disappeared": 3, "reduction in blood": 1, "echocardiography 4 months": 3, "demonstrated a reduction": 1, "in this patient": 1, "surgery by echocardiography": 1, "time of surgery": 1, "confirmed no findings": 1, "surgical ring implantation": 3, "restriction of leaflet": 1, "resection and edge": 1, "at this time": 1, "as the mitral": 1, "closure and opening": 1, "reports demonstrating development": 3, "following ring annuloplasty": 3, "at the time": 1, "years after valve": 1, "at this point": 1, "surgical indications need": 3, "evaluated in patients": 1, "fixed ring size": 3, "requires careful evaluation": 3, "stratification for death": 1, "hospitalization in heart": 1, "heart failure clinic": 3, "failure clinic outpatients": 3, "most heart failure": 3, "risk stratification models": 3, "available outpatient models": 3, "set of variables": 1, "collected clinical data": 3, "risk of death": 8, "cause medical hospitalization": 6, "using a quality": 1, "quality improvement database": 3, "reached primary outcome": 3, "arbitrary start date": 3, "model included blood": 3, "included blood urea": 3, "blood urea nitrogen": 3, "concordance c statistics": 3, "curves and log": 1, "demonstrated excellent risk": 3, "excellent risk stratification": 3, "month event rates": 6, "readily available data": 3, "data to predict": 1, "resources within health": 3, "within health systems": 3, "incidence and predictors": 2, "predictors of end": 1, "stage renal disease": 6, "disease in outpatients": 1, "important prognostic factor": 3, "factor in heart": 1, "equation and patients": 1, "models for time": 1, "composite end point": 3, "constructed and predictors": 1, "need of diuretics": 2, "associated with time": 1, "observed in patients": 2, "uncontrolled hypertension identify": 3, "hypertension identify patients": 3, "epidemic of heart": 1, "measure of patients": 1, "commonly used criterion": 3, "used criterion standard": 3, "using spearman correlations": 3, "differences between patients": 1, "tested with interaction": 1, "curves for death": 1, "proportional hazards models": 15, "p=0.27 for interaction": 1, "category among patients": 3, "high internal consistency": 3, "consistency among patients": 3, "measure of health": 1, "excellent prognostic ability": 3, "including the establishment": 1, "interleukin receptor family": 3, "receptor family member": 3, "prognosis in heart": 1, "doses of \u03b2": 1, "affect sst2 concentrations": 3, "concentrations identify benefit": 3, "subjects with heart": 1, "heart failure attributable": 3, "ventricular systolic dysfunction": 3, "post hoc analysis": 3, "bb at enrollment": 1, "regimen and sst2": 1, "function of baseline": 1, "baseline sst2 status": 3, "daily equivalent dose": 3, "dose of metoprolol": 1, "low sst2 titrated": 3, "lowest cardiovascular event": 3, "cardiovascular event rate": 6, "lowest cumulative hazard": 3, "high sst2 treated": 6, "highest cardiovascular event": 3, "highest cumulative hazard": 3, "intermediate odds ratios": 3, "found for heart": 1, "heart failure hospitalization": 9, "therapy exerted dose": 3, "across all study": 1, "measurement identifies patients": 3, "treatment of heart": 5, "exerts positive inotropic": 3, "effects in vivo": 1, "limited by chemical": 1, "instability and cogeneration": 1, "cogeneration of nitrite": 1, "report on effects": 1, "in adult mouse": 3, "adult mouse ventricular": 3, "mouse ventricular myocytes": 3, "dependently increased sarcomere": 3, "inhibition of protein": 1, "protein kinase a": 3, "soluble guanylate cyclase": 3, "left ventricular end": 3, "myocardial oxygen consumption": 3, "increasing ejection fraction": 3, "maximal ventricular power": 3, "ventricular power index": 3, "in conscious dogs": 3, "dogs with tachypacing": 1, "assessed by end": 1, "provided venoarterial dilation": 3, "right heart filling": 3, "heart filling pressures": 3, "stroke volume index": 3, "arterial pressure declined": 3, "donor to enhance": 1, "enhance myocardial function": 3, "predictors of response": 1, "involved single parameters": 3, "multiparametric echocardiographic score": 6, "score for predicting": 1, "global longitudinal strain": 6, "standard echocardiographic measurements": 3, "underwent baseline echocardiography": 3, "score for prediction": 1, "\u226515 % reduction": 3, "identify the association": 1, "score with death": 1, "assist device implantation": 9, "months of follow": 3, "lv reverse remodeling": 3, "diastolic dimension index": 3, "left atrial area": 6, "right ventricular end": 3, "diastolic area index": 3, "right atrial area": 3, "ventricular fractional area": 3, "fractional area change": 3, "change \u226535 %": 3, "echocardiographic score allowed": 3, "score allowed prediction": 3, "18 heart transplantations": 3, "lv assist device": 3, "assist device implantations": 3, "93 heart failure": 3, "heart failure admissions": 3, "associated with heart": 2, "heart failure admission": 3, "initial functional class": 3, "undergo reverse remodeling": 3, "predicts clinical outcomes": 3, "effectiveness and safety": 4, "safety of spironolactone": 2, "systolic heart failure": 48, "trials to reduce": 1, "mortality in adults": 1, "symptomatic systolic heart": 3, "studied the effectiveness": 1, "spironolactone in adults": 1, "diagnosed systolic heart": 3, "identified all adults": 1, "newly diagnosed heart": 6, "diagnosed heart failure": 6, "previous spironolactone use": 3, "baseline serum creatinine": 3, "serum creatinine level": 3, "serum potassium level": 3, "regression with time": 1, "covariates to evaluate": 1, "association between spironolactone": 1, "use and death": 1, "acute kidney injury": 15, "associated with risk": 2, "risk of hospitalization": 1, "adjusted hazard ratio": 18, "injury during spironolactone": 1, "fold increased risk": 6, "risk of hyperkalemia": 2, "cohort with incident": 1, "incident systolic heart": 3, "use of spironolactone": 1, "associated with risks": 1, "risks of hospitalization": 1, "benefits of spironolactone": 1, "vascular endothelial growth": 9, "endothelial growth factor": 9, "growth factor blockade": 3, "effects of beta": 1, "remodeling in heart": 2, "- myocardial infarction": 9, "myocardial infarction heart": 9, "progression to heart": 2, "- adrenergic receptor": 15, "adrenergic receptor blocker": 3, "receptor blocker therapy": 3, "improve myocardial perfusion": 3, "perfusion by enhancing": 1, "induced myocardial infarction": 3, "heart failure rats": 3, "at the end": 1, "week treatment period": 3, "reduced cardiac diameters": 3, "improved cardiac function": 3, "function in b": 1, "compared with vehicle": 1, "increased cardiac angiogenesis": 3, "vivo coronary perfusion": 3, "reduced cardiac fibrosis": 3, "weeks after b": 1, "treated with drug": 1, "untreated failing hearts": 3, "effects of b": 2, "act via activation": 3, "adenoviral vector encoding": 3, "encoding a decoy": 1, "histological analysis revealed": 3, "perfusion in b": 1, "compared with b": 1, "treated plus ad": 3, "function and remodeling": 2, "promotes cardiac angiogenesis": 3, "angiogenesis in heart": 1, "failure via activation": 3, "outcomes for patients": 2, "vary by emergency": 1, "emergency department volume": 3, "influences patient outcomes": 3, "925 ed visits": 3, "seen in medium": 2, "adjusted odds ratio": 12, "exhibited higher risk": 3, "exhibited worse outcomes": 3, "repeat ed visits": 3, "interventions to improve": 1, "oxidase inhibition preserves": 3, "left ventricular systolic": 3, "cardiac volume overload": 3, "increased in human": 1, "human and rat": 1, "myocytes with volume": 1, "regurgitation and aortocaval": 1, "in the setting": 1, "setting of increased": 1, "decrease mitochondrial respiration": 3, "inhibition improves cardiomyocyte": 3, "improves cardiomyocyte bioenergetics": 3, "acf \u00b1 allopurinol": 3, "37 % increase": 3, "increase in lung": 1, "lv ejection fraction": 3, "maximal systolic elastance": 3, "absence of changes": 1, "isolated cardiomyocytes using": 3, "extracellular flux analyzer": 3, "function and efficiency": 1, "explain the failure": 1, "inhibition to improve": 1, "symptoms and hospitalizations": 1, "hospitalizations in patients": 3, "severe heart failure": 15, "usefulness of tissue": 1, "imaging for assessing": 1, "left ventricular filling": 12, "ventricular filling pressure": 6, "pressure in patients": 1, "severe systolic heart": 3, "early transmitral blood": 3, "transmitral blood flow": 3, "blood flow velocity": 3, "velocity over tissue": 1, "early diastolic mitral": 24, "diastolic mitral annulus": 3, "mitral annulus velocity": 6, "pulmonary capillary wedge": 6, "capillary wedge pressure": 6, "decompensated systolic heart": 3, "sided cardiac catheterization": 3, "catheterization and transthoracic": 1, "echocardiography with measurement": 1, "transmitral flow velocities": 3, "mitral annulus velocities": 3, "\u00b1 8 %": 3, "compared with e": 1, "aucs of e": 1, "using a cutoff": 1, "negative predictive value": 3, "value of e": 1, "negative likelihood ratio": 3, "good diagnostic performance": 6, "performance for detecting": 1, "detecting normal filling": 3, "normal filling pressures": 3, "annular plane systolic": 6, "plane systolic excursion": 6, "pulmonary arterial systolic": 6, "arterial systolic pressure": 6, "systolic pressure relationship": 3, "relationship in heart": 1, "ventricular contractile function": 3, "function and prognosis": 1, "derived pulmonary arterial": 3, "tricuspid annular plane": 3, "end of diastole": 1, "provides an index": 1, "better disclosing prognosis": 3, "natriuretic peptide assessment": 3, "downward regression line": 3, "regression line shift": 3, "shift in nonsurvivors": 1, "along the regression": 1, "ratios for variables": 1, "improves prognostic resolution": 3, "bottleneck stent model": 3, "chronic myocardial ischemia": 9, "ischemia and heart": 2, "failure in pigs": 1, "large animal model": 3, "novel therapeutic approaches": 3, "in this study": 4, "novel percutaneous one-": 3, "myocardial ischemia using": 3, "using a stent": 1, "left anterior descending": 6, "proximal circumflex artery": 3, "given antiarrhythmic medication": 3, "medication to prevent": 1, "prevent sudden death": 3, "duration of antiplatelet": 1, "fractional flow reserve": 3, "flow reserve measurements": 3, "measurements and positron": 1, "positron emission tomography": 3, "emission tomography imaging": 3, "showed severe ischemia": 3, "ischemia after bottleneck": 1, "complete coronary occlusion": 3, "significant collateral growth": 3, "competitive collateral growth": 3, "collateral growth patterns": 3, "model 4 wk": 3, "wk after stenting": 1, "vessel disease model": 3, "novel bottleneck stent": 3, "novel porcine model": 3, "reversible myocardial ischemia": 3, "ischemic heart failure": 15, "new therapeutic approaches": 3, "selective heart rate": 3, "heart rate reduction": 6, "reduction with ivabradine": 2, "ventricle in heart": 2, "isolated heart rate": 3, "ivabradine reduces afterload": 3, "afterload of patients": 1, "effective arterial elastance": 6, "pressure volume relation": 3, "among the patients": 1, "ejection fraction \u226435": 6, "fraction \u226435 %": 6, "placebo or ivabradine": 1, "ivabradine 7.5 mg": 3, "total arterial compliance": 3, "calculated at baseline": 1, "months of treatment": 2, "measured by arm": 1, "assessed by echocardiography": 2, "isolated hr reduction": 6, "reduction by ivabradine": 1, "ivabradine improves tac": 3, "reduction in patients": 1, "preoperative serum albumin": 3, "serum albumin levels": 3, "levels to survival": 1, "indicator in patients": 1, "investigate the association": 3, "association of hypoalbuminemia": 1, "consecutive patients undergoing": 3, "preoperative clinical characteristics": 3, "characteristics and laboratory": 1, "normal albumin concentration": 3, "normal albumin levels": 3, "albumin levels compared": 3, "hypoalbuminemia before surgery": 1, "impact of normalization": 1, "analysis of patients": 1, "decreasing albumin levels": 3, "levels by correcting": 1, "way to improve": 1, "prognosis in patients": 2, "evaluated for lvad": 1, "aortic valve insufficiency": 3, "insufficiency after left": 1, "onset aortic insufficiency": 3, "mechanical circulatory support": 3, "underwent aortic valve": 3, "aortic valve surgery": 3, "patients underwent lvad": 3, "underwent lvad implantation": 3, "requiring surgical intervention": 3, "accompanied by heart": 1, "after medical therapy": 3, "aortic valve procedures": 3, "bioprosthetic valve replacement": 3, "1 dacron patch": 3, "dacron patch closure": 3, "aortic valve repairs": 3, "patients underwent transcatheter": 3, "transcatheter aortic valve": 3, "aortic valve procedure": 3, "aortic valve replacement": 6, "experienced significant improvement": 3, "capacity and symptoms": 1, "failure and sepsis": 1, "aortic valve oversewing": 3, "oversewing or leaflet": 1, "bioprosthetic aortic valve": 3, "restoring functional capacity": 3, "various transcatheter approaches": 3, "less invasive alternatives": 3, "characteristics and outcomes": 5, "determine the characteristics": 1, "5 age groups": 3, "adhere to medication": 1, "youngest age group": 3, "year mortality rates": 3, "respective age categories": 3, "referent age group": 3, "% in ages": 1, "beyond divergent etiology": 3, "etiology and comorbidities": 1, "younger patients exhibited": 3, "differences in presentation": 1, "presentation and outcomes": 1, "higher hospitalization rates": 3, "walking in patients": 1, "within cardiac rehabilitation": 3, "standard cardiac rehabilitation": 9, "cardiac rehabilitation care": 9, "\u00b1 11.4 years": 3, "mean ejection fraction": 9, "minutes of exercise": 1, "exercise per week": 6, "functional capacity assessed": 3, "nordic walking led": 3, "higher functional capacity": 3, "reported physical activity": 3, "\u00b1 118.5 minutes": 3, "\u00b1 125.6 minutes": 3, "increased right grip": 3, "right grip strength": 3, "\u00b1 3.5 kg": 3, "\u00b1 3.1 kg": 3, "fewer depressive symptoms": 3, "peak aerobic capacity": 3, "hand grip strength": 6, "symptoms of anxiety": 1, "care in improving": 1, "improving functional capacity": 3, "ventricular ejection time": 6, "precapillary pulmonary hypertension": 3, "improve the management": 1, "experiencing heart failure": 3, "major right ventricle": 3, "right ventricle overload": 3, "decreased stroke volume": 3, "arterial tonometry study": 3, "carries prognostic value": 3, "value in patients": 1, "ph with heart": 2, "radial artery tonometry": 3, "artery tonometry variables": 3, "obtained at admission": 1, "reconstructed aortic pressure": 3, "aortic pressure curve": 3, "tonometric indices were": 2, "73 % sensitivity": 3, "89 % specificity": 3, "specificity for identifying": 1, "other prognostic factors": 3, "factors at admission": 1, "higher serum levels": 6, "levels of brain": 1, "brain natriuretic peptide": 18, "higher furosemide dose": 6, "higher oxygen flow": 3, "levels of creatinine": 1, "dose and oxygen": 1, "dobutamine or norepinephrine": 1, "admission and follow": 1, "factor in patients": 1, "documented prognostic factors": 3, "right atrial myxoma": 6, "atrial myxoma complicated": 3, "cardiac benign tumors": 3, "pulmonary arterial vasculature": 3, "present a case": 1, "pulmonary arteries treated": 3, "right atrial mass": 3, "atrial mass removal": 3, "right atrium mass": 3, "presented with prolapse": 1, "left pulmonary artery": 3, "right pulmonary artery": 3, "surgical tactics included": 3, "hypothermic circulatory arrest": 3, "test in patients": 2, "advanced chronic organ": 3, "chronic organ failure": 3, "chronic renal failure": 3, "64 % men": 3, "median body mass": 3, "time to complete": 1, "intraclass correlation coefficient": 3, "error of measurement": 3, "minimal detectable change": 3, "sample and subgroups": 1, "statistical improvement occurred": 3, "limits of agreement": 1, "third trial added": 3, "% confidence level": 6, "similar values found": 3, "daily clinical practice": 3, "populations to define": 1, "represents true change": 3, "change in repeated": 1, "risk among patients": 3, "rheumatoid arthritis starting": 3, "associated with elevations": 1, "elevations in tumor": 1, "tumor necrosis factor": 3, "showed no benefit": 1, "worsening of disease": 1, "studied the risk": 1, "among a group": 1, "receiving these agents": 1, "agents to treat": 1, "treat rheumatoid arthritis": 3, "enter the study": 1, "- biological disease": 3, "biological disease modifying": 3, "modifying antirheumatic drug": 3, "stratified by propensity": 1, "propensity score decile": 3, "oral glucocorticoid dosage": 3, "use of loop": 1, "similar baseline covariates": 3, "elevated in subjects": 1, "test for interaction": 1, "1\u22645 mg hr": 3, "exercise to improve": 1, "life for people": 1, "people with heart": 1, "current economic climate": 3, "chronic disease such": 2, "within acute hospital": 3, "acute hospital facilities": 3, "specific health interventions": 3, "assess the benefits": 1, "benefits of participation": 1, "structured exercise programme": 3, "programme for patients": 1, "capacity and quality": 1, "secondary outcome measures": 3, "satisfaction and sustainability": 1, "intervention post study": 3, "overall significant improvements": 3, "found in quality": 1, "demonstrated significant improvements": 3, "improvements with others": 1, "showing minor improvement": 3, "evidence of perceived": 1, "participant satisfaction responses": 3, "met in relation": 1, "relation to sustainability": 1, "sustainability with commissioning": 1, "programmes on completion": 1, "frailty and risk": 2, "risk for heart": 2, "body composition study": 3, "assess the association": 2, "association between frailty": 2, "adverse health outcomes": 3, "impact of frailty": 1, "assessed the association": 1, "age of participants": 1, "\u00b1 3 years": 3, "- frail participants": 3, "risk after adjusting": 1, "per sd decrease": 3, "decrease in score": 1, "controlled for death": 1, "sub - groups": 3, "based on diabetes": 1, "disease at baseline": 1, "change in c": 1, "role of vasopressin": 1, "approaches to improving": 1, "improving the prognosis": 1, "prognosis of patients": 1, "interruption of activated": 1, "activated neurohormonal systems": 3, "use of antagonists": 1, "antagonists and inhibitors": 1, "sympathetic nervous systems": 3, "improved clinical outcomes": 3, "secretion of arginine": 1, "various physiologic processes": 3, "vasopressin receptor antagonist": 6, "receptor antagonist therapy": 3, "new therapeutic approach": 3, "reactivate the transcription": 1, "embryonic gene programs": 6, "pathological heart disease": 3, "driving these gene": 1, "human and mouse": 1, "mutant mice overexpressing": 3, "otherwise healthy heart": 3, "healthy heart muscle": 3, "heart muscle cells": 3, "developed a phenotype": 1, "resistance to pressure": 1, "dysfunction and induction": 1, "fetal gene program": 3, "inhibition of mir-25": 1, "specific antagomir evoked": 3, "spontaneous cardiac dysfunction": 3, "sensitized the murine": 1, "myocardium to heart": 1, "integrate with micrornas": 1, "micrornas to induce": 1, "induce the expression": 1, "bhlh transcription factor": 3, "postnatal mammalian myocardium": 3, "myocardium with impact": 1, "programs in heart": 3, "epidemiology and treatment": 1, "use of bisoprolol": 1, "% of subjects": 1, "years of age": 2, "base of treatment": 1, "includes the use": 1, "use of angiotensin": 1, "angiotensin converting enzyme": 12, "converting enzyme inhibitors": 21, "angiotensin receptor blockers": 18, "blockers in case": 1, "case of angiotensin": 1, "enzyme inhibitors intolerance": 3, "beta receptor blockers": 3, "blockers and mineralocorticoid": 1, "mineralocorticoid receptor antagonists": 12, "negative inotropic effect": 3, "past decades several": 3, "decades several studies": 3, "blockers decrease mortality": 3, "effectiveness of bisoprolol": 1, "bisoprolol in reducing": 1, "number of studies": 2, "causes heart failure": 3, "cause of death": 2, "patients with type": 1, "type 2 diabetes": 21, "diabetes to heart": 1, "hallmark of type": 1, "insulin receptor substrates": 3, "regulating cellular metabolism": 3, "metabolism and survival": 1, "determine the role": 1, "causes myocardial insulin": 3, "myocardial insulin resistance": 3, "mice and liver": 1, "reduced ventricular mass": 3, "developed cardiac apoptosis": 3, "box class o-1": 3, "impaired cardiac metabolic": 3, "cardiac metabolic gene": 3, "metabolic gene expression": 3, "features of heart": 1, "impaired cardiac energy": 3, "cardiac energy metabolism": 3, "energy metabolism gene": 3, "metabolism gene expression": 3, "expression and activation": 1, "activated protein kinase": 3, "using neonatal rat": 3, "neonatal rat ventricular": 3, "rat ventricular cardiomyocytes": 3, "chronic insulin exposure": 3, "prevented insulin action": 3, "action through activation": 1, "activation of p38": 1, "dysfunction during insulin": 1, "resistance and type": 1, "variation in use": 1, "use of recommended": 1, "medications among outpatients": 3, "outpatients with heart": 2, "variation in rates": 1, "rates of guideline": 1, "treatment for outpatients": 1, "examine the association": 1, "association between treatment": 1, "variation and practice": 1, "rates of treatment": 1, "treatment with angiotensin": 1, "blockers and \u03b2": 2, "optimal combined treatment": 9, "combined treatment measure": 3, "determined for patients": 1, "multivariable hierarchical regression": 3, "hierarchical regression models": 3, "adjusted for demographics": 2, "median rate ratio": 6, "describes the likelihood": 1, "patient with given": 1, "randomly selected practices": 3, "level prescription rates": 3, "% for angiotensin": 1, "% for \u03b2": 1, "adjusted median rate": 3, "receptor blockers therapy": 3, "use of guideline": 1, "medications for patients": 1, "component of improving": 1, "quality of care": 4, "care for patients": 3, "patients with breast": 1, "use of trastuzumab": 1, "adjuvant setting improves": 3, "setting improves outcomes": 3, "associated with cardiotoxicity": 1, "rates and risk": 2, "associated with trastuzumab": 1, "breast cancer patients": 9, "diagnosed with stage": 1, "iii breast cancer": 3, "treated with chemotherapy": 1, "included descriptive statistics": 3, "among trastuzumab users": 3, "% in nontrastuzumab": 1, "coronary artery disease": 21, "weekly trastuzumab administration": 3, "increased the risk": 1, "older breast cancer": 3, "rates of trastuzumb": 1, "treated with trastuzumab": 1, "further studies need": 3, "confirm the role": 1, "frequency of administration": 1, "development of trastuzumab": 1, "dash diet scores": 9, "scores and mortality": 1, "mortality in women": 2, "women with heart": 1, "current dietary recommendations": 3, "recommendations for patients": 1, "based on data": 1, "- hf populations": 3, "evidence on associations": 1, "patterns with outcomes": 1, "therefore evaluated associations": 3, "scores with mortality": 1, "mortality among postmenopausal": 3, "among postmenopausal women": 3, "date of death": 1, "last participant contact": 3, "calculated from food": 1, "calculate hazard ratios": 3, "for a median": 1, "years of follow": 1, "adjusted hazard ratios": 6, "dash diet score": 3, "diet score components": 3, "whole grain intake": 3, "higher dash diet": 3, "modestly lower mortality": 3, "data provide support": 3, "dietary recommendations developed": 3, "potentially promising biomarker": 3, "biomarker in heart": 1, "term clinical outcomes": 3, "study of exercise": 1, "evaluable plasma samples": 3, "assess the relationship": 3, "associated with measures": 1, "in univariable analysis": 3, "associated with death": 1, "death or hospitalization": 4, "ratios for log2": 1, "in multivariable models": 3, "associated with outcomes": 2, "outcomes after adjustment": 1, "reclassification of risk": 2, "risk as assessed": 1, "assessed by changes": 1, "significantly affect reclassification": 3, "extended criteria cardiac": 6, "criteria cardiac transplantation": 3, "criteria cardiac transplant": 12, "expand the transplant": 1, "pool by matching": 1, "donors and recipients": 1, "age or comorbidity": 1, "paucity of data": 1, "undergoing isolated heart": 3, "isolated heart transplant": 3, "standard criteria cardiac": 9, "cardiac transplant recipients": 3, "identify clinical variables": 3, "clinical variables contributing": 3, "contributing to survival": 1, "second to determine": 1, "additional risk associated": 3, "associated with assignment": 1, "underwent heart transplant": 3, "underwent standard criteria": 3, "frequency of diabetes": 1, "chronic kidney disease": 6, "cardiac transplant survival": 3, "in a multivariate": 1, "included listing criteria": 3, "- transplant mortality": 3, "heart failure therapy": 3, "- transplant morbidity": 3, "change in readmissions": 1, "readmissions and follow": 1, "visits as part": 1, "heart failure readmission": 3, "failure readmission quality": 3, "readmission quality improvement": 3, "quality improvement initiative": 12, "quantify the change": 1, "readmissions as part": 1, "hospital quality improvement": 3, "assessments of patients": 1, "days of hospital": 1, "known about patient": 1, "retrospective chart review": 3, "heart failure discharges": 3, "quantified the change": 1, "day readmission rate": 15, "events at follow": 1, "age of patients": 1, "cardiologist or heart": 1, "heart failure nurse": 3, "failure nurse practitioner": 3, "percent of patients": 1, "patients had blood": 1, "rate for patients": 3, "decreased in parallel": 1, "testing and medication": 1, "changes at follow": 1, "cardiac magnetic resonance": 18, "magnetic resonance postcontrast": 6, "pathophysiology of heart": 1, "myocardial extracellular matrix": 6, "extracellular matrix accumulation": 3, "extracellular matrix using": 3, "magnetic resonance t1": 6, "resonance t1 mapping": 3, "relationship between pathobiology": 1, "pathophysiology and prognosis": 1, "patients with suspected": 1, "confirmatory diagnostic tests": 3, "magnetic resonance imaging": 9, "imaging including t1": 3, "including t1 mapping": 3, "invasive hemodynamic assessments": 3, "performed at baseline": 2, "patients with confirmed": 1, "resonance t1 time": 3, "pulmonary vascular resistance": 6, "left ventricular biopsies": 3, "quantified by tissuefaxs": 1, "pulmonary arterial coupling": 3, "right ventricular ejection": 3, "present preliminary study": 3, "associated with prognosis": 1, "impact of heart": 2, "heart magnetic resonance": 6, "imaging on chelation": 2, "treatment and risk": 1, "risk of heart": 9, "disease in patients": 2, "patients with thalassaemia": 1, "verify the impact": 1, "value for heart": 1, "failure and arrhythmias": 2, "abnormal cardiac t2": 3, "values determined changes": 3, "changes in treatment": 1, "year for heart": 1, "choice of chelation": 1, "remove heart iron": 3, "influence the risk": 1, "compliance with treatment": 1, "impact of ejection": 1, "mild heart failure": 6, "current guidelines recommend": 3, "recommend cardiac resynchronization": 3, "prolongation and ejection": 1, "assess the effect": 1, "severe systolic dysfunction": 3, "results of patients": 1, "patients with baseline": 1, "blinded core laboratory": 3, "30 % subgroup": 3, "trend for improvement": 1, "clinical composite response": 6, "end systolic volume": 3, "systolic volume index": 3, "\u00b1 17.6 ml": 3, "\u00b1 42.4 g": 3, "time to death": 3, "reverse remodeling parameters": 3, "produced reverse remodeling": 3, "similar clinical benefit": 3, "clinical benefit compared": 3, "compared with subjects": 1, "myocardial titin hypophosphorylation": 3, "contributes to heart": 1, "rat metabolic risk": 3, "metabolic risk model": 3, "important metabolic risk": 3, "metabolic risk factors": 3, "comorbidities in heart": 1, "myocardial diastolic dysfunction": 3, "dd of collagen": 1, "deposition and titin": 1, "rats after heart": 1, "ejection fraction development": 3, "groups of rats": 1, "weeks with repeat": 1, "assessed at euthanization": 1, "collagen cross -": 3, "fpassive)-sarcomere length relations": 3, "small muscle strips": 3, "contributions of titin": 1, "increased lung weight": 3, "left ventricular dd": 3, "underlying myocardial dd": 6, "high muscle strip": 3, "muscle strip stiffness": 3, "elastic n2bus segment": 3, "rats developed heart": 3, "week time span": 3, "longitudinal systolic strain": 6, "measure of left": 1, "left ventricular mechanics": 3, "examine the ability": 1, "predicting cv events": 3, "observational cohort study": 3, "measured by index": 1, "index beat method": 3, "proportional hazards analyses": 3, "- fatal stroke": 6, "stroke and hospitalisation": 1, "hospitalisation for heart": 1, "hospitalisations for heart": 1, "\u00b1 10 months": 3, "in direct comparison": 3, "systolic mitral annulus": 3, "adverse cv events": 9, "containing chronic heart": 3, "prior stroke score": 3, "additional prognostic benefit": 3, "echocardiographic systolic parameters": 3, "morphology and duration": 2, "duration on outcomes": 1, "scale clinical trial": 3, "implantable cardioverter defibrillator": 12, "mortality or heart": 1, "for this substudy": 1, "receiving implantable cardioverter": 3, "duration and extent": 2, "extent of benefit": 1, "support the use": 1, "needs further investigation": 1, "refractory congestive heart": 3, "consecutive case series": 6, "diuretic resistant volume": 3, "resistant volume overload": 3, "overload in heart": 1, "provide potential benefit": 3, "examined the impact": 2, "clinical status hospitalizations": 3, "complications of therapy": 1, "transplant ineligible patients": 3, "ineligible patients receiving": 3, "clinical data reviewed": 3, "- pd initiation": 3, "\u00b1 6.0 %": 3, "majority of patients": 2, "right ventricular dysfunction": 3, "average weight loss": 3, "decrease in re": 1, "admissions per patient": 3, "reduced average length": 3, "length of stay": 7, "\u00b1 2.3 days": 3, "objective criteriabased institution": 3, "diuretic refractory severe": 3, "demonstrated favorable outcomes": 3, "improved clinical status": 3, "hospitalizations and length": 1, "treatable pdrelated complications": 3, "option in refractory": 1, "stage congestive heart": 3, "usefulness and consequences": 1, "therapy in dialysis": 1, "deferred in dialysis": 1, "lack of benefit": 1, "potentially higher risks": 3, "performed a case": 1, "matching for age": 1, "bundle branch morphology": 3, "blocker and angiotensin": 1, "converting enzyme inhibitor": 9, "inhibitor or angiotensin": 2, "angiotensin ii receptor": 3, "ii receptor blocker": 3, "receptor blocker use": 3, "assessed for evidence": 1, "observed among dialysis": 3, "among dialysis patients": 3, "improvement in ejection": 1, "\u00b1 9.2 %": 3, "derived absolute improvements": 3, "year event rates": 3, "in the case": 1, "superior reverse remodeling": 3, "\u00b1 9.5 %": 3, "9.5 % increase": 3, "increase in ejection": 1, "compared with dialysis": 1, "certain dialysis patients": 3, "demonstrated compelling improvement": 3, "improvement after device": 1, "worsened echocardiographic outcomes": 3, "sodium dash diet": 3, "improves diastolic function": 3, "hypertensive heart failure": 3, "dietary sodium restriction": 3, "stiffness and function": 1, "restricted dietary approaches": 3, "approaches to stop": 1, "stop hypertension diet": 3, "ventricular diastolic function": 9, "patients with treated": 1, "consumed the dash": 1, "central blood pressure": 3, "via radial arterial": 3, "radial arterial tonometry": 3, "parametrized diastolic filling": 3, "diastolic filling formalism": 3, "mitral inflow velocity": 3, "e - wave": 6, "previously published techniques": 3, "- post comparisons": 3, "brachial systolic pressure": 3, "diastolic function improved": 3, "\u00b1 8.1 g": 3, "\u00b1 37 g": 3, "restricted dash diet": 3, "resistin in chemotherapy": 1, "induced heart failure": 18, "failure in humanized": 1, "humanized male mice": 3, "treated for breast": 1, "mediator of insulin": 1, "recent clinical studies": 3, "connected elevated resistin": 3, "elevated resistin levels": 3, "development and severity": 1, "severity of heart": 1, "resistin in heart": 1, "humanized mouse model": 3, "model lacking murine": 3, "lacking murine resistin": 3, "resistin but transgenic": 1, "basal and inflammation": 1, "stimulated resistin levels": 3, "resistin levels similar": 3, "- fold induction": 3, "induction of serum": 1, "serum resistin levels": 6, "controls not expressing": 1, "expressing human resistin": 3, "cardiac mrna levels": 3, "cell adhesion genes": 3, "treated with doxorubicin": 1, "showed dramatic induction": 3, "also examined resistin": 3, "examined resistin levels": 3, "treated breast cancer": 3, "levels in women": 1, "women undergoing anthracycline": 3, "elevation in resistin": 1, "correlated with decline": 1, "decline in ejection": 1, "effects on macrophages": 1, "link between inflammation": 1, "outcomes of catheter": 1, "fibrillation in patients": 1, "investigate the efficacy": 1, "efficacy and safety": 3, "safety of catheter": 1, "patients with compensated": 1, "probability after catheter": 1, "ablation and factors": 1, "relating to maintenance": 1, "maintenance of sinus": 3, "strain and strain": 1, "echocardiography at baseline": 1, "months after ablation": 1, "free success rates": 3, "pharmaceutically assisted success": 3, "assisted success rate": 3, "major complications occurred": 3, "occurred during follow": 2, "lack of hypertension": 1, "associated with maintenance": 1, "lv systolic indices": 3, "rate at systole": 1, "rate at diastole": 1, "early transmitral flow": 3, "patients maintaining sinus": 3, "maintaining sinus rhythm": 3, "rhythm at follow": 1, "composite of repeat": 1, "procedures and pharmaceuticals": 1, "pharmaceuticals in patients": 1, "larger randomized control": 3, "randomized control studies": 3, "verify the benefit": 1, "ameliorates mitochondrial dysfunction": 3, "dysfunction in doxorubicin": 1, "failure in rats": 2, "mechanism of cardioprotection": 1, "- neoplastic agent": 3, "effect of nicorandil": 1, "mitochondrial dysfunction induced": 3, "administration of doxorubicin": 1, "doxorubicin in rats": 1, "without doxorubicin treatment": 3, "aortic blood flow": 6, "h after receiving": 1, "dose of doxorubicin": 1, "sacrificed and hearts": 1, "excised for estimation": 1, "adenine nucleotides contents": 6, "contents in addition": 1, "addition to cytochrome": 1, "caspase 3 expression": 3, "mitochondrial oxidative phosphorylation": 6, "oxidative phosphorylation capacity": 6, "creatine kinase activity": 6, "oxidative stress markers": 3, "alleviating the decrement": 1, "decrement of heart": 1, "mitochondrial oxidative stress": 3, "induced by doxorubicin": 1, "also preserved phosphocreatine": 3, "contents by restoring": 1, "restoring mitochondrial oxidative": 3, "capacity and creatine": 1, "cardioprotection via inhibition": 3, "apoptotic signaling pathway": 3, "mitochondrial ultrastructural changes": 3, "effect of doxorubicin": 1, "solid ehrlich carcinoma": 3, "development of doxorubicin": 1, "rats as indicated": 1, "indicated by improvement": 1, "changes without affecting": 3, "preoperative renal dysfunction": 6, "months of isolated": 1, "isolated coronary artery": 3, "artery bypass grafting": 6, "risk of stroke": 1, "primary isolated cabg": 6, "rehospitalization for stroke": 1, "heart failure \u226490": 3, "failure \u226490 days": 3, "logistic regression models": 3, "estimate the risk": 1, "adjusting for confounders": 1, "days of follow": 1, "developed acute kidney": 3, "events after adjustment": 1, "adjustment for age": 2, "increased in patients": 1, "patients with estimated": 1, "enormous clinical burden": 3, "burden in adult": 1, "atheromatous coronary disease": 3, "cause of heart": 1, "paediatric cardiac transplants": 3, "transplants in children": 1, "symptoms in children": 1, "congenital heart lesions": 3, "subgroup of children": 1, "restriction to flow": 1, "poor myocardial function": 3, "comprise those children": 1, "poorly contracting ventricles": 3, "topics of debate": 1, "paediatric heart failure": 3, "heart failure concern": 3, "diagnosis and management": 1, "versus dilated cardiomyopathy": 3, "new onset heart": 3, "onset heart failure": 6, "responses to heart": 1, "anthracycline treated survivors": 3, "survivors of childhood": 1, "childhood malignant disease": 3, "scaffolds in heart": 1, "ability of cardiomyocytes": 1, "cardiomyocytes to detect": 1, "myocardium in response": 1, "workload during stress": 1, "certain stimuli mediate": 3, "adaptation to stress": 1, "leading to heart": 1, "specific signalling pathways": 3, "maladaptive cardiac remodelling": 6, "number of cases": 1, "erk1/2 signalling pathway": 3, "requires a signalosome": 1, "drives the assembly": 1, "pathway to facilitate": 1, "targeting specific effector": 3, "specific effector molecules": 3, "erk1/2 scaffold proteins": 3, "role in determining": 1, "cardiac remodelling is": 2, "field of investigation": 1, "therapeutic strategies capable": 3, "patient with diagnosis": 1, "hypertensive cardiomyiopathy based": 3, "inducible myocardial ischemia": 3, "normal coronary arteries": 3, "typical amyloidotic pattern": 3, "frailty in heart": 1, "important prognostic indicator": 3, "indicator in heart": 1, "accumulation of deficits": 1, "method has strengths": 1, "strengths and limitations": 1, "weak grip strength": 3, "unintentional weight loss": 3, "proportion of deficits": 1, "age 71 \u00b1": 3, "61 % male": 3, "% intermediate frail": 3, "intermediate frail according": 3, "sex and ejection": 1, "biological phenotype had": 2, "0.1 unit increase": 3, "% increased risk": 3, "measures predicted death": 3, "equally predict mortality": 3, "alternative to ascertain": 1, "shaping the future": 1, "heart failure trials": 3, "characterized by disappointments": 1, "studies of therapeutics": 1, "therapeutics including calcium": 3, "agents and antagonists": 1, "antagonists of endothelin": 1, "as a result": 2, "recent studies including": 3, "highlighted the role": 1, "selecting appropriate end": 3, "appropriate end points": 3, "points and sites": 1, "strategies to improve": 1, "improve the potential": 1, "potential for success": 1, "point of care": 2, "failure in patients": 3, "levels of nps": 1, "patients at risk": 1, "risk of developing": 3, "developing heart failure": 3, "embolism or diabetes": 1, "like other biomarkers": 1, "measurement of nps": 1, "clinical care delivery": 3, "systems for measuring": 1, "produce test results": 3, "community outpatient settings": 3, "settings to monitor": 1, "monitor the risk": 1, "use of protocol": 1, "within the time": 1, "accelerate the throughput": 1, "throughput and disposition": 1, "designed clinical trials": 3, "take full advantage": 3, "faster turnaround times": 3, "measuring heart failure": 3, "heart failure care": 3, "rethinking the quality": 1, "quality of outcome": 1, "operationalized hospital quality": 3, "mortality and readmission": 1, "hospitals to improve": 1, "improve the quality": 1, "expected future expansion": 3, "inhibition halts heart": 3, "halts heart failure": 3, "cause of mortality": 2, "involves cardiac hypertrophy": 3, "fibrosis and inflammation": 1, "associated with chromatin": 1, "family bromodomain proteins": 3, "family of acetyl": 1, "lysine reader proteins": 3, "activate a signal": 1, "signal transduction cascade": 3, "set of transcription": 1, "changes in cardiomyocytes": 1, "bets from chromatin": 1, "suppression of downstream": 1, "investigating the role": 1, "role of bets": 1, "neurohormonally induced heart": 3, "induced heart disease": 3, "hypertrophy of cardiomyocytes": 1, "pathological gene induction": 3, "achieved through knockdown": 1, "gene expression profiling": 3, "presence or absence": 1, "abrogated the induction": 1, "in vivo experiments": 3, "induced in mice": 1, "transverse aortic constriction": 9, "several pathological changes": 3, "including cardiac hypertrophy": 3, "toxicity or effects": 1, "systemic blood pressure": 3, "detailed transcriptional analysis": 3, "tissue from mice": 1, "pathological cardiac gene": 3, "cardiac gene expression": 3, "gene expression programme": 3, "targets of bets": 1, "further molecular analysis": 3, "molecular analysis revealed": 3, "role in chromatin": 1, "mediated signal transduction": 3, "activating transcription factor": 3, "transcription factor networks": 3, "including nuclear factor": 3, "factor of activated": 1, "activated t cells": 3, "promoting transcriptional pause": 3, "transcriptional pause release": 3, "implicates epigenetic readers": 3, "cardiac gene control": 3, "via the targeting": 1, "targeting of chromatin": 1, "dependent signal transduction": 3, "abrogate pathological gene": 3, "pathological gene expression": 3, "respiration for quantification": 1, "t1 in swine": 1, "swine with heart": 1, "breathing pulse sequence": 3, "sequence to quantify": 1, "quantify myocardial t1": 3, "myocardial t1 changes": 3, "model of tachycardia": 1, "implanted with pacemakers": 1, "min to induce": 1, "induce heart failure": 3, "t mri scanner": 3, "chelate contrast agent": 3, "baseline and heart": 2, "heart failure scans": 3, "percentage of fibrosis": 1, "fibrosis of heart": 1, "heart failure myocardial": 3, "failure myocardial tissue": 3, "left ventricular tissue": 3, "tissue from control": 1, "trichrome blue histologic": 3, "blue histologic analysis": 3, "in the study": 2, "heart failure t1": 3, "administration of contrast": 1, "\u00b1 94 ms": 3, "contrast agent administration": 3, "\u00b1 171 ms": 3, "animals with heart": 1, "myocardial collagen compared": 3, "compared with tissue": 1, "healthy control animals": 3, "diffuse myocardial changes": 3, "myocardial changes associated": 3, "without the use": 1, "associated with increases": 1, "myocardial delayed enhancement": 3, "delayed enhancement imaging": 3, "technique for detecting": 1, "significant myocardial fibrosis": 3, "ventricular contractile reserve": 12, "reserve in patients": 2, "severe pulmonary hypertension": 6, "approach to assess": 1, "induced pulmonary artery": 3, "pulmonary artery systolic": 3, "artery systolic pressure": 3, "increase by means": 1, "means of stress": 1, "diagnosed pulmonary arterial": 3, "pulmonary arterial hypertension": 9, "thromboembolic pulmonary hypertension": 3, "right ventricular pump": 3, "ventricular pump function": 3, "targeted pulmonary arterial": 3, "arterial hypertension medication": 3, "including stress echocardiography": 3, "cardiopulmonary exercise testing": 15, "on the basis": 2, "\u00b1 1.8 years": 3, "used for factors": 1, "factors predicting survival": 3, "terms of medication": 1, "minute walking distance": 3, "year survival rates": 3, "in the multivariate": 1, "adjusted for age": 1, "age and sex": 1, "increase during exercise": 1, "remained independent prognostic": 3, "independent prognostic markers": 3, "pulmonary hypertension patients": 6, "use of devices": 1, "devices in heart": 1, "become a cornerstone": 1, "cornerstone of heart": 1, "symptoms and mortality": 1, "collected in patients": 1, "data in patients": 1, "preserved systolic function": 3, "interesting therapeutic concepts": 3, "diagnostic features such": 2, "alone diagnostic devices": 3, "mortality and morbidity": 2, "commoner among women": 3, "development of lifesaving": 1, "poses significant challenges": 3, "unfolded protein response": 6, "regulates cardiac sodium": 3, "cardiac sodium current": 3, "systolic human heart": 3, "human heart failure": 9, "alternative mrna splicing": 3, "generating variants encoding": 3, "in this work": 1, "human induced pluripotent": 3, "induced pluripotent stem": 3, "pluripotent stem cell": 3, "exposed to angiotensin": 1, "induced to overexpress": 1, "protein kinase r": 3, "exogenous variants induced": 3, "receptor potential cation": 3, "potential cation channel": 3, "cation channel m7": 3, "prevented the loss": 1, "kv4.3 mrna levels": 3, "mrna levels resulting": 3, "channel mrna splice": 6, "mrna splice variants": 6, "role in downregulation": 1, "multiple cardiac genes": 3, "acute right heart": 6, "normal cardiac function": 3, "receives little attention": 3, "requires diagnostic procedures": 3, "procedures and management": 1, "in this summary": 1, "structure and function": 1, "behind the development": 1, "populations of patients": 1, "chronic pulmonary arterial": 3, "acute pulmonary embolism": 3, "examine clinical circumstances": 3, "clinical circumstances common": 3, "pulmonary embolism represent": 3, "represent a group": 1, "particularly high mortality": 3, "trends in heart": 1, "possibly affect outcomes": 3, "data describing trends": 3, "evaluated temporal trends": 3, "adjustment for patient": 1, "characteristics yielded hazard": 3, "yielded hazard ratios": 3, "indicating a change": 1, "requires new prevention": 3, "new prevention strategies": 3, "versus selective beta": 3, "cardiac sympathetic activity": 6, "activity and hemostasis": 1, "hemostasis in patients": 1, "nonselective \u03b2 -": 3, "selective \u03b2 -": 3, "- blocker metoprolol": 3, "metoprolol in reducing": 1, "reducing the risk": 1, "events in heart": 1, "correlates with levels": 1, "various serum factors": 3, "serve as markers": 1, "markers for coagulability": 1, "label crossover study": 3, "study with masked": 1, "masked outcome assessments": 3, "stable heart failure": 6, "randomized to equipotent": 1, "dosages of carvedilol": 1, "carvedilol or metoprolol": 1, "activity as measured": 1, "secondary outcomes included": 3, "outcomes included markers": 3, "markers of hemostasis": 1, "cardiac washout was": 2, "adrenergic receptor haplotype": 6, "treatment with carvedilol": 2, "157 % \u00b1": 3, "\u00b1 13 %": 3, "compared with metoprolol": 4, "wk of treatment": 1, "receptor haplotype status": 3, "medications to adults": 1, "often contextual factors": 3, "contextual factors such": 2, "competing priorities impact": 3, "priorities impact prescribing": 3, "prescribing of guideline": 1, "performance measurement systems": 3, "health care systems": 3, "prescribed a \u03b2": 1, "reasons for nontreatment": 1, "identified from clinic": 1, "primary care clinicians": 3, "patients not receiving": 1, "drugs for heart": 1, "identified biomedical reasons": 3, "reasons for nonprescribing": 3, "clinician interviews identified": 3, "nonprescribing as chart": 1, "reasons per patient": 3, "in these interviews": 1, "common contextual reasons": 3, "preferences and nonadherence": 1, "thirds of patients": 1, "receive these medications": 1, "tone by pyridostigmine": 1, "prevents ventricular dysfunction": 3, "onset of heart": 1, "elevated sympathetic activity": 3, "reduced parasympathetic control": 3, "experimental evidence suggests": 3, "alternative to slow": 1, "improved by acetylcholinesterase": 1, "acetylcholinesterase inhibitor pyridostigmine": 3, "following myocardial infarction": 3, "elicited in adult": 1, "methylatropine and propranolol": 1, "cardiac sympathovagal balance": 3, "tachycardic response caused": 3, "caused by methylatropine": 1, "bradycardic response caused": 3, "caused by propranolol": 1, "reduced the basal": 1, "basal heart rate": 3, "reduced sympathetic control": 3, "control of heart": 1, "reduced the myocyte": 1, "diameter and collagen": 1, "growth factor protein": 3, "suggesting myocardial angiogenesis": 3, "assessed by means": 1, "volume conductance catheter": 3, "conductance catheter system": 3, "treated with pyridostigmine": 1, "higher stroke volume": 3, "administration of pyridostigmine": 1, "coronary artery ligation": 3, "reduced sympathetic tone": 3, "attenuating cardiac remodeling": 3, "prolonged electromechanical delay": 3, "dyssynchronous heart failure": 6, "branch block type": 3, "altered ventricular structure": 3, "geometry and fiber": 1, "reduced wall stiffness": 3, "local myocyte depolarization": 3, "depolarization and myofiber": 1, "myofiber shortening onset": 3, "aspects in extending": 1, "dyssynchronous failing heart": 3, "induced remodeling aspects": 3, "constructed additional models": 3, "four remodeling aspects": 3, "branch block electrical": 3, "block electrical activation": 3, "electrical activation sequence": 3, "culprit in extending": 1, "aspects of remodeling": 1, "slows myofiber shortening": 3, "myofiber shortening velocity": 3, "activated lateral wall": 3, "myofiber dynamics delay": 3, "delay the onset": 2, "onset of myofiber": 1, "thus giving rise": 3, "right ventricular function": 3, "examine the relationships": 1, "previous studies investigating": 3, "function on body": 1, "linked to weight": 1, "abnormal body composition": 3, "underwent prospective assessment": 3, "assessment of body": 1, "defined as death": 1, "circulatory assist device": 3, "lower body mass": 3, "lower fat mass": 3, "fat mass index": 3, "greater antecedent weight": 3, "antecedent weight loss": 3, "lean body mass": 6, "body mass ratio": 3, "risk of event": 1, "increased body mass": 3, "lower event rate": 3, "higher fat mass": 3, "free mass index": 3, "additive adverse impact": 3, "wasting of fat": 1, "tolerance in heart": 1, "test the effects": 1, "effects of treatment": 1, "treatment with ivabradine": 2, "ivabradine on exercise": 1, "filling in patients": 1, "diastolic filling time": 3, "time by controlling": 1, "controlling heart rate": 3, "onset of symptoms": 1, "assigned to ivabradine": 1, "ivabradine 5 mg": 3, "undertaken at rest": 1, "demonstrated significant improvement": 3, "improvement between baseline": 1, "\u00b1 1.8 mets": 3, "\u00b1 1.9 mets": 3, "peak oxygen uptake": 18, "\u00b1 6.1 ml": 3, "\u00b1 3.3 ml": 3, "reduction in exercise": 1, "ratio of peak": 3, "diastolic mitral flow": 9, "mitral flow velocity": 9, "velocity to peak": 3, "diastolic mitral annular": 12, "mitral annular velocity": 12, "corrected chronotropic response": 3, "difference in heart": 1, "increase in heart": 1, "rate during exercise": 1, "change with treatment": 1, "correlates of increase": 1, "increase in exercise": 1, "correlated with increase": 1, "ivabradine increased exercise": 3, "increased exercise capacity": 3, "filling pressure response": 3, "response to exercise": 2, "therapeutic treatments targeting": 3, "targeting abnormal exercise": 3, "abnormal exercise hemodynamic": 3, "exercise hemodynamic status": 3, "validated clinical tool": 3, "tool to predict": 1, "predict the absence": 1, "prognostic and treatment": 1, "undergo coronary angiography": 3, "clinical prediction rule": 6, "rule to exclude": 1, "undergone coronary angiography": 3, "multivariate logistic regression": 6, "logistic regression analysis": 6, "derived a prediction": 1, "% diameter stenosis": 3, "anterior descending artery": 3, "defined prediction rule": 3, "separate cohort recruited": 3, "electrocardiographic q waves": 3, "nondiabetes risk factors": 3, "rule of having": 1, "independent predictor identified": 3, "prospective validation cohort": 3, "98 % sensitivity": 3, "18 % specificity": 3, "100 % sensitivity": 3, "simple clinical prediction": 3, "accurately identify patients": 3, "eliminate the need": 1, "need for angiography": 1, "proportion of patients": 2, "potentially significant cost": 3, "significant cost savings": 3, "savings and risk": 1, "japanese heart failure": 3, "type 2 receptor": 3, "2 receptor antagonist": 3, "patients in addition": 1, "optimal diuretic therapy": 3, "serum sodium levels": 3, "newly introduced drug": 3, "use in heart": 1, "failure and outcomes": 1, "relieve congestive symptoms": 3, "potential of diuretics": 1, "diuretics to modulate": 1, "adverse neurohormonal activation": 3, "patient with heart": 2, "options and challenges": 1, "older have heart": 1, "ranging from medication": 1, "accurate risk stratification": 3, "stratification of patient": 1, "failure and delivery": 1, "delivery of therapies": 1, "determination of risk": 1, "associated treatment strategies": 3, "human failing hearts": 3, "responses in cardiomyocytes": 1, "altered in heart": 1, "effects on beta": 1, "diminished cyclic adenosine": 3, "cyclic adenosine monophosphate": 3, "augmented cyclic guanosine": 3, "cyclic guanosine monophosphate": 3, "property of being": 1, "increase in camp": 1, "negative cross talk": 3, "radioenzymatic- and fluorescence": 1, "fluorescence resonance energy": 3, "resonance energy transfer": 3, "video edge detection": 3, "expression and activity": 1, "stimulation via catecholamine": 3, "via catecholamine infusions": 3, "infusions in rats": 1, "fold and camp": 1, "camp hydrolytic activity": 3, "blunted cardiac \u03b2": 3, "cardiac \u03b2 -": 3, "in diseased cardiomyocytes": 3, "enhanced by stimulation": 1, "via nitric oxide": 3, "nitric oxide donors": 3, "partially restored \u03b2": 3, "healthy cardiomyocytes reduced": 3, "reduced the rise": 1, "rise in camp": 1, "levels and l": 1, "inotropic effect following": 3, "following acute \u03b2": 3, "acute \u03b2 -": 9, "affecting basal contractility": 3, "protection from norepinephrine": 1, "induced hypertrophic responses": 3, "important defense mechanism": 3, "antagonizing excessive \u03b2": 3, "excessive \u03b2 -": 3, "activating myocardial pde2": 3, "antiadrenergic therapeutic strategy": 3, "safety and efficacy": 5, "efficacy of eplerenone": 2, "eplerenone in patients": 3, "risk for hyperkalemia": 2, "worsening renal function": 6, "investigate the safety": 1, "receiving optimal therapy": 3, "days of inclusion": 1, "underuse of eplerenone": 1, "fear of inducing": 1, "- specified analysis": 3, "analysis of subgroups": 1, "subgroups of patients": 2, "major safety measures": 3, "leading to study": 1, "discontinuation or hospitalization": 1, "risk of potassium": 1, "hospitalization for hyperkalemia": 1, "hyperkalemia or discontinuation": 1, "discontinuation of study": 1, "primary composite endpoint": 3, "meeting specific inclusion": 3, "inclusion and exclusion": 2, "including an egfr": 1, "status in patients": 1, "impact on health": 1, "explore the relation": 1, "relation of hemoglobin": 1, "hrqol and training": 1, "changes in hrqol": 1, "cohort of patients": 1, "trial of exercise": 1, "treatment group effects": 3, "effects on hrqol": 1, "linear mixed models": 3, "mixed models according": 3, "effect of exercise": 3, "correlation with baseline": 1, "hrqol as measured": 1, "effects of hrqol": 1, "hrqol from exercise": 1, "modulated by baseline": 1, "analysis of rhythm": 1, "control vs. rate": 3, "similar efficacy outcomes": 3, "2 treatment strategies": 3, "strategies in patients": 1, "in a substudy": 1, "health care expenditures": 3, "expenditures of patients": 1, "rhythm and rate": 1, "control treatment strategies": 3, "using a cost": 1, "trial resource utilization": 3, "utilization and unit": 1, "supplemented by disease": 1, "\u00b1 9 years": 3, "86 % male": 3, "26 % \u00b1": 3, "\u00b1 6 %": 6, "fewer cardiac procedures": 3, "lower costs related": 3, "cardiac arrhythmia devices": 3, "cost per patient": 3, "therapeutic strategy used": 3, "overall financial burden": 3, "skeletal muscle sarcomere": 3, "muscle sarcomere structure": 3, "structure in patients": 1, "failure and type": 1, "alterations in skm": 1, "skm mitochondrial structure": 3, "improved mitochondrial structure": 3, "facilitate the reversal": 1, "in a pilot": 1, "maximum oxygen consumption": 3, "western blot analysis": 3, "immunohistochemistry and electron": 1, "report severe perturbations": 3, "perturbations in components": 1, "associated protein complex": 3, "microstructure at baseline": 1, "- ordinated fashion": 3, "alterations in markers": 1, "markers of skm": 1, "reach statistical significance": 3, "initial results warrant": 3, "means of improving": 1, "improving muscle function": 3, "chinese herbal medicine": 6, "cardiomyopathy in patients": 1, "evaluate the effectiveness": 1, "treatment for patients": 1, "versus biomedical treatment": 3, "ventricular diastolic end": 6, "diastolic end diameter": 6, "showed significant improvement": 3, "most adverse events": 3, "adverse events observed": 3, "without special treatment": 3, "systemic adverse events": 3, "adverse events evaluation": 3, "verify the efficacy": 1, "enzymes in patients": 1, "evaluating the changes": 1, "period in patients": 1, "apparently healthy volunteers": 3, "key biosynthetic enzymes": 3, "measured in serum": 1, "serum and leukocytes": 1, "leukocytes of participants": 1, "lower median activities": 3, "newly diagnosed patients": 3, "intolerance in heart": 1, "update on exercise": 1, "parameters for diagnosis": 1, "provides an update": 1, "cardiopulmonary exercise variables": 3, "widely accepted peak": 3, "accepted peak oxygen": 3, "peak oxygen consumption": 12, "exercise oscillatory ventilation": 3, "pressure of end": 1, "addition to prognosis": 1, "different mechanisms underlie": 3, "underlie these exercise": 1, "different pathophysiological origin": 3, "evaluating the effect": 1, "effect of interventions": 1, "acute care surgery": 6, "surgery in heart": 1, "heart transplant recipients": 3, "orthotopic heart transplantation": 3, "treatment for end": 1, "consultations and procedures": 1, "year of oht": 1, "oht in recipients": 1, "bridged to transplantation": 1, "including intravenous inotropes": 3, "interval from transplantation": 1, "transplantation to consultation": 1, "interval from consultation": 1, "consultation to operation": 1, "inflammatory abdominal problems": 3, "abdominal problems occurred": 3, "consultation and/or operation": 3, "problems in patients": 1, "patients undergoing oht": 3, "bridged to transplant": 1, "with similar incidence": 3, "consultations and operations": 1, "extracorporeal membrane oxygenation": 12, "oxygenation as bridge": 1, "bridge to recovery": 1, "recovery in infarction": 1, "refractory right heart": 3, "arrest in need": 1, "posterior wall infarction": 3, "cardiac catheterization showed": 3, "right coronary artery": 3, "percutaneous coronary revascularization": 3, "hemodynamically stable situation": 3, "intensive care unit": 3, "failure with therapy": 1, "therapy refractory cardiogenic": 3, "refractory cardiogenic shock": 6, "extra corporeal membrane": 3, "corporeal membrane oxygenation": 3, "emergency cardiac catheterization": 3, "extracorporeal life support": 3, "ischemic right heart": 3, "successful reperfusion therapy": 3, "half of patients": 1, "early research focused": 3, "- diastolic abnormalities": 3, "careful clinical evaluation": 3, "invasive haemodynamic assessment": 3, "in this review": 3, "novel treatment strategies": 3, "incidence and mortality": 1, "outcomes of heart": 1, "advances in treatment": 2, "limited data are": 2, "support this contention": 1, "linked administrative health": 3, "administrative health data": 3, "ratio for death": 1, "year after discharge": 1, "% of incident": 1, "given the lack": 2, "lack of improvement": 1, "therapy during exercise": 1, "low testosterone status": 9, "controlled feasibility study": 3, "assessed the feasibility": 1, "program of exercise": 2, "without intramuscular testosterone": 3, "intramuscular testosterone supplementation": 3, "collected preliminary data": 3, "key health outcomes": 6, "age 67.2 years": 3, "mean \u00b1 sd": 3, "\u00b1 sd testosterone": 3, "sd testosterone levels": 3, "\u00b1 2.6 nmol": 3, "exercise with testosterone": 2, "testosterone or placebo": 1, "assessed in terms": 1, "terms of recruitment": 1, "incremental shuttle walk": 3, "shuttle walk test": 6, "100 % compliance": 3, "compliance to exercise": 1, "exercise and injections": 1, "injections in patients": 1, "completed the study": 1, "improvements in shuttle": 1, "group showed improvements": 3, "improvements from baseline": 1, "baseline in peak": 1, "exercise with placebo": 1, "elderly male patients": 3, "functional electrical stimulation": 6, "peripheral muscles improves": 3, "improves endothelial function": 3, "status in heart": 1, "improves exercise capacity": 9, "impaired systolic function": 3, "investigate the effects": 1, "parameters in patients": 1, "fraction 63 %": 3, "63 % \u00b1": 3, "program or placebo": 1, "completion of training": 1, "minute walked distance": 6, "rated depression scores": 3, "mediated dilatation diameter": 3, "toward lower mitral": 3, "lower mitral e": 3, "also improves exercise": 3, "warrants further investigation": 1, "transforming growth factor": 6, "growth factor beta": 3, "improve cardiac functions": 3, "candidates for cell": 1, "affects the explant": 1, "derived progenitor cells": 3, "determine the effect": 1, "number and phenotype": 1, "cardiac explant c": 3, "descending coronary artery": 3, "coronary artery occlusion": 3, "developed infarcted animals": 3, "left ventricle end": 3, "atrial explants produced": 3, "level of epithelial": 1, "mesenchymal transition markers": 6, "expression of pluripotency": 1, "compared with shams": 1, "\u03b2 receptor type": 3, "stimulated the pluripotency": 1, "differentiation toward cardiomyocyte": 3, "kit+ cell phenotype": 3, "phenotype and function": 1, "optimizing cardiac progenitor": 3, "cardiac progenitor function": 3, "function and cell": 1, "cell expansion protocols": 3, "study breathing control": 3, "following cardiac arrest": 3, "arrest in humans": 1, "pulseless ventricular fibrillation": 3, "newly implanted cardioverter": 3, "class iii heart": 3, "iii heart failure": 3, "permanent periodic breathing": 3, "final data analysis": 3, "effect on pb": 1, "period or amplitude": 1, "cerebral blood flow": 3, "primary oscillations originating": 3, "central pattern generator": 3, "anticoagulants or antiplatelet": 1, "role in treating": 1, "treating heart failure": 3, "risk for stroke": 2, "progress in anticoagulation": 1, "patients in sinus": 1, "agents or anticoagulants": 1, "much work remains": 3, "including better tools": 3, "tools for risk": 1, "stratification and clarity": 1, "regarding the need": 1, "agents in combination": 1, "combination with anticoagulants": 1, "nutrition in heart": 1, "important comorbidities such": 2, "increasing evidence points": 3, "points to alterations": 1, "provides an overview": 1, "different gastrointestinal regions": 3, "disturbed intestinal barrier": 3, "chronic inflammatory state": 3, "imbalance as seen": 1, "particularly poor prognosis": 3, "regulation of feeding": 1, "- inflammatory effects": 3, "role for inflammation": 1, "interventions in heart": 1, "heart failure research": 3, "stable coronary artery": 3, "cardiomyocytes in response": 1, "ventricular wall stress": 3, "biomarkers in patients": 1, "recent data is": 2, "providing prognostic information": 3, "unfavourable clinical outcome": 3, "unilateral renal denervation": 3, "renal denervation improves": 3, "improves autonomic balance": 3, "increased sympathetic tone": 3, "sympathetic tone resulting": 3, "protective mechanisms remain": 3, "unilateral renal dnx": 3, "cardiac autonomic balance": 6, "present study used": 3, "white rabbits undergoing": 3, "undergoing renal dnx": 3, "four treatment groups": 3, "examined several markers": 3, "several markers indicative": 3, "sensitivity and time": 1, "time domain heart": 3, "domain heart rate": 3, "heart rate variability": 9, "compared with sham": 2, "power spectral analysis": 3, "spectral analysis indicated": 3, "indicated an increase": 1, "levels by dnx": 1, "heart rate response": 3, "bolus of metoprolol": 1, "metoprolol or atropine": 1, "cardiac sympathetic tone": 3, "tachycardia in response": 1, "cardiac vagal tone": 3, "prevented the increase": 1, "increase in circulating": 1, "suggest renal dnx": 3, "renal dnx improves": 3, "therapy in heart": 2, "chronic systolic heart": 3, "occurs in patients": 2, "randomized trial involving": 3, "centers to evaluate": 1, "evaluate the effect": 1, "evidence of left": 1, "left ventricular dyssynchrony": 3, "patients underwent device": 3, "underwent device implantation": 3, "primary efficacy outcome": 3, "composite of death": 1, "hospitalization for worsening": 1, "worsening heart failure": 6, "stopped for futility": 1, "data and safety": 1, "safety monitoring board": 3, "at study closure": 3, "primary outcome occurred": 3, "reduce the rate": 1, "rate of death": 1, "hospitalization for heart": 3, "device and extracorporeal": 1, "mechanical cardiac support": 12, "function in children": 2, "investigate the impact": 1, "single center retrospective": 3, "retrospective observational study": 3, "study in children": 1, "group included patients": 9, "receiving ventricular assist": 3, "assist device support": 3, "patients receiving extracorporeal": 3, "receiving extracorporeal membrane": 3, "membrane oxygenation membrane": 3, "oxygenation membrane support": 3, "followed by vad": 1, "comparison of baseline": 1, "during the study": 1, "improvement in egfr": 3, "group until day": 1, "continued until day": 1, "decline in egfr": 1, "renal dysfunction improves": 3, "sensitive outcome change": 3, "outcome change scores": 3, "scores for hospitalized": 1, "hospitalized older adults": 9, "preliminary descriptive study": 3, "mandate to ensure": 1, "ensure effective practice": 3, "outcomes of nursing": 1, "using standardized nursing": 3, "standardized nursing terminologies": 3, "aspects of nursing": 1, "difference in outcome": 1, "exists from admission": 1, "admission to discharge": 2, "retrospective descriptive research": 3, "descriptive research design": 3, "records of patients": 1, "statistically significant improvement": 3, "improvement in outcome": 1, "ratings from admission": 1, "study provide insight": 3, "contribution of nursing": 2, "nursing to outcomes": 1, "outcomes of hospitalized": 1, "sensitive outcome measures": 3, "prospective experimental research": 3, "advancement of science": 1, "regarding effective treatment": 3, "older adults hospitalized": 3, "highlighting the contribution": 1, "care to outcomes": 1, "reciprocal downregulation influences": 3, "influences cardiac hypertrophic": 3, "cardiac hypertrophic response": 3, "response and progression": 1, "cardiac gene therapy": 3, "actions on adenylyl": 1, "desensitization and downregulation": 1, "classic signaling paradigms": 3, "activation of \u03b21ars": 1, "action on camp": 1, "human embryonic kidney": 3, "overexpressing both \u03b21ar": 1, "occur after stimulation": 1, "triggered by isoproterenol": 1, "adrenergic receptor agonist": 3, "show reciprocal regulation": 3, "regulation in mouse": 1, "undergoing chronic \u03b2": 3, "chronic \u03b2 -": 3, "adrenergic receptor stimulation": 3, "postischemic heart failure": 3, "demonstrate that restoration": 1, "cardiac plasma membrane": 3, "plasma membrane levels": 3, "produces beneficial effects": 3, "deleterious \u03b21ar overstimulation": 3, "overstimulation in heart": 1, "impact of physician": 1, "continuity on death": 1, "readmission after discharge": 1, "discharge among patients": 3, "early physician follow": 6, "rates of death": 1, "death and readmission": 1, "readmission among patients": 3, "physician continuity further": 2, "continuity further influences": 1, "outcomes after discharge": 1, "data from linked": 1, "linked administrative databases": 3, "proportional hazard models": 6, "models with time": 1, "covariates to analyze": 1, "analyze the effect": 1, "effect of follow": 1, "month after discharge": 2, "seen the patient": 1, "saw unfamiliar physician(s": 3, "month observation period": 3, "taking into account": 1, "discharge and physician": 1, "altered protein kinase": 3, "- translational state": 3, "adrenergic receptor blockade": 3, "reduces total mortality": 3, "halt disease progression": 3, "dependent protein kinase": 3, "adrenergic receptor activation": 3, "- translational states": 3, "human myocardial tissue": 3, "examine the state": 1, "total myosin binding": 3, "myosin binding protein": 3, "phosphorylation and ser23/24": 1, "demonstrated no change": 1, "change in type": 1, "site specific rii\u03b1": 3, "expression of type": 1, "focusing of ri\u03b1": 1, "vivo phosphorylation sites": 3, "blots with site": 1, "specific monoclonal antibodies": 3, "monoclonal antibodies showed": 3, "mutant ri\u03b1 proteins": 3, "mutant as compared": 1, "failing myocardium displays": 3, "displays altered expression": 3, "- translational modification": 3, "instability in patients": 1, "heart failure prone": 3, "signifies repolarization lability": 3, "sudden cardiac death": 12, "investigate the role": 1, "autonomic nervous system": 6, "nervous system activity": 3, "10 heart failure": 3, "spontaneous ventricular tachycardia": 3, "structurally normal hearts": 3, "beat qt interval": 3, "records of surface": 1, "ecgs at baseline": 1, "pacing and esmolol": 1, "normalized to heart": 1, "group during fixed": 1, "rate atrial pacing": 3, "compared with baseline": 1, "isoprenaline infusion increased": 3, "\u03b2 - adrenoceptor": 6, "- adrenoceptor blockade": 9, "blockade with esmolol": 1, "fluctuations in beat": 1, "consequence of heart": 1, "heart rate variation": 3, "nervous system modulation": 3, "related congestive heart": 3, "failure in survivors": 1, "haematopoietic cell transplantation": 3, "risk for developing": 1, "developing congestive heart": 3, "pre - hct": 3, "- hct exposure": 3, "exposure to anthracyclines": 1, "examined the association": 1, "16 candidate genes": 3, "- oxidant defence": 3, "control study design": 3, "frame for selecting": 1, "cumulative anthracycline exposure": 3, "stem cell source": 3, "length of follow": 1, "variants of genes": 1, "doxorubicin efflux transporter": 3, "chf predictive model": 3, "predictive model performed": 3, "web of complicity": 1, "in this guideline": 1, "moves a step": 1, "language to describe": 1, "describe the development": 1, "development and defects": 1, "propose fundamental definitions": 3, "right heart circulation": 3, "form the foundation": 2, "foundation for describing": 1, "describing a uniform": 1, "right heart circulatory": 3, "heart circulatory failure": 3, "view to foster": 1, "foster collaborative research": 3, "collaborative research initiatives": 3, "effort to provide": 1, "insight into mechanisms": 1, "mechanisms of disease": 1, "class angiotensin receptor": 3, "angiotensin receptor neprilysin": 6, "receptor neprilysin inhibitor": 6, "inhibitor in heart": 1, "natriuretic peptide system": 3, "system by preventing": 1, "preventing the breakdown": 1, "atrial natriuretic peptide": 3, "peptide and b": 1, "neprilysin inhibitor prodrug": 3, "angiotensin receptor antagonist": 3, "receptor antagonist valsartan": 3, "trial of heart": 2, "large outcomes trial": 3, "ejection fraction outcomes": 3, "fraction outcomes trial": 3, "symptoms and signs": 2, "signs of heart": 1, "diagnosis and initiation": 1, "initiation of therapy": 1, "stabilize the patient": 1, "improve clinical symptoms": 3, "term survival rates": 3, "summarizes the principles": 1, "underlying clinical trials": 3, "new pharmacologic targets": 3, "implications of biomarkers": 1, "purely hemodynamic disorder": 3, "results from dysfunction": 1, "interconnected molecular pathways": 3, "focus of research": 1, "measurement and modification": 1, "maladaptive molecular processes": 3, "molecular biomarkers provide": 3, "provide a window": 1, "important therapeutic implications": 3, "use of biomarkers": 1, "result of shortcomings": 1, "shortcomings in research": 1, "dearth of biomarker": 1, "guided clinical trials": 3, "potential therapeutic implications": 3, "implications of promising": 1, "discuss the need": 1, "strict statistical standards": 3, "standards in biomarker": 1, "provide an overview": 1, "overview of biomarker": 1, "guided clinical trial": 3, "clinical trial design": 3, "micrornas in heart": 1, "targets in disease": 1, "fastest growing subclass": 3, "body of evidence": 1, "pathogenesis and progression": 1, "progression of heart": 2, "small noncoding rnas": 3, "expression of target": 1, "genes by sequence": 1, "region of messenger": 1, "results in degradation": 1, "remodeling and heart": 1, "heart failure development": 3, "give an overview": 1, "provide brief insight": 3, "potential of mirnas": 1, "novel therapeutic targets": 3, "targets for heart": 1, "aldosterone system inhibitors": 3, "inhibitors in heart": 1, "carries significant morbidity": 3, "direct renin inhibitors": 3, "neutral endopeptidase inhibitors": 3, "skeletal muscle abnormalities": 3, "abnormalities and exercise": 1, "capacity in adults": 1, "peripheral muscle pump": 3, "promoting cardiac filling": 3, "filling during exercise": 1, "acquired heart failure": 3, "reduced skeletal muscle": 3, "skeletal muscle mass": 12, "mass and/or metabolic": 3, "design and patients": 3, "underwent cardiopulmonary exercise": 3, "lean mass quantification": 3, "dual x -": 3, "magnetic resonance spectroscopy": 3, "spectroscopy as did": 1, "matched and sex": 2, "australian reference data": 3, "single tertiary referral": 3, "tertiary referral centre": 3, "% of predicted": 1, "appendicular lean mass": 3, "lean mass index": 3, "compared with age": 1, "matched reference values": 3, "low skeletal muscle": 3, "muscle mass t": 3, "derived from comparison": 1, "young normal reference": 3, "normal reference mean": 3, "sarcopenic range muscle": 3, "clinically significant wasting": 3, "muscle aerobic capacity": 3, "postexercise phosphocreatine resynthesis": 3, "adults versus controls": 3, "in a sample": 1, "659 heart failure": 3, "performed confirmatory factor": 3, "confirmatory factor analysis": 3, "used exploratory factor": 3, "exploratory factor analysis": 3, "analysis to determine": 1, "determine the presence": 1, "separate scale dimensions": 3, "separate sub -": 3, "sub - sample": 3, "individual scales showed": 3, "excellent fit indices": 3, "contrasting groups validity": 3, "practice and research": 1, "fragments of n": 1, "type natriuretic peptides": 3, "peptides in plasma": 1, "misdiagnosis of heart": 1, "common consensus regarding": 3, "-80 \u00b0 c": 3, "plasma by use": 1, "use of immunoprecipitation": 1, "mass spectrometric analysis": 3, "customized homogeneous sandwich": 3, "sandwich alphalisa \u00ae": 3, "alphalisa \u00ae immunoassays": 3, "identified the presence": 1, "terminally processed forms": 3, "forms of circulating": 1, "low apparent concentration": 3, "concentration of circulating": 1, "increased with antibodies": 1, "terminally truncated fragments": 3, "use of antibodies": 1, "support the development": 1, "targeting nonterminal epitopes": 3, "central glycosylated region": 3, "left ventricular hypertrophy": 3, "hypertrophy in heart": 1, "relative wall thickness": 3, "data among groups": 3, "lower systolic blood": 3, "less renal impairment": 3, "rates of hypertension": 1, "adjustment for covariates": 1, "pressure to end": 1, "-1.5 to -0.5": 1, "elevated cardiac filling": 3, "cardiac filling pressures": 3, "equivalent adverse outcomes": 3, "impact of carvedilol": 2, "carvedilol and metoprolol": 3, "inappropriate implantable cardioverter": 6, "evaluate the effects": 1, "effects of carvedilol": 1, "patients with devices": 1, "received a device": 1, "types of beta": 1, "delivered as antitachycardia": 1, "\u00b1 1.1 years": 3, "significantly decreased risk": 3, "inappropriate therapy compared": 3, "reduction in risk": 1, "inappropriate shock therapy": 3, "inappropriate therapy caused": 3, "reduced in patients": 1, "patients receiving carvedilol": 6, "use of beta": 1, "% lower rate": 6, "rate in patients": 1, "treated with bisphosphonates": 2, "investigate the occurrence": 1, "occurrence of heart": 1, "nationwide retrospective cohort": 3, "retrospective cohort study": 6, "users of bisphosphonates": 1, "bisphosphonates and raloxifene": 1, "general population comprised": 3, "comprised the control": 1, "proportional hazard analyses": 3, "years for alendronate-": 1, "etidronate- and raloxifene": 1, "increased in users": 1, "users of bisphophonates": 1, "mechanism of action": 1, "commonly used bisphosphonates": 3, "alendronate and etidronate": 1, "observed across refill": 3, "across refill compliance": 3, "refill compliance strata": 3, "increasing refill compliance": 3, "compliance for etidronate": 1, "p for trend": 3, "decreased for alendronate": 1, "compared to age-": 1, "age- and gender": 1, "matched control subjects": 3, "users of alendronate": 1, "showed a dose": 1, "alterations by metoprolol": 1, "metoprolol in heart": 1, "order to examine": 1, "examine the reversibility": 1, "reversibility of heart": 1, "weeks infarcted rats": 3, "rates of changes": 1, "changes in pressure": 1, "20 weeks mi": 3, "weeks mi animals": 3, "reversed by metoprolol": 2, "decreases in septum": 1, "posterior wall thickness": 3, "internal diameter were": 2, "animals with metoprolol": 1, "levels of plasma": 2, "norepinephrine and dopamine": 1, "dopamine without affecting": 3, "levels of epinephrine": 1, "myosin heavy chain": 6, "increased mrna level": 3, "level for \u03b2": 1, "performance by \u03b2": 1, "stages of heart": 1, "reversal of changes": 1, "reverse cardiac remodeling": 3, "associated with atherosclerosis": 1, "atherosclerosis and incident": 1, "incident cardiovascular events": 3, "independent risk factor": 3, "shown inconsistent results": 3, "within the population": 1, "association between psoriasis": 1, "subclinical atherosclerosis using": 3, "general linear models": 3, "events for psoriasis": 1, "8,009 reference subjects": 3, "higher diastolic blood": 3, "diastolic blood pressure": 3, "pressure and body": 1, "mass index levels": 3, "adjusted carotid intima": 3, "coronary artery calcium": 3, "artery calcium scores": 3, "risk of incident": 1, "increased in psoriasis": 1, "predominantly mild disease": 3, "events as subjects": 1, "subjects without psoriasis": 3, "dysfunction in patients": 1, "peripheral artery disease": 6, "share many risk": 3, "many risk factors": 3, "prevalence and characteristics": 1, "patients with pad": 3, "patients had brain": 1, "associated with age": 1, "transmitral e -": 3, "quartile of e": 1, "highlighting these patients": 1, "hospital readmission reduction": 3, "readmission reduction program": 3, "rate following hospital": 3, "following hospital stay": 3, "addition to indicating": 1, "possible suboptimal care": 3, "care of patients": 2, "significant economic considerations": 3, "center pilot project": 3, "cardiac specialty hospital": 3, "transitions of care": 2, "ensure adequate self": 3, "training of patients": 1, "health care system": 6, "percent relative reduction": 3, "net economic savings": 3, "urbanized midwestern state": 3, "variability in risk": 1, "majority of studies": 1, "abnormal hr variability": 3, "risk of mortality": 1, "measures of hr": 2, "- linear measures": 3, "used in risk": 1, "reflecting rapid r": 3, "r interval oscillations": 3, "- linear hr": 3, "linear hr variability": 3, "hr variability measures": 3, "term fractal scaling": 3, "fractal scaling exponent": 3, "better prognostic information": 3, "measurement of hr": 2, "variability to identify": 1, "order to assess": 1, "assess the risk": 1, "fatal arrhythmia events": 3, "future randomized trials": 3, "trials using hr": 3, "using hr variability": 3, "- defined inclusion": 3, "defined inclusion criteria": 3, "routine clinical tool": 3, "tool for risk": 1, "renal artery stenosis": 3, "peripheral arterial disease": 3, "pathophysiologic mechanism stems": 3, "renal underperfusion resulting": 3, "present with hypertension": 1, "hypertension and end": 1, "end stage kidney": 3, "stage kidney failure": 3, "computed tomographic angiography": 3, "magnetic resonance angiography": 3, "adequate blood pressure": 3, "blood pressure control": 3, "preventive measures form": 3, "foundation of management": 1, "based percutaneous revascularization": 3, "revascularization with angioplasty": 1, "angioplasty and stenting": 1, "modest clinical benefit": 3, "benefit for patients": 1, "small retrospective studies": 3, "randomized clinical trials": 3, "clinical trials failed": 3, "concrete data regarding": 3, "regarding the role": 1, "role of stenting": 1, "guidelines on evaluation": 1, "evaluation and management": 1, "provide the framework": 1, "framework for determining": 1, "determining individualized assessment": 3, "assessment and treatment": 1, "plans for patients": 1, "analysis of microarray": 1, "several key genes": 3, "key genes related": 3, "related to heart": 1, "major public health": 6, "public health problem": 6, "differentially expressed genes": 3, "heart failure samples": 6, "used for diagnosis": 1, "diagnosis and treatment": 1, "- ischemic heart": 3, "observe the difference": 1, "groups of samples": 1, "functional enrichment analysis": 6, "regulation of programmed": 1, "programmed cell death": 3, "biomarkers to distinguish": 1, "types of heart": 1, "targets to develop": 1, "effects of care": 1, "management and telehealth": 2, "longitudinal analysis using": 3, "analysis using medicare": 3, "using medicare data": 3, "mortality and healthcare": 1, "healthcare utilization effects": 3, "combined care management": 3, "retrospective matched cohort": 3, "matched cohort study": 3, "demonstration participating clinics": 3, "score matched control": 3, "matched control group": 3, "integrates a content": 1, "driven telehealth system": 3, "system with care": 1, "year study period": 3, "negative binomial regression": 3, "binomial regression models": 3, "intervention and survival": 1, "survival and utilization": 1, "groups after matching": 1, "% lower risk": 3, "quarterly inpatient admissions": 3, "admissions from baseline": 1, "use or number": 1, "number of hospital": 1, "days for participants": 1, "admissions for individuals": 1, "disease and mortality": 1, "coupled with content": 1, "driven telehealth technology": 3, "technology has potential": 1, "potential to improve": 1, "improve health outcomes": 3, "strength of race": 1, "contemporary chronic heart": 3, "association with exercise": 1, "exercise training response": 3, "association between race": 1, "race and outcomes": 1, "interactions with exercise": 1, "performed an analysis": 1, "without exercise training": 3, "explored an interaction": 1, "interaction with exercise": 1, "identified black patients": 3, "significantly more hypertension": 1, "hypertension and diabetes": 1, "less ischemic etiology": 3, "lower socioeconomic status": 3, "status versus whites": 3, "minute walk distance": 3, "after multivariable adjustment": 3, "similar cardiovascular mortality": 3, "interaction between race": 1, "training on outcomes": 2, "race in patients": 1, "modifiable risk factors": 3, "lower exercise performance": 3, "rationale and design": 1, "optimal therapy including": 3, "therapy including anticoagulation": 3, "anticoagulation and rate": 1, "major cardiovascular complications": 3, "prevent adverse outcomes": 3, "adverse outcomes related": 3, "rhythm control therapy": 21, "offset by side": 1, "effects of repeated": 1, "preserve atrial structure": 3, "maintain sinus rhythm": 3, "practice of delayed": 1, "delayed rhythm control": 3, "otherwise effective rate": 3, "effective rate control": 3, "new antiarrhythmic drugs": 3, "safety of rhythm": 1, "modern rhythm control": 3, "reduce cardiovascular complications": 3, "recent onset af": 3, "af at risk": 1, "mandated usual care": 3, "early rhythm control": 6, "blinded outcome assessment": 3, "outcome assessment trial": 3, "composite primary outcome": 3, "worsening of heart": 2, "spent in hospital": 1, "consist of anticoagulation": 1, "therapy of underlying": 1, "underlying heart disease": 3, "care plus rhythm": 3, "operated electrocardiographic device": 3, "device to monitor": 1, "key secondary outcomes": 3, "secondary outcomes include": 3, "include cognitive function": 3, "function and quality": 1, "prevent cardiovascular complications": 3, "cardiovascular complications associated": 3, "bleeding in patients": 1, "treated with implantation": 1, "term ventricular assist": 3, "as the use": 1, "health care providers": 3, "significant gastrointestinal bleeding": 3, "housed on units": 1, "managing the device": 1, "develop an understanding": 1, "groups to manage": 1, "manage this population": 1, "management of end": 1, "end stage heart": 9, "increase in incidence": 1, "incidence and prevalence": 1, "causes of death": 1, "death and hospitalisation": 1, "as a consequence": 1, "increase in life": 1, "called end stage": 3, "terminal heart failure": 6, "patients with end": 1, "fall into stage": 1, "advanced structural heart": 3, "structural heart disease": 3, "failure at rest": 1, "minimal physical exertion": 3, "maximal medical treatment": 3, "medical treatment according": 3, "patient population has": 2, "year mortality rate": 3, "special therapeutic interventions": 3, "correct reversible causes": 3, "poor patient compliance": 3, "in this article": 1, "describe current strategies": 3, "treatment of end": 1, "inhibition of l": 1, "ca2 + currents": 3, "influx via l": 3, "supports the plateau": 1, "ventricular action potentials": 3, "trigger for excitation": 1, "monomeric g proteins": 3, "regulates ventricular action": 3, "ventricular action potential": 3, "action potential duration": 3, "ability to inhibit": 2, "inhibit cardiac l": 3, "type channel activity": 3, "occurring rad variant": 3, "failure in humans": 1, "type channel isoforms": 3, "95 % inhibition": 3, "modes of l": 1, "type channel inhibition": 3, "contributes to cardiomyopathy": 1, "via a mechanism": 1, "efficacy in vivo": 1, "ethically complex situations": 3, "situations in pediatrics": 1, "religious beliefs preclude": 3, "preclude the provision": 1, "provision of life": 1, "involving young adults": 3, "reached the age": 1, "decisions about life": 1, "presents a case": 1, "sickle cell disease": 3, "disease has life": 1, "going into heart": 1, "urgently recommend blood": 3, "recommend blood transfusions": 3, "composite quality measures": 3, "inpatient medical conditions": 3, "reporting on quality": 1, "aims to help": 1, "select better hospitals": 3, "individual quality measures": 3, "inferior hospitals based": 3, "based on outcome": 1, "derived composite quality": 3, "composite quality measure": 3, "measure for heart": 1, "composite measure predicts": 3, "future hospital mortality": 3, "created a cohort": 1, "older patients treated": 3, "acute care hospital": 3, "estimated the odds": 1, "odds of future": 1, "versus best quintile": 6, "quintile of hospitals": 1, "repeated this analysis": 1, "performance on existing": 1, "existing quality indicators": 3, "chosen a hospital": 1, "quintile of performance": 1, "odds of dying": 1, "value for difference": 1, "measures of quality": 1, "measures at explaining": 1, "influences the safety": 1, "efficacy of spironolactone": 1, "incidence of hyperkalemia": 1, "caused by mineralocorticoid": 1, "vary by race": 1, "race influences efficacy": 3, "efficacy of mineralocorticoid": 2, "antagonists in heart": 1, "hyperkalemia and outcomes": 1, "randomized to spironolactone": 1, "functional class iv": 3, "rate and heart": 1, "myocardial infarction compared": 3, "- aa participants": 3, "increased with spironolactone": 1, "race by treatment": 1, "throughout the trial": 1, "compared with aas": 1, "non - aas": 3, "attain maximal spironolactone": 3, "maximal spironolactone dose": 3, "rates of hyperkalemia": 1, "rates of hypokalemia": 1, "adjustment for differences": 1, "achieved study drug": 3, "study drug dose": 3, "combined end point": 6, "point of death": 1, "hypokalemia with spironolactone": 1, "less clinical benefit": 3, "differ by race": 1, "proteomics and pathway": 1, "analysis of pressure": 1, "free shotgun proteomics": 3, "shotgun proteomics approach": 3, "approach to evaluate": 1, "global proteomics changes": 6, "tac)-induced heart failure": 3, "associated signaling pathway": 3, "signaling pathway changes": 3, "changes using ingenuity": 3, "using ingenuity pathway": 3, "ingenuity pathway analysis": 6, "categories of actin": 1, "heart failure phenotypes": 3, "mitochondrial damage induced": 3, "mitochondrial proteome changes": 3, "84 % protection": 3, "nonmitochondrial protein changes": 3, "included significant amelioration": 3, "effects on heart": 1, "actin cytoskeleton pathways": 3, "changed in pressure": 1, "induced proteomic alterations": 3, "perturbed mitochondrial function": 3, "alterations in tac": 1, "potential clinical application": 3, "targeted peptide drugs": 3, "treatment heart failure": 3, "stay increase rehospitalization": 3, "rehospitalization of medicare": 1, "skilled nursing facilities": 3, "analyze the relationship": 1, "relationship between length": 1, "stay and rehospitalization": 1, "using the implementation": 1, "- acute care": 6, "acute care transfer": 6, "care transfer policy": 6, "quasi - experiment": 3, "declines in length": 1, "decrease in length": 1, "1.56 percentage points": 3, "0.81 percentage points": 3, "urinary tract infection": 3, "without major complications": 6, "hospitalized for ami": 1, "major complications had": 2, "reduction in hospital": 1, "rate of rehospitalization": 1, "outcomes of care": 1, "need to improve": 1, "costs for patients": 1, "patients undergoing procedures": 3, "association with outcomes": 1, "medically managed diseases": 3, "acute care hospitals": 3, "physicians into quintiles": 1, "volume of patients": 1, "regression to compare": 1, "costs across volume": 3, "across volume groups": 3, "examined physician volume": 3, "volume within strata": 3, "strata of hospital": 1, "volume and physician": 1, "higher readmission rates": 3, "across hospital volume": 6, "hospital volume groups": 6, "relationship between physician": 1, "volume and mortality": 1, "among noncardiologist physicians": 3, "antagonism in heart": 1, "major clinical trials": 3, "clinical trials designed": 3, "analyze clinical outcomes": 3, "clinical outcomes using": 3, "using an aldosterone": 1, "groups with heart": 1, "chronic advanced heart": 6, "therapy with beta": 1, "infarction heart failure": 6, "myocardial infarction patients": 3, "reduction in mortality": 1, "mortality and hospitalizations": 1, "hospitalizations for patients": 1, "aldosterone antagonist eplerenone": 3, "provide the background": 1, "background for aldosterone": 1, "aldosterone antagonist therapy": 3, "improving survival rates": 3, "rates of patients": 2, "idiopathic dilated cardiomyopathy": 18, "impact of evidence": 1, "contemporary therapeutic options": 3, "improvement in survival": 1, "thus examined changes": 3, "changes in prognosis": 1, "dilated cardiomyopathy cohort": 3, "73 % men": 3, "negative coronary angiography": 3, "4 enrollment periods": 3, "basis of heart": 1, "heart failure treatment": 3, "failure treatment eras": 3, "patients receiving angiotensin": 3, "angiotensin receptors blockers": 3, "final evaluation increased": 3, "trend toward enrollment": 3, "dilatation and dysfunction": 1, "point including death": 3, "recent enrollment period": 3, "powerful independent predictor": 3, "42 % risk": 3, "% risk reduction": 3, "reflecting marked decreases": 3, "decreases in heart": 1, "p<001 and hr": 1, "benefits of controlled": 1, "controlled randomized trials": 3, "emphasizing the importance": 1, "importance of tailored": 1, "continuity of care": 1, "indeterminable anaerobic threshold": 3, "threshold in heart": 1, "maximal cardiopulmonary exercise": 3, "cardiopulmonary exercise test": 9, "patients with systolic": 1, "stable clinical conditions": 3, "exercise test investigations": 3, "investigations at study": 1, "based on lack": 1, "lack of achievement": 1, "peak respiratory quotient": 3, "respiratory quotient \u22641.05": 3, "primary study end": 6, "study end point": 9, "urgent cardiac transplant": 3, "secondary end point": 3, "multivariable logistic analysis": 3, "failure in detecting": 1, "reduced peak oxygen": 3, "higher metabolic exercise": 3, "kidney index score": 6, "index score value": 3, "at multivariable analysis": 3, "ventilatory efficiency slope": 3, "modification of diet": 1, "associated to prognosis": 1, "compared with metabolic": 1, "secondary study end": 3, "inability to identify": 1, "independent prognostic role": 3, "heart failure mortality": 3, "mortality in men": 1, "among cardiorespiratory fitness": 3, "cardiovascular risk factors": 9, "versus unfit men": 3, "without a history": 1, "cardiovascular disease underwent": 3, "underwent a baseline": 1, "measures included body": 3, "included body mass": 3, "quantified as duration": 1, "maximal treadmill exercise": 3, "treadmill exercise testing": 3, "divided into age": 1, "obese body mass": 3, "mass index categories": 3, "grouped into categories": 1, "overweight body mass": 3, "mass index strata": 3, "fit men had": 2, "risk in men": 1, "risk factors present": 3, "goal of achieving": 1, "decreased mitochondrial energy": 3, "mitochondrial energy production": 3, "energy production precede": 3, "failure after pressure": 1, "alterations in energy": 1, "changes in energy": 1, "energy metabolism precede": 3, "cardiac hypertrophy secondary": 3, "abdominal aortic constriction": 3, "rates of energy": 1, "energy substrate metabolism": 3, "in vivo assessment": 3, "demonstrated diastolic dysfunction": 3, "20 % increase": 3, "increase in e": 1, "16 % decrease": 3, "decrease in %": 1, "% ejection fraction": 3, "marked cardiac insulin": 3, "2 weeks post": 3, "weeks post -": 3, "decrease in insulin": 1, "rates of glycolysis": 1, "glycolysis and glucose": 1, "plasma membrane translocation": 3, "translocation of glucose": 1, "oxidation of glucose": 1, "myocardial glycolysis rates": 3, "reduced mitochondrial complex": 3, "mitochondrial complex v": 3, "complex v activity": 3, "ratio of phosphocreatine": 1, "decreased mitochondrial oxidative": 3, "mitochondrial oxidative metabolism": 3, "early metabolic changes": 3, "create an energy": 1, "progression from hypertrophy": 1, "hypertrophy to heart": 1, "reality of heart": 1, "guide health service": 3, "health service planning": 3, "prevention and treatment": 2, "relevant health service": 3, "health service provision": 3, "reduced gross income": 3, "lower total expenditure": 6, "expenditure on health": 2, "health per capita": 6, "factors of developed": 1, "including lower risk": 3, "risk of raised": 1, "raised blood glucose": 3, "blood glucose levels": 3, "% of cases": 1, "paradox of having": 1, "epidemiology of developed": 1, "gross national income": 3, "income per capita": 3, "linked to heart": 1, "renal chloride channel": 3, "chloride channel gene": 3, "reported greater risk": 3, "assessing the link": 1, "link between air": 1, "pollution and heart": 1, "ambient air pollution": 3, "recognised risk factor": 3, "new systematic review": 3, "effects of air": 1, "pollution on heart": 1, "common disorder associated": 3, "physicians and professionals": 1, "aggravate cardiovascular health": 3, "lead to hospitalisation": 1, "hospitalisation and death": 1, "exacerbates heart failure": 3, "failure in mice": 1, "cytoskeletal actin dynamics": 3, "implicated in heart": 1, "produced cardiac dysfunction": 3, "dysfunction with conduction": 1, "abnormalities and hypertrophy": 1, "cardiac pathophysiology is": 2, "in these studies": 1, "mildly increased heart": 3, "increased heart mass": 3, "decreases in ejection": 1, "dilatation and hypertrophy": 1, "eliminated cardiac hypertrophy": 3, "cardiac functional deterioration": 3, "hearts with increased": 1, "mechanical support devices": 3, "spite of developments": 1, "requires the collaboration": 1, "collaboration of professionals": 1, "indicated by guidelines": 1, "communication and collaboration": 1, "collaboration among cardiologists": 3, "medical staff responsible": 3, "patient care is": 2, "country has physicians": 1, "across the country": 1, "regarding appropriate referrals": 3, "present consensus report": 3, "strengthen the connection": 1, "connection between certified": 1, "phase and healthcare": 1, "information regarding conditions": 3, "recent postmarketing trials": 3, "risk for hospitalized": 1, "hospitalized heart failure": 3, "examine the associations": 1, "saxagliptin and sitagliptin": 1, "user cohort study": 3, "18 health insurance": 3, "insurance and health": 1, "health system data": 3, "system data partners": 3, "therapy with saxagliptin": 1, "acting insulin products": 3, "principal discharge diagnosis": 3, "553 saxagliptin users": 3, "124 sitagliptin users": 3, "contributed an average": 1, "disease risk score": 3, "saxagliptin versus sitagliptin": 3, "saxagliptin versus pioglitazone": 3, "saxagliptin versus insulin": 3, "stratified hazard ratios": 3, "sitagliptin versus pioglitazone": 3, "sitagliptin versus insulin": 3, "1:1 propensity score": 3, "prior cardiovascular disease": 3, "large cohort study": 3, "observed in users": 1, "users of saxagliptin": 1, "saxagliptin or sitagliptin": 1, "selected antihyperglycemic agents": 3, "effectiveness of implementation": 1, "strategies in improving": 1, "improving physician adherence": 3, "adherence to guideline": 1, "recommendations in heart": 1, "systematic review protocol": 3, "review to identify": 1, "identify implementation strategies": 3, "improve physician adherence": 3, "adherence to class": 1, "outweigh the risks": 1, "methods and analysis": 1, "conduct a literature": 1, "include prospective studies": 3, "prospective studies evaluating": 3, "studies evaluating implementation": 3, "evaluating implementation interventions": 3, "uptake of class": 1, "data in duplicate": 1, "level of application": 1, "common underlying characteristics": 3, "assess the impact": 2, "intervention on adherence": 1, "recommended pharmacological treatment": 3, "referred for device": 1, "education at discharge": 1, "left ventricular function": 3, "ventricular function assessment": 3, "include clinical outcomes": 3, "clinical outcomes such": 2, "readmissions and mortality": 1, "examine the context": 1, "synthesise the results": 1, "results for meta": 1, "discussion and dissemination": 1, "impact of implementation": 1, "factors on physician": 1, "findings through briefing": 1, "publications and presentations": 1, "defibrillator deactivation discussions": 12, "discussions to occur": 1, "occur between physicians": 1, "physicians and heart": 1, "reported the patient": 1, "determine patient awareness": 3, "preferences and timing": 1, "analyze interview data": 3, "25 heart failure": 3, "setting and participants": 3, "felt implantable cardioverter": 3, "mind to engage": 1, "end of life": 2, "wished further review": 1, "previously established preferences": 3, "preferences and decisions": 1, "support the need": 1, "need to include": 1, "deactivation at implant": 1, "within broader discussions": 3, "discussions about end": 1, "life treatment preferences": 3, "using this process": 1, "process to help": 1, "defibrillator deactivation preferences": 3, "reduce the number": 1, "distressing implantable cardioverter": 3, "shocks at end": 1, "assess the safety": 2, "carotid baroreflex activation": 3, "baroreflex activation therapy": 3, "decreased parasympathetic activity": 3, "parasympathetic activity contribute": 3, "symptoms and disease": 1, "centrally mediated reduction": 3, "increased parasympathetic activity": 3, "chronic stable guideline": 3, "directed medical therapy": 3, "receive ongoing gdmt": 3, "gdmt plus bat": 3, "primary safety end": 3, "safety end point": 3, "primary efficacy end": 3, "efficacy end points": 3, "hall walk distance": 3, "compared with control": 1, "control group patients": 3, "\u00b1 14 m": 2, "\u00b1 3.1 points": 3, "functional class ranking": 3, "change in distribution": 1, "significantly reduced n": 3, "toward fewer days": 3, "fewer days hospitalized": 3, "improves functional status": 3, "burden of heart": 1, "heart failure hospitalizations": 3, "report of using": 1, "using cardiopulmonary exercise": 3, "exercise testing guide": 3, "testing guide exercise": 3, "guide exercise rehabilitation": 3, "rehabilitation in patients": 1, "rehabilitation in patient": 1, "standard clinical practice": 3, "guide to prescribe": 1, "prescribe exercise rehabilitation": 3, "limited maximal cpet": 3, "patients as control": 1, "control without exercise": 3, "5 exercise patients": 3, "patients used \u03b450%w": 3, "used \u03b450%w intensity": 3, "intensity to exercise": 1, "12 w rehabilitation": 3, "two groups patients": 3, "min after rehabilitation": 1, "distance 6 minutes": 3, "changes in control": 1, "guiding exercise rehabilitation": 3, "classified as heart": 1, "newer imaging techniques": 3, "function in hfpef": 1, "reduced long axis": 3, "long axis function": 3, "changes on exercise": 1, "history of hypertension": 1, "other cardiovascular risk": 3, "primary symptoms are": 2, "single diagnostic test": 3, "thorough medical history": 3, "include the patient": 1, "rate and rhythm": 1, "standing blood pressure": 3, "pressure and auscultation": 1, "auscultation to rule": 1, "jugular venous pressure": 3, "peripheral oedema allows": 3, "oedema allows assessment": 3, "referred to heart": 1, "heart failure nurses": 3, "local cardiology services": 3, "regular physical activity": 3, "physical activity controls": 3, "acquired cardiovascular risk": 3, "risk factors such": 2, "hypertension and hyperlipidaemia": 1, "50 % reduction": 3, "benefits of exercise": 1, "recent evidence suggests": 3, "exercise prevents cell": 3, "prevents cell senescence": 3, "active individuals are": 2, "developing certain malignancies": 3, "certain malignancies including": 3, "malignancies including cancer": 3, "depression and dementia": 1, "even lower volumes": 3, "volumes of exercise": 1, "recommendations confer health": 3, "confer health benefits": 3, "individuals with established": 1, "established cardiac disease": 3, "cardiac disease including": 3, "disease including heart": 3, "including heart failure": 3, "death in athletes": 1, "rare with.estimates ranging": 3, "death during sport": 1, "aged recreational athletes": 3, "recreational athletes more": 2, "sudden cardiac deaths": 3, "cardiac deaths occur": 3, "occur in males": 1, "- participation screening": 3, "ability to detect": 1, "detect congenital accessory": 3, "congenital accessory pathways": 3, "pathways and ion": 1, "individuals with cardiomyopathy": 1, "limited value given": 3, "training for heart": 2, "small pilot study": 3, "assisted gait therapy": 6, "system in heart": 1, "week aerobic training": 3, "aerobic training period": 3, "trainings per week": 3, "integrated dynamic resistance": 3, "dynamic resistance training": 3, "patients underwent testing": 3, "strength by measuring": 1, "measuring the peak": 1, "peak quadriceps force": 6, "adverse events occurred": 6, "combined training resulted": 3, "improvement in peak": 1, "peak work rate": 3, "% to +": 2, "+ 61 %": 3, "+ 44 %": 3, "aerobic and resistance": 1, "resistance training intervention": 3, "augmented feedback resulted": 3, "resulted in benefits": 1, "benefits in exercise": 1, "strength and quality": 1, "need further validation": 1, "adherence with exercise": 1, "describe the association": 1, "support and barriers": 2, "barriers to participation": 1, "participation with exercise": 1, "surveys to assess": 1, "assess social support": 3, "barriers to exercise": 4, "perceived social support": 3, "social support score": 3, "indicated higher levels": 3, "higher btes indicated": 3, "indicated more barriers": 1, "higher exercise time": 3, "for cardiovascular death": 3, "association between increasing": 1, "usual care group": 3, "poor social support": 3, "lower exercise time": 3, "impact the effect": 1, "impact on patients": 1, "given that exercise": 1, "training improves outcomes": 3, "assessment of perceived": 1, "facilitate individualized approaches": 3, "approaches to implement": 1, "implement exercise training": 3, "exercise training therapy": 3, "reduction and exercise": 1, "recent onset heart": 3, "arguments for beta": 1, "blocker hypo -": 3, "hypo - response": 3, "readmissions in heart": 1, "effect on heart": 1, "assessed the impact": 1, "impact of hr": 1, "reduction with beta": 2, "blockers on exercise": 1, "standardized exercise protocol": 3, "respiratory gas analysis": 3, "analysis at baseline": 1, "recommended target doses": 3, "doses for beta": 1, "resting hr<70 bpm": 3, "patients with resting": 1, "hr<70 versus \u226570": 3, "versus \u226570 bpm": 6, "similar dose uptitration": 3, "versus the latter": 1, "significantly larger hr": 3, "larger hr reduction": 3, "decreased at follow": 1, "compared to baseline": 1, "increase in patients": 1, "lower resting hr": 3, "in recent onset": 3, "bpm with beta": 1, "aggressive dose uptitration": 3, "achieve this target": 1, "little hr reduction": 3, "right interatrial shunting": 6, "shunting for treatment": 1, "treatment of patients": 1, "safety and proof": 1, "principle cohort study": 6, "interventions to reduce": 1, "left atrial pressure": 3, "atrial pressure improve": 3, "pressure improve symptoms": 3, "risk of hospital": 1, "shunting in patients": 1, "canadian special access": 3, "special access programme": 3, "catheterisation with transoesophageal": 1, "transoesophageal echocardiographic guidance": 3, "evaluations at baseline": 1, "baseline and months": 1, "procedural adverse events": 3, "thrombosis or migration": 1, "3 month follow": 3, "6 min walk": 3, "min walk test": 6, "walk test distance": 3, "right atrial pressure": 3, "pulmonary arterial pressure": 3, "admitted to hospital": 2, "hospital for worsening": 1, "bleeding at month": 1, "ventricular tachycardia storm": 3, "failure 2 months": 3, "post - procedure": 3, "right interatrial shunt": 3, "interatrial shunt demonstrates": 3, "demonstrates initial safety": 3, "scale randomised studies": 3, "in this regard": 1, "results of studies": 1, "receptor neprilysin inhibitors": 3, "receptors and neprilysin": 1, "neprilysin blocks renin": 3, "supports natural vasodilatory": 3, "prospective randomized multicenter": 3, "randomized multicenter trial": 3, "multicenter trial paradigm": 3, "individuals with stabilized": 1, "stabilized chronic heart": 3, "20 % decrease": 3, "specified subgroup analyses": 3, "typical adverse event": 3, "without a need": 1, "need to interrupt": 1, "interrupt the treatment": 1, "long time become": 3, "become a change": 1, "stable chronic heart": 3, "systolic dysfunction treatment": 3, "form of heart": 1, "among older persons": 3, "aerobic exercise training": 6, "obese older patients": 6, "factorial trial conducted": 3, "academic medical center": 3, "initially screened participants": 3, "older obese participants": 3, "excluded by inclusion": 1, "weeks of diet": 1, "consisted of telephone": 1, "- primary outcome": 6, "higher scores indicate": 3, "indicate worse heart": 3, "worse heart failure": 3, "completed the trial": 1, "by main effects": 3, "main effects analysis": 3, "kg body mass": 3, "combination of exercise": 1, "statistically significant change": 3, "score with exercise": 1, "change in peak": 1, "change in percent": 1, "percent lean body": 3, "change in thigh": 1, "intermuscular fat ratio": 3, "serious adverse events": 3, "conclusions and relevance": 3, "training increased peak": 3, "effect on quality": 1, "life as measured": 1, "ventricular assist system": 3, "support to patients": 1, "centrifugal flow pump": 3, "hemocompatibility by incorporating": 1, "magnetically levitated rotor": 3, "evaluate the performance": 1, "performance and safety": 1, "support)-derived performance goal": 3, "adults with ejection": 1, "optimal medical management": 3, "listed for transplant": 1, "continued on support": 1, "% received transplants": 3, "survival 92 %": 3, "88 % performance": 3, "% performance goal": 3, "significantly reduced mortality": 3, "reduced mortality risk": 3, "key adverse events": 3, "adverse events included": 3, "events included reoperation": 3, "reoperation for bleeding": 1, "month survival rates": 3, "favorable adverse event": 3, "adverse event profile": 3, "evaluate the cost": 2, "effectiveness of disease": 1, "disease management programs": 12, "heart failure disease": 6, "failure disease management": 6, "influence medical resource": 3, "medical resource use": 3, "use and quality": 2, "costs and survival": 1, "approach to extrapolating": 1, "based simulation tool": 3, "use of evidence": 2, "costs to generate": 1, "projections of resource": 1, "relationships with time": 1, "cohort study designs": 3, "virtual cohorts used": 3, "estimates of resource": 1, "ratios from user": 1, "validity in replicating": 1, "replicating resource use": 3, "simulations to evaluate": 1, "effectiveness of heart": 1, "design a program": 1, "improvements in functioning": 1, "functioning and use": 1, "researchers and providers": 1, "tool for conducting": 1, "analyses of disease": 1, "debilitating chronic disease": 3, "role in supporting": 1, "patients in managing": 1, "managing this disease": 1, "describes the pathophysiology": 1, "nurses to understand": 1, "understand the pathophysiology": 1, "enhancing medical management": 3, "management to alleviate": 1, "deter the advancement": 1, "ultimately reduce morbidity": 3}, "2": {"national trends": 4, "trends in": 6, "patient safety": 6, "safety for": 1, "common conditions": 2, "the effects": 2, "effects of": 22, "decade of": 2, "national efforts": 2, "efforts dedicated": 2, "improve patient": 2, "safety remain": 2, "remain largely": 2, "largely unclear": 2, "this study": 44, "study used": 4, "assess national": 2, "adverse event": 10, "event rates": 12, "rates between": 1, "patients hospitalized": 14, "hospitalized with": 4, "acute myocardial": 22, "myocardial infarction": 70, "congestive heart": 56, "heart failure": 996, "conditions requiring": 2, "requiring surgery": 2, "the analysis": 2, "analysis included": 2, "large study": 2, "study sample": 2, "sample with": 1, "patients across": 2, "the results": 10, "results show": 4, "significant decline": 2, "decline in": 5, "rates for": 2, "translating to": 1, "estimated 81,000": 2, "hospital adverse": 2, "adverse events": 24, "events averted": 2, "averted in": 1, "measurable overall": 2, "overall improvements": 2, "improvements for": 1, "patients admitted": 6, "admitted with": 1, "surgical conditions": 2, "some events": 2, "pressure ulcers": 2, "ulcers in": 1, "surgical patients": 2, "actually increased": 2, "increased despite": 2, "considerable national": 2, "national attention": 2, "attention to": 3, "study suggests": 2, "suggests that": 7, "national patient": 2, "safety initiatives": 2, "led to": 8, "real progress": 2, "progress in": 2, "created across": 2, "board improvements": 2, "cross -": 4, "- talk": 2, "talk between": 3, "adipose tissue": 4, "tissue in": 1, "cachectic heart": 2, "failure patients": 42, "patients with": 281, "respect to": 1, "alterations in": 7, "body composition": 20, "prospective study": 4, "cardiac cachexia": 8, "associated with": 119, "changes in": 32, "increased energy": 2, "energy expenditure": 2, "expenditure caused": 2, "caused by": 7, "b natriuretic": 2, "natriuretic peptides": 10, "role in": 12, "composition in": 1, "progressive loss": 2, "loss of": 3, "fat free": 2, "free mass": 4, "fat mass": 6, "takes place": 2, "composition with": 1, "regard to": 1, "body fat": 2, "fat distribution": 2, "assessed by": 12, "dual energy": 2, "energy x": 4, "x -": 6, "- ray": 6, "ray absorptiometry": 6, "non -": 60, "- diabetic": 2, "diabetic patients": 2, "chronic heart": 64, "- cachectic": 2, "cachectic chf": 2, "individuals with": 8, "prior myocardial": 2, "followed for": 4, "biomarkers of": 1, "neurohormonal stimulation": 2, "endothelial dysfunction": 2, "midregional proanp": 2, "total adiponectin": 4, "elevated in": 2, "correlated inversely": 4, "inverse correlation": 2, "observed between": 1, "pro -": 28, "- adrenomedullin": 2, "follow up": 3, "body weight": 8, "groups even": 2, "increased by": 2, "decreased by": 2, "cc patients": 2, "latter correlated": 2, "baseline nt": 2, "no correlation": 2, "correlation to": 1, "plasma nps": 2, "adiponectin at": 1, "correlate to": 1, "adiponectin during": 1, "stable body": 2, "weight in": 1, "diagnosis of": 14, "failure with": 44, "preserved ejection": 60, "ejection fraction": 228, "role of": 15, "clinical doppler": 2, "developed countries": 4, "% of": 26, "failure show": 2, "show preserved": 2, "preserved left": 20, "left ventricular": 168, "the prevalence": 8, "prevalence of": 7, "steadily increasing": 2, "prognosis is": 1, "lv diastolic": 4, "diastolic dysfunction": 20, "combination with": 2, "figure 1": 2, "major underlying": 2, "underlying mechanism": 2, "mechanism of": 4, "general population": 6, "presence of": 8, "even mild": 2, "mild clinical": 2, "clinical diastolic": 2, "pronounced increases": 2, "increases in": 4, "cause mortality": 26, "dysfunction leading": 2, "leading to": 4, "critical importance": 2, "guidelines based": 2, "based definition": 2, "definition of": 2, "symptoms of": 5, "fraction of": 8, "- dilated": 2, "dilated left": 2, "left ventricle": 20, "evidence of": 4, "impaired lv": 2, "diastolic stiffness": 2, "elevated lv": 2, "filling pressures": 10, "assessed non": 2, "- invasively": 2, "invasively using": 2, "treatment of": 30, "anemia in": 4, "heart disease": 44, "clinical practice": 16, "practice guideline": 2, "guideline from": 1, "provide clinical": 2, "clinical recommendations": 2, "recommendations on": 2, "iron deficiency": 6, "deficiency in": 1, "adult patients": 8, "this guideline": 4, "based on": 13, "published literature": 2, "literature in": 1, "english language": 2, "language on": 1, "deficiency from": 1, "identified using": 4, "reassessed in": 1, "additional studies": 2, "outcomes evaluated": 2, "evaluated for": 2, "guideline included": 2, "included mortality": 2, "exercise tolerance": 6, "quality of": 33, "cardiovascular events": 24, "defined as": 11, "failure exacerbation": 2, "cardiac death": 10, "including hypertension": 2, "venous thromboembolic": 2, "thromboembolic events": 6, "ischemic cerebrovascular": 2, "cerebrovascular events": 2, "the target": 2, "target audience": 2, "audience for": 1, "guideline includes": 2, "target patient": 2, "patient population": 10, "population is": 2, "deficient adult": 2, "guideline grades": 2, "recommendations using": 2, "practice guidelines": 2, "guidelines grading": 2, "grading system": 2, "recommendation 1": 2, "acp recommends": 4, "recommends using": 2, "restrictive red": 2, "red blood": 2, "blood cell": 2, "cell transfusion": 2, "transfusion strategy": 2, "trigger hemoglobin": 2, "hemoglobin threshold": 2, "threshold of": 1, "compared with": 73, "higher hemoglobin": 2, "hemoglobin levels": 4, "hospitalized patients": 6, "coronary heart": 10, "weak recommendation": 2, "quality evidence": 4, "recommendation 2": 2, "recommends against": 1, "use of": 24, "stimulating agents": 6, "agents in": 3, "moderate anemia": 4, "strong recommendation": 2, "systematic review": 16, "the benefits": 6, "benefits of": 6, "anemia treatment": 2, "treatment in": 4, "harms of": 1, "treatments for": 2, "adults with": 15, "clinical trial": 10, "trial registries": 2, "reference lists": 2, "technical advisors": 2, "study selection": 2, "language trials": 2, "trials of": 4, "blood transfusions": 4, "observational studies": 6, "studies of": 3, "data on": 3, "study design": 4, "population characteristics": 2, "health outcomes": 10, "assessed for": 2, "strength evidence": 6, "evidence from": 3, "studies suggests": 2, "liberal transfusion": 2, "transfusion protocols": 2, "improve short": 2, "term mortality": 18, "mortality rates": 10, "rates compared": 2, "less aggressive": 2, "aggressive protocols": 2, "combined relative": 2, "relative risk": 6, "risk among": 4, "among trials": 2, "decreased mortality": 4, "rates occurred": 2, "occurred in": 9, "small trial": 2, "trial of": 6, "acute coronary": 6, "coronary syndrome": 2, "% vs.": 20, "intravenous iron": 4, "iron found": 2, "found improved": 2, "improved short": 2, "term exercise": 2, "life in": 2, "stimulating agent": 2, "agent therapy": 2, "therapy found": 2, "consistent benefits": 2, "venous thromboembolism": 2, "few trials": 2, "examined transfusions": 2, "transfusions in": 1, "potentially confounded": 2, "confounded by": 1, "data supporting": 2, "supporting iron": 2, "iron use": 2, "use come": 2, "come mainly": 2, "large trial": 2, "term effects": 2, "effects are": 1, "higher transfusion": 2, "transfusion thresholds": 2, "consistently improve": 2, "improve mortality": 2, "large trials": 2, "alleviate symptoms": 4, "symptoms in": 3, "also warrants": 2, "warrants further": 2, "benefit patients": 2, "serious harms": 2, "remote ischemic": 2, "ischemic conditioning": 2, "conditioning for": 1, "management of": 16, "stemming from": 1, "nonischemic cardiomyopathies": 2, "inroads made": 2, "made in": 1, "pharmacological armamentarium": 2, "implantable cardioverter": 42, "cardioverter defibrillators": 4, "cardiac resynchronization": 26, "resynchronization therapy": 30, "eventual resort": 2, "resort to": 1, "cardiac transplantation": 4, "right ventricular": 38, "ventricular assist": 44, "assist devices": 18, "both patients": 2, "low left": 4, "ventricular ejection": 70, "admitted to": 6, "hospital frequently": 2, "keep physicians": 2, "physicians busy": 2, "outpatient settings": 4, "also prompting": 2, "search for": 1, "better ways": 2, "deal with": 1, "worldwide epidemic": 2, "impact on": 8, "medical resources": 2, "financial costs": 2, "comments on": 1, "emergency department": 12, "department in": 1, "acute heart": 38, "failure clinical": 2, "clinical trials": 22, "enriching patient": 2, "patient identification": 2, "authors suggest": 2, "patient categorization": 2, "categorization in": 1, "single most": 1, "important component": 4, "focused on": 4, "modern acute": 2, "clinical studies": 6, "highly heterogeneous": 2, "appropriate risk": 2, "risk stratification": 18, "stratification is": 1, "conducting studies": 2, "studies in": 4, "predictors of": 12, "mortality in": 21, "implantable cardiac": 4, "cardiac defibrillator": 2, "many current": 2, "current predictors": 2, "evaluated before": 1, "identify factors": 2, "factors associated": 6, "searched in": 1, "reviewers selected": 2, "selected citations": 2, "included ambulatory": 2, "ambulatory icd": 2, "association between": 12, "mortality using": 4, "using multivariable": 2, "multivariable regression": 2, "analyzed mortality": 2, "using random": 2, "effects models": 2, "studies reviewed": 2, "studies evaluating": 4, "evaluating 63": 2, "predictors on": 1, "patients proved": 2, "proved eligible": 2, "high confidence": 2, "confidence in": 2, "found for": 4, "hazard ratio": 94, "year increase": 2, "% confidence": 88, "confidence interval": 80, "baseline glomerular": 2, "glomerular filtration": 24, "filtration rate": 24, "min decrease": 2, "chronic obstructive": 10, "obstructive pulmonary": 10, "pulmonary disease": 10, "peripheral vascular": 6, "vascular disease": 6, "% increase": 8, "inappropriate icd": 2, "atrial fibrillation": 40, "congestive hf": 2, "strongly associated": 8, "estimates was": 1, "ischemic cardiomyopathy": 6, "male sex": 4, "independent predictors": 6, "this meta": 4, "analysis identified": 2, "identified strong": 2, "strong reliable": 2, "reliable mortality": 2, "mortality predictors": 2, "predictors in": 1, "renal dysfunction": 28, "shocks during": 1, "strong predictors": 2, "sex were": 1, "further research": 2, "study other": 1, "potential predictors": 2, "particularly biomarkers": 2, "dose dopamine": 12, "dose nesiritide": 10, "nesiritide in": 1, "failure randomized": 2, "randomized trial": 8, "small studies": 2, "studies suggest": 2, "suggest that": 13, "enhance decongestion": 4, "preserve renal": 4, "renal function": 32, "function in": 14, "neither strategy": 2, "rigorously tested": 2, "independent hypotheses": 2, "addition of": 4, "min without": 2, "without bolus": 2, "diuretic therapy": 6, "controlled clinical": 2, "estimated glomerular": 22, "rate of": 9, "randomized within": 2, "hours of": 1, "enrollment occurred": 2, "occurred from": 1, "sites in": 1, "randomized in": 2, "allocation ratio": 2, "ratio to": 2, "nesiritide strategy": 2, "active treatment": 2, "the dopamine": 2, "independently compared": 2, "pooled placebo": 2, "placebo group": 6, "main outcomes": 4, "end points": 8, "points included": 2, "included 72": 2, "hour cumulative": 6, "cumulative urine": 6, "urine volume": 6, "decongestion end": 2, "end point": 28, "change in": 20, "serum cystatin": 2, "cystatin c": 6, "c from": 1, "enrollment to": 1, "function end": 2, "dopamine had": 1, "significant effect": 8, "effect on": 10, "vs placebo": 8, "c level": 4, "nesiritide had": 1, "effect of": 22, "nesiritide on": 1, "secondary end": 4, "points reflective": 2, "clinical outcomes": 14, "in participants": 2, "participants with": 1, "nesiritide enhanced": 2, "enhanced decongestion": 2, "improved renal": 2, "function when": 1, "added to": 2, "participating in": 3, "multihospital study": 2, "promote adoption": 2, "adoption of": 1, "failure guidelines": 2, "lessons for": 1, "nurse leaders": 2, "many multisite": 2, "multisite studies": 2, "practice settings": 2, "settings focus": 2, "focus on": 2, "improving processes": 2, "processes of": 2, "adopting evidence": 2, "based practices": 2, "improving patient": 2, "patient outcomes": 4, "specific research": 2, "research questions": 2, "implementation issues": 2, "reveal how": 1, "profoundly transformed": 2, "utilizing voluntary": 2, "voluntary testimonies": 2, "conversations with": 1, "participating nurses": 2, "involvement in": 1, "multisite study": 2, "study extend": 2, "extend beyond": 2, "beyond meeting": 2, "meeting magnet": 2, "research requirements": 2, "systems proteomics": 2, "proteomics of": 1, "cardiac chromatin": 2, "chromatin identifies": 2, "identifies nucleolin": 2, "nucleolin as": 1, "regulator of": 2, "cellular plasticity": 2, "plasticity in": 2, "hypertrophy antecedent": 2, "failure involves": 2, "involves changes": 2, "global gene": 2, "gene expression": 20, "preceding mechanisms": 2, "coordinate dna": 2, "dna accessibility": 2, "accessibility on": 1, "genomic scale": 2, "associated proteins": 4, "proteins alter": 4, "alter chromatin": 4, "chromatin structure": 6, "structure by": 1, "association with": 6, "thereby altering": 2, "expression profile": 4, "known about": 3, "global changes": 2, "chromatin subproteomes": 2, "accompany heart": 2, "mechanisms by": 1, "present study": 10, "study tests": 2, "fundamental hypothesis": 2, "cardiac growth": 2, "setting of": 3, "disease recapitulates": 2, "recapitulates conserved": 2, "conserved developmental": 2, "developmental chromatin": 2, "chromatin remodeling": 2, "remodeling events": 2, "used quantitative": 2, "quantitative proteomics": 2, "identify chromatin": 2, "proteins extracted": 2, "extracted via": 2, "via detergent": 2, "quantify changes": 2, "abundance during": 1, "study identified": 2, "identified 321": 2, "proteins in": 1, "modest conservation": 2, "revealed using": 2, "using strong": 2, "strong acid": 2, "exhibited altered": 2, "altered expression": 4, "expression during": 1, "cardiac hypertrophy": 16, "conducted extensive": 2, "extensive functional": 2, "functional characterization": 2, "characterization of": 1, "based knockdown": 2, "knockdown of": 2, "nucleolin nearly": 2, "nearly abolished": 2, "abolished protein": 2, "protein expression": 4, "surprisingly had": 1, "little impact": 2, "gross morphological": 2, "morphological development": 2, "hearts of": 3, "fish lacking": 2, "displayed severe": 2, "severe developmental": 2, "developmental impairment": 2, "abnormal chamber": 2, "chamber patterning": 2, "functional deficits": 2, "defects in": 1, "cardiac looping": 2, "myocyte differentiation": 2, "the mechanisms": 2, "mechanisms underlying": 2, "defects involve": 2, "involve perturbed": 2, "perturbed bone": 2, "bone morphogenetic": 2, "morphogenetic protein": 2, "protein 4": 4, "decreased rrna": 2, "rrna transcription": 2, "shift to": 1, "heterochromatic chromatin": 2, "study reports": 2, "quantitative analysis": 2, "analysis of": 11, "new chromatin": 2, "chromatin subproteome": 2, "subproteome in": 1, "diseased mouse": 2, "mouse heart": 4, "validation studies": 2, "complementary model": 2, "model system": 2, "system of": 1, "zebrafish examine": 2, "orchestrate genomic": 2, "genomic reprogramming": 2, "reprogramming events": 2, "events shared": 2, "shared between": 1, "risk factors": 32, "outcomes associated": 6, "development of": 24, "myocardial ischemic": 2, "ischemic events": 4, "events in": 6, "receive cardiac": 4, "limited data": 4, "data regarding": 4, "regarding risk": 2, "factors for": 2, "among patients": 26, "therapy with": 8, "efficacy of": 9, "study population": 4, "population comprised": 4, "comprised 1,045": 2, "enrolled in": 6, "used multivariate": 2, "proportional hazards": 14, "hazards regression": 2, "regression modeling": 2, "identify risk": 2, "comprising hospitalization": 2, "hospitalization for": 11, "coronary syndromes": 4, "coronary interventions": 2, "interventions during": 1, "among study": 4, "study patients": 6, "dependent analysis": 4, "risk for": 21, "subsequent heart": 4, "death in": 6, "d recipients": 4, "predictors for": 1, "patients included": 2, "included previous": 2, "previous revascularization": 2, "coronary artery": 28, "artery bypass": 6, "bypass surgery": 2, "percutaneous coronary": 4, "coronary intervention": 2, "increased systolic": 2, "systolic blood": 12, "blood pressure": 30, "left bundle": 10, "bundle branch": 10, "branch block": 10, "block pattern": 2, "pattern on": 1, "baseline electrocardiogram": 2, "reduced risk": 2, "treatment with": 9, "risk compared": 2, "analysis showed": 10, "showed that": 11, "ies among": 2, "increased risk": 26, "in conclusion": 28, "data suggest": 6, "risk of": 48, "benefit of": 4, "attenuated after": 1, "ies in": 1, "dependent effect": 2, "fraction on": 2, "contemporary heart": 2, "resulted in": 8, "improved outcomes": 2, "outcomes among": 4, "differential effect": 4, "mortality after": 2, "acute decompensated": 2, "decompensated hf": 2, "world setting": 2, "mortality at": 3, "years after": 5, "categorized as": 2, "\u226550 %": 4, "% to": 12, "patients enrolled": 4, "severe reductions": 2, "reductions in": 5, "multivariate analysis": 8, "similar risk": 2, "mortality as": 2, "moderate reduction": 2, "reduction in": 19, "severely reduced": 8, "conferred increased": 2, "increased increase": 2, "increase rate": 2, "rate compared": 2, "interaction term": 2, "term analysis": 2, "risk associated": 4, "evident only": 1, "patients \u226475": 2, "\u226475 years": 2, "among older": 8, "older patients": 16, "difference in": 5, "mortality between": 1, "preserved versus": 2, "p value": 4, "value for": 6, "hospitalized for": 8, "experience similar": 2, "similar long": 2, "moderate reductions": 2, "independent predictor": 10, "predictor of": 7, "significantly attenuated": 2, "attenuated in": 1, "older age": 6, "age group": 6, "circulating progenitor": 4, "progenitor cells": 6, "outcome in": 3, "longitudinal study": 2, "involved in": 5, "process of": 1, "endothelial repair": 2, "prognostic factor": 6, "factor in": 3, "cardiovascular diseases": 6, "serial measurements": 2, "measurements of": 1, "functional capacity": 36, "outcomes in": 20, "included 156": 2, "consecutive consenting": 2, "consenting ambulatory": 2, "ambulatory hf": 4, "months for": 1, "measured as": 2, "outgrowth colony": 2, "forming units": 2, "cd133 +": 2, "+ cells": 6, "recorded mortality": 2, "hospital admissions": 4, "assist device": 32, "mean age": 14, "a decrease": 2, "decrease in": 9, "cd34+vegfr2 +": 4, "independently associated": 24, "increased functional": 2, "cell decrease": 2, "increase of": 3, "min in": 1, "interaction effect": 2, "patients without": 6, "without diabetes": 4, "increased peak": 6, "higher eo": 4, "reduced mortality": 8, "noted differential": 2, "differential relations": 2, "relations between": 1, "lower cd34+vegfr2": 2, "improved functional": 4, "nondiabetic patients": 2, "in patients": 26, "lower eo": 2, "the basis": 2, "basis for": 1, "differences requires": 2, "requires further": 1, "implications of": 3, "metric choice": 4, "choice for": 2, "common applications": 2, "applications of": 1, "readmission metrics": 4, "differential impact": 2, "hospital performance": 2, "performance of": 3, "cause readmission": 6, "day readmission": 16, "calculated 30": 2, "readmission rates": 6, "rates using": 2, "using three": 2, "disease groups": 2, "absolute change": 2, "correlation between": 2, "percent of": 4, "hospitals remaining": 2, "remaining in": 1, "extreme deciles": 2, "level of": 8, "differences in": 6, "longitudinal performance": 2, "principal findings": 2, "average hospital": 2, "hospital rates": 2, "generally higher": 2, "correlations between": 1, "rates calculated": 2, "calculated using": 2, "moderately correlated": 2, "hospitals in": 4, "extreme decile": 2, "decile according": 2, "according to": 13, "metric remained": 2, "remained when": 1, "different metric": 2, "correlations among": 2, "among metrics": 2, "modest when": 1, "measuring hospital": 2, "hospital longitudinal": 2, "longitudinal change": 2, "different approaches": 2, "approaches to": 3, "computing readmissions": 2, "produce different": 2, "different hospital": 2, "hospital rankings": 2, "impact pay": 2, "careful consideration": 2, "placed on": 1, "readmission metric": 2, "remote monitoring": 4, "monitoring after": 1, "recent hospital": 4, "hospital discharge": 10, "discharge in": 2, "network meta": 4, "readmission to": 1, "hospital for": 3, "recent discharge": 2, "strategies have": 1, "deliver specialised": 2, "specialised care": 2, "growing needs": 2, "needs of": 1, "failure population": 2, "determine whether": 10, "strategies improve": 2, "improve outcomes": 6, "outcomes for": 4, "recently discharged": 4, "unplanned admission": 2, "admission due": 2, "electronic databases": 4, "searched to": 1, "supplemented by": 3, "searching relevant": 2, "relevant articles": 2, "all randomised": 2, "controlled trials": 2, "observational cohort": 4, "cohort studies": 2, "studies with": 4, "contemporaneous control": 2, "control group": 28, "rm interventions": 2, "interventions included": 2, "included home": 2, "home telemonitoring": 2, "including implanted": 2, "implanted monitoring": 4, "monitoring devices": 4, "medical support": 4, "support provided": 4, "provided during": 2, "office hours": 6, "structured telephone": 2, "telephone support": 2, "programmes delivered": 2, "delivered via": 2, "via human": 2, "human contact": 2, "machine interface": 2, "assessed independently": 2, "enrolled 6317": 2, "studies evaluated": 2, "studies assessed": 2, "study assessed": 6, "no trial": 2, "devices met": 2, "inclusion criteria": 4, "usual care": 18, "reaching statitistical": 2, "statitistical significance": 2, "mortality for": 4, "% credible": 2, "credible interval": 2, "% cri": 4, "exclusion of": 1, "provided better": 2, "usual support": 2, "support to": 2, "group rendered": 2, "comparisons statistically": 2, "statistically significant": 8, "beneficial effect": 10, "observed with": 1, "also observed": 2, "observed in": 9, "cause hospitalisations": 2, "hospitalisations for": 2, "care packages": 2, "packages generally": 2, "generally improved": 2, "improved health": 2, "related quality": 6, "hours showed": 2, "showed beneficial": 2, "beneficial trends": 2, "discharged patients": 2, "care is": 2, "less good": 2, "impact of": 22, "investigation of": 1, "apoptosis in": 2, "canine model": 2, "model of": 10, "failure induced": 2, "induced by": 6, "participation of": 1, "apoptosis during": 1, "induced dilated": 2, "dilated cardiomyopathy": 22, "fully understood": 2, "weeks rapid": 2, "rapid right": 2, "ventricular pacing": 2, "gene expressions": 2, "expressions of": 1, "measured by": 8, "interventricular septum": 2, "septum biopsies": 2, "taken weekly": 2, "beagle dogs": 2, "dogs during": 1, "evaluated protein": 2, "protein levels": 4, "levels of": 14, "genes by": 2, "western blot": 4, "dna fragmentation": 4, "fragmentation by": 1, "method from": 1, "autopsy samples": 2, "expression of": 7, "remained unchanged": 4, "pacing period": 2, "expression transiently": 2, "transiently decreased": 2, "decreased in": 5, "moderate heart": 2, "significantly altered": 2, "expression increased": 2, "increased in": 10, "compared to": 7, "dogs only": 1, "weeks of": 2, "no band": 2, "band of": 1, "found in": 4, "paced myocardium": 2, "significant difference": 8, "difference between": 2, "numbers of": 1, "apoptotic cells": 2, "cells in": 2, "positive cells": 2, "detected in": 1, "paced groups": 2, "favour of": 1, "pathogenesis of": 1, "failure in": 25, "attributed to": 1, "activation of": 8, "pump sternal": 2, "sternal sparing": 2, "sparing approach": 2, "approach for": 2, "become more": 1, "widely used": 4, "used for": 5, "treating patients": 6, "advanced heart": 22, "incidence of": 6, "pump dysfunction": 2, "dysfunction requiring": 2, "requiring pump": 2, "pump replacement": 4, "when dysfunction": 2, "dysfunction is": 1, "pump failure": 2, "driveline injury": 2, "isolated pump": 2, "safe pump": 2, "exchange technique": 2, "redo sternotomy": 4, "cardiopulmonary bypass": 2, "exchange malfunctioning": 2, "consecutive patients": 24, "the patients": 6, "extubated within": 2, "blood loss": 2, "transfusion requirements": 2, "requirements were": 1, "periprocedural deaths": 2, "angiotensin system": 4, "system blocker": 2, "blocker therapy": 14, "therapy in": 14, "reduced versus": 2, "ejection fractions": 6, "in ambulatory": 2, "ambulatory patients": 8, "reduced ejection": 40, "blockers at": 1, "recommended target": 6, "target dose": 4, "dose reduce": 2, "benefits in": 2, "uptitration after": 1, "remain uncertain": 2, "study assesses": 2, "\u03b2 -": 56, "- blocker": 24, "blocker uptitrations": 4, "uptitrations in": 1, "hospital admission": 4, "in consecutive": 2, "hfpef with": 1, "blocker dose": 6, "dose changes": 2, "followed during": 2, "months after": 3, "dose increase": 2, "\u226510 %": 2, "without uptitration": 2, "received uptitration": 2, "significantly younger": 10, "higher heart": 2, "heart rate": 48, "better renal": 2, "received spironolactone": 2, "spironolactone more": 1, "significant reductions": 4, "composite end": 4, "point of": 6, "readmissions in": 2, "ci ]": 10, "hr 0.51": 2, "after correction": 2, "correction for": 1, "spironolactone use": 8, "association remained": 2, "remained significant": 4, "- blockers": 8, "% ci": 44, "ci 0.39": 2, "no benefit": 2, "blocker uptitration": 4, "uptitration of": 1, "neurohumoral blockers": 2, "blockers after": 1, "frequently performed": 2, "performed in": 5, "younger patients": 4, "low co": 2, "co -": 12, "- morbidity": 2, "morbidity burden": 2, "uptitration independently": 2, "independently predicts": 2, "predicts clinical": 4, "clinical outcome": 4, "relationship between": 9, "type natriuretic": 32, "natriuretic peptide": 48, "peptide levels": 4, "levels in": 6, "associations with": 1, "inhospital outcomes": 2, "findings from": 3, "get with": 2, "in heart": 4, "known differences": 2, "plasma b": 2, "levels between": 1, "explored sex": 2, "sex differences": 2, "determine prognostic": 2, "prognostic significance": 2, "significance of": 1, "relates to": 1, "included hospitals": 2, "admitted 99,930": 2, "primary end": 6, "inhospital mortality": 8, "multivariate models": 6, "compute odds": 2, "odds ratios": 6, "accounting for": 3, "hospital clustering": 2, "% female": 6, "women compared": 2, "men had": 2, "higher admission": 2, "admission median": 2, "median bnp": 6, "levels with": 2, "greatest difference": 2, "difference among": 6, "smallest difference": 2, "women vs": 2, "vs men": 2, "ef reduced": 2, "reduced 1,259": 2, "preserved 559": 2, "p <": 60, "patients above": 1, "level had": 1, "higher mortality": 4, "adjusting for": 4, "clinical variables": 6, "ability of": 4, "predict inhospital": 4, "p for": 4, "heterogeneity =": 2, "= .47": 2, "large registry": 2, "found that": 9, "mortality among": 4, "medical management": 10, "pediatric heart": 4, "important cause": 2, "cause of": 14, "this article": 6, "article presents": 2, "presents guidelines": 2, "guidelines for": 1, "early medical": 2, "the guidelines": 4, "assist practitioners": 2, "practitioners in": 1, "emergency room": 2, "room practice": 2, "encounter children": 2, "children with": 4, "undiagnosed heart": 2, "possible hf": 2, "already received": 2, "received surgical": 2, "surgical palliation": 2, "developed using": 2, "accompanied by": 7, "practical recommendations": 2, "recommendations for": 3, "application in": 1, "clinical setting": 2, "online material": 2, "this work": 2, "include recommendations": 2, "advanced management": 2, "management involving": 2, "involving ventricular": 2, "device therapies": 2, "cognitive impairment": 6, "relationships with": 2, "article by": 1, "the authors": 2, "authors evaluated": 2, "evaluated how": 1, "nurse assessment": 2, "assessment of": 8, "impairment at": 1, "documented by": 1, "physician at": 1, "time of": 10, "cohort of": 8, "elderly patients": 2, "authors analyzed": 2, "association of": 3, "impairment with": 1, "month mortality": 2, "rates of": 15, "intubations for": 1, "failure declined": 2, "declined from": 8, "many advances": 2, "made recently": 2, "hypothesize that": 1, "fewer chf": 2, "patients presenting": 4, "presenting to": 3, "retrospective cohort": 8, "patients seen": 2, "seen by": 1, "physicians in": 1, "suburban hospitals": 2, "classified patients": 2, "patients as": 4, "year of": 2, "determined chf": 2, "chf visit": 2, "visit rates": 2, "percentage of": 5, "total ed": 2, "patients intubated": 2, "calculated 95": 2, "confidence intervals": 6, "performed regression": 2, "regression analyses": 4, "age of": 7, "\u00b1 14": 6, "% were": 2, "failure visits": 2, "visits declined": 2, "ed visits": 8, "visits in": 1, "% in": 12, "% relative": 2, "relative decrease": 4, "correlation coefficient": 4, "coefficient r(2": 2, "intubation rates": 4, "rates declined": 4, "the rates": 8, "annual ed": 2, "visits for": 1, "these decreases": 2, "better chf": 2, "chf treatments": 2, "hemodynamic phenotype": 2, "phenotype of": 3, "adult population": 4, "occur even": 2, "normal systolic": 2, "systolic ventricular": 2, "ventricular function": 6, "context of": 2, "significant liver": 2, "liver disease": 4, "hypothesized that": 8, "hemodynamically distinct": 2, "traditional heart": 2, "characterized by": 3, "low systemic": 2, "systemic vascular": 4, "vascular resistance": 8, "preserved cardiac": 2, "cardiac index": 8, "symptomatic adult": 2, "underwent catheterization": 4, "catheterization from": 1, "study group": 2, "predominantly asymptomatic": 2, "asymptomatic pediatric": 2, "pediatric fontan": 2, "catheterization during": 1, "randomly selected": 4, "case cohort": 2, "cohort analysis": 2, "clinical comparisons": 2, "made between": 2, "the adults": 2, "mean catheterization": 2, "catheterization findings": 2, "central venous": 2, "venous pressure": 4, "pressure 18": 2, "\u00b1 6": 6, "\u00b1 3": 4, "index 1,680": 2, "\u00b1 368": 2, "dyn s": 1, "index 2.7": 2, "\u00b1 0.8": 2, "\u00b1 0.7": 2, "by imaging": 2, "cohort demonstrated": 2, "greater incidence": 2, "abnormal liver": 2, "liver texture": 2, "texture changes": 2, "% vs": 16, "circulation had": 1, "lower svr": 2, "similar cardiac": 2, "index compared": 2, "pediatric cohort": 2, "disease in": 5, "distinct circulatory": 2, "circulatory derangement": 2, "derangement with": 1, "hemodynamic features": 2, "features similar": 2, "portal hypertension": 2, "limited ability": 2, "augment cardiac": 2, "cardiac output": 8, "comparison of": 4, "related hospitalization": 2, "versus without": 2, "recognized as": 3, "major cause": 6, "cardiovascular morbidity": 2, "an ability": 2, "identify patients": 6, "adverse outcomes": 8, "careful management": 2, "patients having": 5, "using data": 4, "data from": 7, "enrolled 902": 2, "patients in": 19, "recently hospitalized": 2, "management counseling": 2, "counseling on": 1, "primary outcome": 30, "outcome of": 4, "patients had": 8, "median of": 3, "final multivariate": 2, "male gender": 2, "odds ratio": 20, "distance covered": 4, "covered on": 2, "minute walk": 6, "walk test": 12, "% adherence": 2, "adherence to": 6, "prescribed medications": 2, "- morbidities": 2, "age >": 2, "indicators of": 1, "functional status": 6, "prescribed therapy": 2, "therapy were": 1, "predicting death": 2, "exercise training": 46, "training in": 4, "failure promotes": 2, "promotes restoration": 2, "restoration of": 2, "density lipoprotein": 4, "lipoprotein functional": 2, "functional properties": 2, "exerts endothelial": 2, "protective effects": 8, "effects via": 2, "via stimulation": 2, "stimulation of": 4, "endothelial cell": 2, "nitric oxide": 4, "this function": 2, "impaired in": 2, "cardiovascular disease": 10, "endothelial function": 12, "mediated protective": 2, "respective molecular": 2, "molecular pathways": 4, "pathways in": 1, "isolated from": 2, "healthy controls": 2, "incubated with": 1, "phosphorylation of": 1, "bound malondialdehyde": 2, "no production": 6, "production by": 1, "mediated dilatation": 8, "the proteome": 2, "proteome of": 1, "hdl particles": 2, "profiled by": 1, "incubation of": 1, "lower stimulation": 2, "phosphorylation at": 2, "higher phosphorylation": 2, "production of": 1, "in addition": 26, "elevated activation": 2, "higher amount": 2, "amount of": 2, "malondialdehyde bound": 2, "bound to": 1, "in healthy": 2, "healthy individuals": 4, "hdl function": 6, "significantly improved": 10, "improved hdl": 2, "a correlation": 2, "dilatation improvement": 2, "improvement by": 1, "these results": 8, "results demonstrate": 2, "demonstrate that": 2, "mediated vascular": 2, "vascular effects": 4, "mechanism how": 1, "exerts beneficial": 2, "beneficial effects": 8, "effects in": 3, "determination of": 3, "predictive cutoff": 6, "cutoff value": 6, "value of": 7, "testing for": 1, "term survival": 8, "survival in": 3, "main objective": 2, "objective of": 8, "plasma n": 2, "terminal pro": 26, "- b": 16, "successfully predict": 2, "survival of": 5, "admission to": 3, "best knowledge": 2, "first research": 2, "research done": 2, "year survival": 14, "acute hf": 10, "measured in": 3, "plasma obtained": 2, "obtained from": 2, "ventricular dysfunction": 16, "the end": 2, "survival from": 1, "inclusion through": 1, "\u00b1 10.3": 2, "year follow": 4, "patients died": 4, "- survivors": 2, "years vs": 2, "\u00b1 11.07": 2, "p =": 34, "optimal nt": 2, "cutoff point": 2, "point for": 1, "predicting 4": 2, "survival at": 1, "% sensitivity": 8, "% specificity": 6, "area under": 4, "elevated nt": 2, "levels at": 1, "optimal cutoff": 2, "cutoff level": 2, "predict 4": 2, "survival had": 1, "high sensitivity": 2, "case of": 4, "additional prospective": 2, "multicenter studies": 2, "novel heart": 2, "failure mice": 2, "mice model": 2, "hypertensive heart": 6, "disease by": 1, "salt loading": 10, "new therapeutic": 6, "therapeutic targets": 4, "targets for": 3, "model using": 2, "using simple": 2, "simple experimental": 2, "experimental procedures": 4, "stable phenotypes": 2, "study aimed": 8, "novel mouse": 2, "combining salt": 2, "uninephrectomy with": 1, "old c57bl/6": 2, "male mice": 4, "treated with": 19, "significantly elevated": 2, "significant differences": 4, "parameters between": 1, "wk after": 3, "mice showed": 4, "showed significant": 4, "significant decreases": 2, "decreases in": 4, "fractional shortening": 6, "lung weight": 8, "weight with": 1, "high incidence": 2, "this phenotype": 2, "early deaths": 2, "deaths in": 2, "severe lv": 4, "oxidative stress": 6, "small gtpase": 2, "rac1 activity": 2, "upregulated in": 1, "uninephrectomy to": 1, "infusion mouse": 2, "mouse model": 4, "cardiac function": 20, "significantly impaired": 6, "mice developed": 2, "useful mouse": 2, "transition from": 2, "hypertrophy to": 3, "biomarker approach": 2, "predict heart": 2, "failure risk": 4, "atherosclerosis risk": 2, "risk in": 2, "communities study": 2, "various cardiovascular": 2, "largest increases": 2, "incidence over": 1, "coming decades": 2, "significant value": 4, "evaluated whether": 4, "cardiac troponin": 2, "troponin t": 2, "measured with": 1, "sensitivity assay": 2, "biomarkers strongly": 2, "risk prediction": 4, "prediction in": 1, "using sex": 2, "specific models": 2, "added ctnt": 2, "laboratory report": 6, "includes age": 4, "antihypertensive medication": 2, "medication use": 2, "former smoking": 2, "body mass": 34, "mass index": 30, "prevalent coronary": 2, "participants without": 2, "without prevalent": 2, "prevalent hf": 2, "receiver operating": 4, "operating characteristic": 4, "characteristic curve": 4, "integrated discrimination": 4, "discrimination improvement": 4, "net reclassification": 4, "reclassification improvement": 4, "model fit": 2, "mean follow": 8, "participants developed": 4, "developed incident": 2, "adding ctnt": 4, "model significantly": 2, "statistical parameters": 2, "aucs increased": 2, "continuous nris": 2, "simpler laboratory": 2, "report model": 2, "value in": 2, "simple sex": 2, "specific model": 2, "incorporated in": 1, "good model": 2, "clinical characteristics": 10, "characteristics results": 2, "results in": 5, "excellent hf": 2, "prediction model": 2, "survival after": 2, "device with": 1, "without temporary": 2, "temporary right": 2, "ventricular support": 2, "failure after": 4, "insertion of": 1, "historically results": 2, "poor outcomes": 4, "patients requiring": 10, "requiring temporary": 2, "temporary rv": 2, "support after": 1, "insertion are": 1, "heterogeneous group": 2, "group of": 3, "patients consisting": 2, "consisting of": 2, "cardiogenic shock": 6, "shock after": 1, "chronic decompensated": 2, "decompensated heart": 2, "for patients": 4, "requiring biventricular": 4, "biventricular support": 8, "hybrid system": 2, "system consisting": 2, "the purpose": 10, "purpose of": 7, "requiring isolated": 4, "isolated lvad": 2, "all patients": 10, "conjunction with": 1, "temporary centrimag": 2, "examined from": 1, "preoperative demographics": 2, "operative outcomes": 2, "a total": 16, "total of": 8, "patients required": 2, "required biventricular": 2, "support at": 1, "mean duration": 2, "duration of": 6, "\u00b1 11.9": 2, "successfully explanted": 2, "survival to": 1, "significantly greater": 2, "required isolated": 2, "% versus": 22, "support using": 2, "limited mortality": 2, "however biventricular": 2, "biventricular dysfunction": 2, "favorable outcome": 4, "outcome at": 1, "year when": 1, "isolated heartmate": 2, "eligibility for": 1, "heart transplantation": 6, "transplantation be": 1, "requirement for": 1, "device use": 2, "recommendations based": 2, "used in": 6, "chronic end": 2, "stage heart": 16, "failure as": 1, "bridge to": 3, "ineligible patients": 4, "destination therapy": 4, "evidence on": 2, "clinical effects": 2, "effectiveness of": 7, "types of": 3, "systematically searched": 2, "scientific literature": 2, "identified 14": 2, "economic evaluations": 2, "using simulation": 2, "simulation models": 2, "limited to": 1, "studies per": 2, "per outcome": 2, "made policy": 2, "policy recommendations": 2, "basis of": 6, "complications after": 1, "implantation are": 1, "highly effective": 4, "across transplantation": 2, "transplantation eligibility": 4, "eligibility status": 4, "survival reaching": 2, "reaching 86": 2, "% for": 6, "medical therapy": 8, "currently meet": 2, "meet traditional": 2, "traditional cost": 2, "effectiveness limits": 2, "limits in": 1, "models using": 2, "using historical": 2, "historical data": 2, "standard practice": 2, "practice for": 1, "limited number": 2, "number of": 12, "many regions": 2, "implantation strategies": 2, "strategies tend": 2, "mutually exclusive": 2, "carefully selected": 2, "program infrastructure": 2, "budget are": 1, "evidence gaps": 2, "limitations in": 1, "economic models": 2, "lack of": 7, "canadian data": 2, "data point": 2, "point to": 1, "importance of": 3, "systematic monitoring": 2, "monitoring of": 2, "biventricular pacing": 2, "pacing on": 1, "left heart": 2, "heart twist": 2, "strain in": 1, "porcine model": 4, "right heart": 26, "improves cardiac": 4, "selected cardiac": 2, "cardiac surgery": 2, "surgery patients": 2, "response remains": 2, "remains variable": 2, "better understanding": 2, "understanding of": 5, "used speckle": 2, "speckle tracking": 2, "tracking echocardiography": 2, "analyze bivp": 2, "bivp during": 1, "acute right": 6, "ventricular pressure": 2, "pressure overload": 2, "inferior vena": 2, "vena cava": 2, "control model": 2, "heart block": 2, "pulmonary artery": 8, "artery snared": 2, "ventricular midpapillary": 2, "midpapillary level": 2, "taken at": 1, "varying atrioventricular": 2, "atrioventricular delay": 2, "interventricular delay": 2, "regional circumferential": 2, "circumferential strain": 2, "radial strain": 2, "taken of": 1, "ventricular base": 2, "bivp setting": 2, "setting for": 1, "basal rotations": 2, "correlated against": 1, "mixed linear": 2, "linear models": 4, "correlated with": 14, "apical rotation": 2, "rs synchrony": 8, "during rvpo": 4, "rvpo with": 1, "free wall": 4, "wall rs": 2, "septal wall": 2, "open chest": 2, "chest model": 2, "analyzed by": 1, "noninvasive surrogates": 2, "surrogates for": 1, "varying regional": 2, "regional strain": 2, "strain contributions": 2, "primary mechanism": 2, "mechanism in": 1, "correlation of": 1, "remaining indices": 2, "reflect postsystolic": 2, "postsystolic function": 2, "mitral stenosis": 8, "stenosis reversed": 2, "reversed by": 5, "medical treatment": 16, "treatment for": 12, "reported that": 1, "functional mitral": 4, "stenosis frequently": 2, "frequently develops": 4, "develops after": 2, "ring annuloplasty": 8, "annuloplasty for": 3, "ischemic mitral": 4, "mitral regurgitation": 12, "the mechanism": 4, "combination of": 4, "annular size": 8, "size reduction": 8, "reduction by": 4, "diastolic mitral": 22, "mitral valve": 22, "valve tethering": 4, "anterior leaflet": 4, "leaflet opening": 4, "opening due": 4, "posteriorly displaced": 4, "displaced papillary": 4, "papillary muscles": 4, "muscles with": 2, "ventricular dilatation": 4, "old man": 6, "history of": 10, "successful mitral": 2, "valve plasty": 14, "plasty for": 4, "degenerative mitral": 4, "years later": 6, "developed heart": 6, "severe hypertension": 6, "mild mitral": 2, "significant mitral": 2, "aggressive medical": 6, "reported in": 2, "degenerative mr": 10, "functional ms": 20, "develop even": 6, "successful valve": 6, "reduction for": 1, "dilated by": 3, "another disease": 6, "potentially improve": 2, "improve such": 1, "man had": 1, "severe mr": 2, "prolapse of": 1, "valve in": 1, "grade 4/6": 2, "holosystolic murmur": 2, "third heart": 2, "heart sound": 2, "sound in": 1, "underwent mitral": 2, "prolapse with": 1, "chordal ruptures": 2, "underwent triangular": 2, "triangular resection": 2, "edge anastomosis": 4, "annuloplasty with": 1, "postoperative echocardiography": 2, "echocardiography confirmed": 2, "normal sized": 2, "sized lv": 2, "diastolic volume": 12, "volume index": 8, "index of": 6, "normal lv": 2, "preserved mitral": 2, "valve opening": 6, "opening with": 1, "valve area": 2, "mean pressure": 6, "pressure gradient": 6, "gradient of": 4, "obtained by": 1, "continuity equation": 2, "lv end": 2, "systolic volume": 8, "mitral filling": 4, "filling flow": 4, "flow volume": 2, "\u00d7 velocity": 2, "velocity time": 2, "time integral": 2, "flow by": 1, "continuous wave": 2, "utilized even": 2, "successfully performed": 2, "performed without": 2, "without major": 6, "major concerns": 2, "this time": 2, "hypertension of": 1, "diabetes mellitus": 20, "grade 2": 2, "systolic as": 1, "diastolic murmurs": 2, "demonstrated moderately": 2, "moderately dilated": 2, "dilated lv": 2, "mild mr": 6, "limited mitral": 2, "resulting in": 6, "significant ms": 8, "coronary angiography": 8, "angiography revealed": 2, "significant lesions": 2, "lesions in": 2, "major branches": 2, "the patient": 8, "diagnosed as": 2, "hypertensive lv": 2, "dysfunction with": 2, "mitral leaflet": 2, "leaflet motions": 2, "restricted without": 2, "clear organic": 4, "organic lesion": 4, "the etiology": 2, "etiology of": 2, "as significant": 2, "surgical indication": 2, "indication for": 1, "the possibility": 2, "possibility of": 1, "improve after": 1, "considered because": 1, "highly dynamic": 2, "potentially respond": 2, "respond to": 1, "hypertension with": 1, "symptom as": 1, "cardiac murmurs": 2, "murmurs disappeared": 2, "disappeared with": 1, "pressure to": 1, "repeated echocardiography": 2, "echocardiography 4": 2, "months later": 2, "later demonstrated": 2, "volume of": 2, "disappearance of": 1, "improvement of": 4, "opening to": 1, "surgery by": 1, "direct observation": 2, "observation at": 1, "surgery also": 2, "also confirmed": 4, "findings of": 1, "causes of": 4, "possible reasons": 2, "reasons for": 8, "modest reduction": 2, "surgical ring": 2, "ring implantation": 2, "mild restriction": 2, "restriction of": 1, "leaflet motion": 2, "motion by": 1, "leaflet resection": 2, "degree of": 2, "regurgitation as": 1, "symptoms disappeared": 2, "disappeared after": 1, "patient developed": 2, "moderate lv": 2, "valve demonstrated": 2, "demonstrated restricted": 2, "restricted closure": 2, "opening without": 2, "diastolic tethering": 2, "functional etiology": 2, "reports demonstrating": 2, "demonstrating development": 2, "following ring": 2, "ischemic mr": 2, "this patient": 2, "patient showed": 2, "patient with": 8, "potentially vary": 2, "vary considerably": 2, "second hf": 2, "considered indicative": 2, "after aggressive": 2, "symptom disappeared": 2, "reversed to": 1, "insignificant ms": 2, "considered as": 2, "surgical indications": 4, "indications need": 2, "carefully evaluated": 2, "evaluated in": 3, "addition to": 9, "leaflet configurations": 2, "serial evaluation": 2, "evaluation strongly": 2, "strongly suggested": 2, "suggested that": 1, "therefore dynamic": 2, "opposed to": 1, "annular ms": 2, "fixed ring": 2, "ring size": 2, "this case": 2, "case report": 4, "report demonstrates": 2, "demonstrates that": 1, "thus requires": 2, "requires careful": 2, "careful evaluation": 2, "evaluation of": 2, "stratification for": 1, "cause hospitalization": 8, "hospitalization in": 4, "failure clinic": 2, "clinic outpatients": 6, "most heart": 2, "stratification models": 2, "developed for": 3, "inpatient use": 2, "available outpatient": 2, "outpatient models": 2, "models use": 2, "complex set": 2, "set of": 2, "routinely collected": 2, "collected clinical": 2, "clinical data": 4, "month risk": 4, "cause medical": 4, "medical hospitalization": 4, "quality improvement": 10, "improvement database": 2, "multivariable cox": 2, "reached primary": 2, "externally validated": 2, "patients for": 2, "months from": 1, "recently calculated": 2, "arbitrary start": 2, "start date": 2, "date for": 1, "model included": 2, "included blood": 2, "blood urea": 2, "urea nitrogen": 2, "diabetes status": 2, "hospitalization within": 2, "the concordance": 2, "concordance c": 2, "c statistics": 2, "statistics in": 1, "rank testing": 2, "testing demonstrated": 2, "demonstrated excellent": 2, "excellent risk": 2, "risk group": 4, "month event": 4, "rates in": 2, "cohorts 8%/12%/12": 2, "cohorts 57%/58%/79": 2, "uses readily": 2, "readily available": 2, "available data": 2, "potentially help": 2, "help allocate": 2, "allocate specialized": 2, "resources within": 2, "within health": 2, "health systems": 2, "stage renal": 4, "renal disease": 6, "outpatients with": 5, "important prognostic": 4, "dysfunction progresses": 2, "examined incidence": 2, "systolic hf": 22, "identified in": 4, "onset esrd": 2, "estimated by": 2, "patients grouped": 2, "grouped by": 1, "min per": 12, "group iii": 2, "group iv": 2, "hazard models": 6, "models for": 1, "time to": 5, "included in": 4, "median age": 6, "median left": 2, "fraction was": 1, "median egfr": 2, "egfr was": 1, "patients developed": 8, "egfr group": 4, "uncontrolled hypertension": 4, "need of": 3, "mainly observed": 2, "low egfr": 2, "hypertension identify": 2, "comparable performance": 2, "growing epidemic": 2, "epidemic of": 1, "valid measure": 2, "measure of": 6, "health status": 8, "validated measure": 2, "reduced ef": 4, "prospective hf": 2, "dichotomized patients": 2, "patients into": 1, "the associations": 2, "associations between": 1, "commonly used": 4, "used criterion": 2, "criterion standard": 2, "total symptom": 2, "evaluated using": 2, "using spearman": 2, "spearman correlations": 2, "differences between": 1, "tested with": 1, "interaction terms": 2, "predictive validity": 2, "validity of": 2, "assessed with": 2, "curves for": 1, "made using": 2, "hazards models": 10, "internal reliability": 2, "summary scores": 2, "class in": 1, "p=0.27 for": 1, "year event": 4, "free rates": 2, "rates by": 1, "category among": 2, "log rank": 2, "significant interaction": 6, "interaction by": 1, "domains demonstrated": 2, "demonstrated high": 2, "high internal": 2, "internal consistency": 4, "consistency among": 2, "overall summary": 2, "reliable measure": 2, "offers excellent": 2, "excellent prognostic": 2, "prognostic ability": 2, "future studies": 2, "establishment of": 1, "responsiveness to": 1, "clinical change": 2, "soluble concentrations": 2, "concentrations of": 1, "interleukin receptor": 2, "receptor family": 2, "family member": 2, "predict prognosis": 2, "prognosis in": 6, "recently found": 2, "found changing": 2, "changing doses": 2, "doses of": 2, "affect sst2": 2, "sst2 concentrations": 4, "remains unclear": 4, "concentrations identify": 2, "identify benefit": 2, "subjects with": 9, "failure attributable": 2, "ventricular systolic": 6, "systolic dysfunction": 16, "examined in": 1, "post hoc": 2, "hoc analysis": 2, "taking bb": 2, "bb at": 1, "medication regimen": 2, "sst2 values": 2, "obtained during": 1, "examined as": 1, "function of": 2, "baseline sst2": 2, "sst2 status": 2, "low \u226435": 2, "versus high": 2, "final achieved": 2, "versus low": 2, "mg daily": 4, "daily equivalent": 2, "equivalent dose": 2, "dose of": 3, "metoprolol succinate": 2, "low sst2": 8, "sst2 titrated": 2, "titrated to": 2, "dose bb": 10, "bb had": 2, "lowest cardiovascular": 2, "cardiovascular event": 8, "event rate": 6, "rate at": 5, "lowest cumulative": 2, "cumulative hazard": 4, "high sst2": 8, "intermediate outcomes": 2, "sst2 treated": 4, "highest cardiovascular": 2, "highest cumulative": 2, "ratio of": 14, "intermediate odds": 2, "ratios for": 4, "similar results": 8, "failure hospitalization": 6, "cardiovascular death": 18, "therapy exerted": 2, "exerted dose": 2, "related benefits": 2, "benefits across": 2, "study participants": 2, "sst2 measurement": 2, "measurement identifies": 2, "identifies patients": 2, "particularly benefit": 2, "benefit from": 4, "higher bb": 2, "novel approach": 2, "acute treatment": 2, "the nitroxyl": 2, "exerts positive": 2, "positive inotropic": 2, "vasodilator effects": 2, "camp independent": 2, "clinical usefulness": 2, "limited by": 2, "chemical instability": 2, "cogeneration of": 1, "report on": 1, "pure hno": 4, "isolated myoctyes": 2, "intact hearts": 2, "hearts in": 1, "experimental models": 2, "converts solely": 2, "inactive cxl-1051": 2, "in adult": 2, "adult mouse": 2, "mouse ventricular": 2, "ventricular myocytes": 2, "dose dependently": 2, "dependently increased": 2, "increased sarcomere": 2, "sarcomere shortening": 2, "shortening by": 1, "% rise": 2, "rise in": 2, "transient only": 1, "higher doses": 2, "neither inhibition": 2, "inhibition of": 7, "protein kinase": 10, "kinase a": 2, "soluble guanylate": 2, "guanylate cyclase": 2, "cyclase altered": 2, "contractile response": 2, "unlike isoproterenol": 2, "equally effective": 2, "myocytes from": 1, "failing hearts": 10, "anesthetized dogs": 2, "dogs with": 2, "coronary microembolization": 2, "reduced left": 4, "ventricular end": 4, "diastolic pressure": 12, "myocardial oxygen": 2, "oxygen consumption": 12, "increasing ejection": 2, "fraction from": 1, "maximal ventricular": 2, "ventricular power": 2, "power index": 2, "index by": 1, "in conscious": 4, "conscious dogs": 2, "increased contractility": 2, "contractility assessed": 2, "systolic elastance": 8, "provided venoarterial": 2, "venoarterial dilation": 2, "minimally altered": 2, "heart filling": 2, "increasing cardiac": 2, "stroke volume": 8, "arterial pressure": 4, "pressure declined": 2, "declined modestly": 2, "these data": 4, "data show": 4, "functional efficacy": 2, "novel pure": 2, "enhance myocardial": 2, "myocardial function": 6, "present first": 2, "man evidence": 2, "evidence for": 3, "potential usefulness": 4, "usefulness in": 1, "echocardiographic predictors": 4, "reverse remodeling": 18, "remodeling after": 2, "subsequent events": 2, "response after": 1, "largely involved": 2, "involved single": 2, "single parameters": 2, "combining parameters": 2, "multiparametric echocardiographic": 4, "echocardiographic score": 8, "score for": 2, "global longitudinal": 4, "longitudinal strain": 4, "strain of": 2, "standard echocardiographic": 2, "echocardiographic measurements": 2, "measurements in": 1, "underwent baseline": 2, "baseline echocardiography": 2, "echocardiography before": 1, "underwent follow": 2, "echocardiograms at": 1, "regression analysis": 10, "prediction of": 3, "% reduction": 4, "score with": 2, "device implantation": 10, "hospitalization during": 1, "57\u00b122 months": 2, "months of": 6, "lv reverse": 2, "pre -": 20, "- crt": 2, "diastolic dimension": 4, "dimension index": 2, "index <": 4, "ventricle <": 2, "left atrial": 6, "atrial area": 6, "diastolic area": 2, "area index": 2, "right atrial": 10, "ventricular fractional": 2, "fractional area": 2, "area change": 2, "change \u226535": 2, "\u226535 %": 2, "score allowed": 2, "allowed prediction": 2, "remodeling with": 1, "sensitivity of": 1, "specificity of": 1, "during follow": 6, "heart transplantations": 2, "lv assist": 2, "device implantations": 2, "failure admissions": 2, "the score": 2, "failure admission": 2, "cause death": 4, "ischemic cause": 2, "initial functional": 2, "functional class": 22, "selecting patients": 2, "patients likely": 2, "undergo reverse": 2, "safety of": 8, "spironolactone for": 1, "systolic heart": 32, "receptor antagonists": 10, "shown in": 1, "randomized trials": 6, "reduce morbidity": 4, "symptomatic systolic": 2, "spironolactone in": 4, "newly diagnosed": 8, "diagnosed systolic": 2, "diagnosed heart": 4, "previous spironolactone": 2, "use from": 1, "excluded patients": 4, "baseline serum": 2, "serum creatinine": 2, "creatinine level": 2, "serum potassium": 4, "potassium level": 2, "regression with": 1, "varying covariates": 2, "independent association": 2, "severe hyperkalemia": 4, "acute kidney": 10, "kidney injury": 10, "eligible patients": 4, "median follow": 12, "initiated spironolactone": 2, "adjusted hazard": 16, "ratio 0.91": 2, "interval 0.77": 2, "ratio 0.93": 2, "interval 0.60": 2, "crude rates": 2, "injury during": 1, "seen in": 6, "- fold": 6, "fold increased": 4, "diverse community": 2, "based cohort": 2, "cohort with": 1, "incident systolic": 2, "risks of": 1, "findings suggest": 8, "reduced compared": 4, "recommended medications": 10, "vascular endothelial": 6, "endothelial growth": 6, "growth factor": 10, "factor blockade": 2, "blockade prevents": 2, "therapy on": 2, "remodeling in": 3, "impaired angiogenesis": 2, "angiogenesis in": 2, "post -": 42, "- myocardial": 6, "infarction heart": 6, "heart contributes": 2, "contributes to": 4, "progression to": 2, "the inhibition": 2, "compensatory hypertrophy": 2, "cardiac failure": 4, "- adrenergic": 10, "adrenergic receptor": 20, "receptor blocker": 6, "also shown": 2, "improve myocardial": 2, "myocardial perfusion": 4, "perfusion by": 1, "enhancing neoangiogenesis": 2, "neoangiogenesis in": 1, "failing heart": 4, "weeks from": 1, "surgically induced": 2, "induced myocardial": 2, "failure rats": 2, "end of": 5, "week treatment": 2, "treatment period": 2, "echocardiography revealed": 2, "revealed reduced": 4, "reduced cardiac": 4, "cardiac diameters": 2, "improved cardiac": 2, "treated compared": 2, "treated rats": 2, "b treatment": 4, "increased cardiac": 6, "cardiac angiogenesis": 6, "vivo coronary": 2, "coronary perfusion": 4, "cardiac fibrosis": 2, "weeks after": 2, "cardiac vegf": 2, "no synthase": 2, "synthase activation": 2, "observed by": 1, "comparing b": 2, "untreated failing": 2, "test whether": 4, "proangiogenic effects": 2, "b act": 2, "act via": 2, "via activation": 4, "intravenously injected": 2, "injected with": 1, "adenoviral vector": 2, "vector encoding": 2, "control adenovirus": 2, "start of": 1, "histological analysis": 2, "analysis revealed": 10, "reduced capillary": 2, "perfusion in": 1, "rats compared": 2, "c rats": 2, "inhibition counteracted": 2, "positive effects": 2, "b on": 1, "promotes cardiac": 2, "failure via": 4, "signaling pathway": 6, "induced enhancement": 2, "enhancement of": 2, "favorable effects": 2, "do outcomes": 2, "failure vary": 2, "vary by": 2, "department volume": 2, "common emergency": 2, "volume influences": 2, "influences patient": 2, "adults presenting": 2, "eds between": 1, "responsible diagnosis": 2, "cases seen": 2, "volume eds": 8, "eds had": 1, "less comorbidities": 2, "less likely": 8, "adjusted odds": 8, "aor ]": 2, "of patients": 6, "patients treated": 16, "cases exhibited": 6, "exhibited higher": 2, "higher risk": 10, "visit in": 1, "hospitalized at": 1, "day death": 2, "discharge patients": 2, "failure home": 2, "exhibited worse": 2, "worse outcomes": 2, "driven largely": 2, "repeat ed": 2, "improve management": 2, "required at": 1, "volume sites": 2, "oxidase inhibition": 2, "inhibition preserves": 2, "preserves left": 2, "diastolic function": 14, "cardiac volume": 2, "volume overload": 6, "rat left": 2, "myocytes with": 1, "aortocaval fistula": 2, "decrease mitochondrial": 2, "mitochondrial respiration": 2, "contractile function": 8, "inhibition improves": 2, "improves cardiomyocyte": 2, "cardiomyocyte bioenergetics": 2, "chronic acf": 2, "randomized to": 5, "acf \u00b1": 2, "\u00b1 allopurinol": 2, "echocardiography at": 3, "wk demonstrated": 2, "increase in": 29, "twofold increase": 4, "wall stress": 6, "groups versus": 2, "sham group": 2, "lv ejection": 2, "velocity of": 1, "circumferential shortening": 2, "maximal systolic": 2, "contractile efficiency": 2, "significantly depressed": 2, "improved in": 2, "allopurinol rats": 2, "absence of": 5, "maximum o2": 2, "consumption rate": 2, "rate measured": 2, "isolated cardiomyocytes": 4, "cardiomyocytes using": 2, "extracellular flux": 2, "flux analyzer": 2, "improvement in": 16, "paralleled by": 1, "attenuation in": 1, "allopurinol improves": 2, "efficiency possibly": 2, "effects on": 8, "myofilament ca(2": 2, "diastolic properties": 2, "failure of": 3, "improve symptoms": 4, "hospitalizations in": 4, "severe heart": 10, "usefulness of": 2, "imaging for": 1, "assessing left": 2, "ventricular filling": 8, "filling pressure": 6, "pressure in": 3, "stable severe": 4, "severe systolic": 6, "the ratio": 4, "early transmitral": 4, "transmitral blood": 2, "blood flow": 8, "flow velocity": 8, "velocity over": 1, "early diastolic": 16, "mitral annulus": 6, "annulus velocity": 4, "e /": 14, "/ e": 6, "found unreliable": 2, "estimating pulmonary": 2, "pulmonary capillary": 4, "capillary wedge": 4, "wedge pressure": 4, "decompensated systolic": 2, "the objective": 12, "reliability in": 1, "stable hf": 4, "underwent right": 2, "sided cardiac": 2, "cardiac catheterization": 6, "transthoracic echocardiography": 2, "echocardiography with": 1, "measurement of": 6, "transmitral flow": 4, "flow velocities": 2, "annulus velocities": 2, "velocities during": 1, "\u00b1 8": 2, "% had": 3, "correlated more": 1, "/ e'mean": 2, "p values": 4, "the area": 2, "ci 0.70": 2, "aucs of": 1, "vary with": 1, "cutoff of": 1, "negative predictive": 2, "predictive value": 4, "negative likelihood": 2, "likelihood ratio": 2, "e'lateral showed": 2, "showed good": 4, "good diagnostic": 4, "diagnostic performance": 6, "performance only": 1, "s'lateral of": 1, "e'septal showed": 2, "performance for": 1, "detecting normal": 2, "normal filling": 2, "annular plane": 4, "plane systolic": 4, "systolic excursion": 4, "pulmonary arterial": 16, "arterial systolic": 4, "systolic pressure": 12, "pressure relationship": 2, "relationship in": 1, "ventricular contractile": 10, "derived pulmonary": 2, "tricuspid annular": 2, "basic relevance": 2, "relevance in": 2, "clinical follow": 2, "carrying two-": 2, "two- to": 1, "threefold increase": 2, "cardiac risk": 2, "risk when": 1, "longitudinal rv": 2, "fiber shortening": 2, "force generated": 2, "generated by": 1, "vivo rv": 2, "force relationship": 4, "ratio better": 2, "better disclosing": 2, "disclosing prognosis": 2, "underwent echo": 2, "- brain": 10, "peptide assessment": 2, "tracked for": 1, "relationship showed": 2, "downward regression": 2, "regression line": 4, "line shift": 2, "shift in": 2, "frequently presenting": 2, "presenting with": 1, "higher pasp": 2, "lower tapse": 2, "patients exhibited": 4, "similar distribution": 4, "distribution along": 2, "separate cox": 2, "individual measures": 2, "ratio form": 2, "hazard ratios": 22, "variables retained": 2, "retained in": 1, "multivariate regression": 2, "class <": 2, "< /\u2265": 2, "/\u2265 3": 2, "study shows": 4, "shows that": 2, "shifted downward": 2, "nonsurvivors with": 1, "distribution in": 1, "ratio improves": 2, "improves prognostic": 2, "prognostic resolution": 2, "relationship as": 1, "possible index": 2, "step forward": 4, "efficient rv": 2, "function evaluation": 2, "affected by": 1, "the bottleneck": 4, "bottleneck stent": 8, "stent model": 2, "model for": 2, "chronic myocardial": 6, "myocardial ischemia": 12, "large animal": 2, "animal model": 2, "novel therapeutic": 4, "therapeutic approaches": 4, "novel percutaneous": 2, "percutaneous one-": 2, "vessel model": 4, "ischemia using": 2, "stent coated": 2, "coated with": 1, "polytetrafluoroethylene tube": 2, "tube formed": 2, "formed in": 1, "bottleneck shape": 2, "implanted in": 2, "proximal left": 4, "left anterior": 6, "anterior descending": 6, "proximal circumflex": 2, "circumflex artery": 2, "proximal lcx": 2, "mid lad": 2, "wk later": 2, "infarct size": 2, "collateral growth": 6, "given antiarrhythmic": 2, "antiarrhythmic medication": 2, "prevent sudden": 2, "sudden death": 6, "the occlusion": 2, "occlusion time": 2, "timing of": 4, "modulated by": 2, "antiplatelet medication": 2, "fractional flow": 2, "flow reserve": 2, "reserve measurements": 2, "positron emission": 2, "emission tomography": 2, "tomography imaging": 2, "imaging showed": 2, "showed severe": 2, "severe ischemia": 2, "ischemia after": 1, "bottleneck stenting": 2, "stenting covering": 2, "covering over": 1, "ventricle in": 4, "proximal lad": 4, "complete coronary": 2, "coronary occlusion": 2, "significant collateral": 2, "occurred already": 2, "first wk": 2, "stent occlusion": 2, "competitive collateral": 2, "growth patterns": 2, "model 4": 2, "stenting with": 1, "% infarcted": 2, "infarcted left": 2, "the mortality": 2, "vessel disease": 2, "disease model": 2, "the implantation": 2, "implantation of": 2, "novel bottleneck": 2, "stent in": 1, "novel porcine": 2, "reversible myocardial": 2, "open stent": 2, "ischemic heart": 10, "occluded stent": 2, "selective heart": 2, "rate reduction": 4, "reduction with": 4, "ivabradine unloads": 2, "the study": 6, "isolated heart": 4, "ivabradine reduces": 2, "reduces afterload": 2, "afterload of": 2, "effective arterial": 4, "arterial elastance": 8, "represents resistive": 2, "pulsatile afterload": 2, "heart derived": 2, "derived from": 4, "pressure volume": 2, "volume relation": 2, "hr modulates": 2, "afterload burden": 2, "fraction \u226435": 4, "\u226435 %": 4, "ivabradine in": 1, "ivabradine 7.5": 2, "echocardiographic substudy": 2, "total arterial": 2, "arterial compliance": 2, "calculated at": 1, "arm cuff": 2, "at baseline": 6, "differ significantly": 2, "treated patients": 8, "significantly reduced": 8, "reduced in": 3, "ivabradine group": 4, "marked reduction": 2, "improved tac": 2, "contractility remained": 2, "arterial coupling": 16, "markedly improved": 2, "higher sv": 2, "isolated hr": 4, "hr reduction": 10, "ivabradine improves": 2, "improves tac": 2, "thus reducing": 2, "improved ventricular": 2, "unloading of": 1, "contribute to": 8, "relation of": 2, "preoperative serum": 2, "serum albumin": 2, "albumin levels": 12, "levels to": 1, "patients undergoing": 20, "prognostic indicator": 4, "indicator in": 2, "hypoalbuminemia with": 1, "postoperative mortality": 2, "undergoing left": 2, "studied 272": 2, "implantation from": 1, "preoperative clinical": 2, "laboratory variables": 2, "variables associated": 2, "postoperative survival": 4, "preoperative hypoalbuminemia": 6, "normal albumin": 4, "albumin concentration": 2, "surgery was": 1, "levels compared": 2, "hypoalbuminemia before": 1, "revealed that": 8, "preoperative albumin": 2, "ratio 0.521": 2, "interval 0.290": 2, "normalization of": 3, "levels during": 2, "support on": 2, "analyzed in": 3, "subgroup analysis": 2, "postoperative normalization": 4, "showed improved": 2, "improved survival": 6, "survival compared": 4, "remained hypoalbuminemia": 2, "decreasing albumin": 2, "month survival": 8, "poor prognosis": 6, "prognosis after": 1, "albumin level": 2, "levels by": 3, "correcting nutrition": 2, "hepatic function": 2, "effective way": 2, "improve prognosis": 2, "patients evaluated": 2, "lvad implantation": 4, "surgical correction": 2, "correction of": 1, "aortic valve": 16, "valve insufficiency": 2, "insufficiency after": 1, "onset aortic": 2, "aortic insufficiency": 2, "encountered after": 1, "instituting mechanical": 2, "mechanical circulatory": 2, "circulatory support": 4, "seems more": 1, "continuous flow": 2, "pulsatile devices": 2, "treatment algorithms": 2, "algorithms for": 1, "de novo": 2, "- lvad": 6, "lvad ai": 6, "well defined": 6, "present report": 2, "described 6": 2, "underwent aortic": 2, "valve surgery": 2, "surgery for": 2, "onset post": 2, "patients underwent": 8, "underwent lvad": 2, "cf devices": 2, "examined for": 1, "onset severe": 2, "severe ai": 6, "requiring surgical": 2, "surgical intervention": 4, "developed new": 2, "after medical": 2, "sternotomy for": 1, "valve procedures": 2, "bioprosthetic valve": 2, "valve replacement": 6, "dacron patch": 2, "patch closure": 2, "valve repairs": 2, "underwent transcatheter": 2, "transcatheter aortic": 2, "valve procedure": 2, "requiring revision": 2, "revision by": 1, "open surgery": 2, "experienced significant": 2, "significant improvement": 10, "patient died": 4, "died postoperatively": 2, "postoperatively secondary": 2, "multiorgan failure": 2, "surgical treatment": 2, "valve oversewing": 2, "leaflet repair": 2, "bioprosthetic aortic": 2, "replacement is": 1, "restoring functional": 2, "capacity for": 1, "develop symptomatic": 2, "performed safely": 2, "good results": 2, "various transcatheter": 2, "transcatheter approaches": 2, "difficult problems": 2, "also available": 2, "offer less": 2, "less invasive": 2, "invasive alternatives": 2, "alternatives to": 1, "conventional surgery": 2, "outcomes of": 8, "young adults": 8, "study sought": 12, "few studies": 4, "categorized into": 1, "age groups": 2, "youngest patients": 4, "vs. oldest": 4, "index \u226535": 2, "black ethnicity": 2, "adhere to": 1, "nonadherence in": 1, "salt intake": 2, "dietary measures": 2, "radiological signs": 4, "signs of": 3, "mortality was": 1, "youngest age": 2, "year mortality": 8, "rates across": 2, "respective age": 2, "age categories": 2, "referent age": 2, "cardiovascular mortality": 12, "youngest group": 2, "group even": 2, "multivariable adjustment": 4, "hospitalization rates": 4, "ages 20": 2, "beyond divergent": 2, "divergent etiology": 2, "exhibited striking": 2, "striking differences": 2, "outcomes compared": 2, "older counterparts": 2, "less common": 4, "life was": 1, "nonfatal outcomes": 2, "better survival": 2, "higher hospitalization": 2, "nordic walking": 10, "walking in": 1, "growing population": 2, "population within": 2, "within cardiac": 2, "cardiac rehabilitation": 8, "randomized controlled": 8, "controlled trial": 6, "standard cardiac": 6, "rehabilitation care": 6, "care on": 1, "\u00b1 11.4": 2, "mean ejection": 6, "% \u00b1": 18, "randomly assigned": 8, "assigned to": 4, "groups performed": 2, "performed 200": 2, "minutes of": 2, "exercise per": 4, "per week": 6, "week for": 1, "measured after": 2, "capacity assessed": 2, "standard care": 2, "walking led": 2, "higher functional": 2, "\u00b1 59.4": 2, "\u00b1 71.3": 2, "travelled during": 1, "greater self": 2, "reported physical": 2, "physical activity": 6, "\u00b1 118.5": 2, "minutes vs": 2, "\u00b1 125.6": 2, "increased right": 2, "right grip": 2, "grip strength": 8, "\u00b1 3.5": 2, "kg vs": 4, "\u00b1 3.1": 4, "fewer depressive": 2, "depressive symptoms": 4, "\u00b1 2.4": 2, "peak aerobic": 2, "aerobic capacity": 4, "hand grip": 4, "waist circumference": 2, "care in": 3, "improving functional": 2, "important outcomes": 2, "this exercise": 2, "exercise modality": 2, "promising alternative": 2, "alternative for": 2, "ejection time": 4, "time in": 1, "failure complicating": 2, "complicating precapillary": 2, "precapillary pulmonary": 2, "pulmonary hypertension": 16, "noninvasive tools": 2, "experiencing heart": 2, "major right": 2, "right ventricle": 6, "ventricle overload": 2, "overload leads": 2, "leads to": 1, "decreased stroke": 2, "shortens left": 2, "arterial tonometry": 4, "tonometry study": 2, "study tested": 2, "carries prognostic": 2, "prognostic value": 4, "precapillary ph": 4, "ph with": 2, "radial artery": 2, "artery tonometry": 2, "tonometry variables": 2, "prospectively obtained": 2, "obtained at": 1, "day 3": 2, "clinical deterioration": 4, "measured from": 1, "reconstructed aortic": 2, "aortic pressure": 2, "pressure curve": 2, "overall icu": 2, "median stay": 2, "at admission": 2, "unfavorable outcome": 4, "tonometric indices": 2, "indices were": 1, "specificity for": 2, "identifying death": 2, "other prognostic": 2, "prognostic factors": 4, "factors at": 1, "higher serum": 4, "serum levels": 4, "brain natriuretic": 12, "lower natremia": 2, "higher furosemide": 4, "furosemide dose": 4, "higher oxygen": 2, "oxygen flow": 4, "second evaluation": 2, "norepinephrine requirement": 2, "poor outcome": 2, "the change": 4, "day mortality": 6, "previously documented": 2, "documented prognostic": 2, "confirmed in": 1, "atrial myxoma": 4, "myxoma complicated": 2, "complicated by": 1, "pulmonary embolism": 10, "revealed by": 1, "common type": 2, "type of": 2, "cardiac benign": 2, "benign tumors": 2, "located in": 2, "left atrium": 2, "followed by": 6, "right atrium": 6, "rarely embolize": 2, "embolize to": 1, "arterial vasculature": 2, "report of": 2, "massive embolism": 2, "embolism to": 1, "pulmonary arteries": 2, "arteries treated": 2, "treated surgically": 2, "atrial mass": 2, "mass removal": 2, "pulmonary embolectomy": 2, "atrium mass": 2, "mass presented": 2, "presented with": 1, "prolapse through": 1, "tricuspid valve": 2, "valve causing": 2, "stenotic physiology": 2, "left pulmonary": 2, "completed occluded": 2, "right pulmonary": 2, "partially obstructed": 2, "surgical tactics": 2, "tactics included": 2, "brief hypothermic": 2, "hypothermic circulatory": 2, "circulatory arrest": 2, "patient had": 1, "uneventful recovery": 2, "day test": 4, "retest reliability": 6, "reliability of": 2, "go test": 2, "test in": 2, "advanced chronic": 4, "chronic organ": 2, "organ failure": 2, "chronic renal": 2, "renal failure": 2, "- sectional": 2, "home environment": 2, "% men": 4, "interquartile range": 12, "median body": 2, "advanced copd": 4, "performed on": 2, "the intraclass": 2, "intraclass correlation": 2, "kappa coefficient": 2, "standard error": 6, "error of": 3, "relative minimal": 2, "minimal detectable": 2, "detectable change": 2, "good agreement": 2, "total sample": 6, "values ranging": 2, "ranging from": 4, "kappa coefficients": 2, "coefficients from": 1, "statistical improvement": 2, "improvement occurred": 2, "sample from": 1, "second trial": 2, "trial with": 1, "large limits": 2, "limits of": 1, "mean difference": 6, "third trial": 2, "trial added": 2, "added little": 2, "information to": 1, "measurement value": 2, "absolute value": 4, "confidence level": 4, "relative value": 2, "found between": 3, "similar values": 2, "values found": 2, "values of": 1, "daily clinical": 2, "practice with": 1, "represents true": 2, "true change": 2, "repeated measures": 2, "rheumatoid arthritis": 4, "arthritis starting": 2, "elevations in": 2, "tumor necrosis": 2, "necrosis factor": 2, "several trials": 2, "antagonists showed": 2, "possibly worsening": 2, "worsening of": 3, "known severe": 2, "severe hf": 4, "recurrent hf": 2, "patients receiving": 16, "treat rheumatoid": 2, "used data": 4, "different us": 2, "healthcare programmes": 2, "receiving methotrexate": 2, "study cohort": 4, "switched to": 1, "- biological": 2, "biological disease": 2, "disease modifying": 2, "modifying antirheumatic": 2, "antirheumatic drug": 2, "these groups": 4, "compared in": 1, "regression models": 8, "models stratified": 2, "stratified by": 1, "propensity score": 4, "score decile": 2, "adjusted for": 4, "oral glucocorticoid": 2, "glucocorticoid dosage": 2, "loop diuretics": 2, "compared 8656": 2, "new users": 4, "users of": 6, "antagonist with": 1, "similar baseline": 2, "baseline covariates": 2, "the hr": 4, "hr for": 1, "antagonists compared": 2, "elevated prior": 2, "ci 0.45": 2, "test for": 2, "oral glucocorticoids": 2, "related gradient": 2, "mg hr": 4, "hr 1.30": 2, "hr 1.54": 2, "admissions compared": 2, "using exercise": 2, "improve quality": 2, "life for": 1, "people with": 1, "current economic": 2, "economic climate": 2, "climate within": 2, "change interventions": 2, "interventions in": 2, "chronic disease": 4, "disease such": 1, "exercise programmes": 2, "limited within": 2, "within acute": 2, "acute hospital": 2, "hospital facilities": 2, "the challenge": 2, "deliver cost": 2, "specific health": 2, "health interventions": 2, "result in": 3, "measurable benefits": 2, "methods study": 4, "participation in": 1, "structured exercise": 2, "exercise programme": 2, "programme for": 1, "primary outcomes": 2, "improvements in": 7, "secondary outcome": 4, "outcome measures": 12, "measures related": 2, "related to": 9, "patient satisfaction": 2, "sustainability of": 1, "intervention post": 2, "post study": 2, "overall significant": 2, "significant improvements": 6, "participants demonstrated": 2, "demonstrated significant": 4, "improvements with": 1, "others showing": 2, "showing minor": 2, "minor improvement": 2, "anecdotal evidence": 2, "perceived benefit": 2, "expressed in": 6, "participant satisfaction": 2, "satisfaction responses": 2, "secondary outcomes": 6, "met in": 1, "relation to": 1, "sustainability with": 1, "commissioning of": 1, "based programmes": 2, "programmes on": 1, "completion of": 2, "older adults": 14, "composition study": 2, "the aim": 12, "aim of": 6, "adverse health": 2, "frailty on": 1, "participants aged": 2, "aged 70": 2, "- frail": 2, "frail participants": 2, "ci 1.08": 2, "severe frailty": 2, "ci 1.02": 2, "linearly associated": 2, "risk after": 1, "per sd": 2, "sd decrease": 2, "significant when": 1, "controlled for": 1, "death as": 1, "competing risk": 2, "across age": 2, "sub -": 4, "- groups": 2, "groups based": 4, "disease at": 1, "scores to": 1, "improved discrimination": 2, "ci 0.018": 2, "appropriately reclassified": 2, "reclassified 13.4": 2, "improvement 0.073": 2, "ci 0.021": 2, "the role": 2, "vasopressin in": 1, "abnormalities contribute": 2, "pathophysiology of": 6, "successful approaches": 2, "prognosis of": 4, "based largely": 2, "therapeutic interruption": 2, "interruption of": 1, "activated neurohormonal": 2, "neurohormonal systems": 2, "the use": 6, "inhibitors of": 1, "sympathetic nervous": 2, "nervous systems": 2, "improved clinical": 4, "excessive secretion": 2, "secretion of": 1, "arginine vasopressin": 2, "potential for": 2, "deleterious effects": 2, "various physiologic": 2, "physiologic processes": 2, "processes in": 1, "vasopressin receptor": 4, "receptor antagonist": 8, "antagonist therapy": 4, "therapy is": 1, "potentially beneficial": 2, "beneficial new": 2, "therapeutic approach": 2, "approach to": 2, "mir-25 cooperate": 2, "transcription factor": 10, "aberrant reactivation": 2, "reactivation of": 1, "embryonic gene": 4, "gene programs": 6, "intricately linked": 2, "linked to": 4, "pathological heart": 2, "transcription factors": 6, "factors driving": 2, "programs remain": 2, "remain ill": 2, "report that": 1, "increased calcineurin": 2, "decreased mir-25": 2, "expression integrate": 2, "- express": 2, "basic helix": 2, "factor dhand": 2, "also known": 2, "known as": 1, "diseased human": 2, "mouse myocardium": 2, "in line": 2, "mutant mice": 2, "mice overexpressing": 2, "otherwise healthy": 2, "healthy heart": 2, "heart muscle": 2, "muscle cells": 2, "cells developed": 2, "pathological hypertrophy": 2, "conditional gene": 2, "mice demonstrated": 2, "marked resistance": 2, "resistance to": 1, "induced hypertrophy": 2, "induction of": 4, "fetal gene": 2, "gene program": 2, "vivo inhibition": 2, "mir-25 by": 1, "specific antagomir": 2, "antagomir evoked": 2, "evoked spontaneous": 2, "spontaneous cardiac": 2, "cardiac dysfunction": 8, "murine myocardium": 2, "myocardium to": 1, "dependent manner": 2, "results reveal": 2, "reveal that": 1, "signalling cascades": 2, "cascades integrate": 2, "integrate with": 1, "bhlh transcription": 2, "postnatal mammalian": 2, "mammalian myocardium": 2, "myocardium with": 1, "programs in": 3, "occurs in": 4, "subjects over": 1, "years of": 3, "the base": 2, "base of": 1, "blockade of": 1, "hormonal system": 2, "angiotensin converting": 8, "converting enzyme": 20, "enzyme inhibitors": 14, "angiotensin receptor": 18, "receptor blockers": 16, "blockers in": 1, "inhibitors intolerance": 2, "beta receptor": 2, "mineralocorticoid receptor": 8, "negative inotropic": 2, "inotropic effect": 4, "beta blockers": 8, "neglected for": 1, "long time": 4, "time from": 1, "past decades": 2, "decades several": 2, "several studies": 2, "demonstrated that": 6, "blockers decrease": 2, "decrease mortality": 4, "the effectiveness": 2, "bisoprolol in": 1, "reducing mortality": 2, "documented in": 3, "myocardial loss": 2, "causes heart": 2, "controlled by": 1, "insulin resistance": 12, "type 2": 16, "molecular mechanism": 4, "links diabetes": 2, "diabetes to": 1, "failure remains": 2, "hallmark of": 2, "insulin receptor": 2, "receptor substrates": 2, "substrates 1": 2, "major insulin": 2, "signaling components": 2, "components regulating": 2, "regulating cellular": 2, "cellular metabolism": 2, "examine whether": 2, "hyperinsulinemia causes": 2, "causes myocardial": 2, "myocardial insulin": 2, "cellular dysfunction": 2, "dysfunction via": 2, "generated heart": 2, "specific irs1": 4, "gene double": 2, "reduced ventricular": 2, "ventricular mass": 2, "developed cardiac": 2, "cardiac apoptosis": 2, "showed diminished": 2, "box class": 2, "class o-1": 2, "o-1 signaling": 2, "impaired cardiac": 4, "cardiac metabolic": 2, "metabolic gene": 2, "decreased cardiac": 2, "cardiac irs1": 2, "exhibited features": 2, "features of": 1, "cardiac energy": 2, "energy metabolism": 6, "metabolism gene": 2, "p38\u03b1 mitogen": 2, "activated protein": 2, "using neonatal": 2, "neonatal rat": 2, "rat ventricular": 2, "ventricular cardiomyocytes": 4, "chronic insulin": 2, "insulin exposure": 2, "exposure reduced": 2, "prevented insulin": 2, "insulin action": 2, "action through": 1, "fundamental mechanism": 2, "dysfunction during": 4, "level variation": 4, "variation in": 5, "medications among": 2, "among outpatients": 2, "insights from": 3, "examine practice": 2, "recommended treatment": 2, "treatment variation": 2, "practice site": 2, "patient factors": 2, "cardiology practices": 2, "practices participating": 2, "registry from": 1, "practice rates": 2, "optimal combined": 6, "combined treatment": 6, "treatment measure": 2, "determined for": 1, "documented contraindications": 2, "multivariable hierarchical": 2, "hierarchical regression": 2, "insurance status": 2, "median rate": 4, "rate ratio": 4, "calculated for": 2, "given comorbidities": 2, "differ at": 1, "selected practices": 2, "identified 12": 2, "patients from": 3, "unadjusted practice": 2, "level prescription": 2, "prescription rates": 2, "rates ranged": 2, "ranged from": 2, "adjusted median": 2, "blockers therapy": 4, "medications for": 1, "fraction exists": 2, "exists in": 2, "outpatient setting": 2, "addressing practice": 2, "level differences": 2, "component of": 2, "improving quality": 2, "care for": 3, "related cardiotoxicity": 2, "cardiotoxicity among": 2, "breast cancer": 12, "trastuzumab in": 1, "adjuvant setting": 2, "setting improves": 2, "improves outcomes": 4, "cardiotoxicity manifested": 2, "manifested as": 1, "related chf": 2, "chf among": 2, "cancer patients": 6, "patients at": 6, "years old": 6, "full medicare": 2, "diagnosed with": 1, "cancer between": 1, "trastuzumab use": 2, "version 9": 2, "analyses included": 2, "included descriptive": 2, "descriptive statistics": 2, "in total": 6, "received trastuzumab": 2, "entire cohort": 2, "among trastuzumab": 4, "trastuzumab users": 2, "% compared": 4, "nontrastuzumab users": 4, "artery disease": 18, "weekly trastuzumab": 2, "trastuzumab administration": 2, "large cohort": 4, "older breast": 2, "cardiac comorbidities": 2, "further studies": 2, "studies need": 2, "frequency of": 4, "administration plays": 2, "plays in": 1, "dash diet": 12, "diet scores": 10, "women with": 4, "current dietary": 2, "dietary recommendations": 4, "largely based": 2, "- hf": 2, "hf populations": 2, "associations of": 3, "dietary patterns": 2, "patterns with": 1, "therefore evaluated": 2, "evaluated associations": 2, "scores with": 1, "among postmenopausal": 2, "postmenopausal women": 2, "followed up": 8, "date of": 2, "hospitalization through": 1, "last participant": 2, "participant contact": 2, "contact before": 1, "calculated from": 1, "frequency questionnaires": 2, "models adjusted": 2, "health behaviors": 2, "calculate hazard": 2, "hospitalization died": 2, "across quartiles": 4, "quartiles of": 2, "diet score": 6, "p trend=0.08": 2, "p trend=0.01": 2, "score components": 2, "whole grain": 2, "grain intake": 2, "inversely associated": 2, "higher dash": 2, "modestly lower": 2, "lower mortality": 6, "nonsignificant trend": 2, "trend toward": 8, "inverse association": 2, "data provide": 2, "provide support": 2, "support for": 2, "recommendations developed": 2, "cardiovascular conditions": 2, "general populations": 2, "also be": 1, "term outcomes": 10, "cardioprotective signaling": 2, "signaling in": 2, "identified as": 1, "potentially promising": 2, "promising biomarker": 2, "biomarker in": 1, "term clinical": 2, "randomized study": 2, "study of": 3, "randomized 2331": 4, "subset of": 3, "evaluable plasma": 2, "plasma samples": 4, "relationship among": 2, "median baseline": 2, "modestly associated": 4, "measures of": 4, "in univariable": 2, "univariable analysis": 2, "significantly associated": 10, "log2 ng": 2, "in multivariable": 2, "multivariable models": 2, "outcomes after": 3, "adjustment for": 8, "add significantly": 2, "reclassification of": 2, "risk as": 1, "c statistic": 2, "treated cohort": 2, "significantly affect": 2, "affect reclassification": 2, "year experience": 2, "experience with": 3, "extended criteria": 4, "criteria cardiac": 10, "cardiac transplant": 12, "programs expand": 2, "transplant pool": 2, "pool by": 1, "matching donors": 2, "recipients typically": 2, "typically excluded": 2, "excluded from": 2, "transplant process": 2, "paucity of": 1, "data examining": 2, "examining long": 2, "outcomes with": 1, "undergoing isolated": 2, "heart transplant": 6, "prospectively classified": 2, "classified as": 2, "prespecified criteria": 2, "baseline characteristics": 10, "compared between": 2, "standard criteria": 6, "transplant recipients": 4, "identify clinical": 2, "variables contributing": 2, "contributing to": 2, "survival between": 1, "additional risk": 2, "assignment to": 1, "underwent heart": 2, "underwent standard": 2, "years versus": 2, "higher frequency": 2, "chronic kidney": 4, "kidney disease": 4, "median estimated": 2, "after adjustment": 8, "transplant survival": 2, "multivariate model": 2, "included listing": 2, "listing criteria": 2, "significant predictor": 2, "- transplant": 4, "transplant mortality": 2, "acceptable alternative": 2, "failure therapy": 2, "select patients": 2, "important determinants": 2, "determinants of": 1, "transplant morbidity": 2, "visits as": 1, "part of": 4, "failure readmission": 2, "readmission quality": 2, "improvement initiative": 8, "study objectives": 2, "day follow": 14, "day readmissions": 2, "readmissions as": 1, "hospital quality": 4, "characterize events": 2, "events at": 2, "some data": 2, "outpatient assessments": 2, "assessments of": 1, "failure within": 2, "days of": 5, "prevent readmissions": 2, "patient needs": 2, "needs at": 1, "retrospective chart": 2, "chart review": 6, "review of": 4, "failure discharges": 2, "discharges at": 1, "year before": 2, "year after": 2, "included mandatory": 2, "readmission rate": 10, "rate after": 1, "average age": 4, "years in": 1, "% having": 1, "cause readmissions": 4, "readmissions decreased": 2, "decreased from": 2, "% after": 1, "visits increased": 2, "increased from": 4, "day visits": 2, "visits occurred": 2, "failure nurse": 2, "nurse practitioner": 2, "blood work": 2, "work drawn": 2, "medication dose": 2, "dose changed": 2, "discrepancy between": 1, "medication lists": 2, "rate for": 3, "failure decreased": 2, "parallel with": 3, "often had": 1, "diagnostic testing": 2, "medication changes": 2, "changes at": 1, "cardiac magnetic": 12, "magnetic resonance": 20, "resonance postcontrast": 4, "the underlying": 2, "underlying pathophysiology": 2, "incompletely understood": 2, "myocardial extracellular": 4, "extracellular matrix": 8, "matrix accumulation": 2, "major role": 4, "estimate myocardial": 2, "matrix using": 2, "using cardiac": 2, "resonance t1": 4, "t1 mapping": 6, "observational study": 4, "confirmatory diagnostic": 2, "diagnostic tests": 2, "resonance imaging": 6, "imaging including": 2, "including t1": 2, "invasive hemodynamic": 4, "hemodynamic assessments": 2, "performed at": 2, "longitudinal outcome": 2, "monitoring phase": 2, "cardiac event": 2, "t1 time": 2, "pulmonary vascular": 4, "cardiac events": 4, "times below": 1, "greater risk": 4, "rest of": 1, "matrix of": 1, "ventricular biopsies": 2, "quantified by": 1, "tissuefaxs technology": 2, "technology correlated": 2, "time also": 2, "also correlated": 2, "present preliminary": 2, "preliminary study": 2, "possible biomarker": 2, "biomarker for": 1, "heart magnetic": 4, "imaging on": 2, "chelation choices": 4, "compliance with": 2, "thalassaemia major": 2, "patient compliance": 4, "compliance in": 1, "institution cohort": 2, "cohort as": 1, "abnormal cardiac": 2, "cardiac t2": 2, "values determined": 2, "determined changes": 2, "highly predictive": 2, "year for": 1, "the choice": 2, "choice of": 1, "chelation regimens": 2, "regimens known": 2, "remove heart": 2, "heart iron": 2, "iron efficiently": 2, "treatment had": 1, "remarkable role": 2, "clinical response": 2, "response to": 4, "mild heart": 4, "current guidelines": 4, "guidelines recommend": 2, "recommend cardiac": 2, "\u226430 %": 2, "less severe": 4, "results of": 2, "determined by": 1, "blinded core": 2, "core laboratory": 2, "% subgroup": 4, "trend for": 1, "clinical composite": 4, "composite response": 4, "response with": 1, "end systolic": 2, "\u00b1 21.1": 2, "\u00b1 17.6": 2, "\u00b1 50.5": 2, "\u00b1 42.4": 2, "the time": 2, "first hf": 6, "significantly prolonged": 2, "prolonged with": 1, "remodeling parameters": 2, "important covariates": 2, "improved time": 2, "interaction with": 2, "among subjects": 2, "mild hf": 2, "produced reverse": 2, "similar clinical": 2, "clinical benefit": 6, "benefit compared": 2, "myocardial titin": 2, "titin hypophosphorylation": 4, "hypophosphorylation importantly": 4, "importantly contributes": 2, "fraction in": 2, "rat metabolic": 2, "metabolic risk": 4, "risk model": 2, "important metabolic": 2, "frequent comorbidities": 2, "comorbidities in": 1, "myocardial diastolic": 2, "collagen deposition": 4, "titin modification": 4, "relative importance": 2, "importance for": 1, "myocardial dd": 6, "dd of": 1, "investigated in": 2, "diabetic zsf1": 2, "rats after": 1, "fraction development": 2, "development at": 1, "groups of": 2, "lean zsf1": 4, "obese zsf1": 8, "fat diet": 2, "weeks with": 1, "repeat metabolic": 2, "echocardiographic evaluations": 2, "hemodynamically assessed": 2, "assessed at": 1, "myocardial collagen": 6, "collagen cross": 2, "- linking": 2, "titin isoforms": 2, "also determined": 2, "resting tension": 2, "fpassive)-sarcomere length": 2, "length relations": 2, "obtained in": 1, "small muscle": 2, "muscle strips": 2, "strips before": 1, "unanchors titin": 2, "allows contributions": 2, "contributions of": 3, "matrix to": 1, "groups were": 1, "increased lung": 2, "ventricular dd": 2, "underlying myocardial": 4, "high muscle": 2, "muscle strip": 2, "strip stiffness": 2, "latter occurred": 2, "occurred specifically": 2, "site of": 2, "elastic n2bus": 2, "n2bus segment": 2, "rats developed": 2, "fraction during": 1, "week time": 2, "time span": 2, "importantly contributed": 2, "contributed to": 2, "global left": 4, "ventricular longitudinal": 4, "longitudinal systolic": 4, "systolic strain": 4, "strain as": 1, "major predictor": 2, "sensitive measure": 2, "ventricular mechanics": 2, "relationship with": 1, "adverse cardiovascular": 2, "predicting cv": 2, "cv events": 12, "cohort study": 18, "cardiology in": 1, "university hospital": 2, "persistent af": 4, "patients referred": 2, "referred for": 2, "echocardiographic examination": 2, "the risk": 16, "index beat": 2, "beat method": 2, "method for": 1, "hazards analyses": 2, "- fatal": 4, "fatal stroke": 4, "hospitalisation for": 1, "failure during": 1, "average follow": 2, "\u00b1 10": 2, "showed worsening": 2, "in direct": 2, "direct comparison": 2, "outperformed left": 2, "systolic mitral": 2, "predicting adverse": 4, "adverse cv": 6, "p \u2264": 2, "\u2264 0.043": 2, "model containing": 2, "containing chronic": 2, "age \u2265": 2, "prior stroke": 2, "stroke score": 2, "additional benefit": 2, "benefit in": 1, "major parameter": 2, "additional prognostic": 2, "prognostic benefit": 2, "benefit over": 1, "conventional clinical": 2, "echocardiographic systolic": 2, "systolic parameters": 2, "parameters in": 2, "duration on": 2, "results from": 3, "the impact": 4, "usually assessed": 2, "assessed separately": 2, "the interaction": 2, "interaction between": 4, "simple ecg": 2, "systematically assessed": 2, "assessed in": 4, "scale clinical": 2, "cardioverter defibrillator": 8, "significant reduction": 4, "previous pacemaker": 2, "all baseline": 2, "baseline ecgs": 2, "reviewed by": 1, "panel of": 2, "experienced electrocardiographers": 2, "receiving implantable": 2, "individual component": 2, "continuous relationship": 4, "extent of": 4, "- lbbb": 2, "ratio for": 2, "broader qrs": 2, "greater benefit": 2, "duration is": 1, "delayed benefit": 2, "benefit when": 1, "needs further": 1, "reduced hospitalizations": 4, "refractory congestive": 2, "peritoneal dialysis": 4, "consecutive case": 4, "case series": 4, "term management": 2, "diuretic resistant": 2, "resistant volume": 2, "overload in": 1, "provide potential": 2, "potential benefit": 4, "benefit with": 1, "adverse consequences": 2, "clinical status": 6, "status hospitalizations": 2, "complications of": 1, "severe end": 2, "series of": 2, "transplant ineligible": 2, "volume management": 2, "management between": 1, "evaluated with": 1, "data reviewed": 2, "reviewed pre-": 2, "- pd": 4, "pd initiation": 2, "\u00b1 6.0": 2, "% with": 2, "majority of": 4, "severe right": 2, "average weight": 2, "weight loss": 8, "diuretic response": 2, "peripheral edema": 2, "significant decrease": 4, "- hospitalization": 2, "hospitalization from": 1, "average of": 3, "\u00b1 2.5": 2, "admissions per": 2, "per patient": 10, "reduced average": 2, "average length": 2, "length of": 8, "stay from": 1, "\u00b1 36.7": 2, "\u00b1 2.3": 2, "objective criteriabased": 2, "criteriabased institution": 2, "institution of": 1, "diuretic refractory": 2, "refractory severe": 2, "well tolerated": 2, "demonstrated favorable": 2, "favorable outcomes": 2, "included improved": 2, "easily treatable": 2, "treatable pdrelated": 2, "pdrelated complications": 2, "viable option": 2, "option in": 1, "stage congestive": 2, "consequences of": 1, "dependent patients": 8, "often deferred": 2, "deferred in": 1, "perceived lack": 2, "potentially higher": 2, "higher risks": 2, "therefore studied": 2, "descriptive assessment": 2, "control analysis": 4, "analysis matching": 2, "matching for": 1, "branch morphology": 2, "cardiomyopathy origin": 2, "enzyme inhibitor": 6, "angiotensin ii": 2, "blocker use": 2, "month echocardiograms": 2, "term complications": 2, "observed among": 2, "among dialysis": 2, "dialysis patients": 10, "heterogenous improvement": 2, "+3.1 \u00b1": 2, "\u00b1 9.2": 2, "patients derived": 2, "derived absolute": 2, "absolute improvements": 2, "improvements of": 1, "patients demonstrated": 4, "following 3": 2, "controls demonstrated": 2, "demonstrated superior": 2, "superior reverse": 2, "+9.2 \u00b1": 2, "\u00b1 9.5": 2, "cause hospitalizations": 4, "serious complications": 2, "certain dialysis": 2, "demonstrated compelling": 2, "compelling improvement": 2, "improvement after": 1, "matched controls": 6, "worsened echocardiographic": 2, "echocardiographic outcomes": 2, "sodium dash": 2, "diet improves": 2, "improves diastolic": 2, "coupling in": 3, "involves failure": 2, "cardiovascular reserve": 2, "reserve in": 3, "multiple domains": 2, "animal models": 4, "dietary sodium": 2, "sodium restriction": 2, "restriction improves": 2, "improves ventricular": 2, "vascular stiffness": 2, "restricted dietary": 2, "dietary approaches": 2, "stop hypertension": 2, "hypertension diet": 2, "improve left": 2, "ventricular diastolic": 10, "hypertensive hfpef": 4, "treated hypertension": 2, "target sodium": 2, "mmol/2100 kcal": 2, "measured baseline": 2, "- dash": 2, "central blood": 2, "via radial": 2, "radial arterial": 2, "cardiovascular function": 4, "function with": 1, "echocardiographic measures": 6, "invasively validated": 2, "quantified via": 2, "parametrized diastolic": 2, "diastolic filling": 4, "filling formalism": 2, "yields relaxation": 2, "constants through": 1, "mitral inflow": 2, "inflow velocity": 2, "e -": 4, "- wave": 4, "ratio ees": 2, "determined using": 2, "using previously": 2, "previously published": 2, "published techniques": 2, "pairs signed": 2, "rank tests": 2, "- post": 2, "post comparisons": 2, "the dash": 2, "reduced clinic": 2, "hour brachial": 2, "brachial systolic": 2, "\u00b1 35": 2, "\u00b1 30": 2, "\u00b1 16": 4, "\u00b1 18": 4, "central end": 2, "pressure trended": 2, "trended lower": 2, "in conjunction": 2, "function improved": 2, "\u00b1 8.1": 2, "\u00b1 37": 2, "\u00b1 0.4": 6, "coupling improved": 2, "restricted dash": 2, "favorable changes": 2, "human resistin": 8, "resistin in": 2, "induced heart": 14, "humanized male": 2, "women treated": 2, "treated for": 1, "circulating mediator": 2, "mediator of": 1, "resistance mainly": 2, "mainly expressed": 2, "human monocytes": 2, "inflammatory stimuli": 2, "recent clinical": 2, "connected elevated": 2, "elevated resistin": 4, "resistin levels": 10, "severity of": 1, "humanized mouse": 2, "model lacking": 2, "lacking murine": 2, "murine resistin": 2, "transgenic for": 1, "human retn": 2, "exhibits basal": 2, "stimulated resistin": 2, "levels similar": 2, "explored whether": 4, "resistin underlies": 2, "underlies acute": 2, "acute anthracycline": 2, "induced cardiotoxicity": 6, "kg ip": 2, "fold induction": 2, "serum resistin": 4, "littermate controls": 2, "expressing human": 2, "showed increased": 4, "cardiac mrna": 2, "mrna levels": 6, "cell adhesion": 2, "adhesion genes": 2, "genes compared": 2, "mice treated": 2, "doxorubicin in": 2, "showed dramatic": 2, "dramatic induction": 2, "also examined": 2, "examined resistin": 2, "treated breast": 2, "without cardiotoxicity": 2, "women undergoing": 2, "undergoing anthracycline": 2, "containing chemotherapy": 2, "chemotherapy increased": 2, "increased significantly": 8, "remained elevated": 6, "months in": 1, "subsequent cardiotoxicity": 2, "elevation in": 1, "resistin correlated": 2, "results suggest": 8, "biomarker of": 1, "contribute in": 1, "direct effects": 2, "results further": 1, "implicate resistin": 2, "resistin as": 1, "link between": 2, "catheter ablation": 10, "ablation of": 1, "fibrillation in": 1, "ablation for": 2, "precipitating factor": 2, "factor for": 4, "deterioration of": 1, "free probability": 2, "probability after": 1, "factors relating": 2, "relating to": 1, "maintenance of": 3, "sinus rhythm": 12, "strain rate": 6, "month follow": 4, "procedure drug": 2, "free success": 2, "success rates": 2, "multiple procedures": 2, "pharmaceutically assisted": 2, "assisted success": 2, "success rate": 2, "major complications": 10, "complications occurred": 4, "occurred during": 2, "analyses revealed": 2, "standing persistent": 2, "lv systolic": 2, "systolic indices": 2, "diastolic indices": 2, "diastole with": 1, "improved only": 1, "patients maintaining": 2, "maintaining sinus": 2, "rhythm at": 1, "safely treated": 2, "composite of": 3, "repeat procedures": 2, "pharmaceuticals in": 1, "current study": 2, "arm analysis": 2, "larger randomized": 2, "randomized control": 2, "control studies": 2, "ablation in": 1, "ameliorates mitochondrial": 2, "mitochondrial dysfunction": 6, "dysfunction in": 4, "possible mechanism": 2, "known cardiotoxicity": 2, "effective anti": 2, "anti -": 6, "- neoplastic": 2, "neoplastic agent": 2, "agent in": 1, "several cancers": 4, "cardioprotective effect": 2, "investigated on": 1, "hemodynamic alterations": 2, "dysfunction induced": 2, "cumulative administration": 2, "administration of": 4, "cumulative dose": 2, "given orally": 2, "without doxorubicin": 2, "doxorubicin treatment": 2, "aortic blood": 4, "recorded 24": 2, "h after": 1, "last dose": 2, "rapidly excised": 2, "excised for": 1, "estimation of": 1, "adenine nucleotides": 4, "nucleotides contents": 4, "contents in": 1, "cytochrome c": 2, "caspase 3": 2, "mitochondrial oxidative": 8, "oxidative phosphorylation": 4, "phosphorylation capacity": 4, "creatine kinase": 4, "kinase activity": 4, "stress markers": 2, "measured together": 2, "examination of": 2, "ultrastructural changes": 6, "decrement of": 1, "state of": 2, "stress induced": 2, "doxorubicin cardiotoxicity": 2, "also preserved": 2, "preserved phosphocreatine": 2, "contents by": 1, "restoring mitochondrial": 2, "significant cardioprotection": 2, "cardioprotection via": 2, "via inhibition": 2, "apoptotic signaling": 2, "mitochondrial ultrastructural": 2, "interfere with": 1, "cytotoxic effect": 2, "doxorubicin against": 1, "growth of": 1, "solid ehrlich": 2, "ehrlich carcinoma": 2, "rats as": 1, "indicated by": 2, "hemodynamic perturbations": 2, "changes without": 2, "antitumor activity": 2, "relation between": 1, "preoperative renal": 4, "isolated coronary": 2, "bypass grafting": 4, "infarction after": 1, "early risk": 2, "swedish web": 2, "system for": 1, "based care": 2, "disease evaluated": 2, "evaluated according": 2, "underwent primary": 2, "primary isolated": 4, "isolated cabg": 4, "cabg from": 1, "rehospitalization for": 1, "failure \u226490": 2, "\u226490 days": 2, "days after": 3, "logistic regression": 6, "death from": 2, "developed acute": 2, "injury postoperatively": 2, "ratios with": 1, "intervals for": 1, "events after": 1, "stroke was": 1, "became nonsignificant": 2, "introduced into": 1, "statistical model": 2, "significantly increased": 4, "ratio 1.76": 2, "interval 1.38": 2, "events during": 1, "postoperative months": 2, "enormous clinical": 2, "clinical burden": 2, "burden in": 1, "adult medicine": 2, "atheromatous coronary": 2, "coronary disease": 4, "in children": 2, "leading cause": 6, "important disease": 2, "paediatric cardiac": 2, "cardiac transplants": 2, "transplants in": 1, "cardiac symptoms": 2, "result of": 3, "congenital lesions": 2, "septal defects": 2, "expand on": 1, "congenital heart": 2, "heart lesions": 2, "small subgroup": 2, "subgroup of": 1, "diastolic failure": 2, "failure from": 2, "cardiomyopathic restriction": 2, "the remaining": 2, "remaining patients": 2, "principally related": 2, "poor myocardial": 2, "largely comprise": 2, "dilated poorly": 2, "poorly contracting": 2, "contracting ventricles": 2, "specific aetiologies": 2, "aetiologies in": 1, "particular topics": 2, "topics of": 1, "debate in": 1, "paediatric heart": 2, "failure concern": 2, "versus dilated": 2, "appropriate investigations": 2, "investigations for": 1, "new onset": 2, "onset heart": 4, "cellular responses": 2, "responses to": 1, "increasing population": 2, "population of": 2, "anthracycline treated": 2, "treated survivors": 2, "survivors of": 2, "childhood malignant": 2, "malignant disease": 2, "treatment strategies": 10, "key role": 2, "molecular scaffolds": 2, "scaffolds in": 1, "heart pathology": 2, "the ability": 2, "detect mechanical": 2, "humoral stimuli": 2, "adaptation of": 1, "myocardium in": 1, "new conditions": 2, "increased workload": 2, "workload during": 1, "certain stimuli": 2, "stimuli mediate": 2, "beneficial adaptation": 2, "adaptation to": 1, "stress conditions": 2, "others result": 2, "maladaptive remodelling": 4, "ultimately leading": 2, "specific signalling": 2, "signalling pathways": 2, "pathways activating": 2, "maladaptive cardiac": 4, "cardiac remodelling": 4, "transduction pathways": 2, "pathways involved": 2, "opposing responses": 2, "responses engage": 2, "signalling proteins": 2, "notable example": 2, "erk1/2 signalling": 4, "signalling pathway": 2, "signalling requires": 2, "signalosome complex": 2, "complex where": 1, "scaffold protein": 2, "protein drives": 2, "assembly of": 1, "kinases into": 1, "linear pathway": 2, "sequential phosphorylation": 2, "ultimately targeting": 2, "targeting specific": 2, "specific effector": 2, "effector molecules": 2, "different raf": 2, "erk1/2 scaffold": 2, "scaffold proteins": 2, "remodelling is": 1, "promising field": 2, "field of": 1, "investigation for": 1, "therapeutic strategies": 2, "strategies capable": 2, "selectively potentiating": 2, "adaptive response": 2, "cardiac amyloidosis": 2, "atypical case": 2, "the described": 2, "described report": 2, "report deals": 2, "deals with": 1, "hypertensive cardiomyiopathy": 2, "cardiomyiopathy based": 2, "inducible myocardial": 2, "ischemia with": 1, "normal coronary": 2, "coronary arteries": 2, "typical amyloidotic": 2, "amyloidotic pattern": 2, "final diagnosis": 2, "multiple myeloma": 2, "made at": 1, "osteomedullary biopsy": 2, "measuring frailty": 2, "frailty in": 1, "community perspective": 2, "biological phenotype": 14, "accumulation of": 1, "each method": 2, "method has": 1, "residents with": 1, "recruited from": 2, "frailty according": 2, "weak grip": 2, "physical exhaustion": 2, "low activity": 2, "unintentional weight": 2, "lb in": 1, "intermediate frailty": 2, "the deficit": 6, "deficit index": 12, "proportion of": 4, "deficits present": 2, "age 71": 2, "% male": 4, "% intermediate": 2, "intermediate frail": 2, "frail according": 2, "index ranged": 2, "patients categorized": 2, "phenotype had": 1, "death compared": 2, "unit increase": 2, "% increased": 2, "both measures": 2, "measures predicted": 2, "predicted death": 2, "death equally": 2, "phenotype equally": 2, "equally predict": 2, "predict mortality": 2, "routinely assessed": 2, "assessed clinically": 2, "ascertained from": 1, "medical records": 8, "feasible alternative": 2, "ascertain frailty": 2, "learning from": 1, "recent trials": 4, "future of": 2, "failure trials": 2, "last decade": 2, "disappointments in": 1, "large phase": 2, "phase 2": 2, "pharmacologic studies": 2, "therapeutics including": 2, "including calcium": 2, "sensitizing agents": 2, "antagonists of": 1, "pharmacologic management": 2, "management for": 1, "changed little": 2, "recent years": 6, "rates remain": 2, "remain higher": 2, "chronic hf": 12, "neutral results": 2, "many acute": 2, "recent studies": 6, "studies including": 2, "appropriate timing": 2, "patient enrollment": 2, "selecting appropriate": 2, "appropriate end": 2, "describe lessons": 2, "lessons learned": 2, "learned from": 1, "trials in": 1, "outline strategies": 2, "success in": 1, "future trials": 2, "peptides at": 1, "ambulatory setting": 2, "current status": 4, "future perspectives": 2, "the measurement": 2, "important tool": 2, "tool in": 1, "acute dyspnea": 2, "international guidelines": 2, "subsequent meta": 2, "mixed on": 1, "routine np": 2, "used also": 2, "guide treatment": 2, "assess risk": 2, "developing heart": 2, "receiving chemotherapy": 2, "like other": 1, "measured at": 1, "status of": 1, "measurement together": 2, "potential contribution": 2, "contribution of": 5, "nps to": 1, "clinical care": 4, "care delivery": 4, "delivery in": 1, "several poc": 2, "systems for": 1, "produce test": 2, "test results": 2, "results within": 2, "appear sufficiently": 2, "sufficiently sensitive": 2, "used routinely": 2, "diagnostic evaluations": 2, "care systems": 4, "community outpatient": 2, "testing of": 3, "time frame": 2, "frame of": 1, "patient consultation": 2, "consultation in": 1, "disposition of": 1, "risk patients": 6, "appropriately designed": 2, "designed clinical": 2, "potential benefits": 2, "also important": 2, "take full": 2, "full advantage": 2, "advantage of": 2, "faster turnaround": 2, "turnaround times": 2, "times provided": 2, "provided by": 1, "measuring heart": 2, "failure care": 2, "care by": 1, "operationalized hospital": 2, "care outcomes": 2, "outcomes through": 1, "publicly reported": 2, "reported 30": 2, "day risk": 4, "standardized mortality": 2, "associated penalties": 2, "penalties for": 1, "expected rates": 2, "motivate hospitals": 2, "provide patients": 2, "conditions such": 1, "expected future": 2, "future expansion": 2, "expansion to": 1, "inhibition halts": 2, "halts heart": 2, "modern society": 2, "consequence of": 3, "pathological remodelling": 2, "remodelling of": 1, "involves cardiac": 2, "robust predictor": 2, "subsequent hf": 2, "molecular level": 2, "chromatin hyperacetylation": 2, "reporting in": 1, "show that": 4, "family bromodomain": 2, "bromodomain proteins": 4, "family of": 2, "lysine reader": 2, "reader proteins": 2, "promising targets": 2, "prevention of": 1, "the remodelling": 2, "neuronal stressors": 2, "these activate": 2, "signal transduction": 6, "transduction cascade": 2, "converges on": 1, "defined set": 2, "pathological changes": 4, "cardiomyocytes occur": 2, "occur through": 1, "interplay between": 1, "epigenetic changes": 2, "histone acetyltransferases": 2, "histone deacetylases": 2, "implicated in": 2, "cardiac development": 2, "the group": 2, "group utilized": 2, "recently developed": 2, "developed first": 2, "class inhibitor": 2, "displaces bets": 2, "bets from": 1, "suppression of": 1, "downstream signalling": 2, "signalling to": 1, "bets in": 2, "vitro model": 2, "neurohormonally induced": 2, "authors showed": 2, "nanomolar doses": 2, "significantly blocked": 2, "blocked phenylephrine": 2, "mediated hypertrophy": 2, "hypertrophy of": 1, "pathological gene": 4, "gene induction": 2, "achieved through": 1, "containing protein": 2, "highly expressed": 2, "cardiac tissues": 2, "expression profiling": 2, "profiling of": 1, "cultured cardiomyocytes": 2, "cardiomyocytes in": 2, "drug abrogated": 2, "substantial subset": 2, "induced genes": 2, "in vivo": 4, "vivo experiments": 2, "experiments of": 1, "induced in": 1, "mice via": 2, "via phenylephrine": 2, "haemodynamic stress": 2, "surgical method": 2, "method of": 1, "transverse aortic": 6, "aortic constriction": 8, "protected against": 1, "several pathological": 2, "including cardiac": 2, "systemic blood": 2, "detailed transcriptional": 2, "transcriptional analysis": 2, "cardiac tissue": 2, "tissue from": 3, "vehicle revealed": 2, "inhibition suppresses": 2, "pathological cardiac": 2, "cardiac gene": 6, "expression programme": 2, "targets of": 1, "also found": 2, "human hf": 8, "further molecular": 2, "molecular analysis": 2, "bets play": 2, "crucial role": 2, "mediated signal": 2, "transduction to": 1, "- activating": 4, "activating transcription": 4, "factor networks": 2, "including nuclear": 2, "nuclear factor": 4, "factor of": 1, "activated t": 2, "t cells": 2, "promoting transcriptional": 2, "transcriptional pause": 2, "pause release": 2, "thereby re": 1, "pathological stress": 2, "study implicates": 2, "implicates epigenetic": 2, "epigenetic readers": 2, "readers in": 1, "cardiac biology": 2, "manipulation of": 1, "gene control": 2, "control via": 2, "targeting of": 1, "dependent signal": 2, "potentially abrogate": 2, "abrogate pathological": 2, "mapping mri": 2, "mri during": 1, "tidal respiration": 4, "respiration for": 1, "quantification of": 1, "myocardial t1": 4, "t1 in": 1, "swine with": 1, "breathing pulse": 2, "pulse sequence": 2, "quantify myocardial": 2, "t1 changes": 2, "swine model": 2, "implanted with": 1, "ventricularly paced": 2, "paced at": 1, "induce heart": 2, "scanned twice": 2, "t mri": 2, "mri scanner": 2, "mapping sequence": 2, "performed during": 1, "respiration before": 1, "minutes after": 1, "chelate contrast": 2, "contrast agent": 8, "mapping values": 4, "failure scans": 2, "the percentage": 2, "fibrosis of": 1, "failure myocardial": 2, "myocardial tissue": 4, "similar left": 2, "ventricular tissue": 2, "control animals": 4, "animals using": 2, "using trichrome": 2, "trichrome blue": 2, "blue histologic": 2, "histologic analysis": 2, "failure t1": 2, "values before": 1, "\u00b1 96": 2, "\u00b1 94": 2, "agent administration": 2, "\u00b1 180": 2, "\u00b1 171": 2, "the animals": 2, "animals with": 2, "failure also": 2, "also had": 1, "difference histologically": 2, "collagen compared": 2, "healthy control": 4, "the proposed": 2, "mapping technique": 2, "quantify diffuse": 2, "diffuse myocardial": 2, "myocardial changes": 2, "changes associated": 2, "failure without": 2, "without breath": 2, "changes appear": 2, "detected by": 1, "traditional myocardial": 2, "myocardial delayed": 2, "delayed enhancement": 2, "enhancement imaging": 2, "useful technique": 2, "technique for": 1, "detecting early": 2, "clinically significant": 6, "significant myocardial": 2, "myocardial fibrosis": 2, "prognostic relevance": 4, "relevance of": 1, "contractile reserve": 8, "severe pulmonary": 4, "new approach": 2, "assess exercise": 2, "induced pulmonary": 2, "artery systolic": 2, "increase by": 1, "means of": 3, "echocardiography as": 1, "possible measure": 2, "invasively diagnosed": 2, "diagnosed pulmonary": 2, "arterial hypertension": 6, "inoperable chronic": 2, "chronic thromboembolic": 2, "thromboembolic pulmonary": 2, "impaired right": 2, "ventricular pump": 2, "pump function": 2, "stable targeted": 2, "targeted pulmonary": 2, "hypertension medication": 2, "medication underwent": 2, "broad panel": 2, "noninvasive assessments": 2, "including stress": 2, "stress echocardiography": 2, "cardiopulmonary exercise": 18, "exercise testing": 12, "classified into": 1, "groups according": 2, "increase above": 1, "\u00b1 1.8": 4, "multivariate analyses": 4, "factors predicting": 2, "predicting survival": 2, "median exercise": 2, "low pasp": 4, "patients were": 1, "high pasp": 2, "significantly different": 4, "terms of": 2, "resting hemodynamics": 2, "significantly lower": 6, "minute walking": 2, "walking distance": 2, "peak o2": 6, "per kilogram": 6, "survival rates": 8, "model analysis": 2, "analysis adjusted": 2, "increase during": 1, "kilogram remained": 2, "remained independent": 2, "independent prognostic": 4, "prognostic markers": 2, "high clinical": 2, "hypertension patients": 4, "indicate right": 2, "useful tool": 2, "tool for": 3, "prognostic assessment": 2, "assessment in": 1, "contemporary use": 2, "devices in": 1, "cornerstone of": 1, "improves symptoms": 2, "most data": 2, "collected in": 1, "data in": 4, "preserved systolic": 2, "systolic function": 8, "interesting therapeutic": 2, "therapeutic concepts": 2, "therapeutic functions": 2, "diagnostic features": 2, "features such": 1, "early detection": 2, "detection of": 1, "fluid overload": 4, "alone diagnostic": 2, "diagnostic devices": 2, "disease complex": 2, "challenging therapeutics": 2, "common cause": 6, "cardiovascular hospitalization": 4, "significant portion": 2, "portion of": 1, "care budget": 2, "commoner among": 2, "among women": 2, "underlying hypertension": 2, "significant progress": 2, "achieved in": 1, "lifesaving drugs": 2, "drugs for": 3, "still poses": 2, "poses significant": 2, "significant challenges": 2, "unfolded protein": 4, "protein response": 4, "response regulates": 2, "regulates cardiac": 2, "cardiac sodium": 2, "sodium current": 2, "current in": 1, "systolic human": 2, "human heart": 6, "increases alternative": 2, "alternative mrna": 2, "mrna splicing": 4, "splicing of": 1, "type v": 2, "gated cardiac": 2, "cardiac na+": 4, "channel \u03b1": 2, "generating variants": 2, "variants encoding": 2, "encoding truncated": 2, "nonfunctional channels": 2, "trapped in": 1, "endoplasmic reticulum": 2, "tested whether": 4, "channels activate": 2, "electric remodeling": 2, "human ventricular": 2, "tissue samples": 2, "human induced": 2, "induced pluripotent": 2, "pluripotent stem": 2, "stem cell": 4, "derived cardiomyocytes": 2, "exposed to": 1, "known activators": 2, "activators of": 1, "abnormal scn5a": 2, "induced to": 1, "kinase r": 2, "like er": 2, "variants with": 1, "exogenous variants": 2, "variants induced": 2, "concomitant downregulation": 2, "downregulation of": 2, "perk activation": 2, "activation destabilized": 2, "transient receptor": 2, "receptor potential": 2, "potential cation": 2, "cation channel": 2, "channel m7": 2, "channel mrna": 6, "perk inhibition": 2, "inhibition prevented": 2, "kv4.3 mrna": 2, "levels resulting": 2, "resulting from": 1, "na+ channel": 4, "mrna splice": 4, "splice variants": 4, "initiated by": 1, "reduction of": 4, "effect is": 1, "entirely specific": 2, "important role": 6, "multiple cardiac": 2, "cardiac genes": 2, "genes in": 1, "normal cardiac": 2, "receives little": 2, "little attention": 2, "attention in": 2, "medical literature": 2, "etiologic causes": 2, "acute rv": 8, "failure often": 2, "often differ": 2, "differ from": 2, "encountered in": 1, "failure frequently": 2, "frequently requires": 2, "requires diagnostic": 2, "diagnostic procedures": 4, "management strategies": 4, "routinely used": 2, "intrinsic left": 2, "concentrating on": 1, "pathophysiologic mechanisms": 2, "mechanisms behind": 2, "distinct populations": 2, "populations of": 1, "chronic pulmonary": 2, "acute pulmonary": 2, "in chronic": 2, "chronic pah": 2, "examine clinical": 2, "clinical circumstances": 2, "circumstances common": 2, "provoke acute": 2, "pharmacologic therapies": 2, "failure management": 2, "management in": 1, "embolism represent": 2, "group with": 1, "particularly high": 2, "high mortality": 6, "specific diagnostic": 2, "contemporary trends": 2, "fraction after": 1, "community study": 2, "major changes": 2, "recently occurred": 2, "epidemiology of": 2, "possibly affect": 2, "affect outcomes": 2, "outcomes such": 2, "data describing": 2, "describing trends": 2, "distinguish between": 1, "evaluated temporal": 2, "temporal trends": 2, "all residents": 2, "residents of": 1, "diagnosed in": 1, "classified according": 2, "days to": 1, "patient presentation": 2, "including fewer": 2, "fewer st": 2, "elevation mis": 2, "lower killip": 2, "comorbid conditions": 2, "first week": 2, "adjusted risk": 2, "risk declined": 2, "ratios of": 2, "onset hf": 8, "further adjustment": 2, "characteristics yielded": 2, "yielded hazard": 2, "declines in": 3, "observed for": 1, "case mix": 2, "mix of": 1, "requires new": 2, "new prevention": 2, "prevention strategies": 2, "differential effects": 2, "versus selective": 2, "selective beta": 2, "blockers on": 3, "cardiac sympathetic": 6, "sympathetic activity": 10, "hemostasis in": 1, "nonselective \u03b2": 2, "selective \u03b2": 2, "blocker metoprolol": 2, "metoprolol in": 2, "assess whether": 4, "differential response": 4, "response in": 1, "activity by": 1, "imaging when": 1, "assessed whether": 2, "response correlates": 2, "correlates with": 2, "various serum": 2, "serum factors": 2, "serve as": 1, "markers for": 1, "label crossover": 2, "crossover study": 2, "study with": 1, "masked outcome": 2, "outcome assessments": 2, "stable heart": 4, "equipotent dosages": 2, "dosages of": 1, "metoprolol for": 1, "wk periods": 2, "activity as": 1, "myocardial washout": 2, "outcomes included": 4, "included markers": 2, "markers of": 2, "cardiac washout": 2, "washout was": 1, "metoprolol treatment": 2, "receptor haplotype": 6, "carvedilol resulted": 4, "lower von": 4, "\u00b1 13": 2, "greater reduction": 2, "activity after": 1, "wk of": 2, "factor concentrations": 2, "concentrations in": 1, "haplotype status": 2, "prescribing guideline": 2, "medications to": 1, "often contextual": 2, "contextual factors": 4, "factors such": 2, "patient preferences": 6, "competing priorities": 2, "priorities impact": 2, "impact prescribing": 2, "prescribing of": 1, "performance measurement": 2, "measurement systems": 2, "veterans aged": 2, "aged 50": 2, "health care": 10, "identified from": 2, "clinic notes": 2, "interviews with": 1, "primary care": 2, "care clinicians": 2, "clinicians caring": 2, "caring for": 1, "these reasons": 2, "classified using": 2, "published taxonomy": 2, "receiving guideline": 2, "recommended drugs": 2, "review identified": 2, "identified biomedical": 2, "biomedical reasons": 4, "nonprescribing in": 1, "contextual reasons": 10, "reasons in": 2, "clinician interviews": 2, "interviews identified": 2, "identified twice": 2, "many reasons": 2, "nonprescribing as": 1, "mean 1.6": 2, "reasons per": 2, "cited in": 1, "common contextual": 2, "clinician belief": 2, "indicated in": 1, "prescribing angiotensin": 2, "blockers are": 1, "thirds of": 1, "poorly documented": 2, "the structure": 2, "structure of": 2, "facilitate documentation": 2, "documentation of": 1, "providing guideline": 2, "recommended care": 2, "parasympathetic tone": 4, "tone by": 1, "pyridostigmine prevents": 2, "prevents ventricular": 2, "onset of": 5, "elevated sympathetic": 2, "reduced parasympathetic": 2, "parasympathetic control": 2, "control of": 2, "experimental evidence": 2, "evidence suggests": 4, "parasympathetic function": 2, "therapeutic alternative": 2, "parasympathetic neurotransmission": 2, "improved by": 1, "acetylcholinesterase inhibition": 2, "acetylcholinesterase inhibitor": 2, "inhibitor pyridostigmine": 2, "pyridostigmine on": 1, "sympathovagal balance": 4, "cardiac remodeling": 8, "following myocardial": 2, "elicited in": 1, "adult male": 2, "pyridostigmine administration": 2, "per os": 2, "cardiac sympathovagal": 2, "tachycardic response": 2, "response caused": 4, "vagal tone": 4, "bradycardic response": 2, "sympathetic tone": 12, "conscious hf": 2, "pyridostigmine reduced": 2, "basal heart": 2, "increased vagal": 2, "reduced sympathetic": 4, "sympathetic control": 2, "myocyte diameter": 2, "collagen density": 2, "density of": 1, "surviving left": 2, "also increased": 2, "increased vascular": 2, "factor protein": 2, "protein in": 1, "suggesting myocardial": 2, "myocardial angiogenesis": 2, "volume conductance": 2, "conductance catheter": 2, "catheter system": 2, "rats treated": 2, "pyridostigmine exhibited": 2, "higher stroke": 2, "contractility of": 1, "term administration": 2, "pyridostigmine started": 2, "started right": 2, "artery ligation": 2, "ligation augmented": 2, "augmented cardiac": 2, "cardiac vagal": 4, "attenuating cardiac": 2, "progression of": 3, "mechanistic insight": 2, "insight into": 3, "prolonged electromechanical": 2, "electromechanical delay": 4, "delay in": 1, "dyssynchronous heart": 4, "computational study": 2, "block type": 2, "electrical activation": 4, "remodeling aspects": 8, "aspects associated": 2, "electromechanical behavior": 2, "behavior of": 1, "altered ventricular": 2, "ventricular structure": 2, "sheet orientation": 2, "abnormal ca(2": 4, "slowed conduction": 2, "reduced wall": 2, "wall stiffness": 2, "in dyssynchronous": 2, "dyssynchronous hf": 8, "time interval": 2, "interval between": 1, "local myocyte": 2, "myocyte depolarization": 2, "myofiber shortening": 8, "shortening onset": 2, "major hf": 2, "aspects in": 1, "dyssynchronous failing": 2, "heart remain": 2, "remain unknown": 2, "the goal": 4, "goal of": 3, "combined contributions": 2, "induced remodeling": 2, "aspects to": 1, "used mri": 2, "based models": 2, "models of": 1, "dyssynchronous nonfailing": 2, "canine electromechanics": 2, "constructed additional": 2, "additional models": 2, "models in": 1, "varying combinations": 2, "combinations of": 1, "block electrical": 2, "activation sequence": 2, "simulated in": 1, "the simulation": 2, "simulation results": 2, "results revealed": 2, "primary culprit": 2, "culprit in": 1, "aspects of": 3, "remodeling contributing": 2, "contributing insignificantly": 2, "handling in": 1, "slows myofiber": 2, "shortening velocity": 2, "velocity at": 1, "activated septum": 2, "stretch rate": 2, "activated lateral": 2, "lateral wall": 2, "these changes": 2, "myofiber dynamics": 2, "dynamics delay": 2, "thus giving": 2, "giving rise": 2, "rise to": 1, "prolonged emd": 2, "relationships between": 2, "previous studies": 2, "studies investigating": 2, "related cachexia": 2, "function on": 1, "abnormal body": 2, "worsened prognosis": 2, "advanced hf": 4, "underwent prospective": 2, "prospective assessment": 2, "skinfold thickness": 2, "comprehensive echocardiography": 2, "blood testing": 2, "circulatory assist": 2, "lower body": 2, "lower fat": 4, "display cachexia": 2, "the extent": 2, "dysfunction correlated": 2, "greater antecedent": 2, "antecedent weight": 2, "lean body": 4, "mass ratio": 2, "increased body": 2, "lower event": 2, "hr per": 2, "mediated by": 1, "higher fat": 2, "cachexia often": 2, "often coexist": 2, "additive adverse": 2, "adverse impact": 2, "mechanistically interrelated": 2, "wasting of": 1, "lean mass": 6, "adverse outcome": 2, "suggesting that": 3, "fat loss": 2, "surrogate of": 1, "enhanced catabolism": 2, "channel inhibition": 4, "inhibition on": 1, "hemodynamic status": 4, "tolerance in": 1, "ivabradine on": 1, "exercise capacity": 24, "filling in": 1, "typically exertional": 2, "optimization of": 1, "filling time": 2, "time by": 1, "controlling heart": 2, "ivabradine 5": 2, "mg twice": 2, "twice daily": 2, "days in": 1, "blind trial": 2, "testing with": 1, "echocardiographic assessment": 2, "undertaken at": 1, "the ivabradine": 2, "group demonstrated": 2, "improvement between": 1, "mets vs.": 2, "\u00b1 1.9": 2, "peak oxygen": 20, "oxygen uptake": 12, "\u00b1 6.1": 2, "kg vs.": 2, "\u00b1 3.3": 2, "simultaneous reduction": 2, "induced increase": 2, "peak early": 12, "mitral flow": 6, "mitral annular": 8, "annular velocity": 8, "\u00b1 2.7": 2, "work load": 2, "corrected chronotropic": 2, "chronotropic response": 2, "exercise time": 8, "time at": 2, "slower increase": 2, "rate during": 1, "treated group": 2, "change with": 1, "exertional increase": 2, "independent correlates": 2, "correlates of": 1, "independently correlated": 2, "term treatment": 2, "ivabradine increased": 2, "increased exercise": 2, "contribution from": 1, "improved left": 2, "pressure response": 2, "exercise as": 1, "reflected by": 1, "therapeutic treatments": 2, "treatments targeting": 2, "targeting abnormal": 2, "abnormal exercise": 2, "exercise hemodynamic": 2, "prove useful": 2, "simple validated": 2, "validated clinical": 2, "clinical tool": 4, "unclear etiology": 6, "treatment implications": 2, "undergo coronary": 2, "clinical prediction": 4, "prediction rule": 12, "a derivation": 2, "derivation cohort": 4, "formed of": 1, "undergone coronary": 2, "angiography with": 1, "primary diagnosis": 2, "using multivariate": 2, "multivariate logistic": 4, "rule for": 1, "severe cad": 10, "% diameter": 2, "diameter stenosis": 2, "stenosis in": 1, "left main": 2, "descending artery": 2, "defined prediction": 2, "prospectively validated": 2, "validated in": 1, "separate cohort": 2, "cohort recruited": 2, "including 15": 2, "included diabetes": 2, "ratio 5.1": 2, "electrocardiographic q": 2, "q waves": 2, "ratio 3.8": 2, "nondiabetes risk": 2, "tobacco use": 2, "ratio 4.8": 2, "a prediction": 2, "rule of": 1, "predictor identified": 2, "identified 97": 2, "prospective validation": 2, "validation cohort": 2, "rule had": 1, "sensitivity for": 1, "simple clinical": 2, "accurately identify": 2, "need for": 3, "angiography in": 1, "substantial proportion": 2, "potentially significant": 2, "significant cost": 2, "cost savings": 2, "risk avoidance": 2, "experience of": 1, "unique indication": 2, "indication in": 1, "japanese heart": 2, "vasopressin type": 2, "indicated for": 1, "severe hyponatremia": 2, "hyponatremia in": 1, "indication is": 1, "optimal diuretic": 2, "serum sodium": 2, "sodium levels": 2, "newly introduced": 2, "introduced drug": 2, "experience in": 1, "diuretic use": 4, "use in": 2, "frequently administered": 2, "relieve congestive": 2, "congestive symptoms": 2, "widespread use": 2, "prospective data": 2, "potential of": 3, "related morbidity": 2, "diuretic efficacy": 2, "adverse neurohormonal": 2, "neurohormonal activation": 2, "occur in": 5, "current knowledge": 4, "knowledge on": 1, "risk patient": 2, "treatment options": 2, "an estimated": 2, "estimated 5.1": 2, "aged 20": 4, "older have": 1, "heart failure.(1": 2, "with therapies": 2, "therapies ranging": 2, "physical therapy": 2, "therapy to": 1, "implantable defibrillators": 2, "possibly transplantation": 2, "accurate risk": 2, "stratification of": 3, "delivery of": 1, "therapies appropriate": 2, "disease severity": 2, "becoming increasingly": 2, "increasingly important": 2, "associated treatment": 2, "subject of": 1, "brief review": 2, "regulated in": 2, "human failing": 2, "blunts beta": 2, "adrenergic responses": 2, "responses in": 1, "study investigated": 2, "investigated whether": 2, "myocardial phosphodiesterase-2": 2, "altered in": 1, "mediated effects": 2, "diseased cardiomyocytes": 4, "diminished cyclic": 2, "cyclic adenosine": 2, "adenosine monophosphate": 2, "augmented cyclic": 2, "cyclic guanosine": 2, "guanosine monophosphate": 2, "unique property": 2, "property of": 1, "stimulated by": 1, "thus leading": 2, "remarkable increase": 2, "camp hydrolysis": 2, "hydrolysis mediating": 2, "negative cross": 2, "cross talk": 4, "camp signaling": 2, "poorly understood": 4, "fluorescence resonance": 2, "resonance energy": 2, "energy transfer": 2, "based assays": 2, "video edge": 2, "edge detection": 2, "epifluorescence microscopy": 2, "current measurements": 2, "myocardial tissues": 2, "cardiomyocytes from": 1, "experimental hf": 2, "fold higher": 2, "advanced human": 2, "chronic \u03b2": 4, "stimulation via": 2, "via catecholamine": 2, "catecholamine infusions": 2, "infusions in": 1, "rats enhanced": 2, "camp hydrolytic": 2, "hydrolytic activity": 2, "blunted cardiac": 2, "cardiac \u03b2": 2, "- ar": 8, "in diseased": 2, "higher pde2": 2, "enhanced by": 1, "cgmp synthesis": 2, "synthesis via": 2, "via nitric": 2, "oxide donors": 2, "specific pde2": 2, "inhibition partially": 2, "partially restored": 2, "restored \u03b2": 2, "overexpression in": 2, "healthy cardiomyocytes": 2, "cardiomyocytes reduced": 2, "camp levels": 2, "current amplitude": 2, "effect following": 2, "following acute": 2, "acute \u03b2": 6, "affecting basal": 2, "basal contractility": 2, "overexpressing cardiomyocytes": 2, "cardiomyocytes showed": 2, "showed marked": 2, "marked protection": 2, "protection from": 1, "induced hypertrophic": 2, "hypertrophic responses": 2, "desensitizes against": 1, "important defense": 2, "defense mechanism": 2, "mechanism during": 1, "cardiac stress": 2, "antagonizing excessive": 2, "excessive \u03b2": 2, "activating myocardial": 2, "myocardial pde2": 2, "novel intracellular": 2, "intracellular antiadrenergic": 2, "antiadrenergic therapeutic": 2, "therapeutic strategy": 4, "strategy in": 1, "eplerenone in": 3, "high risk": 10, "worsening renal": 4, "analyses of": 2, "study subgroups": 2, "mild patients": 2, "enrolled patients": 2, "potassium <": 4, "receiving optimal": 2, "optimal therapy": 4, "cardiovascular reason": 2, "reason within": 2, "underuse of": 1, "fear of": 1, "inducing hyperkalemia": 2, "- specified": 4, "specified analysis": 2, "subgroups of": 2, "patients \u2265": 2, "pressure <": 2, "< median": 2, "major safety": 2, "safety measures": 2, "hyperkalemia leading": 2, "drug discontinuation": 2, "risk subgroups": 2, "potassium >": 4, "discontinuation of": 1, "study medication": 2, "medication due": 2, "primary composite": 2, "composite endpoint": 2, "endpoint in": 1, "meeting specific": 2, "specific inclusion": 2, "exclusion criteria": 4, "safe when": 1, "carefully monitored": 2, "subgroups at": 1, "developing hyperkalemia": 2, "a comparison": 2, "when treated": 2, "status in": 2, "prevalence ranging": 2, "risk factor": 6, "significant gaps": 2, "gaps in": 1, "induced changes": 2, "hrqol in": 1, "measured using": 2, "treatment group": 4, "group effects": 2, "estimated using": 2, "using linear": 2, "linear mixed": 2, "mixed models": 2, "models according": 2, "treat principle": 2, "baseline kccq": 2, "training on": 5, "significantly correlated": 2, "baseline hrqol.": 2, "subscales relative": 2, "action cohort": 2, "correlation with": 1, "baseline hrqol": 2, "hrqol as": 1, "hrqol from": 1, "cost analysis": 2, "control vs.": 2, "vs. rate": 2, "control strategies": 4, "similar efficacy": 2, "efficacy outcomes": 2, "economic impact": 2, "strategies in": 2, "province of": 2, "substudy of": 1, "care expenditures": 2, "expenditures of": 1, "control treatment": 2, "compared from": 1, "payer perspective": 2, "perspective using": 2, "minimization approach": 2, "trial resource": 2, "resource utilization": 2, "unit costs": 2, "estimated from": 1, "databases supplemented": 2, "specific costs": 2, "costs from": 1, "\u00b1 9": 2, "n =": 2, "= 149": 2, "related costs": 2, "costs accounted": 2, "accounted for": 1, "total expenditures": 2, "control patients": 2, "fewer cardiac": 2, "cardiac procedures": 2, "driven by": 1, "fewer cardioversions": 2, "lower costs": 2, "costs related": 2, "antiarrhythmic drugs": 6, "offset by": 2, "higher expenditures": 2, "expenditures due": 2, "hospitalizations for": 2, "noncardiovascular diagnoses": 2, "cardiac arrhythmia": 2, "arrhythmia devices": 2, "noncardiovascular drugs": 2, "drugs in": 1, "total cost": 2, "cost per": 2, "strategy used": 2, "failure appears": 2, "little influence": 2, "influence on": 1, "overall financial": 2, "financial burden": 2, "remains substantial": 2, "perturbations in": 2, "skeletal muscle": 14, "muscle sarcomere": 2, "sarcomere structure": 2, "structure in": 1, "restorative effects": 2, "rich cocoa": 4, "detrimental alterations": 4, "demonstrated recently": 2, "improves skm": 2, "skm mitochondrial": 2, "mitochondrial structure": 4, "improved mitochondrial": 2, "reversal of": 3, "sarcomeric microstructure": 6, "pilot study": 6, "treadmill testing": 2, "maximum oxygen": 2, "skm biopsies": 2, "blot analysis": 2, "electron microscopy": 2, "report severe": 2, "severe perturbations": 2, "components of": 2, "associated protein": 2, "protein complex": 2, "microstructure at": 1, "induced recovery": 2, "- ordinated": 2, "ordinated fashion": 2, "skm growth": 2, "differentiation consistent": 2, "myofibre regeneration": 2, "~24 %": 2, "reach statistical": 2, "statistical significance": 2, "initial results": 2, "results warrant": 2, "warrant further": 1, "rigorous investigation": 2, "pure epicatechin": 2, "novel means": 2, "improving muscle": 2, "muscle function": 2, "chinese herbal": 4, "herbal medicine": 4, "medicine as": 1, "adjunctive treatment": 6, "cardiomyopathy in": 2, "studies on": 1, "biomedical treatment": 12, "versus biomedical": 2, "treatment alone": 6, "retrieved from": 1, "major databases": 2, "overall effects": 2, "effective rate": 6, "diastolic end": 4, "end diameter": 4, "most adverse": 2, "events observed": 2, "resolved without": 2, "without special": 2, "special treatment": 2, "analysis indicated": 4, "indicated that": 1, "term follow": 2, "systemic adverse": 2, "events evaluation": 2, "ethnic groups": 2, "still required": 2, "week follow": 4, "activity of": 1, "metabolic enzymes": 4, "enzymes in": 1, "healthy volunteers": 4, "aimed at": 2, "activating factor": 2, "enzymes over": 1, "period in": 1, "matched apparently": 2, "apparently healthy": 2, "key biosynthetic": 2, "biosynthetic enzymes": 4, "paf acetyltransferase": 2, "acetyltransferase [": 2, "glycerol cholinephosphotransferase": 2, "catabolic isoenzymes": 2, "associated phospholipase": 2, "leukocytes of": 1, "lower median": 2, "median activities": 2, "activities of": 2, "higher activities": 2, "at follow": 2, "levels marginally": 2, "marginally increased": 2, "remained downregulated": 2, "elevated compared": 2, "diagnosed patients": 2, "drug treatment": 2, "treatment have": 1, "affected profile": 2, "profile of": 1, "exercise intolerance": 6, "intolerance in": 1, "update on": 2, "exercise parameters": 2, "parameters for": 1, "therapeutic interventions": 4, "hallmark feature": 2, "feature of": 1, "this review": 10, "review provides": 4, "exercise variables": 6, "prognostically important": 2, "widely accepted": 2, "accepted peak": 2, "exercise oscillatory": 2, "oscillatory ventilation": 2, "partial pressure": 2, "pressure of": 2, "gain attention": 2, "interpretation of": 1, "pathophysiological origin": 4, "also discussed": 2, "different mechanisms": 2, "mechanisms underlie": 2, "variables with": 1, "important contribution": 2, "peripheral abnormalities": 2, "different pathophysiological": 2, "multivariate assessment": 2, "assessment with": 1, "inclusion of": 1, "aforementioned parameters": 2, "prognostic purposes": 2, "acute care": 12, "care surgery": 4, "surgery in": 1, "orthotopic heart": 2, "optimal treatment": 2, "institutional experience": 2, "experience between": 1, "procedures within": 2, "oht in": 1, "recipients bridged": 2, "bridged to": 2, "transplantation with": 1, "including intravenous": 2, "intravenous inotropes": 2, "required in": 1, "the interval": 2, "interval from": 2, "transplantation to": 1, "consultation to": 1, "operation was": 1, "require consultation": 2, "consultation for": 1, "abdominal problems": 4, "inflammatory abdominal": 2, "problems occurred": 2, "occurred after": 1, "per cent": 2, "cent with": 1, "deaths occurring": 2, "occurring within": 2, "in summary": 2, "largest series": 2, "problems in": 1, "undergoing oht": 2, "oht bridged": 2, "transplant with": 1, "with similar": 2, "similar incidence": 2, "incidence in": 1, "extracorporeal membrane": 8, "membrane oxygenation": 10, "oxygenation as": 1, "recovery in": 1, "refractory right": 2, "man with": 1, "cardiac arrest": 4, "arrest in": 2, "cardiopulmonary resuscitation": 2, "posterior wall": 4, "wall infarction": 2, "hospitalized in": 1, "cardiac centre": 2, "catheterization showed": 2, "thrombotic obstruction": 2, "obstruction of": 1, "right coronary": 2, "after percutaneous": 2, "coronary revascularization": 2, "hemodynamically stable": 2, "stable situation": 2, "intensive care": 2, "care unit": 2, "patient became": 2, "became again": 1, "hemodynamically unstable": 2, "therapy refractory": 2, "refractory cardiogenic": 4, "decided within": 2, "heart team": 4, "team for": 1, "extra corporeal": 2, "corporeal membrane": 2, "applied during": 1, "the extracorporeal": 2, "extracorporeal support": 2, "needed for": 1, "emergency cardiac": 2, "transferred to": 1, "intermediate care": 2, "extracorporeal life": 2, "life support": 2, "support is": 1, "feasible und": 2, "und effective": 2, "bridging therapy": 2, "acute ischemic": 2, "ischemic right": 2, "successful reperfusion": 2, "reperfusion therapy": 2, "half of": 2, "values observed": 2, "effective treatment": 4, "early research": 2, "research focused": 2, "multiple non": 2, "- diastolic": 2, "diastolic abnormalities": 2, "abnormalities in": 1, "function also": 2, "also contribute": 2, "frequently challenging": 2, "relies upon": 2, "careful clinical": 2, "clinical evaluation": 2, "invasive haemodynamic": 2, "haemodynamic assessment": 2, "principal mechanisms": 2, "diagnostic approaches": 2, "discussion of": 1, "novel treatment": 2, "hold promise": 2, "promise for": 1, "trends from": 1, "mortality outcomes": 2, "based study": 2, "first acute": 2, "infarction in": 1, "advances in": 2, "beneficial impact": 2, "deaths attributable": 2, "complicating ami": 4, "data are": 1, "western australian": 2, "linked administrative": 4, "administrative health": 2, "health data": 2, "identify 20": 2, "aged 40": 2, "ami between": 1, "temporal incidence": 2, "death associated": 2, "concurrent with": 1, "comprised 75": 2, "day case": 2, "fatality rate": 4, "concurrent hf": 4, "declined marginally": 2, "without concurrent": 2, "rate declined": 2, "day survivors": 4, "occurrence of": 2, "index ami": 2, "encouraging declines": 2, "common problem": 2, "problem with": 1, "increased attention": 2, "needed given": 2, "term prognosis": 2, "therapy during": 1, "exercise rehabilitation": 12, "rehabilitation in": 4, "male patients": 8, "low testosterone": 6, "testosterone status": 6, "blind randomized": 2, "controlled feasibility": 2, "feasibility study": 2, "feasibility of": 1, "week program": 2, "program of": 2, "without intramuscular": 2, "intramuscular testosterone": 2, "testosterone supplementation": 4, "collected preliminary": 2, "preliminary data": 2, "data for": 1, "key health": 4, "age 67.2": 2, "range 51": 2, "mean \u00b1": 2, "\u00b1 sd": 2, "sd testosterone": 2, "testosterone levels": 2, "\u00b1 2.6": 2, "randomly allocated": 2, "exercise with": 3, "placebo groups": 2, "intervention compliance": 2, "incremental shuttle": 2, "shuttle walk": 4, "muscular strength": 4, "inflammatory markers": 4, "living with": 4, "% compliance": 2, "injections in": 1, "similar improvements": 2, "the exercise": 6, "testosterone group": 2, "group showed": 2, "showed improvements": 2, "improvements from": 1, "baseline in": 1, "leg strength": 2, "several medical": 2, "form quality": 2, "life domains": 2, "mostly unchanged": 2, "shows for": 1, "first time": 2, "supplementation during": 1, "rehabilitation is": 1, "positively impact": 2, "range of": 1, "elderly male": 2, "functional electrical": 4, "electrical stimulation": 4, "peripheral muscles": 2, "muscles improves": 2, "improves endothelial": 2, "emotional status": 4, "improves exercise": 6, "emotional stress": 2, "impaired systolic": 2, "fraction 63": 2, "training protocol": 2, "included 6": 2, "minute walked": 4, "walked distance": 4, "rated depression": 2, "depression scores": 2, "dilatation diameter": 2, "group compared": 6, "peptide also": 2, "also declined": 2, "tendency toward": 2, "toward lower": 2, "lower mitral": 2, "mitral e": 2, "wave ratio": 2, "also improves": 2, "effective evidence": 2, "based therapies": 2, "therapies in": 1, "transforming growth": 4, "factor beta": 2, "dependent yield": 2, "functional decline": 2, "atrial explant": 2, "derived c": 4, "kit+ cells": 2, "cells isolated": 2, "cardiac explant": 4, "derived cells": 2, "cells modestly": 2, "modestly improve": 2, "improve cardiac": 4, "cardiac functions": 2, "functions after": 1, "full potential": 2, "for instance": 2, "potential candidates": 2, "candidates for": 1, "cell therapy": 2, "therapy suffer": 2, "suffer from": 1, "unclear how": 1, "disease affects": 2, "derived progenitor": 2, "explant c": 2, "kit+ progenitors": 2, "elucidate mechanisms": 2, "mechanisms of": 2, "created by": 1, "descending coronary": 2, "artery occlusion": 2, "operated animals": 2, "used as": 1, "developed infarcted": 2, "infarcted animals": 2, "selected on": 1, "ventricle end": 2, "pressure \u2265": 2, "scar size": 2, "size \u2265": 2, "atrial explants": 2, "explants produced": 2, "produced less": 2, "less c": 2, "sham explants": 2, "cells exhibited": 2, "exhibited upregulated": 2, "upregulated transforming": 2, "increased level": 2, "mesenchymal transition": 4, "transition markers": 4, "diminished expression": 2, "pluripotency markers": 2, "markers compared": 2, "intervention with": 2, "\u03b2 signaling": 2, "signaling by": 1, "\u03b2 receptor": 2, "receptor type": 2, "using small": 2, "molecule inhibitors": 2, "inhibitors improved": 2, "cell yield": 2, "attenuated epithelial": 2, "pluripotency marker": 2, "improved efficiency": 2, "efficiency of": 1, "cell differentiation": 2, "differentiation toward": 2, "toward cardiomyocyte": 2, "like cells": 2, "taken together": 2, "\u03b2 inhibition": 2, "inhibition positively": 2, "positively modulates": 2, "cell phenotype": 2, "considered in": 1, "optimizing cardiac": 2, "cardiac progenitor": 2, "progenitor function": 2, "cell expansion": 2, "expansion protocols": 2, "protocols for": 1, "clinical application": 4, "periodic breathing": 4, "breathing with": 1, "heart beat": 2, "a protocol": 2, "originally designed": 2, "study breathing": 2, "breathing control": 2, "control during": 1, "following cardiac": 2, "taking advantage": 2, "period of": 3, "pulseless ventricular": 2, "ventricular fibrillation": 2, "produced while": 1, "newly implanted": 2, "implanted cardioverter": 2, "defibrillator device": 4, "a patient": 2, "patient aged": 2, "aged in": 1, "60s with": 1, "class iii": 2, "originally part": 2, "study displayed": 2, "displayed permanent": 2, "permanent periodic": 2, "final data": 2, "data analysis": 2, "presented in": 1, "incidentally produced": 2, "produced during": 1, "ascending phase": 2, "phase of": 3, "pb cycle": 2, "recovery period": 2, "low bp": 2, "recovery had": 1, "pb characteristics": 2, "this occurred": 2, "occurred despite": 2, "profound change": 2, "cerebral blood": 2, "perfusion of": 1, "carotid bodies": 2, "concluded that": 1, "produced by": 1, "primary oscillations": 2, "oscillations originating": 2, "originating from": 1, "central pattern": 2, "pattern generator": 2, "antiplatelet drugs": 2, "drugs have": 1, "treating heart": 2, "new options": 2, "options for": 1, "antiplatelet agents": 4, "much work": 2, "work remains": 2, "establish efficacy": 2, "additional progress": 2, "including better": 2, "better tools": 2, "tools for": 2, "clarity regarding": 2, "anticoagulants for": 1, "vascular diseases": 2, "nutrition in": 1, "increasingly recognized": 2, "multisystem disease": 2, "disease with": 1, "important comorbidities": 2, "comorbidities such": 1, "autonomic dysbalance": 2, "recent findings": 2, "increasing evidence": 2, "evidence points": 2, "points to": 1, "intestinal morphology": 2, "absorption function": 2, "overview of": 3, "functional abnormalities": 2, "abnormalities of": 2, "different gastrointestinal": 2, "gastrointestinal regions": 2, "intestinal dysfunction": 2, "disturbed intestinal": 2, "intestinal barrier": 2, "lead to": 3, "chronic inflammatory": 2, "inflammatory state": 2, "anabolic imbalance": 2, "imbalance as": 1, "terminal stage": 2, "stage of": 1, "particularly poor": 2, "review highlights": 2, "knowledge of": 1, "nutritional abnormalities": 2, "including fat": 2, "the regulation": 2, "regulation of": 3, "nutritional strategies": 2, "strategies with": 1, "potentially anti": 2, "- inflammatory": 2, "inflammatory effects": 2, "the gut": 2, "role for": 2, "dietary interventions": 2, "crucial target": 2, "target of": 1, "failure research": 2, "diagnostic role": 2, "stable coronary": 2, "terminal fragment": 2, "released from": 1, "ventricular wall": 2, "reliable diagnostic": 2, "prognostic biomarkers": 2, "biomarkers in": 3, "diagnostic roles": 2, "roles of": 1, "great number": 2, "stable cad": 2, "limited amount": 2, "recent data": 2, "data is": 2, "thus providing": 2, "providing prognostic": 2, "prognostic information": 4, "information for": 1, "unfavourable clinical": 2, "therapeutic implications": 8, "elucidated in": 1, "unilateral renal": 4, "renal denervation": 4, "denervation improves": 2, "improves autonomic": 2, "autonomic balance": 8, "balance in": 2, "conscious rabbits": 2, "rabbits with": 1, "a hallmark": 2, "increased sympathetic": 4, "tone resulting": 2, "autonomic imbalance": 2, "symptomatic improvement": 2, "protective mechanisms": 2, "mechanisms remain": 2, "remain unclear": 2, "hypothesized in": 1, "renal dnx": 8, "cardiac autonomic": 4, "used conscious": 2, "chronically instrumented": 2, "white rabbits": 2, "rabbits undergoing": 2, "undergoing renal": 2, "dnx prior": 2, "treatment groups": 2, "- dnx": 4, "nonpace dnx": 2, "pace non": 2, "examined several": 2, "several markers": 2, "markers indicative": 2, "time domain": 2, "domain heart": 2, "rate variability": 6, "restored to": 1, "sham levels": 4, "power spectral": 2, "spectral analysis": 2, "ratio in": 2, "normalized to": 2, "withdrawal of": 1, "rate response": 2, "intravenous bolus": 2, "bolus of": 1, "intravenous metoprolol": 2, "exacerbated in": 1, "rabbits compared": 2, "normalized in": 1, "tachycardia in": 1, "intravenous atropine": 2, "also prevented": 2, "circulating plasma": 2, "suggest renal": 2, "dnx improves": 2, "narrow qrs": 4, "reduces morbidity": 2, "chronic systolic": 2, "wide qrs": 2, "mechanical dyssynchrony": 2, "dyssynchrony also": 2, "also occurs": 2, "trial involving": 2, "involving 115": 2, "echocardiographic evidence": 2, "ventricular dyssynchrony": 2, "underwent device": 2, "capability turned": 2, "turned on": 1, "primary efficacy": 4, "efficacy outcome": 2, "first hospitalization": 2, "worsening heart": 4, "stopped for": 1, "futility on": 1, "recommendation of": 1, "safety monitoring": 2, "monitoring board": 2, "at study": 2, "study closure": 2, "undergone randomization": 2, "mean of": 4, "outcome occurred": 2, "increase mortality": 2, "comparative effects": 2, "oxygenation on": 1, "mechanical cardiac": 8, "cardiac support": 8, "single center": 2, "center retrospective": 2, "retrospective observational": 2, "study in": 1, "failure supported": 2, "supported on": 1, "pediatric mechanical": 2, "divided into": 4, "group included": 6, "included patients": 6, "receiving ventricular": 2, "device support": 2, "receiving extracorporeal": 2, "oxygenation membrane": 2, "membrane support": 2, "ecmo+vad group": 8, "vad support": 2, "study period": 6, "steady improvement": 2, "egfr in": 2, "group until": 1, "day 7": 2, "egfr continued": 2, "continued until": 1, "day 28": 2, "steady decline": 2, "much higher": 2, "group in": 1, "dysfunction improves": 2, "improves early": 2, "sensitive outcome": 4, "outcome change": 2, "change scores": 2, "scores for": 1, "hospitalized older": 6, "preliminary descriptive": 2, "descriptive study": 2, "social mandate": 2, "ensure effective": 2, "effective practice": 2, "practice within": 2, "nursing care": 6, "using standardized": 2, "standardized nursing": 2, "nursing terminologies": 2, "terminologies makes": 2, "measure aspects": 2, "outcome ratings": 4, "ratings exists": 2, "exists from": 1, "discharge for": 1, "retrospective descriptive": 2, "descriptive research": 2, "research design": 2, "inpatient records": 2, "records of": 2, "patients discharged": 2, "discharged with": 1, "year period": 2, "outcomes demonstrated": 2, "demonstrated statistically": 2, "ratings from": 1, "study provide": 2, "provide insight": 4, "insight on": 1, "possible contribution": 2, "nursing to": 1, "incorporating nursing": 2, "measures in": 1, "future prospective": 2, "prospective experimental": 2, "experimental research": 2, "advancement of": 2, "science regarding": 2, "regarding effective": 2, "adults hospitalized": 2, "care to": 1, "phosphate receptor": 4, "receptor 1": 4, "reciprocal downregulation": 2, "downregulation influences": 2, "influences cardiac": 2, "cardiac hypertrophic": 2, "hypertrophic response": 2, "protective role": 2, "gene therapy": 2, "coupled receptors": 4, "receptors expressed": 2, "opposing actions": 2, "actions on": 1, "adenylyl cyclase": 2, "differential g": 2, "protein coupling": 2, "regulated by": 1, "actions of": 2, "coupled receptor": 4, "triggers desensitization": 2, "downregulation processes": 2, "classic signaling": 2, "signaling paradigms": 2, "paradigms suggest": 2, "simultaneous activation": 2, "simply result": 2, "opposing action": 2, "action on": 1, "camp production": 2, "direct interaction": 2, "regulatory involvement": 2, "involvement of": 1, "human embryonic": 2, "embryonic kidney": 2, "cells overexpressing": 2, "\u03b21ar downregulation": 2, "occur after": 1, "stimulation with": 1, "triggered by": 1, "receptor agonist": 2, "this cross": 2, "distinct g": 2, "receptors appears": 2, "physiological significance": 2, "show reciprocal": 2, "reciprocal regulation": 2, "regulation in": 1, "mouse hearts": 2, "hearts undergoing": 2, "undergoing chronic": 2, "receptor stimulation": 2, "rat model": 2, "postischemic heart": 2, "cardiac plasma": 2, "plasma membrane": 4, "membrane levels": 2, "produces beneficial": 2, "deleterious \u03b21ar": 2, "\u03b21ar overstimulation": 2, "overstimulation in": 1, "physician continuity": 8, "continuity on": 1, "urgent readmission": 4, "readmission after": 1, "discharge among": 2, "early physician": 4, "physician follow": 4, "lower rates": 4, "readmission among": 2, "continuity further": 1, "influences outcomes": 2, "administrative databases": 2, "databases for": 1, "adults aged": 2, "discharged alive": 2, "hospital between": 1, "time diagnosis": 2, "proportional hazard": 6, "models with": 1, "dependent covariates": 2, "familiar physician": 10, "physician within": 2, "first month": 6, "month after": 2, "discharge on": 1, "readmission over": 1, "patient at": 1, "least twice": 2, "index admission": 4, "identified patients": 2, "saw unfamiliar": 2, "unfamiliar physician(s": 2, "unplanned readmission": 2, "readmission during": 1, "month observation": 2, "observation period": 2, "unfamiliar physician": 2, "adjusted hr": 6, "hr 0.90": 2, "early follow": 2, "taking into": 1, "visits over": 1, "month period": 2, "visits with": 1, "unfamiliar physicians": 2, "hr 0.91": 2, "better outcomes": 4, "explore whether": 2, "settings other": 1, "altered protein": 2, "a subunit": 2, "subunit expression": 4, "- translational": 6, "translational state": 2, "receptor blockade": 2, "blockade reduces": 2, "reduces total": 2, "total mortality": 2, "halt disease": 2, "disease progression": 4, "dependent protein": 2, "signaling downstream": 2, "receptor activation": 2, "persist through": 1, "unique post": 2, "translational states": 2, "human myocardial": 2, "total myosin": 2, "myosin binding": 2, "binding protein": 2, "c phosphorylation": 2, "ser23/24 troponin": 2, "phosphorylation significantly": 2, "significantly decreased": 4, "subunits demonstrated": 2, "type ii": 2, "site specific": 2, "specific rii\u03b1": 2, "regulatory subunit": 2, "focusing of": 1, "ri\u03b1 demonstrated": 2, "demonstrated up": 1, "vivo phosphorylation": 2, "phosphorylation sites": 2, "western blots": 2, "blots with": 1, "specific monoclonal": 2, "monoclonal antibodies": 2, "antibodies showed": 2, "phosphorylation in": 1, "camp binding": 2, "binding by": 1, "wild type": 2, "mutant ri\u03b1": 2, "ri\u03b1 proteins": 2, "proteins demonstrated": 2, "demonstrated reduced": 2, "double mutant": 2, "mutant as": 1, "failing myocardium": 2, "myocardium displays": 2, "displays altered": 2, "translational modification": 2, "modification of": 3, "impact downstream": 2, "downstream signaling": 2, "autonomic modulation": 2, "modulation of": 1, "repolarization instability": 2, "instability in": 1, "failure prone": 2, "ventricular tachycardia": 6, "qt variability": 2, "signifies repolarization": 2, "repolarization lability": 2, "risk predictor": 2, "predictor for": 1, "sudden cardiac": 10, "autonomic nervous": 4, "nervous system": 4, "system activity": 2, "activity on": 1, "spontaneous ventricular": 2, "tachycardia [": 2, "without spontaneous": 2, "spontaneous vt": 4, "structurally normal": 2, "normal hearts": 2, "the beat": 2, "beat qt": 2, "qt interval": 2, "measured on": 1, "min records": 2, "surface ecgs": 2, "ecgs at": 1, "atrial pacing": 4, "atropine infusion": 2, "variability in": 2, "expressed as": 1, "sd of": 1, "rr intervals": 2, "calculated as": 1, "higher baseline": 4, "sdrr ratio": 2, "groups compared": 2, "group during": 1, "rate atrial": 2, "isoprenaline infusion": 2, "infusion increased": 2, "group relative": 2, "- adrenoceptor": 6, "adrenoceptor blockade": 6, "blockade with": 1, "larger fluctuations": 2, "fluctuations in": 1, "this appears": 2, "genuine effect": 2, "rate variation": 2, "the effect": 2, "acute autonomic": 2, "system modulation": 2, "modulation on": 1, "limited in": 1, "genetic susceptibility": 2, "susceptibility to": 1, "related congestive": 2, "haematopoietic cell": 2, "cell transplantation": 4, "developing congestive": 2, "primarily due": 2, "- hct": 8, "hct exposure": 2, "exposure to": 1, "polymorphisms in": 1, "candidate genes": 2, "genes involved": 2, "anthracycline metabolism": 2, "iron homeostasis": 2, "- oxidant": 2, "oxidant defence": 2, "myocardial remodelling": 2, "nested case": 2, "control study": 2, "this cohort": 2, "cohort formed": 2, "sampling frame": 2, "frame for": 1, "selecting controls": 2, "matched on": 1, "cumulative anthracycline": 2, "anthracycline exposure": 2, "cell source": 2, "cases with": 1, "germline dna": 2, "odds of": 3, "< 0\u00b701": 6, "chest radiation": 2, "variants of": 1, "genes coding": 2, "coding for": 1, "oxidase subunit": 2, "doxorubicin efflux": 2, "efflux transporter": 2, "a combined": 2, "chf predictive": 2, "predictive model": 2, "model performed": 2, "performed better": 4, "models alone": 2, "web of": 1, "common language": 2, "common syndrome": 2, "syndrome of": 1, "first propose": 2, "propose fundamental": 2, "fundamental definitions": 2, "definitions of": 1, "distinctive components": 2, "heart circulation": 2, "provide consensus": 2, "consensus on": 1, "universal definition": 2, "these definitions": 2, "foundation for": 1, "uniform nomenclature": 2, "nomenclature for": 1, "heart circulatory": 2, "circulatory failure": 2, "view to": 1, "foster collaborative": 2, "collaborative research": 2, "research initiatives": 2, "conjoint education": 2, "education in": 1, "disease unique": 2, "class angiotensin": 2, "receptor neprilysin": 6, "neprilysin inhibitor": 6, "inhibitor in": 1, "inhibitors augment": 2, "peptide system": 2, "system by": 1, "breakdown of": 1, "atrial natriuretic": 2, "inhibitor composed": 2, "composed of": 1, "inhibitor prodrug": 2, "antagonist valsartan": 2, "proven effective": 2, "shown promise": 2, "promise in": 1, "pilot trial": 2, "tested in": 1, "large outcomes": 2, "outcomes trial": 4, "a preserved": 2, "fraction outcomes": 2, "pharmacological treatment": 4, "current treatment": 2, "new targets": 4, "rapid onset": 2, "threatening situation": 2, "situation in": 1, "initiation of": 1, "therapy are": 1, "the treatment": 4, "treatment aims": 2, "improve clinical": 2, "clinical symptoms": 4, "increase long": 2, "few treatments": 2, "review summarizes": 2, "principles of": 1, "pharmacologic treatment": 2, "underlying clinical": 2, "new pharmacologic": 2, "pharmacologic targets": 2, "progressed from": 1, "concept of": 1, "purely hemodynamic": 2, "hemodynamic disorder": 2, "disorder to": 1, "interconnected molecular": 2, "focus of": 1, "research investigations": 2, "maladaptive molecular": 2, "molecular processes": 2, "accumulating evidence": 2, "evidence shows": 2, "molecular biomarkers": 2, "biomarkers provide": 2, "window into": 1, "therefore have": 1, "important therapeutic": 2, "remains in": 1, "shortcomings in": 1, "research studies": 2, "dearth of": 1, "guided clinical": 4, "potential therapeutic": 2, "promising biomarkers": 2, "uniquely capture": 2, "molecular dysfunction": 2, "strict statistical": 2, "statistical standards": 2, "standards in": 1, "biomarker studies": 2, "trial design": 2, "therapeutic potential": 2, "based strategy": 2, "micrornas in": 1, "targets in": 1, "disease management": 10, "western society": 2, "fastest growing": 2, "growing subclass": 2, "subclass of": 1, "an increasing": 2, "increasing body": 2, "body of": 1, "evidence indicates": 2, "small noncoding": 2, "noncoding rnas": 2, "regulate expression": 2, "target genes": 2, "specific binding": 2, "binding to": 1, "untranslated region": 2, "region of": 2, "translational repression": 2, "to date": 2, "many mirnas": 2, "diverse aspects": 2, "failure development": 2, "cardiac pathogenesis": 2, "provide brief": 2, "brief insight": 2, "mirnas as": 1, "aldosterone system": 4, "system inhibitors": 2, "inhibitors in": 1, "common condition": 2, "carries significant": 2, "significant morbidity": 2, "good evidence": 2, "the renin": 2, "effective target": 2, "target in": 1, "using angiotensin": 2, "aldosterone blockade": 2, "evidence in": 1, "less clear": 2, "review aims": 2, "look first": 2, "newer drugs": 2, "act on": 1, "direct renin": 2, "renin inhibitors": 2, "neutral endopeptidase": 2, "endopeptidase inhibitors": 2, "vasopeptidase inhibitors": 2, "muscle abnormalities": 2, "capacity in": 2, "peripheral muscle": 2, "muscle pump": 2, "promoting cardiac": 2, "cardiac filling": 4, "filling during": 1, "subpulmonary ventricle": 2, "a muscle": 2, "wasting syndrome": 2, "syndrome exists": 2, "acquired heart": 2, "investigate whether": 2, "circulation exhibit": 2, "exhibit reduced": 2, "reduced skeletal": 2, "muscle mass": 8, "metabolic abnormalities": 2, "underwent cardiopulmonary": 2, "mass quantification": 2, "quantification with": 1, "dual x": 2, "calf muscle": 2, "resonance spectroscopy": 2, "spectroscopy as": 1, "healthy age": 2, "australian reference": 2, "reference data": 2, "single tertiary": 2, "tertiary referral": 2, "referral centre": 2, "predicted values": 2, "mass assessed": 2, "relative appendicular": 2, "appendicular lean": 2, "matched reference": 2, "reference values": 2, "score -1.46\u00b10.22": 2, "low skeletal": 2, "mass correlated": 2, "poorer vo2": 2, "mass t": 2, "comparison with": 1, "young normal": 2, "normal reference": 2, "reference mean": 2, "subjects had": 1, "sarcopenic range": 2, "range muscle": 2, "muscle wasting": 2, "score <": 4, "less marked": 2, "significant wasting": 2, "muscle aerobic": 2, "rate constant": 2, "postexercise phosphocreatine": 2, "phosphocreatine resynthesis": 2, "adults versus": 2, "versus controls": 2, "the self": 2, "psychometric profile": 2, "still questioned": 2, "sample of": 1, "performed confirmatory": 2, "confirmatory factor": 2, "factor analysis": 4, "original construct": 2, "construct of": 1, "v.6.2 scales": 2, "limited success": 2, "used exploratory": 2, "exploratory factor": 2, "separate scale": 2, "scale dimensions": 2, "separate sub": 2, "- sample": 2, "construct validity": 2, "individual scales": 2, "scales showed": 2, "showed excellent": 2, "excellent fit": 2, "fit indices": 2, "confidence scale": 2, "contrasting groups": 2, "groups validity": 2, "supported as": 1, "this evidence": 2, "evidence provides": 2, "new understanding": 2, "circulating fragments": 2, "fragments of": 3, "peptides in": 1, "plasma of": 1, "nonstandardized n": 2, "misdiagnosis of": 1, "common consensus": 2, "consensus regarding": 2, "circulating forms": 2, "forms of": 4, "current assays": 2, "various forms": 2, "circulation of": 1, "collected from": 2, "stored at": 1, "\u00b0 c": 2, "enriched from": 1, "patient plasma": 2, "plasma by": 1, "immunoprecipitation followed": 2, "mass spectrometric": 2, "spectrometric analysis": 2, "customized homogeneous": 2, "homogeneous sandwich": 2, "sandwich alphalisa": 2, "\u00ae immunoassays": 2, "quantify 6": 2, "spectrometry identified": 2, "several n-": 2, "terminally processed": 2, "processed forms": 2, "physiological proteolysis": 2, "proteolysis between": 1, "immunoassays demonstrated": 2, "antibodies targeting": 4, "extreme n": 2, "termini measured": 2, "low apparent": 2, "apparent concentration": 2, "concentration of": 1, "apparent circulating": 2, "circulating nt": 2, "increased with": 2, "targeting nonglycosylated": 2, "nonterminal epitopes": 4, "in plasma": 2, "plasma collected": 2, "immunoreactive nt": 2, "multiple n-": 2, "terminally truncated": 2, "truncated fragments": 2, "full length": 2, "immunodetection of": 1, "improved with": 1, "terminal regions": 2, "these findings": 4, "findings support": 2, "next generation": 2, "assay targeting": 2, "targeting nonterminal": 2, "epitopes as": 1, "central glycosylated": 2, "glycosylated region": 2, "versus concentric": 2, "concentric left": 2, "ventricular hypertrophy": 2, "hypertrophy in": 2, "concentric remodeling": 2, "concentric hypertrophy": 2, "common forms": 2, "eccentric hypertrophy": 2, "also occur": 2, "well described": 2, "described in": 1, "prospectively studied": 2, "studied 402": 2, "normal geometry": 2, "relative wall": 2, "wall thickness": 4, "compared clinical": 2, "outcome data": 2, "data among": 2, "among groups": 2, "lower systolic": 2, "less renal": 2, "renal impairment": 2, "similar rates": 2, "contractility compared": 2, "lower lvef": 2, "\u03b2 coefficient": 6, "-1.1 %": 2, "also associated": 2, "compliance compared": 2, "volume at": 1, "similarly elevated": 2, "elevated cardiac": 2, "equivalent adverse": 2, "distinct subset": 2, "pathophysiologically similar": 2, "metoprolol on": 3, "inappropriate implantable": 4, "defibrillator therapy": 4, "endpoint of": 2, "inappropriate therapy": 12, "using time": 2, "dependent cox": 2, "compared patients": 2, "different types": 2, "primary endpoint": 6, "delivered as": 1, "antitachycardia pacing": 2, "shock therapy": 8, "secondary endpoints": 2, "therapy due": 4, "atrial tachyarrhythmias": 2, "also evaluated": 2, "evaluated as": 1, "therapy occurred": 2, "patients during": 1, "\u00b1 1.1": 2, "decreased risk": 2, "therapy compared": 4, "the reduction": 2, "inappropriate atp": 4, "inappropriate shock": 2, "therapy caused": 2, "also reduced": 2, "receiving carvedilol": 4, "carvedilol compared": 4, "general use": 2, "adherence in": 1, "% lower": 6, "lower rate": 4, "rate in": 2, "receiving metoprolol": 2, "nationwide retrospective": 2, "study from": 1, "raloxifene between": 1, "matched subjects": 2, "hazard analyses": 2, "years for": 1, "absolute risk": 2, "exposed group": 2, "crude rr": 2, "rr 1.71": 2, "ci 1.34": 2, "by comparison": 2, "different mechanism": 2, "hr 1.07": 2, "ci 0.76": 2, "used bisphosphonates": 2, "analysed separately": 2, "significant trends": 2, "observed across": 2, "across refill": 2, "refill compliance": 4, "compliance strata": 2, "failure increased": 2, "increasing refill": 2, "compliance for": 1, "trend <": 4, "decreased for": 1, "failure compared": 2, "matched control": 4, "control subjects": 2, "alendronate showed": 2, "dependent reduction": 2, "subcellular alterations": 2, "alterations by": 2, "failure due": 4, "in order": 2, "reversibility of": 1, "weeks infarcted": 2, "infarcted rats": 2, "without metoprolol": 2, "depressed left": 2, "negative rates": 2, "pressure development": 2, "weeks mi": 2, "mi animals": 2, "partially reversed": 6, "induced decreases": 2, "thickness as": 1, "internal diameter": 2, "diameter were": 1, "fully reversible": 2, "metoprolol partially": 2, "elevated levels": 6, "plasma norepinephrine": 2, "dopamine without": 2, "sarcoplasmic reticular": 2, "protein content": 2, "content for": 1, "infarcted hearts": 2, "partially reversible": 2, "depressed myofibrillar": 2, "myofibrillar ca(2+)-stimulated": 2, "levels for": 1, "myosin heavy": 4, "heavy chain": 4, "increased mrna": 2, "mrna level": 2, "level for": 1, "- myosin": 2, "partial improvement": 2, "cardiac performance": 2, "performance by": 1, "blockade at": 1, "advanced stages": 2, "stages of": 1, "partial reversal": 2, "complete reverse": 2, "reverse cardiac": 2, "partial reduction": 2, "plasma catecholamines": 2, "incident cardiovascular": 2, "independent risk": 2, "available studies": 2, "shown inconsistent": 2, "inconsistent results": 2, "embedded within": 2, "cardiovascular outcomes": 2, "adjusted means": 2, "subclinical atherosclerosis": 2, "atherosclerosis using": 2, "using general": 2, "general linear": 2, "hazards of": 1, "events for": 1, "dependent variable": 2, "% systemic": 2, "uv treatment": 2, "reference subjects": 4, "psoriasis patients": 4, "smoked more": 1, "higher diastolic": 2, "diastolic blood": 2, "index levels": 2, "adjusted carotid": 2, "carotid intima": 2, "media thickness": 2, "adjusted ankle": 2, "brachial index": 4, "wave velocity": 2, "artery calcium": 2, "calcium scores": 2, "differ between": 1, "ratio 0.73": 2, "interval 0.50": 2, "similar when": 1, "analyzed separately": 2, "predominantly mild": 2, "mild disease": 2, "disease from": 1, "develop atherosclerosis": 2, "events as": 1, "subjects without": 2, "without psoriasis": 2, "peripheral artery": 4, "share many": 2, "many risk": 2, "characteristics of": 1, "fully examined": 2, "investigated 120": 2, "defined by": 2, "index \u2264": 4, "levels \u2265": 2, "high bnp": 8, "low bnp": 2, "transmitral e": 2, "analysis established": 2, "established that": 1, "highest quartile": 2, "quartile of": 1, "pad suggests": 2, "routine bnp": 2, "hospital readmission": 2, "readmission reduction": 2, "reduction program": 2, "program for": 1, "rate following": 2, "following hospital": 2, "hospital stay": 2, "stay for": 1, "approaches 30": 2, "percent nationally": 2, "indicating possible": 2, "possible suboptimal": 2, "suboptimal care": 2, "care of": 2, "significant economic": 2, "economic considerations": 2, "- randomized": 2, "center pilot": 2, "pilot project": 2, "cardiac specialty": 2, "specialty hospital": 2, "community of": 1, "population in": 1, "predominantly rural": 2, "rural south": 2, "admitted between": 1, "intensive transitions": 4, "transitions of": 2, "care program": 4, "ensure adequate": 2, "adequate self": 2, "management training": 2, "training of": 2, "appropriate out": 1, "patient follow": 2, "patient by": 1, "care system": 4, "percent relative": 2, "relative reduction": 2, "documented for": 1, "patients participating": 2, "pilot program": 2, "this represented": 2, "net economic": 2, "economic savings": 2, "even accounting": 2, "added cost": 2, "cost of": 1, "program decreases": 2, "- urbanized": 2, "urbanized midwestern": 2, "midwestern state": 2, "state like": 2, "cardiac patients": 6, "extensively studied": 2, "studied in": 1, "patients surviving": 2, "the majority": 2, "shown that": 1, "abnormal hr": 4, "hr variability": 12, "variability have": 1, "mortality within": 2, "various measures": 4, "hr dynamics": 2, "- linear": 4, "linear measures": 2, "prognostic power": 2, "power of": 1, "reflecting rapid": 2, "rapid r": 2, "r interval": 2, "interval oscillations": 2, "almost identical": 2, "linear hr": 2, "variability measures": 2, "term fractal": 2, "fractal scaling": 2, "scaling exponent": 2, "provided somewhat": 2, "somewhat better": 2, "better prognostic": 2, "variability predicts": 2, "- sudden": 2, "remodeling of": 1, "arrhythmia substrate": 2, "substrate after": 1, "early measurement": 2, "repeated later": 2, "fatal arrhythmia": 2, "arrhythmia events": 2, "future randomized": 2, "trials using": 2, "using hr": 2, "turbulence as": 1, "- defined": 2, "defined inclusion": 2, "show whether": 2, "routine measurement": 2, "routine clinical": 2, "renal artery": 2, "artery stenosis": 4, "common form": 4, "form of": 2, "peripheral arterial": 2, "arterial disease": 2, "predominantly unilateral": 2, "pathophysiologic mechanism": 2, "mechanism stems": 2, "stems from": 1, "renal underperfusion": 2, "underperfusion resulting": 2, "renin- angiotensin": 2, "aldosterone pathway": 2, "clinically present": 2, "present with": 1, "progressive disease": 4, "resistant hypertension": 2, "end stage": 10, "stage kidney": 2, "kidney failure": 2, "screening patients": 2, "computed tomographic": 2, "tomographic angiography": 2, "resonance angiography": 2, "angiography is": 1, "adequate blood": 2, "pressure control": 2, "directed lipid": 2, "lowering therapy": 2, "smoking cessation": 2, "preventive measures": 2, "measures form": 2, "foundation of": 1, "based percutaneous": 2, "percutaneous revascularization": 2, "revascularization with": 1, "stenting showed": 2, "showed modest": 2, "modest clinical": 2, "benefit for": 1, "small retrospective": 2, "retrospective studies": 2, "randomized clinical": 2, "trials failed": 2, "beneficial results": 2, "current ongoing": 2, "ongoing cardiovascular": 2, "provide more": 1, "concrete data": 2, "stenting in": 1, "surgical revascularization": 2, "considered only": 1, "based revascularization": 2, "revascularization is": 1, "guidelines on": 1, "framework for": 1, "determining individualized": 2, "individualized assessment": 2, "treatment plans": 2, "plans for": 1, "bioinformatic analysis": 2, "microarray data": 2, "data reveals": 2, "reveals several": 2, "several key": 2, "key genes": 2, "genes related": 2, "major public": 4, "public health": 6, "health problem": 4, "problem worldwide": 2, "still unclear": 2, "study aims": 2, "discover differentially": 2, "differentially expressed": 4, "expressed genes": 2, "- ischemic": 8, "failure samples": 4, "downloaded from": 1, "including 3": 2, "normal samples": 2, "ischemic samples": 2, "data processing": 2, "differential analysis": 2, "carried out": 1, "packages of": 1, "also performed": 2, "performed for": 1, "globally observe": 2, "interactors of": 1, "retrieved with": 1, "overlapping part": 2, "selected out": 1, "functional enrichment": 4, "enrichment analysis": 4, "applied with": 1, "obtained for": 2, "programmed cell": 2, "cell death": 2, "represented in": 1, "common degs": 2, "develop treatments": 2, "care management": 8, "longitudinal analysis": 2, "analysis using": 4, "using medicare": 2, "medicare data": 2, "evaluate mortality": 2, "healthcare utilization": 2, "utilization effects": 2, "combined care": 2, "targeting individuals": 2, "retrospective matched": 2, "matched cohort": 2, "service beneficiaries": 6, "demonstration participating": 2, "participating clinics": 2, "score matched": 2, "driven telehealth": 4, "telehealth system": 2, "system with": 1, "inpatient admissions": 4, "hospital days": 4, "visits during": 1, "year study": 2, "negative binomial": 2, "binomial regression": 2, "controlling for": 2, "health characteristics": 2, "statistically different": 2, "groups after": 1, "participants offered": 2, "lower risk": 6, "quarterly inpatient": 2, "admissions from": 1, "baseline to": 3, "% greater": 2, "controls during": 1, "time period": 2, "no relationship": 2, "days for": 1, "fewer admissions": 2, "admissions for": 1, "management coupled": 2, "coupled with": 1, "telehealth technology": 2, "technology has": 1, "improve health": 2, "the strength": 2, "strength of": 1, "race as": 1, "contemporary chronic": 2, "training response": 2, "well established": 2, "explore interactions": 2, "interactions with": 1, "care with": 1, "without exercise": 4, "examined characteristics": 2, "race using": 2, "using adjusted": 2, "identified black": 2, "black patients": 2, "significantly more": 1, "less ischemic": 2, "ischemic etiology": 2, "lower socioeconomic": 2, "socioeconomic status": 2, "status versus": 2, "versus whites": 2, "blacks had": 1, "walk distance": 4, "lower peak": 2, "black race": 8, "after multivariable": 2, "increased mortality": 4, "the hazard": 4, "hazard associated": 2, "largely caused": 2, "given similar": 2, "similar cardiovascular": 2, "race in": 1, "increased prevalence": 2, "modifiable risk": 2, "lower exercise": 4, "exercise performance": 6, "improving outcomes": 2, "design of": 1, "early treatment": 4, "fibrillation for": 2, "therapy including": 2, "including anticoagulation": 2, "rate control": 6, "major cardiovascular": 2, "cardiovascular complications": 6, "prevent adverse": 2, "outcomes related": 2, "rhythm control": 16, "control therapy": 16, "moderately effective": 2, "published trials": 2, "side effects": 2, "repeated interventions": 2, "therapy applied": 2, "applied early": 4, "first diagnosis": 2, "preserve atrial": 2, "atrial structure": 2, "maintain sinus": 2, "rhythm more": 1, "current practice": 2, "practice of": 1, "delayed rhythm": 2, "symptoms persist": 2, "persist after": 1, "otherwise effective": 2, "new antiarrhythmic": 2, "potential effectiveness": 2, "modern rhythm": 2, "reduce cardiovascular": 2, "complications in": 1, "randomize approximately": 2, "recent onset": 10, "onset af": 2, "af at": 1, "mandated usual": 2, "early rhythm": 4, "blinded outcome": 2, "outcome assessment": 2, "assessment trial": 2, "trial for": 1, "composite primary": 2, "nights spent": 2, "spent in": 1, "counted as": 1, "coprimary outcome": 2, "consist of": 3, "therapy of": 1, "underlying heart": 2, "control as": 1, "initial approach": 2, "therapy by": 1, "operated electrocardiographic": 2, "electrocardiographic device": 2, "ongoing rhythm": 2, "key secondary": 2, "outcomes include": 2, "include cognitive": 2, "cognitive function": 2, "initial diagnosis": 2, "prevent cardiovascular": 2, "complications associated": 2, "gastrointestinal bleeding": 12, "bleeding in": 2, "cardiac nurse": 2, "term ventricular": 2, "care providers": 2, "faced with": 1, "managing clinically": 2, "significant gastrointestinal": 2, "housed on": 1, "units accustomed": 2, "accustomed to": 1, "cardiac nurses": 4, "often asked": 2, "asked about": 1, "article describes": 4, "possible causes": 2, "array of": 1, "procedures for": 1, "topic so": 1, "partner with": 1, "subspecialty groups": 2, "dependent increase": 2, "leading causes": 2, "hospitalisation among": 2, "worldwide increase": 2, "life expectancy": 4, "advanced phase": 2, "called end": 2, "terminal heart": 4, "steadily growing": 2, "failure fall": 2, "fall into": 1, "classification of": 1, "functional classification": 2, "characterised by": 1, "advanced structural": 2, "structural heart": 2, "pronounced symptoms": 2, "failure at": 1, "minimal physical": 2, "physical exertion": 2, "maximal medical": 2, "treatment according": 2, "population has": 1, "mortality rate": 2, "requires special": 2, "special therapeutic": 2, "every attempt": 2, "correct reversible": 2, "reversible causes": 2, "causes for": 1, "poor patient": 2, "myocardial ischaemia": 2, "valvular regurgitation": 2, "describe current": 2, "current strategies": 2, "strategies for": 1, "potent inhibition": 2, "type ca2": 2, "currents by": 1, "variant associated": 2, "influx via": 2, "via l": 2, "type voltage": 2, "channels supports": 2, "plateau phase": 2, "ventricular action": 4, "action potentials": 2, "trigger for": 1, "member of": 1, "monomeric g": 2, "g proteins": 2, "regulates ventricular": 2, "action potential": 2, "potential duration": 2, "coupling gain": 2, "gain through": 1, "inhibit cardiac": 2, "cardiac l": 2, "type channel": 8, "channel activity": 2, "potential dysfunction": 2, "dysfunction of": 1, "naturally occurring": 2, "occurring rad": 2, "rad variant": 2, "even eliminates": 2, "inhibitory actions": 2, "channel isoforms": 2, "isoforms known": 2, "murine equivalent": 2, "equivalent of": 1, "human rad": 2, "inhibits l": 2, "type currents": 2, "currents conducted": 2, "conducted by": 1, "cav1.3 channels": 2, "channels as": 2, "% inhibition": 2, "gating movement": 2, "movement of": 1, "indicating that": 1, "differentially impair": 2, "described modes": 2, "modes of": 1, "inhibition by": 1, "conclude that": 1, "inhibit l": 2, "dependent processes": 2, "processes per": 2, "per se": 2, "rule out": 2, "decreased expression": 2, "altered regulation": 2, "efficacy in": 1, "young adult": 2, "severe anemia": 2, "ethically complex": 2, "complex situations": 2, "situations in": 1, "involving families": 2, "religious beliefs": 2, "beliefs preclude": 2, "provision of": 1, "sustaining treatment": 4, "involving young": 2, "legal majority": 2, "face decisions": 2, "decisions about": 2, "this month": 2, "case in": 1, "complexities overlapped": 2, "old jehovah": 2, "sickle cell": 2, "cell disease": 2, "disease has": 1, "threatening anemia": 2, "going into": 1, "doctors urgently": 2, "urgently recommend": 2, "recommend blood": 2, "young woman": 2, "family adamantly": 2, "adamantly refuse": 2, "doctors let": 2, "composite quality": 4, "quality measures": 4, "measures for": 1, "common inpatient": 2, "inpatient medical": 2, "medical conditions": 2, "public reporting": 2, "reporting on": 1, "quality aims": 2, "help patients": 4, "patients select": 2, "select better": 2, "better hospitals": 2, "individual quality": 2, "identifying superior": 2, "inferior hospitals": 2, "hospitals based": 2, "outcome performance": 2, "combine structure": 2, "measures into": 1, "empirically derived": 2, "derived composite": 2, "quality measure": 2, "measure for": 1, "assess how": 1, "composite measure": 2, "measure predicts": 2, "predicts future": 2, "future high": 4, "low performers": 4, "explains variance": 2, "variance in": 1, "future hospital": 2, "hospital mortality": 2, "using national": 2, "national medicare": 2, "treated at": 1, "care hospital": 2, "ranked hospitals": 2, "hospitals on": 1, "performance on": 2, "adjusted mortality": 4, "versus best": 4, "best quintile": 4, "quintile of": 2, "using 2005": 4, "existing quality": 2, "quality indicators": 2, "including mortality": 2, "the composite": 2, "vs. hospital": 4, "explained 68": 2, "future ami": 2, "hospital in": 1, "performance using": 2, "dying in": 1, "composite measures": 2, "quality for": 1, "existing measures": 2, "measures at": 1, "explaining variation": 2, "future mortality": 2, "predicting future": 2, "race influences": 4, "the incidence": 2, "hyperkalemia caused": 2, "influences efficacy": 2, "antagonists in": 1, "assessed hyperkalemia": 2, "african americans": 2, "- aas": 6, "aa participants": 4, "ischemic hf": 2, "class iv": 2, "higher estimated": 2, "less hypertension": 2, "infarction compared": 2, "- aa": 2, "potassium increased": 2, "race by": 1, "treatment interaction": 2, "remained higher": 2, "attain maximal": 2, "maximal spironolactone": 2, "spironolactone dose": 2, "higher rates": 2, "achieved study": 2, "study drug": 2, "drug dose": 2, "spironolactone reduced": 2, "combined end": 4, "aas with": 1, "exhibited less": 2, "less hyperkalemia": 2, "hypokalemia with": 1, "spironolactone compared": 2, "derive less": 2, "less clinical": 2, "these hypothesis": 2, "generating findings": 2, "differ by": 1, "global proteomics": 6, "pathway analysis": 6, "attenuation by": 1, "targeted peptides": 2, "targeted antioxidant": 2, "protective peptides": 2, "proteomic remodeling": 2, "signaling pathways": 4, "improved label": 2, "free shotgun": 2, "shotgun proteomics": 2, "proteomics approach": 2, "proteomics changes": 4, "tac)-induced heart": 2, "associated signaling": 2, "pathway changes": 2, "changes using": 2, "using ingenuity": 2, "ingenuity pathway": 4, "proteins significantly": 2, "significantly changed": 4, "changed after": 1, "mapped to": 1, "top pathways": 2, "categories of": 2, "actin cytoskeleton": 4, "mitochondrial function": 4, "intermediate metabolism": 2, "citrate cycle": 2, "concomitant treatment": 2, "failure phenotypes": 2, "mitochondrial damage": 2, "damage induced": 2, "global attenuation": 4, "attenuation of": 3, "mitochondrial proteome": 2, "proteome changes": 2, "% protection": 2, "protection of": 1, "nonmitochondrial protein": 2, "protein changes": 2, "this included": 2, "included significant": 2, "significant amelioration": 2, "amelioration of": 1, "analysis noted": 2, "noted above": 1, "modest effects": 2, "tracked with": 1, "partial attenuation": 2, "cytoskeleton pathways": 2, "significantly protected": 2, "protected in": 1, "metabolic pathways": 2, "pathways essentially": 2, "essentially were": 1, "study elucidates": 2, "pathways significantly": 2, "changed in": 1, "induced proteomic": 2, "proteomic alterations": 2, "targeted peptide": 4, "perturbed mitochondrial": 2, "upstream signal": 2, "signal to": 1, "pathway alterations": 2, "potential clinical": 2, "application of": 1, "peptide drugs": 2, "treatment heart": 2, "reducing length": 2, "stay increase": 2, "increase rehospitalization": 2, "rehospitalization of": 2, "medicare fee": 2, "beneficiaries discharged": 2, "discharged to": 1, "skilled nursing": 2, "nursing facilities": 2, "hospitals nationwide": 2, "beneficiaries associated": 2, "day rehospitalization": 6, "rehospitalization derived": 2, "hospital claims": 2, "claims using": 2, "implementation of": 1, "- acute": 4, "care transfer": 4, "transfer policy": 4, "policy as": 1, "quasi -": 2, "- experiment": 2, "policy led": 2, "immediate declines": 2, "day decrease": 2, "absolute increase": 2, "percentage points": 4, "= 0.03": 2, "kidney infection": 4, "urinary tract": 2, "tract infection": 2, "individuals hospitalized": 2, "ami without": 2, "complications had": 1, "day reduction": 2, "hospital length": 2, "consistently associated": 2, "higher rate": 2, "physician volume": 10, "urgent need": 2, "reduce costs": 2, "costs for": 1, "undergoing procedures": 2, "medically managed": 2, "managed diseases": 2, "well understood": 2, "inpatient data": 2, "admissions to": 1, "care hospitals": 2, "divided physicians": 2, "physicians into": 1, "quintiles according": 2, "used patient": 2, "level regression": 2, "compare 30": 2, "costs across": 2, "across volume": 2, "volume groups": 6, "hospital characteristics": 2, "examined physician": 2, "volume within": 2, "within strata": 2, "strata of": 1, "hospital volume": 6, "physician specialty": 2, "patients cared": 4, "cared for": 2, "volume physicians": 8, "physicians had": 2, "volume hospitals": 2, "in contrast": 2, "higher readmission": 2, "across hospital": 4, "the relationship": 2, "volume institutions": 2, "among noncardiologist": 2, "noncardiologist physicians": 2, "clinician expertise": 2, "antagonism in": 1, "neurohormone known": 2, "affect electrolytes": 2, "implicated as": 1, "major clinical": 2, "trials designed": 2, "analyze clinical": 2, "outcomes using": 2, "aldosterone antagonist": 8, "done in": 3, "groups with": 1, "symptomatic chronic": 2, "chronic advanced": 4, "mortality significantly": 2, "significantly compared": 2, "very few": 1, "standard therapy": 2, "beta blockade": 2, "another study": 2, "infarction patients": 2, "patients randomized": 2, "antagonist eplerenone": 2, "these trial": 2, "trial results": 2, "results provide": 2, "background for": 1, "improving survival": 2, "idiopathic dilated": 12, "based management": 2, "contemporary therapeutic": 2, "therapeutic options": 6, "substantial improvement": 2, "limited evidence": 2, "available specifically": 2, "thus examined": 2, "examined changes": 2, "large idiopathic": 2, "cardiomyopathy cohort": 2, "cohort systematically": 2, "systematically followed": 2, "53\u00b112 years": 2, "32\u00b110 %": 2, "criteria for": 1, "including negative": 2, "negative coronary": 2, "subdivided in": 1, "enrollment periods": 2, "periods on": 1, "failure treatment": 2, "treatment eras": 2, "receiving angiotensin": 2, "angiotensin receptors": 2, "receptors blockers": 2, "devices at": 1, "final evaluation": 2, "evaluation increased": 2, "period 1": 2, "period 4": 6, "toward enrollment": 2, "enrollment of": 1, "severe left": 2, "point including": 2, "including death": 2, "failure related": 2, "recent enrollment": 2, "enrollment period": 2, "period represented": 2, "powerful independent": 2, "period 2": 2, "period 3": 2, "each period": 2, "% risk": 2, "risk reduction": 2, "reduction versus": 2, "reflecting marked": 2, "marked decreases": 2, "related mortality": 2, "based treatment": 2, "dramatic improvement": 2, "cardiomyopathy during": 1, "controlled randomized": 2, "replicated in": 1, "real world": 2, "tailored follow": 2, "term continuity": 2, "continuity of": 1, "indeterminable anaerobic": 2, "anaerobic threshold": 4, "threshold in": 1, "maximal cardiopulmonary": 2, "exercise test": 6, "always identified": 2, "finding has": 1, "prognostic meaning": 2, "prospectively followed": 2, "dedicated hf": 2, "stable clinical": 2, "clinical conditions": 2, "underwent clinical": 2, "test investigations": 2, "investigations at": 1, "study enrollment": 2, "excluded 921": 2, "maximal exercise": 2, "achievement of": 1, "anaerobic metabolism": 2, "peak respiratory": 2, "respiratory quotient": 2, "quotient \u22641.05": 2, "primary study": 4, "study end": 6, "urgent cardiac": 2, "point was": 1, "at multivariable": 4, "multivariable logistic": 2, "logistic analysis": 2, "resulted significantly": 2, "reduced peak": 2, "higher metabolic": 2, "metabolic exercise": 4, "kidney index": 4, "index score": 4, "score value": 2, "powerful prognostic": 2, "prognostic composite": 2, "composite hf": 2, "multivariable analysis": 2, "following variables": 4, "% pred": 2, "ventilatory efficiency": 2, "efficiency slope": 2, "diet in": 1, "at nonidentification": 2, "associated to": 1, "prognosis also": 2, "secondary study": 2, "the inability": 2, "identify at": 2, "often occurs": 2, "prognostic role": 2, "cardiorespiratory fitness": 4, "failure mortality": 2, "joint associations": 2, "associations among": 2, "among cardiorespiratory": 2, "additive effect": 2, "increasing number": 2, "cardiovascular risk": 6, "factors on": 2, "versus unfit": 2, "unfit men": 6, "men without": 2, "disease underwent": 2, "baseline examination": 2, "examination between": 1, "measures included": 2, "included body": 2, "quantified as": 1, "maximal treadmill": 2, "treadmill exercise": 2, "specific low": 2, "high crf": 2, "computed with": 1, "deaths occurred": 2, "ratios across": 2, "across high": 2, "low crf": 2, "obese body": 2, "index categories": 2, "categories were": 1, "when grouped": 2, "grouped into": 1, "fit compared": 2, "men in": 1, "overweight body": 2, "index strata": 2, "obese men": 2, "within men": 2, "men matched": 2, "matched for": 1, "fit men": 2, "lower hf": 4, "mortality risk": 4, "factors present": 2, "counseled on": 1, "activity with": 1, "achieving at": 1, "moderate level": 2, "presumably decreasing": 2, "cardiac insulin": 6, "decreased mitochondrial": 4, "mitochondrial energy": 2, "energy production": 2, "production precede": 2, "overload hypertrophy": 2, "significant alterations": 2, "metabolism precede": 2, "hypertrophied heart": 2, "subjected to": 3, "hypertrophy secondary": 2, "overload as": 1, "abdominal aortic": 2, "energy substrate": 2, "substrate metabolism": 2, "isolated working": 2, "working hearts": 2, "hearts obtained": 2, "obtained 1": 2, "mice subjected": 2, "progressive development": 2, "vivo assessment": 2, "via echocardiography": 2, "demonstrated diastolic": 2, "dysfunction by": 2, "% decrease": 4, "% ejection": 2, "marked cardiac": 2, "resistance by": 1, "weeks post": 6, "- aac": 6, "evidenced by": 1, "stimulated rates": 2, "glucose oxidation": 2, "membrane translocation": 2, "translocation of": 1, "glucose transporter": 2, "transporter 4": 2, "overall atp": 2, "production rates": 2, "decreased at": 2, "mitochondrial oxidation": 2, "oxidation of": 1, "fatty acids": 2, "myocardial glycolysis": 2, "glycolysis rates": 2, "reduced mitochondrial": 2, "mitochondrial complex": 2, "complex v": 2, "v activity": 2, "phosphocreatine to": 1, "the development": 2, "oxidative metabolism": 2, "early metabolic": 2, "metabolic changes": 2, "energy deficit": 2, "progression from": 1, "the reality": 2, "reality of": 1, "guide health": 2, "health service": 4, "service planning": 2, "planning in": 1, "adequacy of": 1, "relevant health": 2, "service provision": 2, "provision related": 2, "well delineated": 2, "systematic search": 2, "search of": 1, "undertaken for": 1, "reduced gross": 2, "gross income": 2, "lower total": 4, "total expenditure": 4, "expenditure on": 2, "health per": 4, "per capita": 6, "heterogeneous region": 2, "region with": 1, "factors of": 2, "nondeveloped countries": 2, "including lower": 2, "raised blood": 2, "blood glucose": 2, "glucose levels": 2, "systemic hypertension": 2, "rheumatic fever": 4, "main etiologies": 2, "etiologies of": 1, "alcohol related": 2, "the prognosis": 2, "main cause": 2, "varies from": 1, "awful paradox": 2, "paradox of": 1, "countries with": 1, "added factors": 2, "scenario of": 1, "lower gross": 2, "gross national": 2, "national income": 2, "income per": 2, "new strategies": 2, "previously linked": 2, "individuals aged": 2, "genotyped for": 1, "renal chloride": 2, "chloride channel": 2, "channel gene": 2, "the following": 2, "total cholesterol": 2, "novel finding": 2, "partly explain": 2, "reported greater": 2, "failure linked": 2, "requires confirmation": 2, "confirmation on": 1, "air pollution": 8, "ambient air": 2, "recognised risk": 2, "cardiovascular health": 6, "important trigger": 2, "trigger of": 1, "colleagues provide": 2, "new systematic": 2, "pollution on": 1, "common disorder": 2, "disorder associated": 2, "high morbidity": 2, "elderly people": 2, "professionals in": 1, "pollution experienced": 2, "experienced in": 2, "industrial areas": 2, "aggravate cardiovascular": 2, "cardiac overexpression": 2, "overexpression of": 1, "exacerbates heart": 2, "key regulator": 2, "cytoskeletal actin": 2, "actin dynamics": 2, "previously demonstrated": 2, "cardiac mena": 2, "deletion produced": 2, "produced cardiac": 2, "conduction abnormalities": 2, "expression correlates": 2, "precise role": 2, "cardiac pathophysiology": 2, "pathophysiology is": 1, "evaluated mice": 2, "mice with": 1, "cardiac myocyte": 2, "specific mena": 2, "cardiac pathology": 2, "morphologically comparable": 2, "type littermates": 2, "mildly increased": 2, "increased heart": 2, "heart mass": 2, "mass in": 1, "transgenic mice": 2, "particularly susceptible": 2, "cardiac injury": 4, "animals experienced": 2, "experienced pronounced": 2, "pronounced decreases": 2, "shortening as": 1, "heart dilatation": 2, "hypertrophy after": 1, "turning off": 1, "discovered that": 1, "levels eliminated": 2, "eliminated cardiac": 2, "preclude post": 2, "- tac": 2, "tac cardiac": 2, "cardiac functional": 2, "functional deterioration": 2, "findings indicate": 2, "indicate that": 1, "hearts with": 1, "increased levels": 2, "fare worse": 2, "worse when": 1, "mechanical support": 2, "support devices": 2, "a cardiology": 2, "considerable number": 2, "patients eventually": 2, "eventually reach": 2, "terminal phase": 4, "spite of": 1, "developments in": 1, "diagnostic procedure": 2, "alternative treatments": 2, "slow progression": 2, "palliative care": 2, "accurate recognition": 2, "recognition of": 1, "advanced disease": 2, "overall management": 2, "failure requires": 2, "collaboration of": 1, "professionals from": 1, "multiple disciplines": 2, "managed by": 1, "collaboration among": 2, "among cardiologists": 2, "cardiovascular surgeons": 2, "medical staff": 2, "staff responsible": 2, "patient care": 2, "country has": 1, "physicians experienced": 2, "distributed evenly": 2, "equitable access": 2, "access to": 1, "progress has": 1, "made regarding": 2, "regarding appropriate": 2, "appropriate referrals": 2, "patient circulation": 2, "the aims": 2, "aims of": 1, "present consensus": 2, "consensus report": 2, "connection between": 1, "experienced centers": 2, "patients irrespective": 2, "disease phase": 2, "healthcare staff": 2, "raise awareness": 2, "provide information": 2, "information regarding": 2, "regarding conditions": 2, "conditions in": 1, "other antihyperglycemic": 2, "recent postmarketing": 2, "postmarketing trials": 2, "trials produced": 2, "produced conflicting": 2, "conflicting results": 2, "results about": 1, "hospitalized heart": 2, "dipeptidyl peptidase-4": 2, "creating uncertainty": 2, "uncertainty about": 1, "antihyperglycemic agents": 4, "user cohort": 2, "health insurance": 2, "health system": 2, "system data": 2, "data partners": 2, "partners in": 1, "patients aged": 2, "aged 18": 2, "initiated therapy": 2, "generation sulfonylureas": 2, "acting insulin": 2, "insulin products": 2, "products from": 1, "identified by": 1, "codes 402.x1": 2, "recorded as": 1, "principal discharge": 2, "discharge diagnosis": 2, "saxagliptin users": 2, "sitagliptin users": 2, "users contributed": 2, "data to": 1, "pairwise comparisons": 2, "study drugs": 2, "ratios from": 2, "disease risk": 2, "risk score": 2, "saxagliptin versus": 8, "versus sitagliptin": 2, "versus pioglitazone": 4, "versus insulin": 4, "stratified hazard": 2, "sitagliptin versus": 6, "matched analyses": 2, "also similar": 2, "without prior": 2, "prior cardiovascular": 2, "subgroup defined": 2, "highest drs": 2, "residual confounding": 2, "short follow": 2, "sitagliptin compared": 2, "selected antihyperglycemic": 2, "implementation strategies": 6, "improving physician": 2, "physician adherence": 6, "guideline recommendations": 2, "recommendations in": 2, "review protocol": 2, "the uptake": 2, "uptake of": 2, "remains suboptimal": 2, "identify implementation": 2, "improve physician": 2, "clear evidence": 2, "benefits outweigh": 2, "use american": 2, "guidelines as": 1, "literature search": 2, "search in": 1, "databases of": 1, "include prospective": 2, "prospective studies": 2, "evaluating implementation": 2, "implementation interventions": 2, "interventions aimed": 2, "improving uptake": 2, "extract data": 2, "classify interventions": 2, "interventions according": 2, "systems level": 2, "common underlying": 2, "underlying characteristics": 2, "financial incentives": 2, "intervention on": 1, "include proportion": 2, "recommended pharmacological": 2, "device consideration": 2, "provided self": 2, "care education": 2, "education at": 1, "provided left": 2, "function assessment": 2, "include clinical": 2, "common elements": 2, "elements of": 1, "failing interventions": 2, "context in": 1, "contextual framework": 2, "results narratively": 2, "pool results": 2, "results for": 1, "explore why": 1, "succeed in": 1, "fail in": 1, "findings through": 1, "briefing reports": 2, "patient perceptions": 2, "perceptions of": 1, "defibrillator deactivation": 16, "deactivation discussions": 8, "qualitative study": 2, "recommendation for": 1, "occur between": 1, "perspective on": 1, "determine patient": 2, "patient awareness": 2, "grounded theory": 2, "analyze interview": 2, "interview data": 2, "the sample": 2, "predominately male": 2, "patients identified": 2, "identified three": 2, "stages where": 1, "felt implantable": 2, "significant deterioration": 2, "sound mind": 2, "engage in": 2, "patients wished": 2, "wished further": 1, "previously established": 2, "established preferences": 2, "most patients": 2, "consider deactivation": 2, "never turn": 2, "preferences identified": 2, "study support": 2, "include information": 2, "information on": 1, "deactivation at": 1, "within broader": 2, "broader discussions": 2, "discussions about": 1, "life treatment": 2, "treatment preferences": 2, "patients determine": 2, "deactivation preferences": 2, "patients experiencing": 2, "experiencing distressing": 2, "distressing implantable": 2, "defibrillator shocks": 2, "shocks at": 1, "comment on": 1, "carotid baroreflex": 2, "baroreflex activation": 2, "activation therapy": 2, "decreased parasympathetic": 2, "parasympathetic activity": 4, "activity contribute": 2, "bat results": 2, "centrally mediated": 2, "mediated reduction": 2, "sympathetic outflow": 2, "increased parasympathetic": 2, "fractions <": 2, "% on": 1, "chronic stable": 2, "stable guideline": 2, "directed medical": 2, "enrolled at": 2, "centers in": 1, "receive ongoing": 2, "ongoing gdmt": 4, "gdmt alone": 2, "primary safety": 2, "safety end": 2, "related major": 2, "major adverse": 4, "adverse neurological": 4, "efficacy end": 2, "life score": 6, "minute hall": 2, "hall walk": 2, "free rate": 2, "confidence bound": 2, "bound 91.4": 2, "patients assigned": 2, "group patients": 2, "experienced improvements": 2, "distance walked": 2, "walked in": 1, "\u00b1 13.2": 2, "points vs.": 2, "class ranking": 2, "bat significantly": 2, "reduced n": 2, "toward fewer": 2, "fewer days": 2, "days hospitalized": 2, "improves functional": 2, "burden of": 1, "failure hospitalizations": 2, "preliminary report": 2, "using cardiopulmonary": 2, "testing guide": 2, "guide exercise": 2, "standard clinical": 2, "rare using": 2, "prescribe exercise": 2, "performed symptom": 2, "symptom limited": 2, "limited maximal": 2, "maximal cpet": 2, "cpet in": 1, "randomly divided": 2, "control without": 2, "exercise patients": 2, "patients used": 2, "used \u03b450%w": 2, "\u03b450%w intensity": 2, "exercise 30": 2, "x12 w.": 2, "w rehabilitation": 2, "evaluated functions": 2, "groups patients": 2, "exercise duration": 2, "min to": 1, "min after": 1, "distance 6": 2, "minutes walking": 2, "score of": 3, "exercise group": 8, "nosignificant changes": 2, "changes were": 1, "guiding exercise": 2, "failure affects": 2, "affects nearly": 2, "people in": 1, "patients have": 1, "newer imaging": 2, "imaging techniques": 2, "confirmed that": 1, "hfpef patients": 2, "completely normal": 2, "reduced long": 2, "long axis": 2, "axis function": 2, "subtle changes": 2, "changes on": 1, "older women": 2, "other cardiovascular": 2, "signs in": 1, "often nonspecific": 2, "primary symptoms": 2, "symptoms are": 1, "fluid retention": 2, "single diagnostic": 2, "diagnostic test": 2, "cornerstone in": 1, "assessment remains": 2, "thorough medical": 2, "medical history": 2, "physical examination": 4, "the duration": 2, "classify patients": 2, "patients according": 2, "functional assessment": 2, "standing blood": 2, "valvular disease": 2, "pulmonary congestion": 2, "jugular venous": 2, "peripheral oedema": 2, "oedema allows": 2, "allows assessment": 2, "volume status": 2, "referred to": 1, "failure nurses": 2, "local cardiology": 2, "cardiology services": 2, "services as": 1, "reduce mortality": 2, "regular physical": 2, "activity controls": 2, "controls acquired": 2, "acquired cardiovascular": 2, "generally associated": 2, "events from": 1, "exercise extend": 2, "extend well": 2, "cardiovascular system": 2, "recent evidence": 2, "exercise prevents": 2, "prevents cell": 2, "cell senescence": 2, "active individuals": 2, "individuals are": 1, "developing certain": 2, "certain malignancies": 2, "malignancies including": 2, "including cancer": 2, "cancer of": 1, "exercise regularly": 2, "regularly extend": 2, "expectancy by": 1, "aerobic exercise": 6, "even lower": 2, "lower volumes": 2, "volumes of": 1, "exercise below": 1, "recommendations confer": 2, "confer health": 2, "health benefits": 2, "highly relevant": 2, "established cardiac": 2, "cardiac disease": 2, "disease including": 2, "including heart": 2, "athletes under": 1, "rare with.estimates": 2, "with.estimates ranging": 2, "congenital abnormalities": 2, "nontraumatic death": 2, "death during": 1, "sport in": 1, "young athletes": 4, "in middle": 2, "aged recreational": 2, "recreational athletes": 2, "athletes more": 1, "cardiac deaths": 2, "deaths occur": 2, "atherosclerotic cad": 4, "advocate pre": 2, "- participation": 2, "participation screening": 2, "screening of": 1, "detect congenital": 2, "congenital accessory": 2, "accessory pathways": 2, "ion channelopathies": 2, "frequently abnormal": 2, "screening with": 1, "older athletes": 2, "limited value": 2, "value given": 2, "overwhelming contribution": 2, "assisted training": 2, "training for": 2, "small pilot": 2, "assess robot": 2, "assisted gait": 4, "gait therapy": 4, "\u00ae system": 2, "system in": 1, "% completed": 2, "week aerobic": 2, "aerobic training": 2, "training period": 2, "period with": 1, "trainings per": 2, "integrated dynamic": 2, "dynamic resistance": 2, "resistance training": 4, "lower limbs": 2, "underwent testing": 2, "inflammatory biomarkers": 4, "strength by": 1, "peak quadriceps": 4, "quadriceps force": 4, "events occurred": 4, "combined training": 2, "training resulted": 2, "peak work": 2, "work rate": 2, "+ 61": 2, "oxygen pulse": 2, "+ 44": 2, "the quality": 2, "life assessment": 2, "assessment indicated": 2, "indicated better": 2, "better well": 2, "+0.5 to": 1, "+0.2 to": 1, "combined aerobic": 2, "training intervention": 2, "augmented feedback": 2, "feedback resulted": 2, "muscle strength": 2, "need further": 1, "validation in": 1, "larger studies": 2, "psychosocial factors": 2, "influence adherence": 2, "adherence with": 1, "social support": 10, "participation with": 1, "exercise adherence": 2, "completed surveys": 2, "assess social": 2, "perceived social": 2, "support score": 2, "exercise score": 2, "higher psss": 4, "indicated higher": 2, "higher levels": 2, "higher btes": 2, "btes indicated": 2, "indicated more": 1, "months correlated": 2, "r= 0.13": 2, "higher exercise": 2, "time associated": 2, "lower btes": 4, "for cardiovascular": 2, "randomization group": 2, "corresponded to": 1, "borderline association": 2, "increasing btes": 2, "ratio 1.25": 2, "interval 0.99": 2, "association in": 1, "care group": 2, "ratio 0.83": 2, "interval 0.66": 2, "poor social": 2, "high barriers": 2, "training had": 1, "greater impact": 2, "training improves": 2, "perceived barriers": 2, "facilitate individualized": 2, "individualized approaches": 2, "implement exercise": 2, "training therapy": 2, "performance in": 1, "arguments for": 1, "blocker hypo": 2, "hypo -": 2, "- response": 2, "blockers reduce": 2, "explained by": 1, "standardized exercise": 2, "exercise protocol": 2, "protocol with": 1, "respiratory gas": 2, "gas analysis": 2, "analysis at": 1, "baseline as": 1, "patients participated": 2, "participated in": 1, "care programme": 2, "programme aiming": 2, "achieve guideline": 2, "target doses": 2, "doses for": 1, "resting hr<70": 4, "hr<70 bpm": 2, "dose after": 1, "hr<70 versus": 2, "versus \u226570": 4, "\u226570 bpm": 4, "similar dose": 2, "dose uptitration": 4, "latter had": 1, "significantly larger": 2, "larger hr": 2, "17\u00b122 versus": 2, "significantly higher": 2, "higher when": 1, "resting hr": 6, "hr was": 1, "observed after": 1, "baseline had": 1, "kg increase": 4, "lower resting": 2, "in recent": 2, "better when": 1, "controlled <": 2, "bpm with": 1, "aggressive dose": 2, "many patients": 2, "target as": 1, "little hr": 2, "unidirectional left": 2, "right interatrial": 6, "interatrial shunting": 4, "shunting for": 1, "principle cohort": 4, "reduce elevated": 2, "elevated left": 2, "atrial pressure": 4, "pressure improve": 2, "potential efficacy": 2, "therapeutic left": 2, "shunting in": 1, "study at": 1, "centre in": 1, "aged \u226518": 2, "enrolled under": 1, "canadian special": 2, "special access": 2, "access programme": 2, "shunt implants": 2, "done after": 1, "transseptal catheterisation": 2, "catheterisation with": 1, "transoesophageal echocardiographic": 2, "echocardiographic guidance": 2, "guidance under": 1, "general anaesthesia": 2, "echocardiography evaluations": 2, "evaluations at": 1, "months 1": 2, "shunt implantation": 2, "enrolled ten": 2, "the device": 2, "successfully implanted": 2, "procedural adverse": 2, "month showed": 2, "from baseline": 2, "recorded improvements": 2, "mean score": 4, "sd 6\u00b72": 2, "[ 12\u00b79": 2, "sd 9\u00b78": 2, "min walk": 4, "test distance": 2, "sd 112": 2, "reduced from": 1, "pulmonary resistance": 2, "no patient": 2, "hospital with": 1, "bleeding at": 1, "month 1": 2, "died after": 1, "incessant ventricular": 2, "tachycardia storm": 2, "failure 2": 2, "months post": 2, "- procedure": 2, "man experience": 2, "implanted left": 2, "interatrial shunt": 2, "shunt demonstrates": 2, "demonstrates initial": 2, "initial safety": 2, "early beneficial": 2, "beneficial clinical": 2, "haemodynamic outcomes": 2, "further large": 2, "scale randomised": 2, "randomised studies": 2, "study paradigm": 2, "paradigm shift": 2, "crucial problem": 2, "problem of": 1, "current cardiology": 2, "major development": 2, "first results": 2, "neprilysin inhibitors": 2, "considered hopeful": 2, "dual inhibition": 2, "neprilysin blocks": 2, "blocks renin": 2, "concurrently supports": 2, "supports natural": 2, "natural vasodilatory": 2, "diuretic effect": 2, "scale prospective": 2, "prospective randomized": 2, "randomized multicenter": 2, "multicenter trial": 2, "trial paradigm": 2, "stabilized chronic": 2, "elevated bnp": 2, "pro bnp": 2, "shown 20": 2, "group treated": 2, "treated by": 1, "consistent also": 2, "specified subgroup": 2, "subgroup analyses": 2, "including quality": 2, "typical adverse": 2, "dual ras": 2, "neprilysin inhibition": 2, "time become": 2, "stable chronic": 2, "dysfunction treatment": 2, "significantly contributed": 2, "study sites": 2, "thanked for": 1, "quality work": 2, "work provided": 2, "failure among": 2, "older persons": 2, "primary symptom": 2, "symptom of": 1, "chronic hfpef": 2, "major determinant": 2, "determinant of": 1, "reduced quality": 2, "caloric restriction": 4, "obese older": 4, "factorial trial": 2, "trial conducted": 2, "conducted from": 1, "urban academic": 2, "academic medical": 2, "medical center": 2, "initially screened": 2, "screened participants": 2, "older obese": 2, "obese participants": 2, "stable hfpef": 4, "excluded by": 1, "declined participation": 2, "attention control": 2, "control consisted": 2, "consisted of": 1, "telephone calls": 2, "capacity measured": 2, "- primary": 4, "score range": 2, "higher scores": 2, "scores indicate": 2, "indicate worse": 2, "worse heart": 2, "enrolled participants": 2, "participants completed": 2, "exercise attendance": 2, "diet adherence": 2, "adherence was": 1, "by main": 2, "main effects": 2, "effects analysis": 2, "kg body": 2, "the combination": 2, "joint effect": 2, "significant change": 2, "total score": 2, "main effect": 2, "-1 unit": 2, "-8 to": 1, "-6 units": 2, "positively correlated": 2, "percent lean": 2, "thigh muscle": 2, "intermuscular fat": 2, "fat ratio": 2, "related serious": 2, "serious adverse": 2, "weight decreased": 2, "diet group": 4, "among obese": 2, "clinically stable": 2, "training increased": 2, "neither intervention": 2, "intervention had": 1, "life as": 1, "assist system": 2, "provide long": 2, "term support": 2, "centrifugal flow": 2, "flow pump": 2, "designed for": 1, "enhanced hemocompatibility": 2, "hemocompatibility by": 1, "magnetically levitated": 6, "levitated rotor": 2, "rotor with": 1, "wide blood": 2, "flow paths": 2, "artificial pulse": 2, "multicenter study": 2, "support)-derived performance": 2, "performance goal": 4, "fraction \u2264": 2, "without inotropes": 2, "optimal medical": 2, "listed for": 1, "the indications": 2, "indications for": 1, "patients continued": 2, "continued on": 1, "% received": 2, "received transplants": 2, "% died": 2, "survival 92": 2, "% performance": 2, "support with": 1, "levitated lvas": 2, "risk by": 1, "predicted survival": 2, "key adverse": 2, "events included": 2, "included reoperation": 2, "reoperation for": 1, "driveline infection": 2, "debilitating stroke": 2, "pump exchanges": 2, "pump malfunctions": 2, "pump thrombosis": 2, "hemolysis events": 2, "life scores": 2, "scores showed": 2, "showed progressive": 2, "sustained improvement": 2, "levitated centrifugal": 2, "flow chronic": 2, "favorable adverse": 2, "event profile": 2, "improved quality": 2, "a web": 2, "based program": 2, "program designed": 2, "management programs": 8, "failure disease": 4, "influence medical": 2, "medical resource": 2, "resource use": 8, "adjusted survival": 2, "projecting long": 2, "term costs": 2, "valid approach": 2, "extrapolating short": 2, "based simulation": 2, "simulation tool": 2, "tool designed": 2, "integrate data": 2, "laboratory characteristics": 2, "based medications": 2, "generate predicted": 2, "predicted outcomes": 2, "survival projections": 2, "modified seattle": 2, "projections of": 1, "modeled using": 2, "using relationships": 2, "the model": 4, "evaluate parallel": 2, "study designs": 2, "hypothetical programs": 2, "simulations consist": 2, "pairs of": 1, "virtual cohorts": 2, "cohorts used": 2, "generate estimates": 2, "estimates of": 1, "incremental cost": 2, "effectiveness ratios": 2, "user inputs": 2, "model demonstrated": 2, "demonstrated acceptable": 2, "acceptable internal": 2, "external validity": 2, "validity in": 1, "replicating resource": 2, "survival estimates": 2, "estimates from": 1, "programs across": 2, "scenarios demonstrate": 2, "demonstrate how": 1, "program in": 1, "term improvements": 2, "based treatments": 2, "treatments are": 1, "demonstrate good": 2, "good long": 2, "term value": 2, "value to": 1, "provides researchers": 2, "providers with": 1, "conducting long": 2, "term cost": 2, "effectiveness analyses": 2, "debilitating chronic": 2, "upcoming years": 2, "years due": 2, "demographic changes": 2, "nurses in": 1, "settings have": 1, "essential role": 2, "supporting patients": 2, "nursing interventions": 2, "nursing actions": 2, "actions have": 1, "enhancing medical": 2, "pathophysiologic state": 2, "ultimately reduce": 2, "optimize quality": 2}, "1": {"national": 9, "trends": 8, "patient": 77, "safety": 25, "four": 12, "common": 32, "conditions": 14, "2005": 9, "-": 218, "2011": 13, "the": 256, "effects": 44, "decade": 2, "efforts": 1, "dedicated": 2, "improve": 25, "remain": 6, "largely": 9, "unclear": 10, "this": 60, "study": 156, "used": 57, "medicare": 17, "monitoring": 9, "system": 24, "mpsms": 1, "database": 3, "assess": 21, "adverse": 32, "event": 16, "rates": 47, "patients": 598, "hospitalized": 25, "acute": 68, "myocardial": 76, "infarction": 37, "congestive": 31, "heart": 651, "failure": 559, "pneumonia": 5, "requiring": 9, "surgery": 25, "analysis": 65, "included": 35, "large": 16, "sample": 7, "60,000": 1, "across": 16, "4372": 1, "hospitals": 13, "results": 131, "show": 9, "significant": 62, "decline": 5, "translating": 1, "estimated": 18, "81,000": 1, "hospital": 45, "events": 52, "averted": 1, "2010\u20132011": 1, "however": 46, "measurable": 2, "overall": 13, "improvements": 13, "admitted": 9, "surgical": 14, "some": 2, "pressure": 53, "ulcers": 1, "actually": 1, "increased": 84, "considerable": 2, "attention": 7, "problems": 5, "suggests": 8, "initiatives": 2, "led": 8, "real": 4, "progress": 5, "areas": 2, "created": 3, "board": 3, "cross": 5, "talk": 3, "adipose": 2, "tissue": 10, "cachectic": 2, "respect": 1, "alterations": 10, "body": 33, "composition": 10, "prospective": 15, "objectives": 20, "cardiac": 185, "cachexia": 8, "cc": 6, "associated": 127, "changes": 50, "lipolysis": 1, "energy": 10, "expenditure": 3, "caused": 7, "a-": 1, "b": 27, "natriuretic": 29, "peptides": 7, "nps": 6, "suggested": 3, "play": 6, "role": 32, "tested": 8, "hypothesis": 5, "neurohormones": 1, "adipokines": 1, "progressive": 5, "loss": 9, "fat": 13, "free": 10, "mass": 37, "ffm": 6, "fm": 8, "takes": 1, "place": 1, "methods": 78, "regard": 2, "distribution": 5, "assessed": 34, "dual": 5, "x": 3, "ray": 3, "absorptiometry": 3, "dxa": 3, "19": 6, "non": 31, "diabetic": 3, "chronic": 70, "chf": 76, "38": 1, "controls": 13, "individuals": 16, "prior": 11, "n": 61, "=": 107, "followed": 21, "12": 24, "months": 35, "biomarkers": 13, "neurohormonal": 4, "stimulation": 11, "inflammation": 6, "endothelial": 14, "dysfunction": 70, "measured": 26, "terminal": 21, "probnp": 34, "nt": 34, "midregional": 1, "proanp": 3, "mr": 20, "total": 28, "adiponectin": 3, "elevated": 20, "p<0.001": 21, "correlated": 19, "inversely": 3, "bmi": 3, "an": 9, "inverse": 2, "correlation": 8, "observed": 21, "pro": 15, "adrenomedullin": 1, "proadm": 2, "during": 14, "follow": 64, "weight": 13, "unaltered": 2, "groups": 44, "even": 15, "1.35": 3, "kg": 32, "p<0.05": 8, "decreased": 26, "0.5": 1, "latter": 3, "baseline": 57, "no": 16, "found": 29, "conclusions": 73, "plasma": 14, "correlate": 1, "prospectively": 6, "stable": 18, "diagnosis": 24, "preserved": 59, "ejection": 122, "fraction": 116, "clinical": 101, "doppler": 11, "echocardiography": 21, "in": 125, "developed": 32, "countries": 5, "least": 6, "38\u201354": 1, "%": 559, "left": 117, "ventricular": 142, "lv": 75, "prevalence": 11, "hfpef": 69, "steadily": 2, "increasing": 9, "prognosis": 21, "poor": 10, "diastolic": 55, "either": 14, "alone": 8, "combination": 6, "factors": 33, "figure": 1, "1": 56, "major": 30, "underlying": 9, "mechanism": 14, "general": 9, "population": 29, "presence": 9, "mild": 16, "pronounced": 3, "increases": 5, "cause": 47, "mortality": 127, "hence": 2, "prognostic": 27, "leading": 8, "critical": 3, "importance": 8, "european": 2, "society": 4, "cardiology": 9, "guidelines": 15, "based": 38, "definition": 2, "requires": 9, "signs": 5, "symptoms": 27, "dilated": 17, "ventricle": 14, "evidence": 36, "impaired": 11, "relaxation": 2, "stiffness": 5, "filling": 15, "pressures": 5, "invasively": 3, "using": 63, "treatment": 118, "anemia": 14, "disease": 97, "practice": 24, "guideline": 22, "american": 6, "college": 4, "physicians": 14, "description": 1, "acp": 4, "present": 17, "provide": 16, "recommendations": 14, "iron": 10, "deficiency": 3, "adult": 11, "published": 4, "literature": 5, "english": 2, "language": 3, "1947": 1, "july": 4, "2012": 7, "identified": 30, "medline": 5, "cochrane": 4, "library": 2, "reassessed": 1, "april": 1, "2013": 5, "additional": 7, "studies": 51, "outcomes": 108, "evaluated": 28, "hospitalization": 58, "exercise": 134, "tolerance": 3, "quality": 54, "life": 42, "cardiovascular": 64, "defined": 20, "exacerbation": 1, "arrhythmia": 5, "death": 70, "harms": 4, "including": 27, "hypertension": 38, "venous": 4, "thromboembolic": 4, "ischemic": 27, "cerebrovascular": 1, "target": 11, "audience": 1, "includes": 4, "clinicians": 3, "anemic": 1, "deficient": 1, "grades": 1, "grading": 2, "recommendation": 6, "recommends": 2, "restrictive": 1, "red": 1, "blood": 28, "cell": 17, "transfusion": 5, "strategy": 9, "trigger": 3, "hemoglobin": 6, "threshold": 3, "7": 23, "8": 19, "g": 12, "/": 195, "dl": 6, "compared": 90, "higher": 61, "levels": 52, "coronary": 36, "grade": 5, "weak": 2, "low": 55, "2": 61, "use": 51, "erythropoiesis": 4, "stimulating": 4, "agents": 9, "moderate": 19, "strong": 5, "systematic": 11, "review": 26, "background": 69, "benefits": 15, "uncertain": 2, "purpose": 7, "evaluate": 16, "treatments": 8, "adults": 27, "data": 59, "sources": 3, "embase": 4, "databases": 8, "trial": 49, "registries": 2, "reference": 9, "lists": 2, "technical": 1, "advisors": 1, "selection": 2, "trials": 35, "transfusions": 3, "observational": 7, "extraction": 2, "design": 23, "characteristics": 20, "health": 52, "extracted": 3, "synthesis": 2, "strength": 12, "6": 58, "26": 9, "liberal": 1, "protocols": 3, "short": 10, "term": 38, "less": 25, "aggressive": 5, "combined": 11, "relative": 13, "risk": 142, "among": 57, "0.94": 2, "95": 140, "ci": 114, "0.61": 2, "1.42": 1, "i2": 1, "16.8": 1, "occurred": 18, "small": 10, "syndrome": 4, "1.8": 6, "vs.": 29, "13.0": 2, "p": 182, "0.032": 1, "3": 49, "intravenous": 6, "improved": 35, "moderate-": 1, "high": 58, "17": 8, "agent": 6, "therapy": 94, "offered": 2, "consistent": 9, "may": 74, "thromboembolism": 1, "limitations": 3, "few": 4, "examined": 16, "potentially": 12, "confounded": 1, "indication": 5, "supporting": 2, "come": 1, "mainly": 3, "long": 37, "unknown": 8, "conclusion": 31, "thresholds": 1, "consistently": 2, "needed": 8, "help": 4, "alleviate": 2, "also": 38, "warrants": 2, "seem": 1, "benefit": 21, "serious": 3, "remote": 3, "conditioning": 1, "management": 47, "hf": 370, "stemming": 1, "nonischemic": 1, "cardiomyopathies": 1, "continues": 1, "problematic": 1, "inroads": 1, "made": 9, "pharmacological": 3, "armamentarium": 1, "implantable": 24, "cardioverter": 22, "defibrillators": 4, "resynchronization": 23, "eventual": 1, "resort": 1, "transplantation": 16, "and/or": 10, "right": 54, "assist": 28, "devices": 24, "both": 7, "frequently": 9, "serially": 1, "keep": 1, "busy": 1, "outpatient": 5, "settings": 6, "prompting": 1, "search": 3, "better": 17, "ways": 1, "deal": 1, "worldwide": 3, "epidemic": 2, "impact": 35, "medical": 36, "resources": 2, "financial": 3, "costs": 12, "comments": 1, "emergency": 12, "department": 9, "enriching": 1, "identification": 1, "enrollment": 9, "collins": 1, "et": 12, "al": 4, "as": 13, "authors": 4, "suggest": 15, "categorization": 1, "perhaps": 1, "single": 12, "important": 25, "component": 3, "focused": 4, "modern": 3, "ahf": 4, "highly": 7, "heterogeneous": 3, "appropriate": 11, "stratification": 9, "essential": 4, "conducting": 2, "area": 11, "predictors": 17, "defibrillator": 27, "meta": 11, "many": 10, "current": 22, "icds": 2, "conducted": 5, "identify": 17, "icd": 6, "searched": 3, "cinahl": 2, "two": 23, "reviewers": 2, "selected": 8, "citations": 1, "ambulatory": 10, "addressed": 1, "association": 45, "predictor": 10, "multivariable": 9, "regression": 20, "analyzed": 9, "random": 1, "models": 37, "of": 18, "10,420": 1, "reviewed": 9, "72": 5, "evaluating": 4, "63": 3, "257,692": 1, "proved": 1, "eligible": 4, "confidence": 50, "estimates": 4, "age": 54, "hazard": 65, "ratio": 84, "hr": 87, "1.45": 2, "10": 26, "year": 36, "increase": 44, "interval": 46, "1.56": 4, "glomerular": 12, "filtration": 12, "rate": 77, "1.25": 2, "15": 15, "ml": 51, "min": 32, "decrease": 17, "1.15": 2, "obstructive": 5, "pulmonary": 39, "1.54": 2, "1.38": 3, "1.71": 4, "diabetes": 32, "1.37": 1, "1.79": 2, "peripheral": 11, "vascular": 14, "1.43": 1, "1.2": 5, "1.72": 1, "0.77": 5, "0.73": 4, "0.83": 8, "inappropriate": 13, "shocks": 3, "2.34": 1, "1.59": 2, "3.44": 1, "new": 49, "york": 21, "class": 41, "atrial": 36, "fibrillation": 22, "strongly": 7, "cardiomyopathy": 23, "male": 14, "sex": 17, "independent": 17, "reliable": 4, "renal": 49, "further": 7, "research": 15, "potential": 24, "particularly": 9, "dose": 39, "dopamine": 11, "nesiritide": 10, "rose": 2, "randomized": 36, "enhance": 3, "decongestion": 5, "preserve": 3, "function": 85, "neither": 5, "rigorously": 1, "objective": 27, "test": 26, "hypotheses": 1, "placebo": 23, "addition": 19, "\u03bcg": 2, "0.005": 4, "without": 33, "bolus": 2, "diuretic": 10, "setting": 21, "and": 45, "participants": 34, "multicenter": 10, "double": 7, "blind": 4, "controlled": 16, "optimization": 2, "strategies": 24, "evaluation": 13, "360": 1, "60": 8, "min/1.73": 6, "m2": 4, "within": 28, "24": 13, "hours": 6, "admission": 22, "september": 2, "2010": 7, "march": 3, "sites": 5, "north": 2, "america": 4, "interventions": 26, "open": 6, "1:1": 3, "allocation": 1, "2:1": 1, "active": 2, "122": 1, "119": 2, "independently": 16, "pooled": 1, "group": 83, "main": 11, "measures": 28, "coprimary": 2, "end": 67, "points": 9, "hour": 4, "cumulative": 8, "urine": 3, "volume": 52, "point": 21, "change": 28, "serum": 12, "cystatin": 3, "c": 24, "effect": 39, "8524": 1, "7917": 1, "9131": 1, "vs": 30, "8296": 2, "7762": 2, "8830": 2, "difference": 21, "229": 1, "-714": 1, "1171": 1, ".59": 1, "level": 25, "0.12": 1, "mg": 17, "l": 30, "0.06": 3, "0.18": 1, "0.11": 2, "0.16": 2, "0.01": 15, "-0.08": 1, "0.10": 2, ".72": 1, "similarly": 3, "8574": 1, "8014": 1, "9134": 1, "279": 1, "-618": 1, "1176": 1, ".49": 2, "0.07": 1, "0.13": 4, "-0.04": 1, "-0.13": 1, "0.05": 11, ".36": 1, "secondary": 11, "reflective": 1, "relevance": 5, "enhanced": 7, "added": 7, "participating": 5, "multihospital": 1, "promote": 1, "adoption": 1, "lessons": 2, "nurse": 4, "leaders": 1, "multisite": 2, "focus": 4, "improving": 11, "processes": 6, "care": 71, "adopting": 1, "practices": 4, "specific": 20, "questions": 1, "implementation": 6, "issues": 1, "reveal": 2, "organizations": 1, "profoundly": 1, "transformed": 1, "utilizing": 1, "voluntary": 1, "testimonies": 1, "conversations": 1, "nurses": 6, "involvement": 2, "extend": 4, "beyond": 3, "meeting": 2, "magnet": 1, "\u00ae": 4, "requirements": 2, "systems": 10, "proteomics": 6, "chromatin": 14, "identifies": 2, "nucleolin": 5, "regulator": 2, "growth": 12, "cellular": 4, "plasticity": 2, "cardiomyocytes": 16, "myocyte": 6, "hypertrophy": 23, "antecedent": 2, "involves": 3, "global": 11, "gene": 23, "expression": 32, "preceding": 1, "mechanisms": 9, "coordinate": 1, "dna": 6, "accessibility": 1, "genomic": 2, "scale": 9, "proteins": 20, "alter": 2, "structure": 14, "changing": 2, "thereby": 3, "altering": 1, "profile": 5, "little": 9, "known": 14, "subproteomes": 1, "accompany": 1, "tests": 4, "fundamental": 3, "recapitulates": 1, "conserved": 1, "developmental": 2, "remodeling": 29, "quantitative": 2, "via": 17, "detergent": 1, "quantify": 7, "abundance": 1, "321": 1, "subproteome": 2, "demonstrating": 2, "modest": 5, "conservation": 1, "37": 11, "revealed": 13, "acid": 1, "176": 1, "exhibited": 10, "altered": 9, "extensive": 2, "functional": 61, "characterization": 1, "one": 29, "morpholino": 1, "knockdown": 2, "nearly": 2, "abolished": 2, "protein": 25, "surprisingly": 2, "gross": 3, "morphological": 1, "development": 36, "hearts": 15, "fish": 1, "lacking": 2, "displayed": 2, "severe": 42, "impairment": 5, "abnormal": 11, "chamber": 1, "patterning": 1, "deficits": 4, "ostensibly": 1, "due": 21, "defects": 4, "looping": 1, "differentiation": 3, "involve": 1, "perturbed": 2, "bone": 1, "morphogenetic": 1, "4": 36, "rrna": 1, "transcription": 10, "shift": 4, "heterochromatic": 1, "reports": 4, "normal": 20, "diseased": 4, "mouse": 11, "validation": 3, "complementary": 2, "model": 53, "zebrafish": 1, "examine": 12, "orchestrate": 1, "reprogramming": 1, "shared": 1, "receive": 5, "limited": 18, "regarding": 7, "ies": 3, "ic": 3, "crt": 40, "d": 7, "efficacy": 19, "device": 29, "comprised": 3, "1,045": 1, "enrolled": 15, "automatic": 4, "implantation": 23, "multivariate": 18, "cox": 23, "proportional": 12, "hazards": 8, "modeling": 2, "ie": 7, "comprising": 1, "syndromes": 2, "time": 51, "dependent": 18, "performed": 31, "subsequent": 7, "recipients": 6, "previous": 5, "revascularization": 5, "artery": 25, "bypass": 4, "1.88": 2, "0.003": 3, "percutaneous": 4, "intervention": 14, "3.21": 1, "0.001": 20, "systolic": 77, "1.67": 1, "0.02": 14, "bundle": 6, "branch": 6, "block": 6, "pattern": 3, "electrocardiogram": 1, "reduced": 86, "0.62": 1, "0.87": 6, "0.51": 2, "showed": 33, "twofold": 3, "reduce": 17, "attenuated": 3, "survey": 2, "israel": 2, "contemporary": 5, "therapies": 8, "resulted": 9, "lvef": 25, "sought": 12, "differential": 9, "decompensated": 4, "world": 4, "all": 12, "years": 78, "categorized": 3, "\u226550": 4, "mildly": 2, "40": 16, "49": 4, "moderately": 4, "30": 44, "39": 4, "severely": 5, "1,620": 1, "20": 21, "25": 11, "reductions": 6, "respectively": 33, "similar": 33, "reduction": 37, "0.92": 6, "0.40": 2, "1.01": 4, "0.90": 3, "conferred": 1, "1.20": 3, "0.04": 5, "interaction": 14, "evident": 4, "\u226475": 1, "1.49": 1, "older": 28, "versus": 56, "1.02": 5, "0.86": 4, "value": 19, "0.03": 4, "experience": 7, "remains": 11, "significantly": 57, "circulating": 10, "progenitor": 4, "cells": 19, "outcome": 47, "longitudinal": 11, "cpcs": 5, "involved": 6, "process": 5, "repair": 2, "factor": 25, "diseases": 8, "serial": 2, "measurements": 8, "capacity": 34, "156": 1, "consecutive": 16, "consenting": 1, "peak": 37, "vo2": 13, "every": 4, "early": 36, "outgrowth": 1, "colony": 1, "forming": 1, "units": 4, "eo": 7, "cfus": 6, "cd34": 1, "+": 20, "vegfr2": 1, "cd133": 1, "recorded": 4, "admissions": 8, "transplant": 18, "mean": 36, "55": 4, "\u00b1": 83, "a": 59, "cd34+vegfr2": 3, "0.2": 2, "<": 78, "cfu": 1, "0.28": 1, "0.25": 3, "0.09": 3, "0.69": 3, "noted": 4, "relations": 2, "lower": 52, "nondiabetic": 1, "basis": 7, "differences": 15, "examination": 7, "implications": 6, "metric": 6, "choice": 3, "applications": 2, "readmission": 25, "metrics": 7, "performance": 21, "three": 20, "acr": 3, "m": 1, "preventable": 1, "ppr": 2, "centers": 7, "medicaid": 3, "day": 45, "cms": 6, "2000": 5, "2009": 11, "california": 2, "office": 5, "statewide": 1, "planning": 2, "discharge": 21, "nonpublic": 1, "file": 1, "calculated": 13, "ami": 18, "absolute": 7, "percent": 7, "remaining": 3, "extreme": 3, "deciles": 2, "agreement": 3, "principal": 3, "findings": 17, "average": 9, "generally": 4, "correlations": 4, "highest": 5, "r": 10, "0.67": 6, "0.84": 2, "0.50": 7, "between": 5, "47": 3, "75": 6, "decile": 2, "according": 13, "remained": 15, "different": 15, "measuring": 5, "approaches": 10, "computing": 1, "readmissions": 12, "produce": 2, "rankings": 2, "pay": 1, "careful": 4, "consideration": 2, "placed": 1, "recent": 22, "network": 4, "context": 4, "rm": 5, "deliver": 2, "specialised": 1, "way": 3, "meet": 2, "growing": 5, "needs": 3, "determine": 16, "recently": 12, "discharged": 5, "28": 11, "days": 28, "following": 9, "unplanned": 2, "fourteen": 1, "electronic": 2, "psycinfo": 1, "january": 5, "supplemented": 3, "hand": 3, "searching": 1, "relevant": 5, "articles": 1, "randomised": 2, "rcts": 2, "cohort": 43, "contemporaneous": 1, "control": 57, "home": 4, "telemonitoring": 1, "tm": 6, "implanted": 7, "support": 41, "provided": 12, "24/7": 1, "structured": 2, "telephone": 2, "sts": 7, "programmes": 4, "delivered": 2, "human": 26, "contact": 2, "hh": 4, "machine": 1, "interface": 1, "hm": 6, "validity": 5, "twenty": 4, "6317": 1, "11": 8, "9": 9, "met": 2, "inclusion": 7, "criteria": 13, "usual": 11, "reaching": 2, "statitistical": 1, "significance": 4, "trended": 2, "credible": 1, "cri": 3, "0.55": 3, "1.08": 6, "0.76": 2, "0.49": 3, "1.18": 4, "tm24/7": 1, "0.20": 1, "exclusion": 3, "rendered": 1, "comparisons": 5, "statistically": 6, "beneficial": 15, "hospitalisations": 4, "packages": 2, "related": 31, "acceptable": 3, "reducing": 6, "where": 1, "good": 8, "likely": 20, "greater": 13, "investigation": 6, "apoptosis": 4, "canine": 2, "induced": 43, "tachycardia": 6, "participation": 5, "pacing": 10, "fully": 6, "understood": 5, "after": 19, "weeks": 22, "rapid": 3, "expressions": 1, "bax": 5, "bcl-2": 4, "caspase-3": 3, "rtq": 1, "pcr": 1, "interventricular": 2, "septum": 3, "biopsies": 3, "taken": 4, "weekly": 2, "21": 8, "beagle": 1, "dogs": 4, "genes": 11, "western": 6, "blot": 2, "fragmentation": 3, "tunel": 3, "method": 4, "autopsy": 1, "samples": 10, "unchanged": 4, "period": 27, "mrna": 11, "transiently": 1, "band": 1, "activated": 6, "caspase": 2, "paced": 3, "myocardium": 8, "assay": 3, "numbers": 1, "apoptotic": 2, "positive": 4, "detected": 2, "favour": 1, "pathogenesis": 6, "could": 21, "attributed": 1, "activation": 16, "safe": 10, "effective": 27, "pump": 12, "sternal": 1, "sparing": 1, "approach": 9, "heartmate": 12, "ii": 41, "exchange": 3, "lvads": 6, "become": 4, "widely": 3, "treating": 5, "advanced": 26, "incidence": 13, "replacement": 5, "when": 4, "driveline": 2, "injury": 8, "isolated": 17, "curative": 1, "quick": 1, "technique": 4, "avoids": 1, "redo": 2, "sternotomy": 2, "cardiopulmonary": 12, "malfunctioning": 1, "14": 12, "extubated": 2, "nominal": 1, "periprocedural": 2, "deaths": 10, "strokes": 1, "uptitration": 9, "renin": 7, "angiotensin": 33, "blocker": 25, "beta": 21, "fractions": 3, "ref": 4, "ras": 13, "\u03b2": 48, "blockers": 26, "recommended": 13, "pef": 1, "well": 35, "assesses": 1, "ras-": 5, "uptitrations": 2, "hfref": 19, "immediately": 3, "209": 1, "108": 1, "\u226540": 1, "index": 58, "\u226510": 1, "received": 6, "younger": 8, "spironolactone": 18, "often": 12, "composite": 17, "0.36": 4, "]": 6, "0.22": 1, "0.60": 3, "0.32": 4, "0.81": 5, "correction": 2, "0.54": 6, "0.31": 1, "0.93": 2, "0.027": 1, "0.65": 1, "0.39": 2, "1.09": 3, "0.101": 1, "neurohumoral": 1, "co": 15, "morbidity": 14, "burden": 5, "predicts": 4, "relationship": 20, "type": 46, "peptide": 26, "associations": 6, "inhospital": 5, "get": 2, "with": 13, "registry": 10, "bnp": 26, "ef": 30, "explored": 5, "relates": 1, "99,930": 1, "borderline": 4, "40%-49": 1, "primary": 37, "compute": 1, "odds": 17, "ratios": 16, "accounting": 3, "clustering": 1, "47,025": 1, "female": 6, "13,950": 1, "48": 9, "38,955": 1, "65": 2, "women": 15, "men": 18, "median": 33, "greatest": 1, "smallest": 1, "1,259": 1, "1,113": 1, "pg": 6, "821": 1, "732": 1, "559": 1, "540": 1, ".001": 13, "2.7": 4, "adjusting": 4, "variables": 12, "ability": 10, "predict": 10, "subgroups": 10, "heterogeneity": 1, ".47": 1, "values": 14, "presentation": 4, "children": 10, "canadian": 4, "pediatric": 5, "childhood": 3, "article": 6, "presents": 2, "recognition": 2, "infancy": 2, "adolescence": 1, "intended": 2, "practitioners": 1, "room": 1, "encounter": 1, "undiagnosed": 1, "possible": 10, "rather": 2, "already": 2, "palliation": 1, "assessment": 22, "methodology": 2, "accompanied": 7, "practical": 1, "application": 4, "online": 1, "material": 1, "work": 7, "include": 7, "involving": 5, "cognitive": 4, "relationships": 4, "read": 1, "dodson": 1, "interest": 1, "documented": 7, "physician": 23, "elderly": 6, "subsequently": 1, "month": 20, "ed": 27, "visits": 25, "intubations": 1, "declined": 12, "1996": 10, "2008": 16, "advances": 3, "hypothesize": 1, "fewer": 8, "presenting": 4, "intubated": 3, "retrospective": 12, "seen": 8, "suburban": 1, "jersey": 1, "protocol": 6, "classified": 6, "international": 5, "classification": 8, "ninth": 2, "revision": 3, "codes": 3, "for": 8, "determined": 7, "visit": 3, "percentage": 7, "student": 1, "intervals": 7, "cis": 1, "analyses": 15, "2,374,428": 1, "32,036": 1, "1.3": 5, "76": 8, "57": 2, "1.6": 5, "21%-30": 1, "coefficient": 6, "r(2": 2, "778": 1, "2.4": 3, "intubation": 2, "3.6": 1, "1.7": 6, "53": 3, "31%-68": 1, "annual": 1, "these": 20, "decreases": 6, "hemodynamic": 9, "phenotype": 12, "failing": 11, "fontan": 14, "occur": 9, "liver": 4, "hypothesized": 9, "hemodynamically": 4, "distinct": 5, "traditional": 3, "characterized": 3, "systemic": 6, "resistance": 17, "svr": 3, "seven": 8, "symptomatic": 7, "saf": 4, "underwent": 25, "catheterization": 6, "2001": 2, "constituted": 1, "fifty": 4, "predominantly": 4, "asymptomatic": 3, "pf": 4, "randomly": 9, "perform": 2, "case": 18, "classes": 1, "iii": 20, "iv": 8, "52": 2, "94": 2, "central": 6, "18": 13, "mm": 23, "hg": 18, "1,680": 1, "368": 1, "1,960": 1, "550": 1, "dyn": 1, "cm(5)/m(2": 1, "0.8": 3, "2.8": 4, "0.7": 2, "m(2": 20, "by": 4, "imaging": 9, "demonstrated": 30, "texture": 1, "96": 4, "nodularity": 1, "77": 5, "42": 4, "circulation": 7, "circulatory": 7, "derangement": 1, "features": 3, "portal": 1, "augment": 2, "output": 4, "comparison": 6, "recognized": 3, "facilitate": 6, "studied": 8, "adherence": 12, "retention": 2, "hart": 3, "902": 1, "nyha": 22, "self": 14, "counseling": 1, "208": 1, "692": 1, "1,080": 1, "final": 5, "gender": 6, "or": 16, "3.45": 1, "0.004": 6, "3.05": 1, "0.008": 4, "distance": 10, "covered": 2, "minute": 7, "walk": 8, "mwt": 3, "620": 2, "feet": 2, "2.81": 1, "0.013": 1, "80": 7, "prescribed": 4, "medications": 8, "2.61": 1, "0.018": 2, "diuretics": 7, "3.06": 1, "\u22653": 1, "morbidities": 1, "2.11": 1, "0.0001": 8, "1.94": 1, "1.90": 1, ">": 13, "1.63": 3, "indicators": 2, "status": 28, "unique": 6, "predicting": 8, "training": 37, "promotes": 2, "restoration": 2, "density": 3, "lipoprotein": 3, "properties": 2, "rationale": 3, "hdl": 12, "exerts": 3, "protective": 7, "ec": 6, "nitric": 2, "oxide": 2, "production": 7, "mediated": 13, "respective": 2, "molecular": 10, "pathways": 11, "16": 12, "healthy": 11, "hdl(healthy": 3, "hdl(nyha": 5, "iiib": 6, "ecs": 1, "incubated": 1, "phosphorylation": 12, "enos": 4, "ser(1177": 2, "thr(495": 2, "pkc": 2, "\u03b2ii": 2, "ser(660": 1, "p70s6k": 1, "ser(411": 1, "bound": 3, "malondialdehyde": 2, "quantified": 5, "flow": 24, "dilatation": 13, "proteome": 2, "particles": 1, "profiled": 1, "shotgun": 2, "lc": 1, "ms": 39, "incubation": 1, "triggered": 2, "p70s6": 1, "k": 3, "amount": 2, "improvement": 37, "demonstrate": 6, "determination": 3, "predictive": 9, "cutoff": 6, "testing": 16, "survival": 43, "successfully": 4, "to": 3, "best": 3, "knowledge": 3, "first": 31, "done": 5, "prescriptive": 1, "obtained": 9, "99": 2, "dyspnea": 2, "71.1": 1, "10.3": 1, "50": 17, "died": 6, "survivors": 7, "64.26": 1, "11.42": 1, "72.83": 1, "11.07": 1, ".002": 2, "optimal": 10, "2300": 1, "85.9": 1, "sensitivity": 9, "39.1": 1, "specificity": 4, "curve": 5, "0.639": 1, ".044": 1, "furthermore": 7, "especially": 7, "required": 8, "confirm": 4, "novel": 16, "mice": 30, "hypertensive": 9, "infusion": 9, "nephrectomy": 1, "salt": 7, "loading": 5, "hhd": 4, "useful": 8, "investigate": 12, "pathophysiology": 11, "therapeutic": 24, "targets": 9, "simple": 5, "experimental": 6, "procedures": 13, "phenotypes": 2, "established": 7, "aimed": 12, "develop": 11, "combining": 3, "uninephrectomy": 4, "ang": 6, "eight": 4, "week": 12, "old": 8, "c57bl/6": 1, "treated": 38, "at": 30, "ans": 5, "parameters": 10, "wk": 10, "fractional": 5, "shortening": 10, "lung": 5, "reproducible": 1, "perioperative": 1, "fibrosis": 7, "oxidative": 6, "stress": 15, "gtpase": 1, "rac1": 1, "activity": 25, "upregulated": 2, "might": 4, "transition": 4, "compensated": 3, "troponin": 3, "t": 7, "biomarker": 7, "atherosclerosis": 6, "communities": 2, "various": 7, "projected": 1, "largest": 2, "coming": 1, "decades": 4, "therefore": 15, "prediction": 13, "ctnt": 6, "incident": 7, "aric": 4, "race": 19, "laboratory": 8, "report": 16, "antihypertensive": 1, "medication": 13, "former": 2, "smoking": 2, "prevalent": 3, "9868": 1, "receiver": 2, "operating": 2, "characteristic": 3, "auc": 7, "integrated": 3, "discrimination": 3, "net": 4, "reclassification": 5, "nri": 1, "fit": 6, "described": 5, "over": 5, "10.4": 2, "970": 1, "adding": 2, "statistical": 5, "aucs": 2, "0.040": 1, "0.057": 1, "continuous": 6, "nris": 1, "50.7": 1, "54.7": 1, "interestingly": 5, "simpler": 1, "incorporated": 1, "provides": 6, "excellent": 4, "temporary": 3, "rv": 23, "insertion": 3, "lvad": 24, "historically": 1, "consisting": 2, "cardiogenic": 3, "shock": 7, "biventricular": 8, "hybrid": 1, "centrimag": 3, "rvad": 3, "conjunction": 2, "2006": 4, "preoperative": 9, "demographics": 3, "operative": 1, "139": 1, "34": 2, "duration": 14, "11.9": 1, "range": 15, "56": 4, "91.8": 1, "31": 7, "rvads": 1, "explanted": 1, "95.2": 1, "88.2": 1, "87": 1, "favorable": 6, "should": 2, "eligibility": 3, "requirement": 3, "stage": 19, "bridge": 3, "btt": 6, "ineligible": 2, "destination": 2, "dt": 5, "cost": 17, "effectiveness": 17, "types": 3, "heartware": 3, "systematically": 3, "scientific": 1, "june": 5, "approximately": 8, "2900": 1, "200": 4, "economic": 9, "evaluations": 4, "simulation": 3, "per": 27, "policy": 3, "complications": 14, "frequent": 2, "86": 4, "78": 4, "currently": 3, "limits": 3, "historical": 1, "standard": 17, "number": 13, "regions": 3, "tend": 1, "longer": 2, "mutually": 1, "exclusive": 1, "conclude": 2, "sufficient": 3, "regardless": 3, "carefully": 3, "program": 17, "infrastructure": 1, "budget": 2, "adequate": 3, "gaps": 2, "lack": 8, "mandatory": 2, "twist": 4, "strain": 13, "porcine": 2, "bivp": 6, "improves": 20, "response": 26, "variable": 2, "necessitating": 1, "understanding": 6, "accordingly": 2, "speckle": 1, "tracking": 2, "ste": 4, "analyze": 6, "overload": 12, "rvpo": 3, "materials": 3, "nine": 2, "pigs": 4, "inferior": 2, "vena": 1, "cava": 1, "ivc": 3, "snared": 2, "establish": 2, "initiated": 4, "echocardiograms": 4, "midpapillary": 2, "varying": 5, "atrioventricular": 1, "delay": 6, "avd": 3, "vvd": 3, "regional": 2, "circumferential": 2, "cs": 8, "radial": 3, "rs": 9, "base": 2, "apex": 3, "occlusion": 6, "apical": 2, "basal": 4, "rotations": 1, "synchrony": 5, "indices": 6, "mixed": 5, "linear": 6, "rotation": 1, "variations": 1, "wall": 11, "septal": 2, "variation": 9, "chest": 2, "noninvasive": 3, "surrogates": 1, "contributions": 4, "reflect": 1, "postsystolic": 1, "mitral": 36, "stenosis": 7, "reversed": 7, "reported": 9, "develops": 2, "ring": 7, "annuloplasty": 4, "regurgitation": 7, "annular": 11, "size": 9, "valve": 25, "tethering": 3, "restricting": 2, "anterior": 5, "leaflet": 7, "opening": 6, "posteriorly": 2, "displaced": 2, "papillary": 2, "muscles": 3, "man": 5, "history": 12, "successful": 8, "plasty": 7, "degenerative": 7, "later": 7, "another": 7, "dynamic": 6, "acting": 2, "prolapse": 3, "4/6": 1, "holosystolic": 1, "murmur": 1, "third": 2, "sound": 2, "120/70": 1, "p3": 1, "chordal": 1, "ruptures": 1, "triangular": 1, "resection": 2, "edge": 5, "anastomosis": 2, "physio": 1, "edwards": 1, "lifesciences": 1, "irvine": 1, "ca": 1, "disappeared": 4, "postoperative": 7, "confirmed": 6, "sized": 1, "71": 4, "0.70": 8, "mva": 10, "cm2": 6, "gradient": 4, "4.4": 3, "fig": 3, "1a": 1, "continuity": 6, "equation": 2, "\u00d7": 2, "velocity": 15, "integral": 2, "wave": 5, "utilized": 2, "concerns": 1, "191/104": 1, "mellitus": 10, "3/6": 1, "murmurs": 2, "audible": 1, "84": 8, "resulting": 7, "8.4": 1, "1b": 1, "angiography": 7, "lesions": 5, "branches": 1, "diagnosed": 9, "motions": 1, "restricted": 4, "clear": 5, "organic": 2, "lesion": 2, "etiology": 7, "discussed": 5, "possibility": 2, "considered": 10, "respond": 1, "consequently": 1, "vasodilators": 1, "started": 3, "symptom": 5, "140/80": 1, "repeated": 5, "66": 5, "disappearance": 1, "4.6": 2, "1c": 1, "direct": 5, "observation": 2, "rheumatic": 3, "causes": 7, "modestly": 6, "reasons": 14, "restriction": 6, "motion": 1, "degree": 2, "closure": 3, "vary": 4, "considerably": 1, "second": 7, "indicative": 5, "insignificant": 1, "indications": 3, "need": 13, "configurations": 1, "subvalvular": 1, "opposed": 1, "fixed": 2, "demonstrates": 2, "thus": 11, "clinic": 8, "outpatients": 8, "most": 5, "inpatient": 7, "available": 10, "complex": 10, "set": 2, "routinely": 4, "collected": 5, "derived": 14, "severity": 3, "hfpsi": 6, "university": 5, "michigan": 1, "um": 4, "1,536": 1, "314": 1, "reached": 3, "externally": 1, "validated": 6, "ann": 1, "arbor": 1, "veterans": 2, "affairs": 1, "va": 10, "445": 1, "106": 1, "rt": 4, "486": 1, "141": 1, "arbitrary": 1, "start": 2, "date": 4, "urea": 1, "nitrogen": 1, "flutter": 1, "concordance": 1, "statistics": 3, "cohorts": 4, "0.71/0.68/0.74": 1, "kaplan": 3, "meier": 3, "curves": 2, "log": 2, "rank": 3, "8%/12%/12": 1, "57%/58%/79": 1, "uses": 1, "readily": 1, "allocate": 1, "specialized": 1, "progresses": 1, "esrd": 10, "danish": 2, "onset": 23, "dialysis": 13, "kidney": 14, "epidemiology": 5, "collaboration": 4, "grouped": 2, "egfr)-group": 1, "\u226560": 1, "1.73": 6, "59": 5, "29": 2, "constructed": 4, "8204": 1, "70": 7, "q": 4, "61": 4, "egfr": 14, "68": 5, "51": 4, "85": 3, "forty": 2, "1.3/1000": 1, "uncontrolled": 2, "p=0.049": 1, "p=0.016": 1, "rare": 3, "comparable": 5, "kansas": 6, "city": 7, "questionnaire": 11, "valid": 3, "measure": 13, "exists": 4, "kccq": 11, "dichotomized": 1, "ef\u2264": 1, "ef\u226550": 1, "commonly": 2, "criterion": 1, "summary": 9, "domains": 5, "spearman": 1, "anova": 1, "terms": 3, "scores": 14, "covariate": 1, "adjustment": 11, "internal": 5, "reliability": 5, "cronbach": 2, "\u03b1": 3, "849": 1, "r=-0.62": 1, "r=-0.55": 1, "p=0.27": 1, "category": 1, "0": 3, "25=13.8": 1, "50=59.1": 1, "75=73.8": 1, "100=77.8": 1, "p=0.37": 1, "consistency": 2, "\u03b1=0.96": 1, "\u22650.69": 1, "subdomains": 1, "seems": 2, "offers": 1, "future": 15, "replicate": 1, "establishment": 1, "responsiveness": 3, "soluble": 4, "concentrations": 5, "interleukin": 1, "receptor": 43, "family": 5, "member": 2, "st2": 12, "s)st2": 1, "doses": 5, "bb": 14, "affect": 5, "sst2": 13, "151": 1, "subjects": 23, "attributable": 3, "post": 25, "hoc": 1, "taking": 3, "regimen": 1, "\u226435": 3, "35": 8, "ng": 5, "achieved": 5, "daily": 4, "equivalent": 3, "metoprolol": 22, "succinate": 1, "titrated": 2, "lowest": 3, "0.53": 2, "p=0.001": 3, "p=0.003": 1, "those": 1, "intermediate": 6, "1.19": 2, "2.08": 1, "6.77": 1, "p=0.18": 2, "exerted": 1, "measurement": 14, "nitroxyl": 2, "hno": 5, "donor": 3, "angeli": 1, "inotropic": 3, "lusitropic": 1, "vasodilator": 1, "vivo": 8, "camp": 9, "usefulness": 5, "chemical": 1, "instability": 2, "cogeneration": 1, "nitrite": 1, "here": 5, "pure": 3, "cxl-1020": 6, "myoctyes": 1, "intact": 1, "converts": 1, "solely": 3, "inactive": 1, "cxl-1051": 1, "t1/2": 1, "minutes": 8, "myocytes": 3, "dependently": 1, "sarcomere": 2, "210": 1, "500": 1, "\u03bcmol": 1, "\u224830": 1, "rise": 3, "ca(2": 7, "transient": 2, "inhibition": 21, "kinase": 8, "guanylate": 1, "cyclase": 2, "contractile": 10, "unlike": 1, "isoproterenol": 2, "equally": 3, "anesthetized": 1, "microembolization": 1, "oxygen": 16, "consumption": 8, "27": 7, "maximal": 8, "power": 3, "conscious": 4, "tachypacing": 1, "contractility": 5, "elastance": 8, "venoarterial": 1, "dilation": 1, "minimally": 1, "stroke": 19, "arterial": 24, "echocardiographic": 20, "reverse": 11, "would": 11, "robust": 3, "multiparametric": 2, "score": 35, "334": 1, "224": 1, "65\u00b112": 1, "create": 2, "\u226515": 1, "57\u00b122": 1, "n=161": 1, "pre": 10, "dimension": 2, "3.1": 5, "cm": 3, "-7": 1, "cm(2": 2, "10.0": 1, "cm(2)/m(2": 1, "\u226535": 2, "allowed": 1, "79": 3, "134": 2, "transplantations": 1, "implantations": 1, "93": 4, "0.97": 5, "0.95": 2, "0.98": 7, "0.96": 6, "initial": 5, "helpful": 1, "selecting": 3, "undergo": 2, "aldosterone": 12, "antagonists": 10, "shown": 10, "newly": 6, "kaiser": 1, "permanente": 1, "northern": 1, "excluded": 6, "creatinine": 4, "2.5": 6, "potassium": 7, "5.0": 5, "meq": 1, "l.": 2, "covariates": 5, "hyperkalemia": 14, "2,538": 1, "521": 1, "22": 5, "adjusted": 29, "0.91": 5, "1.44": 1, "crude": 4, "3.5": 4, "fold": 6, "diverse": 2, "community": 7, "risks": 3, "blockade": 10, "prevents": 3, "angiogenesis": 6, "contributes": 4, "progression": 10, "vegf": 6, "signaling": 17, "crucial": 7, "compensatory": 1, "importantly": 8, "adrenergic": 11, "perfusion": 5, "enhancing": 2, "neoangiogenesis": 1, "surgically": 2, "rats": 21, "bisoprolol": 3, "vehicle": 3, "diameters": 1, "moreover": 8, "akt": 1, "synthase": 1, "comparing": 1, "drug": 9, "untreated": 2, "proangiogenic": 1, "act": 2, "pathway": 11, "intravenously": 1, "injected": 2, "adenoviral": 1, "vector": 1, "encoding": 2, "decoy": 1, "ad": 4, "flk": 2, "adenovirus": 1, "b.": 1, "histological": 2, "capillary": 3, "plus": 8, "counteracted": 1, "enhancement": 4, "do": 2, "influences": 5, "eds": 5, "1999": 3, "responsible": 3, "n=44": 1, "925": 1, "76.4": 1, "cases": 11, "comorbidities": 8, "54.5": 1, "medium": 3, "61.8": 1, "aor": 8, "1.16": 3, "1.10\u20131.23": 1, "73.6": 1, "1.95": 2, "1.83\u20132.07": 1, "released": 2, "22.0": 1, "44.9": 1, "16.3": 1, "0.73\u20130.90": 1, "35.3": 1, "0.79": 3, "0.73\u20130.86": 1, "0.61\u20130.78": 1, "30.2": 1, "0.61\u20130.74": 1, "24.3": 1, "21.9": 2, "0.76\u20130.91": 1, "18.1": 1, "0.70\u20130.85": 1, "worse": 6, "driven": 5, "repeat": 3, "xanthine": 2, "oxidase": 3, "preserves": 1, "xo": 5, "rat": 5, "vo": 1, "aortocaval": 1, "fistula": 1, "acf": 6, "atp": 8, "demand": 1, "ros": 2, "mitochondrial": 24, "respiration": 3, "cardiomyocyte": 2, "bioenergetics": 1, "sprague": 1, "dawley": 1, "sham": 13, "allopurinol": 3, "100": 13, "mg\u00b7kg(-1)\u00b7day(-1": 1, "\u22657": 1, "efficiency": 4, "depressed": 3, "absence": 5, "maximum": 2, "o2": 4, "extracellular": 5, "flux": 1, "analyzer": 1, "paralleled": 1, "attenuation": 5, "possibly": 5, "diminishing": 1, "myofilament": 1, "explain": 2, "hospitalizations": 11, "assessing": 2, "transmitral": 4, "annulus": 3, "e": 32, "unreliable": 1, "estimating": 3, "wedge": 2, "pcwp": 4, "130": 4, "sided": 1, "transthoracic": 1, "velocities": 2, "systole": 3, "diastole": 3, "e'septal": 4, "e'lateral": 2, "0.41": 1, "e'mean": 1, "estimation": 2, "0.72": 1, "0.63": 6, "0.82": 2, "elateral": 1, "emean": 2, "eseptal": 1, "s'septal": 1, "qrs": 16, "width": 1, "negative": 7, "89": 4, "likelihood": 2, "0.15": 1, "diagnostic": 18, "s'lateral": 2, "4.5": 2, "0.71": 3, "\u22644.5": 1, "0.38": 1, "detecting": 3, "tricuspid": 3, "plane": 2, "excursion": 2, "abstract": 2, "echo": 3, "pasp": 21, "tapse": 12, "basic": 2, "carrying": 1, "two-": 1, "threefold": 1, "fiber": 2, "force": 5, "generated": 2, "length": 13, "disclosing": 1, "hundred": 3, "ninety": 1, "247": 1, "46": 2, "brain": 7, "tracked": 2, "20.8": 1, "mo": 1, "downward": 2, "line": 3, "nonsurvivors": 2, "along": 2, "given": 10, "collinearity": 1, "separate": 4, "individual": 6, "form": 7, "retained": 1, "follows": 1, "/\u2265": 3, "mmhg": 1, "5.1": 4, "4.1": 1, "shows": 3, "shifted": 2, "resolution": 1, "step": 2, "forward": 2, "efficient": 1, "affected": 2, "bottleneck": 6, "stent": 8, "ischemia": 7, "animal": 3, "one-": 1, "vessel": 5, "coated": 1, "polytetrafluoroethylene": 1, "tube": 1, "formed": 3, "shape": 1, "proximal": 6, "descending": 3, "lad": 7, "circumflex": 1, "lcx": 6, "mid": 1, "5": 21, "infarct": 1, "collateral": 3, "antiarrhythmic": 4, "prevent": 4, "sudden": 9, "timing": 4, "modulated": 2, "antiplatelet": 4, "reserve": 6, "positron": 1, "emission": 1, "tomography": 1, "stenting": 4, "covering": 1, "complete": 3, "necessary": 2, "mostly": 3, "competitive": 1, "patterns": 2, "64": 3, "41": 3, "44": 8, "infarcted": 4, "32": 2, "reversible": 4, "occluded": 2, "feasible": 5, "selective": 3, "ivabradine": 14, "unloads": 1, "reduces": 3, "afterload": 3, "ea": 9, "represents": 3, "resistive": 1, "pulsatile": 2, "relation": 5, "modulates": 2, "inhibitor": 9, "275": 1, "132": 1, "143": 2, "7.5": 1, "twice": 5, "substudy": 3, "compliance": 10, "tac": 13, "ees": 6, "arm": 3, "cuff": 1, "sv": 3, "differ": 6, "ivabradine-": 1, "marked": 6, "coupling": 11, "markedly": 2, "0.002": 5, "unloading": 1, "contribute": 10, "albumin": 9, "undergoing": 13, "hypoalbuminemia": 7, "indicator": 2, "272": 1, "institution": 3, "125": 1, "concentration": 3, "\u22653.5": 1, "147": 1, "93.2": 1, "82.4": 1, "88.4": 1, "75.2": 1, "0.521": 1, "0.290": 1, "0.934": 1, "0.029": 1, "normalization": 3, "subgroup": 6, "81": 1, "decreasing": 2, "92.6": 1, "63.6": 1, "65.0": 1, "correcting": 1, "nutrition": 2, "hepatic": 1, "aortic": 16, "insufficiency": 2, "ai": 7, "encountered": 2, "instituting": 1, "mechanical": 8, "cf": 4, "algorithms": 1, "de": 1, "novo": 1, "from": 5, "271": 2, "225": 1, "203": 1, "thoratec": 1, "corp": 1, "pleasanton": 1, "calif": 1, "hvad": 1, "intl": 1, "inc": 1, "framingham": 2, "failed": 2, "bioprosthetic": 2, "dacron": 1, "patch": 1, "repairs": 1, "transcatheter": 2, "procedure": 6, "experienced": 8, "postoperatively": 2, "multiorgan": 1, "sepsis": 1, "oversewing": 1, "restoring": 2, "safely": 3, "difficult": 1, "offer": 2, "invasive": 4, "alternatives": 1, "conventional": 2, "young": 12, "charm": 1, "programme": 5, "candesartan": 1, "69": 7, "\u226570": 4, "youngest": 6, "obese": 14, "oldest": 2, "23": 4, "black": 6, "ethnicity": 2, "idiopathic": 7, "62": 4, "adhere": 1, "nonadherence": 2, "intake": 2, "dietary": 8, "radiological": 2, "categories": 6, "13": 9, "referent": 1, "1.00": 6, "0.049": 2, "0.42": 3, "0.186": 1, "ages": 1, "divergent": 1, "striking": 1, "counterparts": 1, "yet": 8, "fatal": 4, "nonfatal": 1, "discordant": 1, "nordic": 5, "walking": 7, "rehabilitation": 12, "compare": 4, "centre": 5, "parallel": 5, "54": 3, "aged": 13, "62.4": 1, "11.4": 2, "26.9": 1, "assigned": 6, "400": 1, "6mwt": 2, "\u03b4": 8, "125.6": 2, "59.4": 1, "57.0": 1, "71.3": 1, "travelled": 1, "physical": 9, "158.5": 1, "118.5": 1, "155.5": 1, "grip": 4, "2.3": 2, "0.3": 3, "0.026": 1, "depressive": 2, "anxiety": 2, "depression": 8, "-1.7": 1, "0.014": 2, "aerobic": 8, "waist": 1, "circumference": 1, "superior": 3, "modality": 1, "promising": 5, "alternative": 7, "complicating": 3, "precapillary": 3, "tools": 6, "ph": 4, "experiencing": 2, "leads": 1, "shortens": 1, "lvet": 7, "tonometry": 3, "carries": 3, "biologic": 1, "icu": 6, "deterioration": 4, "reconstructed": 1, "stay": 9, "shorter": 3, "unfavorable": 2, "228": 1, "milliseconds": 5, "25th-75th": 1, "percentiles": 1, "212": 1, "278": 1, "257": 1, "237": 2, "277": 1, ".032": 1, "tonometric": 1, "entry": 1, "73": 5, "identifying": 3, "other": 3, "natremia": 1, "dobutamine": 2, "furosemide": 2, "norepinephrine": 3, "90": 6, "shortened": 1, "previously": 6, "myxoma": 2, "complicated": 1, "embolism": 6, "myxomas": 2, "benign": 1, "tumors": 1, "located": 2, "atrium": 4, "rarely": 1, "embolize": 1, "vasculature": 1, "massive": 1, "arteries": 2, "removal": 1, "embolectomy": 1, "presented": 2, "causing": 1, "stenotic": 1, "physiology": 1, "completed": 5, "partially": 7, "obstructed": 1, "tactics": 1, "brief": 3, "hypothermic": 1, "arrest": 3, "uneventful": 1, "recovery": 5, "retest": 3, "timed": 2, "up": 2, "&": 2, "go": 2, "organ": 1, "tug": 3, "copd": 4, "crf": 11, "sectional": 1, "environment": 1, "n=235": 1, "70y": 1, "interquartile": 6, "77y": 1, "25.6kg": 1, "22.8": 1, "29.4kg": 1, "n=95": 1, "n=68": 1, "n=72": 1, "applicable": 1, "assessors": 1, "intraclass": 1, "icc": 2, "kappa": 2, "error": 3, "minimal": 2, "detectable": 1, "mdc": 4, "ranging": 4, ".85": 1, ".98": 1, "coefficients": 1, "3.00": 1, "-4.94s": 1, "p<.01": 1, "information": 5, "seconds": 2, "mdc95": 1, "mdc95%%": 1, "populations": 5, "define": 2, "expected": 5, "true": 1, "rheumatoid": 2, "arthritis": 2, "starting": 1, "tnf": 6, "antagonist": 11, "elevations": 2, "tumor": 1, "necrosis": 1, "tnf)\u03b1": 1, "several": 10, "worsening": 8, "recurrent": 1, "receiving": 15, "treat": 2, "ra": 3, "us": 1, "healthcare": 4, "methotrexate": 1, "enter": 1, "switched": 1, "biological": 8, "modifying": 1, "antirheumatic": 1, "nbdmard": 3, "stratified": 2, "propensity": 3, "oral": 2, "glucocorticoid": 1, "dosage": 1, "loop": 2, "8656": 1, "users": 14, "587": 1, "0.85": 8, "1.14": 1, "but": 1, "2002": 1, "2.17": 2, "0.45": 3, "10.50": 1, "p=0.036": 1, "glucocorticoids": 1, "1\u22645": 1, "1.30": 2, "1.85": 1, "\u22655": 1, "2.19": 1, "nbdmards": 1, "people": 3, "climate": 1, "nhs": 1, "behavioural": 1, "facilities": 2, "challenge": 1, "participatory": 1, "result": 9, "undertaken": 3, "satisfaction": 2, "sustainability": 2, "others": 3, "showing": 1, "minor": 1, "anecdotal": 1, "perceived": 4, "expressed": 8, "participant": 2, "responses": 5, "commissioning": 1, "hospital-": 1, "completion": 2, "frailty": 13, "aging": 2, "aim": 7, "abc": 3, "battery": 4, "habc": 3, "gill": 2, "2825": 1, "74": 3, "white": 3, "7.1": 1, "11.7": 1, "466": 1, "frail": 4, "1.36": 2, "3.47": 1, "linearly": 1, "1.24": 4, "1.13": 3, "sd": 16, "competing": 2, "1.55": 1, "sub": 2, "0.010": 1, "appropriately": 2, "reclassified": 1, "13.4": 1, "0.073": 1, "0.021": 1, "0.125": 1, ".006": 2, "8.3": 1, "vasopressin": 6, "abnormalities": 9, "interruption": 1, "inhibitors": 18, "sympathetic": 15, "nervous": 3, "excessive": 2, "secretion": 1, "arginine": 1, "avp": 2, "deleterious": 2, "physiologic": 1, "nfat": 3, "mir-25": 3, "cooperate": 1, "reactivate": 1, "hand2": 6, "aberrant": 1, "reactivation": 1, "embryonic": 3, "programs": 9, "intricately": 1, "linked": 6, "pathological": 9, "driving": 1, "ill": 1, "calcineurin": 1, "signalling": 7, "integrate": 3, "express": 1, "helix": 2, "bhlh": 2, "dhand": 1, "mutant": 3, "overexpressing": 3, "otherwise": 2, "muscle": 18, "conversely": 2, "conditional": 1, "targeted": 6, "induction": 6, "fetal": 1, "antagomir": 1, "evoked": 1, "spontaneous": 4, "sensitized": 1, "murine": 3, "manner": 1, "cascades": 1, "micrornas": 3, "induce": 2, "postnatal": 1, "mammalian": 3, "hungary": 1, "occurs": 4, "neuro": 1, "hormonal": 1, "converting": 10, "enzyme": 10, "intolerance": 4, "mineralocorticoid": 4, "neglected": 1, "past": 3, "irs1": 8, "irs2": 8, "p38alpha": 1, "mapk": 1, "insulin": 17, "links": 1, "hallmark": 3, "substrates": 1, "components": 4, "regulating": 1, "metabolism": 10, "hyperinsulinemia": 1, "knockout": 2, "h": 3, "dko": 4, "diminished": 3, "akt\u2192forkhead": 1, "box": 1, "o-1": 1, "metabolic": 11, "content": 4, "p38\u03b1": 1, "mitogen": 1, "p38": 2, "neonatal": 1, "exposure": 3, "prevented": 3, "action": 15, "revealing": 1, "insights": 2, "ncdr": 1, "pinnacle": 1, "site": 5, "innovation": 1, "excellence": 1, "december": 3, "contraindications": 1, "hierarchical": 1, "insurance": 3, "describes": 3, "556": 1, "45": 9, "unadjusted": 1, "prescription": 1, "ranged": 2, "75%-89": 1, "92": 5, "83%-95": 1, "66%-85": 1, "1.11": 3, "1.05": 4, "1.17": 2, "1.26": 2, "addressing": 1, "trastuzumab": 11, "cardiotoxicity": 9, "breast": 6, "cancer": 8, "adjuvant": 1, "manifested": 1, "full": 5, "coverage": 1, "i": 4, "chemotherapy": 5, "seer": 1, "texas": 1, "version": 3, "coding": 2, "descriptive": 4, "9,535": 1, "2,203": 1, "23.1": 1, "entire": 1, "29.4": 1, "18.9": 1, "nontrastuzumab": 2, "1.75": 1, "1.53": 1, "2.10": 1, "1.82": 1, "1.34": 3, "2.48": 1, "1.50": 2, "administration": 9, "1.33": 2, "1.68": 1, "trastuzumb": 1, "frequency": 7, "plays": 1, "mediterranean": 5, "dash": 11, "diet": 24, "initiative": 8, "stop": 2, "postmenopausal": 1, "last": 3, "august": 1, "food": 2, "questionnaires": 1, "behaviors": 1, "calculate": 1, "1385": 1, "3215": 1, "43.1": 1, "0.89": 2, "quartiles": 2, "trend=0.08": 1, "1.04": 1, "1.21": 1, "trend=0.01": 1, "vegetables": 1, "nuts": 1, "whole": 1, "grain": 1, "nonsignificant": 2, "trend": 8, "toward": 6, "concept": 2, "cardioprotective": 3, "investigating": 7, "2331": 2, "0.35": 2, "subset": 3, "910": 1, "evaluable": 1, "23.7": 1, "18.6": 1, "31.8": 1, "univariable": 1, "1.48": 2, "p<0.0001": 5, "2.14": 2, "2.33": 1, "log2": 1, "amino": 1, "add": 2, "statistic": 1, "ten": 2, "extended": 2, "ecct": 8, "expand": 2, "pool": 2, "matching": 3, "donors": 2, "typically": 2, "comorbidity": 1, "paucity": 1, "examining": 2, "prespecified": 1, "contributing": 3, "assignment": 2, "454": 1, "18.5": 1, "66.6": 1, "53.2": 1, "46.4": 1, "24.6": 1, "61.6": 1, "p=0.035": 3, "listing": 1, "0.1": 3, "select": 2, "determinants": 1, "part": 5, "characterize": 2, "assessments": 4, "center": 9, "chart": 3, "discharges": 1, "connecticut": 2, "398": 1, "79.9": 1, "45.9": 1, "thirty": 5, "27.5": 1, "19.1": 2, ".024": 1, "19.6": 1, "46.9": 1, ".01": 2, "eighty": 1, "cardiologist": 1, "practitioner": 1, "drawn": 1, "changed": 4, "only": 2, "discrepancy": 1, "magnetic": 10, "resonance": 11, "postcontrast": 3, "t1": 18, "incompletely": 1, "matrix": 4, "accumulation": 2, "thought": 1, "aims": 6, "estimate": 2, "mapping": 8, "pathobiology": 1, "suspected": 1, "n=100": 1, "confirmatory": 2, "sixty": 2, "entered": 1, "phase": 8, "22.9\u00b15.0": 1, "0.99": 6, "p=0.046": 1, "1.03": 4, "p<0.01": 5, "p=0.03": 5, "times": 4, "388.3": 1, "rest": 4, "n=9": 1, "tissuefaxs": 1, "technology": 3, "r=0.98": 1, "r=-0.36": 1, "r=0.28": 1, "p=0.01": 3, "preliminary": 5, "suggesting": 5, "chelation": 3, "choices": 2, "thalassaemia": 1, "verify": 3, "arrhythmias": 2, "t2": 2, "regimens": 1, "remove": 1, "efficiently": 1, "influence": 4, "remarkable": 2, "recommend": 2, "prolongation": 3, "\u226430": 2, "reverses": 1, "n=177": 1, "n=431": 1, "blinded": 2, "core": 1, "on": 5, "off": 1, "p=0.06": 1, "-6.7": 1, "21.1": 1, "2.1": 3, "17.6": 1, "50.5": 1, "42.4": 1, "p=0.04": 4, "prolonged": 4, "0.26": 1, "p=0.012": 1, "p=0.02": 4, "0.58": 2, "p=0.047": 1, "produced": 7, "titin": 8, "hypophosphorylation": 3, "obesity": 3, "dd": 5, "collagen": 7, "deposition": 2, "modification": 6, "investigated": 11, "zsf1": 8, "wistar": 2, "kyoto": 1, "n=11": 4, "lean": 7, "euthanization": 1, "linking": 1, "isoforms": 2, "resting": 8, "tension": 1, "fpassive)-sarcomere": 1, "strips": 1, "kcl": 1, "ki": 1, "unanchors": 1, "allows": 2, "fpassive": 1, "discerned": 1, "obvious": 1, "strip": 1, "\u00b180": 1, "specifically": 4, "s3991": 1, "elastic": 1, "n2bus": 1, "segment": 3, "s12884": 1, "pevk": 1, "span": 1, "contributed": 3, "gls": 7, "sensitive": 4, "mechanics": 1, "cv": 10, "af": 23, "196": 1, "persistent": 2, "referred": 3, "beat": 6, "hospitalisation": 3, "1.121": 1, "1.023": 1, "1.228": 1, "p=0.014": 1, "outperformed": 1, "sa": 3, "univariate": 4, "\u2264": 4, "0.043": 1, "besides": 2, "containing": 3, "\u2265": 5, "p=0.022": 1, "parameter": 1, "stronger": 1, "morphology": 4, "defibrillation": 2, "raft": 1, "usually": 2, "separately": 3, "ecg": 3, "pacemaker": 1, "ecgs": 2, "panel": 2, "electrocardiographers": 1, "1483": 1, "1175": 1, "lbbb": 6, "308": 1, "extent": 5, "\u2265160": 2, "0.52": 1, "0.29": 1, "p=0.033": 1, "160": 2, "0.88": 3, "p=0.155": 1, "broader": 3, "delayed": 3, "refractory": 7, "peritoneal": 2, "series": 3, "pd": 8, "resistant": 2, "consequences": 2, "2007": 6, "pre-": 1, "initiation": 3, "24.5": 1, "6.0": 3, "majority": 5, "9/10": 1, "ckd": 1, "almost": 2, "0.016": 1, "edema": 1, "3.2": 1, "0.007": 2, "36.7": 1, "0.78": 2, "0.019": 1, "criteriabased": 1, "tolerated": 1, "easily": 1, "treatable": 1, "pdrelated": 1, "appears": 5, "viable": 1, "option": 1, "deferred": 1, "origin": 3, "heterogenous": 1, "+3.1": 1, "9.2": 2, "82": 2, "+9.2": 1, "9.5": 1, "0.038": 1, "0.047": 1, "certain": 3, "compelling": 1, "matched": 15, "worsened": 2, "sodium": 8, "multiple": 8, "srd": 4, "thirteen": 1, "consumed": 2, "mmol/2100": 1, "kcal": 1, "brachial": 4, "parametrized": 1, "formalism": 1, "yields": 1, "viscoelastic": 1, "passive": 1, "constants": 1, "inflow": 1, "contours": 1, "techniques": 2, "wilcoxon": 1, "pairs": 2, "signed": 1, "155": 2, "138": 1, "123": 2, "116": 2, "111": 1, "p=0.12": 1, "c=24.3": 1, "5.3": 1, "22.7": 1, "8.1": 1, "k=252": 1, "115": 2, "170": 1, "s(2": 1, "2.0": 2, "0.4": 3, "p=0.007": 1, "ea=1.5": 1, "resistin": 15, "humanized": 2, "mediator": 1, "monocytes": 1, "responsive": 1, "inflammatory": 10, "stimuli": 3, "connected": 1, "transgenic": 2, "retn": 6, "hum": 5, "exhibits": 1, "stimulated": 4, "humans": 3, "underlies": 1, "anthracycline": 8, "remarkably": 1, "doxorubicin": 13, "25mg": 1, "ip": 1, "littermate": 1, "expressing": 2, "retn(-/-": 2, "adhesion": 1, "macrophages": 2, "vitro": 4, "dramatic": 2, "hretn": 1, "intriguingly": 1, "elevation": 2, "implicate": 1, "link": 2, "catheter": 9, "ablation": 8, "precipitating": 1, "probability": 1, "relating": 1, "maintenance": 5, "sinus": 6, "rhythm": 21, "single-": 1, "success": 4, "33": 2, "pharmaceutically": 1, "assisted": 5, "standing": 2, "1.81": 2, "3.17": 1, "0.24": 1, "maintaining": 1, "effectively": 3, "pharmaceuticals": 1, "larger": 4, "nicorandil": 8, "ameliorates": 1, "cardioprotection": 2, "still": 7, "anti": 3, "neoplastic": 1, "cancers": 2, "obtain": 2, "orally": 1, "sacrificed": 1, "rapidly": 1, "excised": 1, "phosphocreatine": 4, "adenine": 2, "nucleotides": 2, "contents": 2, "cytochrome": 1, "bcl2": 1, "creatine": 2, "markers": 11, "together": 3, "ultrastructural": 3, "alleviating": 1, "decrement": 1, "state": 6, "interfere": 1, "cytotoxic": 1, "solid": 1, "ehrlich": 1, "carcinoma": 1, "indicated": 9, "perturbations": 4, "affecting": 3, "antitumor": 1, "grafting": 2, "cabg": 5, "swedish": 2, "web": 4, "36,284": 1, "sweden": 1, "rehospitalization": 7, "\u226490": 1, "logistic": 4, "confounders": 2, "2,462": 1, "617": 1, "1.06": 3, "became": 2, "introduced": 2, "1.76": 1, "2.25": 1, "enormous": 1, "medicine": 3, "atheromatous": 1, "paediatric": 2, "transplants": 2, "congenital": 4, "amenable": 1, "cardiomyopathic": 1, "principally": 1, "comprise": 1, "poorly": 4, "contracting": 1, "ventricles": 1, "aetiologies": 1, "particular": 1, "topics": 1, "debate": 1, "concern": 1, "myocarditis": 1, "investigations": 4, "malignant": 1, "key": 9, "erk1/2": 4, "scaffolds": 1, "pathology": 2, "detect": 3, "humoral": 1, "adaptation": 2, "sustaining": 3, "workload": 1, "mediate": 1, "maladaptive": 5, "remodelling": 7, "ultimately": 3, "activating": 5, "adaptive": 4, "paradoxically": 1, "transduction": 4, "opposing": 3, "engage": 3, "notable": 1, "example": 2, "raf": 2, "mek1/2": 2, "signalosome": 1, "scaffold": 2, "drives": 1, "assembly": 1, "kinases": 1, "sequential": 1, "targeting": 8, "effector": 1, "molecules": 1, "determining": 2, "field": 1, "capable": 1, "selectively": 1, "potentiating": 1, "amyloidosis": 1, "atypical": 1, "deals": 1, "cardiomyiopathy": 1, "angina": 1, "inducible": 1, "typical": 2, "amyloidotic": 1, "myeloma": 1, "osteomedullary": 1, "biopsy": 1, "perspective": 3, "each": 2, "strengths": 1, "utility": 1, "never": 2, "southeastern": 1, "minnesota": 7, "residents": 2, "recruited": 3, "exhaustion": 1, "slowness": 1, "unintentional": 1, "lb": 1, "deficit": 7, "proportion": 4, "223": 1, "0.75": 1, "unit": 4, "predicted": 4, "0.687": 1, "0.700": 1, "clinically": 6, "ascertained": 1, "records": 6, "ascertain": 1, "learning": 1, "shaping": 1, "disappointments": 1, "pharmacologic": 5, "therapeutics": 2, "calcium": 2, "sensitizing": 1, "endothelin": 1, "adenosine": 2, "neutral": 2, "relax": 1, "astronaut": 1, "pronto": 1, "highlighted": 1, "describe": 4, "learned": 1, "outline": 1, "perspectives": 1, "np": 7, "tool": 6, "routine": 4, "guide": 4, "developing": 4, "like": 5, "poc": 5, "contribution": 6, "delivery": 3, "appear": 2, "sufficiently": 1, "monitor": 2, "frame": 2, "consultation": 5, "accelerate": 1, "throughput": 1, "disposition": 1, "designed": 6, "redesigned": 1, "take": 1, "advantage": 2, "faster": 1, "turnaround": 1, "rethinking": 1, "services": 3, "operationalized": 1, "publicly": 1, "standardized": 3, "penalties": 1, "motivate": 1, "expansion": 2, "bromodomain": 4, "halts": 1, "consequence": 3, "hyperacetylation": 1, "now": 1, "reporting": 2, "anand": 1, "bet": 3, "bets": 6, "acetyl": 2, "lysine": 1, "reader": 1, "prevention": 6, "precedes": 1, "haemodynamic": 5, "neuronal": 1, "stressors": 1, "activate": 2, "signal": 4, "cascade": 1, "converges": 1, "interplay": 1, "epigenetic": 4, "writer": 1, "histone": 2, "acetyltransferases": 1, "erasers": 1, "deacetylases": 1, "implicated": 3, "readers": 2, "jq1": 5, "displaces": 1, "suppression": 1, "downstream": 3, "rna": 2, "polymerase": 1, "pol": 2, "neurohormonally": 1, "nanomolar": 1, "blocked": 1, "phenylephrine": 3, "brd4": 1, "tissues": 3, "profiling": 1, "cultured": 1, "abrogated": 1, "substantial": 4, "experiments": 1, "transverse": 3, "constriction": 4, "protected": 2, "toxicity": 1, "detailed": 1, "transcriptional": 2, "tac-": 1, "operated": 3, "suppresses": 1, "networks": 3, "causal": 1, "nuclear": 2, "\u03bab": 2, "nf": 1, "gata4": 1, "promoting": 2, "pause": 1, "release": 1, "implicates": 1, "biology": 1, "manipulation": 1, "abrogate": 1, "multiacquisition": 1, "mri": 3, "tidal": 3, "quantification": 2, "swine": 3, "breathing": 4, "pulse": 4, "sequence": 4, "yorkshire": 1, "pacemakers": 1, "ventricularly": 1, "beats": 1, "animals": 11, "scanned": 1, "1.5": 2, "scanner": 1, "gadolinium": 1, "chelate": 1, "contrast": 5, "scans": 1, "trichrome": 1, "blue": 1, "histologic": 1, "960": 1, "726": 1, "546": 1, "180": 2, "300": 1, "171": 1, "histologically": 1, "5.4": 1, "1.0": 3, "9.4": 2, "proposed": 1, "diffuse": 1, "breath": 2, "holding": 1, "means": 4, "inoperable": 1, "broad": 1, "assumption": 1, "3.0": 1, "124": 3, "58": 1, "hemodynamics": 1, "kilogram": 3, "1-": 1, "3-": 1, "2.56": 1, "2.84": 1, "indicate": 3, "cornerstone": 2, "scarce": 3, "interesting": 1, "concepts": 1, "evolving": 1, "functions": 3, "detection": 2, "fluid": 3, "stand": 1, "challenging": 3, "consumes": 1, "portion": 1, "commoner": 1, "lifesaving": 1, "drugs": 12, "poses": 1, "challenges": 2, "unfolded": 2, "regulates": 2, "splicing": 2, "v": 2, "voltage": 2, "gated": 2, "na+": 6, "channel": 12, "subunit": 5, "scn5a": 9, "generating": 2, "variants": 8, "truncated": 3, "nonfunctional": 1, "channels": 6, "trapped": 1, "endoplasmic": 1, "reticulum": 1, "upr": 6, "electric": 1, "pluripotent": 1, "stem": 2, "hipsc": 1, "exposed": 3, "angii": 2, "hypoxia": 2, "activators": 1, "overexpress": 1, "effectors": 1, "er": 1, "perk": 3, "calreticulin": 1, "chop": 1, "exogenous": 1, "concomitant": 3, "downregulation": 6, "destabilized": 1, "kv4.3": 2, "mrnas": 1, "cation": 1, "m7": 1, "trpm7": 1, "splice": 2, "entirely": 1, "transcript": 1, "receives": 1, "etiologic": 1, "intrinsic": 1, "concentrating": 1, "pathophysiologic": 3, "behind": 1, "pah": 3, "circumstances": 1, "provoke": 1, "decompensation": 1, "represent": 3, "mi": 12, "describing": 2, "conflicting": 2, "distinguish": 2, "temporal": 2, "olmsted": 1, "county": 1, "2,596": 1, "ever": 1, "1990": 3, "late": 5, "st": 1, "mis": 1, "killip": 1, "comorbid": 1, "715": 1, "475": 1, "age-": 4, "2004": 1, "yielded": 1, "0.66": 3, "early-": 1, "declines": 3, "indicating": 3, "mix": 1, "nonselective": 2, "hemostasis": 2, "carvedilol": 13, "123)i": 4, "iodobenzylguanidine": 1, "mibg": 3, "correlates": 3, "serve": 1, "coagulability": 1, "label": 2, "crossover": 1, "masked": 1, "homozygous": 1, "arg16": 2, "gln27": 2, "gly16": 2, "glu27": 2, "haplotype": 4, "8)": 2, "\u03b22": 4, "equipotent": 1, "dosages": 1, "periods": 3, "washout": 2, "12.9": 1, "3.9": 1, "22.1": 1, "irrespective": 4, "von": 2, "willebrand": 2, "149": 2, "157": 1, "prescribing": 3, "contextual": 8, "preferences": 8, "priorities": 1, "295": 2, "nontreatment": 1, "notes": 1, "interviews": 3, "caring": 1, "taxonomy": 2, "biomedical": 8, "nonprescribing": 3, "42%-58": 1, "11%-17": 1, "clinician": 3, "cited": 1, "50%-70": 1, "64%-70": 1, "comanagement": 1, "32%-35": 1, "15%-24": 1, "belief": 1, "12%-20": 1, "thirds": 1, "documentation": 1, "providing": 2, "parasympathetic": 7, "tone": 10, "pyridostigmine": 8, "slow": 2, "evolution": 1, "neurotransmission": 1, "acetylcholinesterase": 2, "sympathovagal": 2, "balance": 6, "elicited": 1, "os": 1, "methylatropine": 2, "propranolol": 2, "tachycardic": 1, "vagal": 4, "bradycardic": 1, "diameter": 6, "surviving": 2, "conductance": 1, "ligation": 1, "augmented": 3, "attenuating": 1, "mechanistic": 1, "insight": 4, "electromechanical": 3, "dyssynchronous": 8, "computational": 1, "electrical": 4, "aspects": 7, "behavior": 1, "geometry": 2, "sheet": 1, "orientation": 1, "handling": 3, "slowed": 1, "conduction": 2, "emd": 5, "local": 2, "depolarization": 1, "myofiber": 5, "extending": 2, "goal": 6, "nonfailing": 1, "electromechanics": 1, "combinations": 1, "represented": 4, "simulated": 1, "deranged": 1, "culprit": 1, "insignificantly": 1, "mechanistically": 2, "slows": 1, "depresses": 1, "stretch": 1, "lateral": 1, "dynamics": 3, "giving": 1, "408": 1, "skinfold": 1, "thickness": 5, "comprehensive": 1, "display": 1, "541": 1, "150": 2, "3.09": 1, "2.18": 1, "4.45": 1, "2.90": 1, "2.00": 1, "4.12": 1, "protection": 3, "coexist": 1, "additive": 4, "interrelated": 1, "wasting": 4, "surrogate": 1, "catabolism": 1, "exertional": 3, "controlling": 3, "4.2": 2, "mets": 2, "5.7": 1, "1.9": 1, "uptake": 8, "14.0": 1, "6.1": 1, "17.0": 1, "3.3": 1, "simultaneous": 2, "load": 1, "corrected": 1, "chronotropic": 1, "slower": 1, "0.34": 1, "reflected": 1, "exertion": 2, "prove": 1, "shortness": 1, "congestion": 3, "actrn12610001087044": 1, "cad": 21, "controversial": 1, "derive": 2, "validate": 1, "rule": 8, "exclude": 1, "derivation": 2, "undergone": 2, "institutions": 2, "electrocardiographic": 2, "waves": 1, "3.8": 1, "\u22652": 2, "nondiabetes": 1, "\u226555": 1, "\u226565": 1, "dyslipidemia": 1, "tobacco": 2, "4.8": 2, "\u22651": 2, "97": 2, "98": 1, "accurately": 1, "eliminate": 1, "savings": 2, "avoidance": 1, "tolvaptan": 3, "japanese": 1, "hyponatremia": 1, "united": 5, "states": 6, "japan": 2, "administered": 1, "relieve": 1, "widespread": 1, "modulate": 1, "herein": 1, "options": 5, "million": 4, "americans": 2, "failure.(1": 1, "accurate": 2, "becoming": 1, "increasingly": 3, "subject": 1, "phosphodiesterase-2": 2, "regulated": 3, "blunts": 1, "pde2": 12, "ar": 7, "cyclic": 2, "monophosphate": 2, "guanosine": 1, "cgmp": 4, "pde": 1, "superfamily": 1, "property": 1, "able": 1, "hydrolysis": 1, "mediating": 1, "immunoblotting": 1, "radioenzymatic-": 1, "fluorescence": 1, "transfer": 3, "assays": 3, "video": 1, "epifluorescence": 1, "microscopy": 2, "ca2(+": 2, "~2": 1, "catecholamine": 1, "infusions": 1, "hydrolytic": 1, "blunted": 1, "restored": 2, "overexpression": 4, "amplitude": 2, "hypertrophic": 2, "desensitizes": 1, "constitute": 1, "defense": 1, "antagonizing": 1, "drive": 1, "intracellular": 1, "antiadrenergic": 1, "eplerenone": 10, "emphasis": 3, "wrf": 5, "mmol": 9, "reason": 1, "underuse": 1, "fear": 1, "inducing": 1, "specified": 2, "5.5": 3, "discontinuation": 2, "endpoint": 5, "efficacious": 1, "monitored": 1, "medicines": 1, "nct00232180": 1, "hrqol": 7, "explore": 4, "hgb": 7, "annually": 1, "intention": 1, "principle": 3, "scales": 3, "hrqol.": 2, "subscales": 1, "rhythm-": 1, "province": 2, "qu\u00e9bec": 3, "canada": 4, "expenditures": 3, "payer": 1, "minimization": 1, "resource": 5, "utilization": 3, "ontario": 1, "costing": 1, "304": 1, "accounted": 1, "146": 1, "238": 1, "cardioversions": 1, "$": 10, "21-$96": 1, "1319": 1, "1124-$1522": 1, "offset": 2, "noncardiovascular": 2, "diagnoses": 1, "72,764": 1, "61,575-$85,145": 1, "78,767": 1, "67,101-$92,139": 1, "manage": 2, "skeletal": 7, "restorative": 1, "rich": 2, "cocoa": 2, "t2d": 2, "associate": 1, "detrimental": 2, "skm": 4, "epicatechin": 2, "taub": 1, "ramirez": 1, "sanchez": 1, "ciaraldi": 1, "perkins": 1, "murphy": 1, "naviaux": 1, "hogan": 1, "ceballos": 1, "maisel": 1, "henry": 1, "clin": 1, "trans": 1, "sci": 1, ".": 1, "43": 1, "reversal": 3, "sarcomeric": 3, "microstructure": 3, "pilot": 6, "five": 6, "erc": 3, "treadmill": 2, "vo2max": 4, "immunohistochemistry": 1, "electron": 1, "dapc": 2, "dystrophin": 1, "ordinated": 1, "fashion": 1, "myofibre": 1, "regeneration": 1, "~24": 1, "reach": 3, "warrant": 1, "rigorous": 1, "chinese": 2, "herbal": 2, "adjunctive": 3, "chm": 5, "dcm": 4, "retrieved": 2, "pubmed": 1, "1980": 1, "1887": 1, "5.88": 1, "3.92": 1, "7.85": 1, "-2.78": 1, "-5.15": 1, "-0.42": 1, "resolved": 1, "special": 3, "ethnic": 1, "paf": 18, "enzymes": 4, "volunteers": 2, "platelet": 1, "sex-": 1, "apparently": 1, "biosynthetic": 2, "lyso": 5, "acetyltransferase": 1, "[": 4, "dithiothreitol": 1, "dtt]-insensitive": 1, "cdp": 1, "choline": 1, "alkyl-2": 1, "sn": 1, "glycerol": 1, "cholinephosphotransferase": 1, "cpt": 3, "catabolic": 2, "isoenzymes": 1, "acetylhydrolase": 1, "ah": 3, "phospholipase": 1, "a2": 1, "lp": 3, "pla2": 3, "leukocytes": 1, "activities": 2, ".07": 2, ".05": 5, ".02": 3, "marginally": 2, ".1": 1, "downregulated": 1, ".004": 1, "update": 4, "feature": 1, "proven": 3, "prognostically": 1, "accepted": 1, "ven": 1, "vco2": 1, "slope": 2, "oscillatory": 1, "ventilation": 1, "eov": 1, "partial": 6, "co2": 1, "petco2": 1, "gain": 2, "interpretation": 3, "pathophysiological": 2, "underlie": 1, "aforementioned": 1, "encouraged": 1, "purposes": 1, "orthotopic": 1, "oht": 3, "institutional": 1, "acs": 5, "consultations": 3, "bridged": 2, "mt": 7, "169": 1, "inotropes": 2, "vads": 1, "0.015": 1, "operation": 2, "require": 1, "abdominal": 3, "88": 3, "vad": 10, "cent": 1, "occurring": 2, "operations": 1, "infrequent": 1, "extracorporeal": 6, "membrane": 8, "oxygenation": 5, "resuscitation": 1, "cpr": 3, "posterior": 2, "thrombotic": 1, "obstruction": 1, "situation": 2, "intensive": 3, "course": 1, "unstable": 1, "decided": 1, "team": 2, "extra": 1, "corporeal": 1, "ecmo": 8, "applied": 6, "transferred": 1, "und": 1, "bridging": 1, "reperfusion": 1, "half": 2, "relies": 1, "cardiography": 1, "discussion": 2, "hold": 1, "promise": 2, "20,812": 1, "australia": 1, "contention": 1, "australian": 2, "administrative": 2, "812": 1, "concurrent": 5, "1998": 1, "28.1": 1, "16.5": 1, "0.44": 1, "fatality": 2, "20.5": 1, "15.9": 1, "11.0": 1, "2.2": 3, "occurrence": 2, "encouraging": 1, "problem": 4, "testosterone": 9, "feasibility": 3, "intramuscular": 1, "supplementation": 2, "67.2": 1, "10.7": 1, "2.6": 1, "nmol": 1, "309": 1, "allocated": 1, "recruitment": 1, "attrition": 2, "incremental": 2, "shuttle": 2, "muscular": 2, "beck": 4, "inventory": 4, "living": 4, "injections": 1, "-1.3": 1, "leg": 1, "apparent": 3, "positively": 3, "emotional": 3, "fes": 6, "walked": 3, "zung": 2, "rated": 1, "f": 8, "21.61": 1, "8.68": 1, "6.43": 1, ".017": 1, "6.66": 1, ".015": 1, "6.25": 1, ".019": 1, "11.98": 1, "0.249": 1, ".622": 1, "tendency": 1, "3.066": 1, ".091": 1, "transforming": 2, "yield": 2, "explant": 4, "kit+": 8, "realized": 1, "instance": 1, "candidates": 1, "suffer": 1, "affects": 2, "progenitors": 1, "elucidate": 1, "regulation": 5, "scar": 1, "explants": 2, "tgf": 4, "epithelial": 2, "mesenchymal": 2, "pluripotency": 2, "shams": 1, "inhibiting": 1, "smad": 1, "2/3": 1, "molecule": 3, "marker": 1, "nanog": 1, "optimizing": 1, "periodic": 2, "originally": 2, "pulseless": 1, "pvf": 3, "60s": 1, "permanent": 1, "pb": 4, "8-": 1, "incidentally": 1, "ascending": 1, "cycle": 2, "bp": 1, "profound": 1, "paco2": 1, "cerebral": 1, "carotid": 3, "bodies": 1, "concluded": 1, "oscillations": 2, "originating": 1, "generator": 1, "anticoagulants": 3, "anticoagulation": 3, "much": 2, "clarity": 1, "multisystem": 1, "autonomic": 9, "dysbalance": 1, "apart": 1, "intestinal": 3, "permeability": 1, "absorption": 1, "overview": 3, "sonographic": 1, "gastrointestinal": 7, "disturbed": 1, "barrier": 1, "lead": 4, "anabolic": 1, "imbalance": 2, "highlights": 1, "nutritional": 2, "carbohydrates": 1, "water": 1, "micronutrients": 1, "feeding": 1, "gut": 1, "fragment": 1, "roles": 1, "great": 1, "unfavourable": 1, "indistinct": 1, "elucidated": 1, "unilateral": 3, "denervation": 2, "rabbits": 4, "dnx": 15, "chronically": 1, "instrumented": 1, "zealand": 1, "nonpace": 2, "innervated": 1, "inv": 10, "pace": 2, "baroreflex": 3, "domain": 3, "variability": 13, "hrv": 1, "spectral": 2, "lf": 1, "normalized": 3, "withdrawal": 1, "atropine": 3, "bradycardia": 1, "exacerbated": 1, "ne": 1, "narrow": 2, "wide": 2, "dyssynchrony": 2, "msec": 2, "capability": 1, "turned": 1, "stopped": 1, "futility": 1, "809": 1, "randomization": 2, "19.4": 1, "404": 1, "102": 2, "405": 1, "28.7": 1, "25.2": 1, "1.57": 1, "p=0.15": 1, "11.1": 1, "6.4": 2, "2.93": 1, "comparative": 1, "supported": 2, "divided": 5, "ecmo+vad": 5, "smaller": 2, "steady": 2, "continued": 2, "nursing": 13, "social": 6, "mandate": 1, "ensure": 2, "accountable": 1, "terminologies": 1, "makes": 1, "ratings": 2, "noc": 2, "268": 1, "top": 2, "validating": 1, "incorporating": 2, "advancement": 2, "science": 1, "highlighting": 2, "beta1": 1, "sphingosine-1": 3, "phosphate": 3, "s1pr1": 7, "reciprocal": 2, "\u03b21": 1, "\u03b21ar": 4, "coupled": 5, "receptors": 7, "actions": 4, "adenylyl": 1, "kinase-2": 2, "triggers": 1, "desensitization": 1, "classic": 1, "paradigms": 1, "\u03b21ars": 1, "s1pr1s": 1, "simply": 1, "uncovered": 1, "regulatory": 3, "hek": 1, "293": 2, "agonist": 2, "physiological": 2, "interact": 1, "postischemic": 1, "produces": 1, "counterbalance": 1, "overstimulation": 1, "urgent": 5, "alberta": 1, "alive": 1, "familiar": 5, "5336": 1, "373": 1, "855": 1, "69.2": 1, "saw": 3, "2182": 1, "9.0": 1, "unfamiliar": 3, "physician(s": 1, "exclusively": 1, "43.6": 2, "62.9": 1, "account": 1, "translational": 4, "nonetheless": 1, "halt": 1, "pka": 4, "persist": 2, "subunits": 3, "myosin": 3, "binding": 3, "ser23/24": 1, "rii\u03b1": 2, "catalytic": 1, "c\u03b1": 2, "ser96": 1, "thr197": 1, "ri": 1, "isoelectric": 1, "focusing": 1, "ri\u03b1": 3, "ser77": 2, "ser83": 3, "blots": 1, "monoclonal": 1, "antibodies": 4, "fluo": 1, "wild": 4, "phosphomimic": 1, "kd": 1, "wt": 1, "displays": 1, "modulation": 2, "repolarization": 2, "prone": 1, "qt": 5, "qtv": 5, "signifies": 1, "lability": 1, "hfvt(+": 4, "vt": 2, "hfvt(-": 3, "structurally": 1, "hnorm": 5, "surface": 1, "esmolol": 2, "isoprenaline": 2, "sdqt": 6, "rr": 3, "sdrr": 2, "adrenoceptor": 3, "fluctuations": 1, "genuine": 1, "genetic": 3, "susceptibility": 1, "haematopoietic": 2, "hct": 7, "primarily": 1, "anthracyclines": 1, "polymorphisms": 1, "candidate": 1, "homeostasis": 1, "oxidant": 1, "defence": 1, "nested": 1, "2950": 1, "1988": 1, "hope": 1, "survived": 1, "sampling": 1, "source": 1, "allogeneic": 1, "autologous": 1, "seventy": 1, "germline": 1, "178": 1, "genotyped": 2, "females": 1, "2\u00b79": 2, "0\u00b701": 4, "radiation": 1, "4\u00b77": 1, "0\u00b705": 2, "nad(p)h": 1, "rac2": 1, "rs13058338": 1, "7508t\u2192a": 1, "2\u00b78": 1, "hfe": 1, "rs1799945": 1, "63c\u2192g": 1, "2\u00b75": 1, "efflux": 1, "transporter": 2, "abcc2": 1, "rs8187710": 1, "1515g\u2192a": 1, "4\u00b73": 1, "0\u00b779": 1, "0\u00b767": 1, "0\u00b769": 1, "complicity": 1, "foundation": 3, "working": 2, "moves": 1, "exemplify": 1, "propose": 1, "definitions": 2, "distinctive": 1, "consensus": 4, "universal": 1, "uniform": 1, "nomenclature": 1, "view": 1, "foster": 1, "collaborative": 1, "conjoint": 1, "education": 3, "effort": 1, "neprilysin": 7, "preventing": 1, "breakdown": 1, "lcz696": 2, "composed": 1, "prodrug": 1, "valsartan": 2, "beginning": 1, "threatening": 2, "stabilize": 1, "summarizes": 1, "principles": 1, "progressed": 1, "purely": 1, "disorder": 2, "interconnected": 1, "accumulating": 1, "window": 1, "partly": 2, "shortcomings": 1, "dearth": 1, "guided": 2, "summarize": 1, "uniquely": 1, "capture": 1, "discuss": 2, "strict": 1, "standards": 1, "multimarker": 1, "fastest": 1, "subclass": 1, "indicates": 1, "mirnas": 5, "noncoding": 1, "rnas": 1, "regulate": 1, "untranslated": 1, "region": 3, "messenger": 1, "degradation": 1, "repression": 1, "give": 1, "condition": 2, "raas": 2, "look": 1, "newer": 2, "namely": 1, "endopeptidase": 1, "vasopeptidase": 1, "subpulmonary": 1, "acquired": 2, "exhibit": 1, "sixteen": 1, "30\u00b12": 1, "calf": 1, "31)p": 1, "spectroscopy": 1, "tertiary": 1, "referral": 1, "1.9\u00b10.1": 1, "66\u00b13": 1, "appendicular": 1, "z": 1, "-1.46\u00b10.22": 1, "poorer": 1, "max": 1, "r=0.67": 1, "p=0.004": 1, "-1.47\u00b10.21": 1, "4/16": 1, "sarcopenic": 1, "-2.0": 1, "9/16": 1, "\u2265-2.0": 1, "constant": 1, "postexercise": 1, "resynthesis": 1, "1.48\u00b10.13": 1, "2.40\u00b10.33": 1, "min(-1": 1, "psychometric": 2, "6.2": 2, "schfi": 3, "v.6.2": 3, "questioned": 1, "659": 1, "italy": 1, "cfa": 2, "original": 1, "construct": 2, "exploratory": 1, "dimensions": 1, "cfi": 3, ".92": 1, "rmsea": 3, ".95": 1, ".99": 1, "contrasting": 1, "supports": 4, "fragments": 3, "nonstandardized": 1, "misdiagnosis": 1, "forms": 4, "stored": 1, "-80": 1, "\u00b0": 1, "enriched": 1, "immunoprecipitation": 1, "spectrometric": 1, "customized": 1, "homogeneous": 1, "sandwich": 1, "alphalisa": 2, "immunoassays": 2, "spectrometry": 1, "n-": 2, "terminally": 2, "processed": 1, "proteolysis": 1, "pro2": 1, "leu3": 2, "gly4": 1, "pro6": 1, "gly7": 1, "pro75": 1, "arg76": 1, "termini": 1, "nonglycosylated": 1, "nonterminal": 2, "epitopes": 2, "immunoreactive": 1, "immunodetection": 1, "next": 1, "generation": 2, "avoiding": 1, "glycosylated": 1, "eccentric": 2, "concentric": 3, "cr": 2, "ch": 6, "eh": 9, "402": 2, "lvh": 4, "rwt": 4, "\u22640.42": 2, "-3.2": 1, "-5.4": 1, "-1.1": 1, "-1.5": 1, "-0.5": 1, "idealized": 1, "14.2": 1, "denotes": 1, "pathophysiologically": 1, "madit": 4, "1,790": 2, "antitachycardia": 1, "endpoints": 1, "tachyarrhythmias": 1, "253": 1, "3.4": 1, "1.1": 2, "0.64": 4, "0.48": 2, "0.009": 1, "0.80": 1, "36": 4, "nct00180271": 1, "bisphosphonates": 4, "nationwide": 2, "denmark": 1, "raloxifene": 3, "342": 1, "307.026": 1, "4.9": 1, "alendronate-": 1, "etidronate-": 1, "3.7": 1, "bisphophonates": 1, "1.41": 1, "1.07": 2, "alendronate": 4, "etidronate": 2, "analysed": 1, "refill": 2, "strata": 3, "bisphosphonate": 1, "subcellular": 1, "order": 2, "reversibility": 1, "epinephrine": 1, "sarcoplasmic": 1, "reticular": 1, "sr": 4, "ca(2+)-uptake": 1, "ca(2+)-pump": 3, "phospholamban": 2, "myofibrillar": 1, "ca(2+)-stimulated": 1, "atpase": 1, "heavy": 2, "chain": 2, "unaffected": 1, "stages": 2, "catecholamines": 1, "psoriasis": 10, "rotterdam": 2, "cvd": 2, "inconsistent": 1, "embedded": 1, "subclinical": 1, "262": 1, "uv": 1, "8,009": 1, "smoked": 1, "intima": 1, "media": 1, "1.02\u00b10.18": 1, "1.02\u00b10.16": 1, "ankle": 2, "pad": 4, "share": 1, "120": 1, "0.9": 1, "quartile": 1, "nationally": 1, "suboptimal": 3, "considerations": 1, "project": 1, "specialty": 3, "150,000": 1, "rural": 1, "south": 2, "dakota": 2, "transitions": 2, "implemented": 1, "urbanized": 1, "midwestern": 1, "extensively": 1, "reflecting": 2, "identical": 1, "fractal": 1, "scaling": 1, "exponent": 1, "somewhat": 1, "substrate": 2, "turbulence": 2, "stems": 1, "underperfusion": 1, "renin-": 1, "nephropathy": 1, "screening": 3, "ultrasonography": 1, "computed": 2, "tomographic": 1, "preferred": 1, "directed": 2, "lipid": 1, "lowering": 1, "cessation": 1, "preventive": 1, "angioplasty": 1, "ongoing": 4, "atherosclerotic": 3, "coral": 1, "concrete": 1, "unsuitable": 1, "unsuccessful": 1, "framework": 2, "individualized": 2, "plans": 1, "bioinformatic": 1, "microarray": 1, "reveals": 1, "public": 4, "discover": 1, "differentially": 3, "degs": 4, "gse9128": 1, "downloaded": 1, "omnibus": 1, "processing": 1, "carried": 1, "r.": 1, "cluster": 1, "globally": 1, "observe": 1, "interactors": 1, "osprey": 1, "overlapping": 1, "cytoscape": 1, "enrichment": 2, "david": 1, "133": 1, "programmed": 1, "telehealth": 4, "northwest": 1, "fee": 3, "service": 5, "beneficiaries": 4, "1,767": 1, "demonstration": 1, "clinics": 1, "buddy": 4, "integrates": 1, "binomial": 1, "demographic": 3, "0.74": 2, ".03": 1, "quarterly": 1, "-0.054": 1, "-0.010": 1, ".005": 1, "interactions": 1, "749": 1, "blacks": 2, "socioeconomic": 1, "whites": 1, "1.46": 1, "1.77": 1, "1.58": 1, "1.27": 1, "1.96": 1, ".5": 1, "modifiable": 1, "conceptually": 1, "side": 1, "maintain": 1, "east": 3, "randomize": 1, "3,000": 1, "cha\u2082ds\u2082vasc": 1, "mandated": 1, "nights": 1, "spent": 1, "counted": 1, "consist": 3, "bleeding": 7, "know": 1, "grown": 1, "providers": 2, "faced": 1, "managing": 3, "uncommon": 1, "housed": 1, "accustomed": 1, "asked": 1, "array": 1, "complication": 1, "topic": 1, "partner": 1, "subspecialty": 1, "europe": 2, "expectancy": 2, "called": 1, "fall": 1, "abcd": 1, "acc)/american": 1, "aha": 2, "characterised": 1, "structural": 1, "attempt": 1, "correct": 1, "ischaemia": 1, "tachy-": 1, "bradyarrhythmias": 1, "valvular": 3, "infection": 5, "potent": 1, "ca2": 1, "currents": 2, "rad": 13, "variant": 2, "influx": 1, "plateau": 1, "potentials": 1, "excitation": 1, "contraction": 1, "rgk": 3, "rem": 1, "rem2": 1, "gem": 1, "kir": 1, "monomeric": 1, "inhibit": 2, "naturally": 1, "q66p": 5, "eliminates": 1, "inhibitory": 1, "cav1.2": 2, "cav1.3": 2, "q65p": 3, "inhibits": 1, "potently": 1, "attenuates": 1, "gating": 1, "movement": 1, "substitution": 1, "impair": 1, "modes": 1, "se": 1, "mistargeting": 1, "jehovah": 2, "witness": 2, "ethically": 1, "situations": 1, "pediatrics": 1, "families": 1, "whose": 1, "religious": 1, "beliefs": 1, "preclude": 2, "provision": 2, "legal": 1, "face": 1, "decisions": 2, "ethics": 1, "rounds": 1, "complexities": 1, "overlapped": 1, "sickle": 1, "going": 1, "doctors": 2, "urgently": 1, "woman": 1, "adamantly": 1, "refuse": 1, "let": 1, "die": 1, "is": 1, "combine": 1, "empirically": 1, "pna": 4, "performers": 2, "explains": 1, "variance": 1, "n=1,203,595": 1, "n=625,595": 1, "n=1,234,299": 1, "ranked": 1, "worst": 2, "quintile": 2, "existing": 2, "explained": 2, "chosen": 1, "1.61": 1, "1.39": 2, "dying": 1, "explaining": 1, "african": 1, "aas": 10, "n=120": 1, "n=1543": 1, "aldactone": 2, "rales": 1, "aa": 2, "4.29\u00b10.5": 1, "4.55\u00b10.49": 1, "4.32\u00b10.54": 1, "4.31\u00b10.49": 1, "throughout": 1, "attain": 1, "13.9": 1, "5.8": 1, "potassium>5.5": 1, "9.7": 2, "p<0.046": 1, "hypokalemia": 2, "potassium<3.5": 1, "5.6": 2, "17.9": 1, "interaction=0.032": 1, "seemed": 1, "antioxidant": 1, "szeto": 1, "schiller": 1, "ss": 1, "ss20": 3, "proteomic": 2, "tac)-induced": 1, "ingenuity": 2, "538": 1, "mapped": 1, "actin": 3, "cytoskeleton": 2, "glycolysis": 3, "gluconeogenesis": 1, "citrate": 1, "ss31": 2, "ameliorated": 1, "damage": 1, "nonmitochondrial": 1, "amelioration": 1, "essentially": 1, "elucidates": 1, "upstream": 1, "does": 1, "skilled": 1, "six": 3, "thousand": 1, "2,101,481": 1, "claims": 1, "quasi": 1, "experiment": 1, "immediate": 1, "0.30": 1, "2.82": 1, "1.60": 1, "urinary": 1, "tract": 1, "uti": 2, "medically": 1, "managed": 2, "quintiles": 1, "cared": 2, "8.9": 1, "strongest": 2, "25.8": 1, "21.5": 1, "p<0001": 1, "finally": 1, "8982": 1, "8731": 1, "p=0.002": 1, "internists": 1, "10.6": 1, "weakest": 1, "cardiologists": 2, "6.7": 1, "p=0.485": 1, "noncardiologist": 1, "expertise": 1, "antagonism": 1, "neurohormone": 1, "electrolytes": 1, "playing": 2, "very": 1, "ephesus": 1, "tuscany": 1, "1977": 2, "603": 1, "53\u00b112": 1, "32\u00b110": 1, "fulfilling": 1, "organization": 2, "8.8\u00b16.3": 1, "subdivided": 1, "eras": 1, "1984": 1, "n=66": 1, "1985": 1, "n=102": 1, "1991": 1, "n=197": 1, "n=238": 1, "n=142": 1, "n=71": 1, "noncardiac": 1, "n=22": 1, "n=36": 1, "powerful": 2, "0.14": 1, "p<001": 2, "replicated": 1, "emphasizing": 1, "tailored": 1, "indeterminable": 1, "anaerobic": 3, "always": 1, "finding": 2, "meaning": 1, "3058": 1, "921": 1, "achievement": 1, "respiratory": 2, "quotient": 1, "\u22641.05": 1, "3.01": 1, "4.98": 1, "1935": 1, "2137": 1, "90.54": 1, "pred": 1, "hr]=0.977": 1, "ci]=0.97": 1, "ventilatory": 1, "hr=1.02": 1, "ci=1.01": 1, "hr=0.931": 1, "ci=0.87": 1, "hr=0.948": 1, "ci=0.94": 2, "hr=0.990": 1, "ci=0.98": 1, "hr=0.967": 1, "nonidentification": 2, "hr=1.41": 1, "ci=1.06": 1, "1.89": 1, "hr=1.459": 1, "ci=1.09": 1, "1.10": 1, "inability": 1, "cardiorespiratory": 2, "fitness": 2, "cooper": 1, "joint": 2, "unfit": 4, "674": 1, "1971": 1, "19.8\u00b110.4": 1, "153": 1, "3.97": 1, "overweight": 3, "3.71": 1, "upper": 1, "p<0.002": 1, "p\u22640.02": 1, "counseled": 1, "achieving": 1, "presumably": 1, "precede": 2, "hypertrophied": 1, "subjected": 3, "aac": 6, "evidenced": 1, "glucose": 4, "oxidation": 2, "translocation": 1, "lactate": 1, "fatty": 1, "acids": 1, "reality": 1, "latin": 2, "la": 9, "adequacy": 1, "delineated": 1, "website": 1, "income": 2, "capita": 3, "nondeveloped": 1, "raised": 1, "sh": 3, "fever": 2, "chagas": 1, "c'd": 4, "etiologies": 2, "alcohol": 1, "6.3": 1, "varies": 1, "awful": 1, "paradox": 1, "scenario": 1, "clcnka": 4, "polymorphism": 1, "rs10927887": 2, "p.": 1, "arg83gly": 1, "renastur": 1, "569": 1, "caucasian": 1, "snp": 2, "ka": 1, "chloride": 1, "min./1.73": 1, "cholesterol": 2, "ldl": 1, "gg": 1, "genotype": 1, "or=1.65": 1, "ci=1.04": 1, "2.62": 1, "confirmation": 1, "air": 4, "pollution": 4, "ambient": 1, "recognised": 1, "lancet": 1, "anoop": 1, "shah": 1, "colleagues": 1, "professionals": 3, "aware": 1, "urban": 2, "industrial": 1, "aggravate": 1, "enabled": 2, "mena": 10, "exacerbates": 1, "cytoskeletal": 1, "deletion": 1, "precise": 1, "tta": 5, "tgtetmena": 5, "functionally": 1, "morphologically": 1, "littermates": 1, "susceptible": 1, "turning": 1, "discovered": 1, "normalizing": 1, "eliminated": 1, "fare": 1, "eventually": 1, "spite": 1, "developments": 1, "palliative": 1, "vital": 1, "disciplines": 1, "communication": 1, "surgeons": 1, "staff": 2, "country": 2, "distributed": 1, "evenly": 1, "equitable": 1, "access": 2, "referrals": 1, "strengthen": 1, "connection": 1, "certified": 1, "raise": 1, "awareness": 2, "turkey": 1, "saxagliptin": 9, "sitagliptin": 9, "antihyperglycemic": 3, "postmarketing": 1, "hhf": 4, "dipeptidyl": 1, "peptidase-4": 1, "dpp-4": 2, "creating": 1, "uncertainty": 1, "user": 2, "partners": 1, "u.s.": 1, "mini": 1, "sentinel": 1, "pioglitazone": 3, "sulfonylureas": 3, "products": 1, "402.x1": 1, "404.x1": 1, "404.x3": 1, "428.xx": 1, "553": 1, "298": 1, "pairwise": 1, "drs)-stratified": 1, "0.47": 1, "drs": 2, "limitation": 1, "residual": 1, "confounding": 1, "introduction": 1, "cpg": 3, "conduct": 2, "outweigh": 1, "healthstar": 1, "campbell": 1, "joanna": 1, "briggs": 1, "institute": 1, "reviews": 1, "dissemination": 2, "centres": 1, "extract": 1, "duplicate": 1, "classify": 2, "provider": 1, "organisation": 2, "eg": 1, "decision": 1, "incentives": 1, "cpgs": 2, "elements": 1, "redesign": 1, "synthesise": 1, "narratively": 1, "succeed": 1, "fail": 1, "disseminate": 1, "briefing": 1, "publications": 1, "presentations": 1, "perceptions": 1, "deactivation": 9, "discussions": 5, "qualitative": 1, "grounded": 1, "theory": 1, "collect": 1, "interview": 1, "toronto": 1, "predominately": 1, "felt": 1, "mind": 1, "communicate": 2, "wished": 1, "said": 1, "consider": 1, "undecided": 1, "adamant": 1, "turn": 1, "implant": 1, "distressing": 1, "comment": 1, "bat": 6, "centrally": 1, "outflow": 1, "gdmt": 4, "system-": 1, "neurological": 2, "hall": 1, "97.2": 1, "91.4": 1, "59.6": 1, "13.2": 1, "17.4": 1, "ranking": 1, "0.08": 1, "cpet": 3, "prescribe": 1, "china": 1, "\u03b450%w": 1, "intensity": 2, "w": 2, "x12": 1, "w.": 1, "before": 1, "394": 1, "470": 1, "nosignificant": 1, "p>0.05": 1, "guiding": 1, "uk": 1, "completely": 1, "axis": 2, "subtle": 1, "nonspecific": 1, "breathlessness": 1, "fatigue": 1, "thorough": 1, "lying": 1, "auscultation": 1, "jugular": 1, "oedema": 1, "regular": 1, "hyperlipidaemia": 1, "senescence": 1, "malignancies": 1, "prostate": 1, "colon": 1, "osteoporosis": 1, "dementia": 1, "regularly": 1, "volumes": 1, "confer": 1, "athletes": 5, "with.estimates": 1, "50,000": 1, "200,000": 1, "hereditary": 1, "nontraumatic": 1, "sport": 1, "middle": 1, "recreational": 1, "males": 1, "esc": 1, "advocate": 1, "accessory": 1, "ion": 1, "channelopathies": 1, "overwhelming": 1, "robot": 3, "gait": 2, "lokomat": 2, "trainings": 1, "limbs": 1, "quadriceps": 2, "+233": 1, "733": 1, "hscrp": 3, "il6": 2, "il": 1, "+0.5": 1, "+0.2": 1, "6.5": 1, "feedback": 1, "psychosocial": 2, "barriers": 6, "2279": 1, "97.8": 1, "surveys": 1, "psss": 5, "btes": 7, "r=": 2, "r=-0.11": 1, "r=-0.12": 1, "p<0.005": 1, "corresponded": 1, "implement": 1, "arguments": 1, "hypo": 1, "gas": 1, "participated": 1, "aiming": 1, "achieve": 2, "hr<70": 2, "bpm": 5, "value=0.631": 1, "17\u00b122": 1, "4\u00b115": 1, "value=0.027": 1, "17.5\u00b15.5": 1, "14.4\u00b13.3": 1, "value=0.038": 1, "2.0\u00b13.2": 1, "1.2\u00b17.7": 1, "value=0.033": 1, "unidirectional": 1, "interatrial": 3, "shunting": 2, "proof": 2, "\u226518": 1, "shunt": 3, "implants": 1, "transseptal": 1, "catheterisation": 1, "transoesophageal": 2, "guidance": 1, "anaesthesia": 1, "oct": 1, "2015": 1, "procedural": 1, "shunts": 1, "patent": 1, "thrombosis": 2, "migration": 1, "p=0\u00b70004": 1, "duke": 1, "6\u00b72": 1, "24\u00b78": 1, "12\u00b79": 1, "p=0\u00b7016": 2, "44\u00b73": 1, "9\u00b78": 1, "79\u00b71": 1, "13\u00b70": 1, "p=0\u00b70001": 1, "244": 1, "112": 1, "318": 1, "p=0\u00b7035": 1, "incessant": 1, "storm": 1, "warranted": 1, "paradigm": 4, "arni": 3, "hopeful": 1, "at1": 1, "blocks": 1, "aldosteron": 1, "concurrently": 1, "natural": 1, "vasodilatory": 1, "8000": 1, "stabilized": 1, "sacubiltril": 1, "hypotension": 1, "interrupt": 1, "czech": 1, "republic": 1, "congratulated": 1, "thanked": 1, "caloric": 3, "more": 1, "persons": 1, "determinant": 1, "qol": 4, "factorial": 1, "february": 1, "november": 1, "2014": 1, "academic": 1, "577": 1, "initially": 1, "screened": 1, "67": 1, "39.3": 1, "366": 1, "consisted": 1, "calls": 1, "mlhf": 3, "105": 1, "attendance": 1, "-1": 1, "-8": 1, ".70": 1, "-6": 1, "-12": 1, ".08": 1, ".003": 1, "thigh": 1, "intermuscular": 1, "0.27": 1, "magnetically": 4, "levitated": 4, "lvas": 5, "centrifugal": 2, "hemocompatibility": 1, "rotor": 1, "paths": 1, "artificial": 1, "intermacs": 1, "interagency": 1, "mechanically": 1, "support)-derived": 1, "inotrope": 1, "listed": 1, "exceeded": 1, "seattle": 3, "0.0093": 1, "reoperation": 1, "debilitating": 2, "modified": 2, "rankin": 1, "exchanges": 1, "malfunctions": 1, "hemolysis": 1, "sustained": 1, "projecting": 1, "extrapolating": 1, "valuable": 1, "generate": 2, "projections": 2, "modeled": 1, "designs": 1, "hypothetical": 1, "simulations": 2, "10,000": 1, "virtual": 1, "inputs": 1, "external": 1, "replicating": 1, "scenarios": 1, "functioning": 1, "researchers": 1, "upcoming": 1, "understand": 1, "deter": 1, "such": 1, "optimize": 1}}